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ABSTRACT 
Scott T. Devine 
The Identification And Validation Of Neural Tube Defects In The General Practice 
Research Database 
(Under the direction of Dr. Suzanne West) 
 
Background: Our objectives were to develop an algorithm for the identification of 
pregnancies in the General Practice Research Database (GPRD) that could be used to study 
birth outcomes and pregnancy and to determine if the GPRD could be used to identify cases 
of neural tube defects (NTDs).   
Methods: We constructed a pregnancy identification algorithm to identify pregnancies in 15 
to 45 year old women between January 1, 1987 and September 14, 2004. The algorithm was 
evaluated for accuracy through a series of alternate analyses and reviews of electronic 
records. We then created electronic case definitions of anencephaly, encephalocele, 
meningocele and spina bifida and used them to identify potential NTD cases. We validated 
cases by querying general practitioners (GPs) via questionnaire.  
Results: We analyzed 98,922,326 records from 980,474 individuals and identified 255,400 
women who had a total of 374,878 pregnancies.   There were 271,613 full-term live births, 
2,106 pre- or post-term births, 1,191 multi-fetus deliveries, 55,614 spontaneous abortions or 
miscarriages, 43,264 elective terminations, 7 stillbirths in combination with a live birth, and 
1,083 stillbirths or fetal deaths.  A marker of pregnancy care was identifiable for 330,153 
pregnancies, eighty-four percent of which had data available at least 180 days prior to the 
first marker of pregnancy care. From the same population of 980,474 individuals, 217 NTD 
cases were identified.  We attempted to validate all 217 NTD cases and 165 GP 
 - iv- 
questionnaires were returned. We validated a NTD diagnosis for 117 cases, giving our 
electronic case definitions a positive predictive value of 0.71. The positive predictive value 
varied by NTD type: 0.81 for anencephaly, 0.83 for cephalocele, 0.64 for meningocele, and 
0.47 for spina bifida.  
Conclusions: We were successful in identifying a large number of pregnancies in the GPRD.  
Our use of a hierarchical approach to identify pregnancy outcomes builds upon the methods 
suggested in previous work, while implementing additional steps to minimize potential 
misclassification of pregnancy outcomes. Our NTD identification algorithm was useful in 
identifying three of the four types of NTDs studied.  Additional information is necessary to 
accurately identify cases of spina bifida. 
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I. INTRODUCTION 
 
 The purpose of this study is to develop methods for use in a comprehensive electronic 
medical records system that can identify neural tube defects (NTDs) for future 
epidemiologic study. We use The General Practice Research Database (GPRD) to 
develop these methods.  The GPRD is a large electronic medical record system use by 
general practitioners in the United Kingdom. Using this data, in combination with a 
specially designed General Practitioner (GP) questionnaire, we have developed and 
validated operational case definitions for the identification of NTDs.  
 In addition to this introduction, there are five primary chapters to this dissertation.  
We begin with Chapter II: a review of the literature.  This review introduces the current 
state of knowledge on the biology of NTDs, the known risk factors and known 
relationships between medications and NTDs, the current clinical practice for the 
identification of neural tube defects, and the current prevalence and means of monitoring 
for NTDs in the United Kingdom. Finally, we introduce the GPRD and discuss some of 
the previous birth defect and pregnancy identification research using the data.   
 Chapter III discusses the specific aims for this dissertation.  We introduce our 
working hypothesis and propose several specific aims meant to address these research 
questions.   Chapter IV provides a detailed description of the methods used in this 
research.  After an overview and discussion of the data used, we describe in detail the 
procedures used for the identification of pregnancies and neural tube defects. We end our 
discussion of methods with a description of the analyses used to assess the procedures. 
 Chapter V discusses the results of this dissertation.  Results are divided into three 
sections: 1) The identification of pregnancies within the GPRD, 2) the identification and 
validation of NTDs within the GPRD and 3) the discussion of several additional analyses 
conducted beyond the primary results for the pregnancy and NTD identification 
procedures.  Chapter VI concludes this dissertation with a discussion of the conclusions 
drawn upon completion of this project and the future directions necessary to continue this 
work.      
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II. REVIEW OF THE LITERATURE 
A. Neural Tube Defects  
1. Biology 
 
NTDs are a group of severe central nervous system abnormalities that occur during early 
embryonic development when the neural tube fails to close. The neural tube is an epithelial 
tube formed from the neuroectoderm of the early embryo by the closure of the neural groove.  
Through cell proliferation and organization, the neural tube develops into the central nervous 
system.
1
 The neurulation process (neural tube closure) requires 10 days to complete and 
occurs during the 3
rd
 to 4
th
 week post-fertilization.
2, 3
 Neural tube formation and neurulation 
are the most complex phases of embryogenesis involving both extrinsic and intrinsic forces.
2
 
These forces work together in the elevation and support of the neural plate, which then leads 
to the folding and closure of the neural tube.
2
  
Extrinsic forces involve cell structures and tissues outside of the neural plate.  Defects 
can occur in the neural tube when there is disruption of these extrinsic forces during initial 
stages of neural plate elevation, or abnormal cell proliferation or inhibition of cell surface 
glycoproteins of the neural and non-neural ectoderm.
2
 Intrinsic forces include the forces 
occurring within the neural plate itself.  Cytoskeletal elements, such as microtubules, actin 
microfilaments and actin-binding proteins, are important during the process of transformation 
of the neural plate epithelium.
2
 Disruption in these cytoskeletal elements has been shown to 
cause severe NTDs in chicks and rodents.
4, 5
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The final stages of neural tube closure, particularly the actual site on the neural tube 
where closure is initiated, remain controversial.
2
 Neural tube closure may occur following the 
pattern of the mouse neural tube, whereby the tube closes in a zipper like fashion from the 
cervical region to the posterior neuropore.
6
 Alternatively, neural tube closure may be more 
similar to that of a chick, which closes at two initiation sites, a cervical site and a rostral 
forebrain site.
7
 This controversy is partly due to the fact that mechanisms of closure and the 
shape of the neural tube differ in different anatomic regions.  Defects in different regions 
may be the result of teratogenic agents that affect different mechanisms at a particular site 
during the closure process.
2
 These delicate processes are of particular interest to researchers 
as they occur during a period of time that a woman may not know she is pregnant, which 
may present a critical window of exposure for medications to inflict damage to the growing 
fetus. 
2. The Role Of Folic Acid 
 
In mammals, folate is an essential nutrient for cell function, division and differentiation.
8
 
Folate is an important substrate in the formation of adenosine, guanine, and methionine 
synthesis via homocysteine and serine and glycine interconversion.  Adenosine, guanine and 
methionine are involved in basic processes of cell formation and division, including 
neurulation. There has been evidence of a relationship between folic acid deficiency and 
malformations dating back to the middle of the 20
th
 century.  After early work in animal 
models,
9
 the potent folic acid antagonist, aminopterin, was administered as an abortifacient 
between 22 and 62 days of gestation.
10
 Spontaneous abortions resulted in 10 of the 12 cases.  
In two surgically induced abortions various malformations including cleft palate and 
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hydrocephalus were seen.    In a follow-up series of these 12 women that received 
aminopterin early in pregnancy, one child with anencephaly was delivered.
11, 12
   These early 
observations were the first evidence that chemical exposure to an embryo could result in a 
malformation and provided early insight into folic acids role in neurulation.
12
   
There are a number of ways folate deficiencies can develop including inadequate dietary 
intake, malabsorption, altered metabolism and increased elimination.
8
 Proposed mechanisms 
for folic acid’s role in the prevention of NTDs focus on overcoming these folate deficiencies 
as well as decreasing the risks associated with genetic predisposition or metabolic 
disturbances.  Increased requirements, poor absorption or inadequate conversion of folate in 
women with genetic predispositions for NTD have all been hypothesized as mechanisms for 
the beneficial effect of folate in decreasing NTDs.
8, 13-15
  The ability of folic acid to surmount 
metabolic disturbances of folate regulated metabolic pathways, primarily those involved in 
the methylation process, has been demonstrated in a number studies.
16-18
 Impaired 
methylation can cause errors in DNA synthesis and receptor molecule formation.
8
 
Homocysteine metabolism is inter-related with folate status through the activities of 5-
methyltetrahydrofolate, methionine synthase and the conversion of homocysteine to 
methionine.
8
 Levels of homocysteine have been shown to be elevated in women who gave 
birth to children with NTDs.
19, 20
  There are several possible disturbances in homocysteine 
and folate metabolism that may lead to NTDs.  Defects in enzymes involved in the 
remethylation and transsulphuration of homocysteine can lead to elevated levels of 
homocysteine.  While common errors in transsulphuration do not appear to be associated 
with NTDs,
21
  disturbances in remethylation do appear to have a relationship with the 
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occurrence of NTDs.
20, 22
  Although still unclear, additional folate intake by the mother may 
be enough to overcome elevated levels of homocysteine leading to a decrease in NTDs. 
Clinical evidence for the role of folic acid in primary and secondary prevention dates 
back to the 1960’s with some of the first work being done on the relationship between 
multivitamin use and congenital abnormalities.
23
 Early theories focused on poor general 
nutritional being the cause of NTDs.   The hypothesis that multivitamin supplementation 
(containing folic acid) prior to conception could decrease the number of central nervous 
system defects was tested by the work of Smithells et al.
24
 The authors found that in a 
secondary prevention cohort of mothers who were given the multivitamin supplement had 
fewer subsequently affected newborns than mothers who were not given a multivitamin (0.6 
versus 5.0 percent).  Although this study had several methodological flaws,
25, 26
 it provided 
important rationale to pursue data  through randomized controlled trials.   
Shortly after the Smithells study was published, Laurence et al published a double-blind 
randomized controlled trial of secondary prevention of NTDs with folate treatment.
27
 The 
treatment group was given 2 mg of folic acid twice daily pre-conceptually.   In these high 
risk women, the group on folic acid had no NTDs in 44 pregnancies, while the control group 
had four in 51.
12
 Poor compliance and possible misclassification of outcomes left questions 
as to the differences in impact of folic acid and placebo.
12
 
Many of the shortcomings of these studies were meant to be addressed in the Medical 
Research Council Trial.
28
 This randomized, multi-center, placebo controlled trial allocated 
1817 women with a previous NTD pregnancy to either folic acid, a multivitamin, both or 
placebo.  Of 1195 pregnancies from this group, 6 of the 593 on folic acid had a NTD, while 
21 of 602 in the other groups had a NTD yielding a relative risk of 0.28 (95% CI: 0.12 - 
 - 6- 
0.71).  Despite the criticisms of this study, including inadequate control for socioeconomic 
status, uncertainty about the diagnosis of the initial NTDs and a failure to address primary 
prevention, it was the strongest evidence to date concerning the protective nature of folic acid 
supplementation and the prevention of secondary NTDs.
12
 
The first study to address primary prevention of NTDs was conducted as part of the 
Metropolitan Atlanta Birth Defects Program.
29
 In this case-control study, women were asked 
about pre-conception vitamin use.  Of the 14 percent of women who reported pre-conception 
vitamin use, twice as many controls as cases reported that they took vitamin 
supplementation.  Criticisms of this study included the potential for recall bias, the failure to 
ascertain stillbirths in the control group, and participation differences for whites and non-
whites.
12
 However, this study did offer the first evidence that not only high-risk mothers 
could benefit from folic acid supplementation.  Werler and colleagues extended these results 
to include periconceptional folic acid exposure at differing doses.
30
 In women without a prior 
history of NTD pregnancies who used folic acid containing vitamins 28 days before and after 
their last menstrual period, the risk of NTD was 60% lower (RR=0.4, 95%CI: 0.2-0.6) than 
those who did not take folic acid.  When the dose of folic acid was 0.4mg the relative risk 
estimate was 0.3 (95% CI: 0.1-0.6).   
Several additional studies relying on patient self-report followed the Atlanta study, each 
with mixed results.  A case-control study sponsored by the NIH
31
 of women in California and 
Illinois showed no major difference in the use of multivitamins or folate containing 
supplements.  A prospective cohort study conducted in Boston
32
 showed a substantial 
decrease in the number of births with NTDs born to women using folate supplements.  
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Studies from Australia
14
, and Hungary
33
, each showed no definitive evidence of an 
association between folic acid supplementation and primary prevention of NTDs.   
 In an attempt to summarize these data, Lumley et al conducted a systematic review of 
the literature to assess the effects of increased consumption of folate on the prevalence of 
NTDs.
34
 The authors identified four studies that met their inclusion criteria.
27, 28, 33, 35
 Pre-
conceptual folate supplementation reduced the incidence of NTDs by 72 percent (relative risk 
0.28, 95% CI: 0.13 to 0.58).  The primary and secondary prevention of NTDs with folate 
supplementation was associated with a 93 percent reduction (relative risk 0.07, 95% 
confidence interval 0.00 to 1.32) and a 69 percent reduction (relative risk 0.31, 95% CI: 0.14 
to 0.66) respectively.   
3. Genetic Risk Factors 
 
NTDs are thought to have both genetic and environmental determinants.  Single gene 
mutations and chromosomal abnormalities are associated with various NTDs. It is difficult to 
determine what proportion of NTDs is due to these genetic causes or a combination of 
environmental and genetic causes.  In several studies, the proportion of fetuses with NTDs 
that had chromosomal abnormalities ranged from 0 to 100 percent although not all studies 
included spontaneous abortuses, stillborn and live born births.
36-39
 Autosomal recessive 
disorders such as Meckel-Gruber syndrome and Walker-Warburg syndrome are associated 
with encepholoceles.
40
 Trisomy 13 and 18 syndromes are also associated with anencephaly, 
meningomyelocele and microencephaly (abnormal smallness of the brain).
40
 Pregnancies 
with these syndromes may be classified separately, as it is suspected that the etiology of the 
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NTDs in these cases are mostly genetic in origin.
41
 These cases may constitute a base NTD 
prevalence. 
Even in non-syndromal NTDs, there is evidence that genetic components are important.
8
 
There are sex differences in the birth prevalence of certain NTDs.
42
 The sex distribution of 
spina bifida is closer to birth proportions in most countries, with a slight female 
predominance.
43
 There is also a reported excess of live born females with anencephaly, 
however, it is unknown if this is actually a favoring of females, or selective loss of males 
prior to birth.
44, 45
  Khoury et al evaluated data from the US national Birth Defects 
Monitoring Program (1970-1978) and the Metropolitan Atlanta Congenital Defects Program 
(1968-1979), and found that there was a female predominance among anencephaly and spina 
bifida in cases of single NTDs.
46
 Hypotheses proposed to explain these sex distributions 
include: 1) sex related differences in the rate of spontaneous abortions; 2) sex differences in 
the process of early development of the embryo; 3) sex differences in susceptibility to 
teratogens; and 4) genetic factors.
42, 43
 
Studies of affected siblings have provided evidence for genetic risk factors.  Elwood et al 
estimated that the risk triples with each subsequent NTD-affected pregnancy after the first.
43
 
Janerich and Piper conducted a review of New York State birth records looking at the 
recurrence frequency of anencephaly and spina bifida in siblings of initial cases with 
anencephaly or spina bifida.
47
 While the percentage of siblings of initial cases with 
anencephaly or spina bifida was 1.8 percent, concordant twin pairs had a recurrence risk of 
6.8 percent, indicating a genetic component.  First, second and third-degree relatives of initial 
cases with NTDs also appear to be at higher risk.  In a study of spina bifida and anencephaly, 
Toriello and Higgins contacted parents’ groups and genetic clinics to identify cases and seek 
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information about other affected family members.
48
 The occurrence of a NTD in first-degree 
relatives was 3.2 percent, second-degree relatives were 0.5 percent and it was 0.17 percent in 
third degree relatives.  There is an increased prevalence of NTDs when the parents are 
related.  In a 1966 WHO study by Stevenson et al, the rates of NTDs in consanguineous 
versus non-consanguineous marriages were 14.2 versus 5.7 per thousand total births 
respectively, further adding to the evidence of a genetic component to NTD occurrence.
44, 49
   
4. Maternal Factors 
 
There are several maternal factors that appear to affect NTD prevalence. Ethnic 
differences in the occurrence of NTDs are evident.  Ethnicity as a risk factor was first 
introduced to help explain the variability in prevalence of NTDs in the British Isles.
41
 In the 
US, the risk among African Americans is low, while the risk among Hispanics, even after 
controlling for diabetes and obesity, is high.
50, 51
  Maternal age appears to have only a minor 
affect on the risk of NTD.
41
 When an association has been found, it appears to be in those 
mothers under 20 and over 35.
44
 Parity may have a stronger effect than maternal age, with a 
“modest risk in mothers of parity three or more”,
43
 however, other markers of maternal 
fertility and the use of treatments for infertility do not appear to be associated with increased 
risk.
41, 52
   
Studies in Texas and California produced different results regarding the relationship 
between previous pregnancy terminations and NTDs. In a case-control study of Hispanics in 
Texas, Canfield et al. determined that women with a previous pregnancy termination had a 
risk of anencephaly that was 2.4 (95 % CI: 1.2-4.8) times as high as those who did not have a 
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previous pregnancy termination.
50
 Todoroff and Shaw, in a study of prior spontaneous or 
elective abortions, found a slightly decreased risk of NTDs.
53
    
Obesity has been shown to increase the risk of NTD in several studies.
51, 54, 55
 Shaw and 
colleagues investigated this risk using the data from a population-based case-control study 
with cases identified from the California Birth Defects Monitoring Program.
51
 Women in the 
highest pre-pregnancy weight group (pre-pregnancy weight of >100kg) had an increased risk 
of having a child with a NTD (RR=2.1; 95% CI: 0.8 to 5.8) compared to those whose weight 
was between 48 and 77 kg.  Watkins et al conducted a similar study using data from the 
Metropolitan Atlanta Birth Defects Case-Control Study.
54
 Obese women had an increased 
risk 1.9 (95% CI: 1.1-3.4) times as high as average-weight women to give birth to an infant 
with a NTD.   
Because many obese women also have type II diabetes, Hendricks et al tried to establish 
if obesity or underlying hyperinsulinemia was associated with an increased risk of NTD.
56
 
They found that the presence of hyperinsulinemia and obesity yielded an odds ratio of 1.9 
(95% CI: 1.2-3.0) compared to the absence of these two factors. Hyperinsulinemia adjusted 
for obesity had a similar effect with an odds ratio of 1.8 (95% CI: 1.1-2.8).  Obesity adjusted 
for hyperinsulinemia had a more modest impact with an odds ratio of 1.4 (95% CI: 0.8-2.5). 
Several maternal illnesses including “flu” or “cold” syndromes, and febrile illnesses have 
been associated with increased risk of NTDs.  In a study of records from the Finnish Register 
of Congenital Malformations, Kurppa et al assessed the association between reported first 
trimester maternal cold and anencephaly.
57
 In a case-control study of 393 mother-child pairs, 
70 mothers with an anencephaly-affected child versus 17 control mothers reported a common 
cold with or without a fever in the first trimester (adjusted OR 4.5, 95% CI: 2.2-9.1).  When 
 - 11- 
those without a fever were excluded, the result was similar but less precise (adjusted OR 4.7, 
95% CI: 1.0-22.5).   
Lynberg et al, using the Atlanta Birth Defects Case-Control Study data, evaluated the 
association between NTDs and maternal exposure to flu, fever and medications taken for 
illness.
58
 For mothers who reported episodes of flu with fever that lasted 2 or more days in 
the time period from 1 month prior to 3 months post-conception, the risk of any NTD was 3.0 
(95 percent CI: 1.9-4.7) times as high as the risk of any NTD in those mothers without an 
episode.  The risk of NTD when the mother had flu without fever prior to or after conception 
was 2.0 (95% CI: 1.1-4.0) times as high as the risk in those who did not have the flu.  The 
risk of NTD for women who took medications for their flu episode was 4.3 (95% CI: 2.6-7.1) 
times as high as the risk of NTD for women who did not take medications for the flu episode.  
Shaw et al, using the California Birth Defects Monitoring Program data, evaluated the impact 
of a variety of maternal illnesses on NTD occurrence.
59
 While still finding an association 
between fever (OR 1.99, 95 percent CI: 1.37-2.90) or febrile illness (OR 1.99, 95 percent CI: 
1.12-3.46) and NTDs, they failed to find the strong association between medication use and 
NTD occurrence.  
5. Medications 
 
 While the mechanism for medication induced NTDs are primarily unknown, those 
that affect folic acid activity have been shown to be associated with an increase risk for 
NTDs.  There are a variety of pharmacodynamic mechanisms that medications can make use 
of that can have this effect.  Medications that can antagonize the effects of folic acid within 
the body include pyrimethamine, trimethoprim, trimetrexate, triamterene, and sulfasalazine 
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because they inhibit dihydrofolate reductase producing antifolate effects.
60
 Aminopterin and 
methotrexate, antineoplastic agents, are potent folic acid antagonists and are known 
teratogens.
61
 As mentioned above in the section on folic acid, aminopterin’s effects were 
identified in early work on folic acid’s role in neural tube formation.
10
 By blocking the 
conversion of folic acid to tetrahydrofolic acid, these agents can limit the formation of 
important amino acids involved in cell formation.  
A medication or its metabolite can also affect folic acid activity by impairing absorption 
or altering hepatic metabolism.
62-64
 Colchicine, a common medication for gout, reduces blood 
folate concentrations through an unknown mechanism.
65
 Cycloserine combined with 
isoniazid for the treatment of tuberculosis results in lower serum folate levels compared with 
isoniazid alone.
66
 Oral contraceptives have also been shown to lower folate concentrations.
66
 
Colchicine, cycloserine, isoniazid and oral contraceptives have not been associated with 
NTDs.   
Several antiepileptic medications have been shown to increase the risk of NTDs.  
Phenytoin reduces folic acid levels by affecting several enzymes involved in the metabolism 
of folic acid or tetrahydrofolic acid.
67-69
 In a small study of multiple antiepileptic agents, 
phenytoin use was associated with a case of anencephaly.
62
 Carbamazepine has been shown 
to reduce serum folate levels by interfering with folate metabolism.
70
 Calandre et al found 
that serum folate levels were lower in patients with higher serum carbamazepine levels.    
Carbamazepine has been associated with spina bifida.  In a review of literature, Rosa found a 
1% incidence of spina bifida associated with carbamazepine treatment.
71
 Valproic acid 
inhibits the metabolism of folic acid decreasing serum folic acid levels.  Valproic acid is also 
linked to spina bifida.  Rosa reported a 1 to 2 percent risk of spina bifida associated with 
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maternal valproic acid use.
71
 Combinations of these medications are also associated with 
higher rates of birth defects.  Lindhout found that pregnancies of women using 
carbamazepine, valproic acid and phenobarbital (a barbiturate often used as for epilepsy) 
with or without phenytoin resulted in a birth defect 58 percent of the time.
72
   
6. Other Risk Factors 
 
A variety of other risk factors have also been identified.  Dietary, occupational and other 
exposures have been examined as possible risk factors for NTDs.  Tea use,
73
 lead exposure
74
 
and high levels of organic matter in drinking water
75
 have been associated with increased 
NTD occurrence.  Some occupations with exposure to industrial chemicals and/or pesticides 
have been associated with increased risk of NTDs.
76-80
 Parental socioeconomic status has 
been associated with differing rates of NTDs, but contrary evidence leaves it a weak 
predictor of risk.
41
 
B. Clinical Definitions 
 
The NTDs of interest in this study are anencephaly, craniorachischisis, encephalocele, 
encephalomyelocele, meningocele and spina bifida. The clinical definitions for each of 
these conditions are presented below.  There are multiple reasons for choosing the 
specific malformations to be studied in this project.  The primary determinant is that 
these are the most commonly occurring NTDs in the United Kingdom (UK).  These 
malformations, while relatively uncommon, carry a substantial burden in terms of 
morbidity and mortality of the affected offspring.   They also occur in sufficient numbers 
for us to develop a monitoring system in the GPRD.  
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Additionally, these malformations have clear clinical definitions that decrease the 
likelihood of misdiagnosis.   The potential does exist that some of the malformations 
could be misclassified within a category of NTD (i.e. a meningocele is incorrectly 
diagnosed as a spina bifida) however; this will not impact our primary results of total 
NTDs.   
The ultimate goal of this research is to provide validated case definitions identifying 
new NTD cases and to further research of medications as risk factors.  We are thus 
interested in conditions that have unknown etiologies, not genetic syndromes.  Although 
some of these malformations do occur with certain genetic syndromes, none have a 
syndrome as their sole cause.  
1. Anencephaly 
 
Anencephaly is the complete or partial absence of all or part of the brain, neurocranium 
and the covering skin.
40, 45, 81
 When the cephalic neural tube fails to close, brain protrudes and 
subsequently degenerates.  Holo-anencephaly, or the complete absence of the brain, accounts 
for 65 percent of cases in the US, with the remainder being cases of mero-anencephaly, or 
partial absence of the brain.
82
 Because of the extreme nature of this disorder, anencephaly is 
readily apparent at birth.  In cases of anencephaly the failure of the cephalic neural tube 
closure occurs on or about the 24
th
 day post fertilization.
45
 The diagnosis of anencephaly can 
occur upon routine obstetric ultrasound, generally based upon a coronal view that reveals the 
absence of the brain.  A diagnosis can be made as early as 11 weeks;
83
 however an 
anencephalic fetus can also resemble a normal brain before 14 to 15 weeks of gestation.
45
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Craniorachischisis is similar to anencephaly in that the fetus is absent a developed brain, 
and is associated with a contiguous spina bifida.
45, 81, 84
  The cervical spine is retroflexed to 
the point that the head is set gazing upward.
45
 Craniorachischisis is often misdiagnosed as 
iniencephaly, which is characterized by a closed cranium, enlarged foramen magnum as well 
as a retroflexed spine with upward gaze.
81
 Cases of holo-anencephaly are associated with 
craniorachischisis about 80 percent of the time.
82
 Diagnosis of craniorachischisis is similar to 
that of anencephaly, occurring upon routine obstetric ultrasound at or after 14 to 15 weeks of 
gestation.   
The prognosis for the infant with anencephaly or craniorachischisis is uniformly fatal, 
with a live born infant dying within hours to days after birth.
45, 85, 86
  Postnatal care is 
supportive only, and generally not indicated.  Prior to advances in prenatal diagnosis, the 
ratio of stillbirth to live birth was approximately 50 percent.
82
 Between 1985 and 2000 in a 
cohort of 171 cases of anencephaly in Utah, approximately 66 percent of all anencephaly 
cases were terminated prior to delivery.
87
  
2. Encephalocele 
 
Cephaloceles are a group of anomalies due to a congenital defect of the skull resulting in 
a skin covered herniation of the brain (encephalocele), brain and spinal cord 
(encephalomyelocele) or a non-brain containing sac (cranial meningocele).
45, 81
  Most 
cephaloceles occur along the midline of the cranium with lesions occurring in the occipital 
region 74 percent of the time.
45, 88, 89
  Encephaloceles can have varying degrees of severity 
with approximately 50 percent of infants with encephaloceles having additional congenital 
defects.
90
 Cephaloceles range in size from very small to larger than the head.
45
 Because 
 - 16- 
cephaloceles are skin covered, alpha-fetoprotein (AFP) levels are generally not elevated, thus 
most cases are identified from prenatal ultrasounds in low risk populations.
45
 The differential 
diagnosis of cephalocele should include cystic hygroma, scalp edema, blebs, a normal ear, 
brachial cleft cysts, amniotic band syndrome and cloverleaf skull, not just a paracranial 
mass.
45, 91, 92
    
Prognosis is determined by the content of the lesion rather than the size, with some small 
lesions containing important brain tissue and/or signifying underlying CNS malformations.
45, 
93, 94
  Prognosis is generally best with frontoethmoidal lesions and tend to be most grave with 
rostral parietal lesions.
45
 Surgical repair is possible, and includes attempts to enlarge the 
cranial cavity to preserve cerebral tissue and its vascular supply.  However, when lesions 
contain cortex, are associated with an absent corpus callosum, or other malformations, poor 
survival and decreased intellect are often unavoidable. 
3. Spina Bifida And Meningocele 
 
Spina bifida is a defect of closure of the bones producing the spine due to failed fusion of 
the caudal portion of the neural tube.
45, 81
  This defect may be covered by normal skin in the 
case of spina bifida occulta.  It may be a protruding sac in the case of spina bifida cystica.  It 
may also result in a completely open spine, in the case of rachischisis, which is often 
incompatible with life.
1, 90
  Protrusion of neural tissue in a posterior spina bifida cystica is 
readily apparent at birth with lesions occurring in varying sizes at any location along the 
spine.  Matson et al determined the location of lesions for a group of cases and found 42.2 
percent lumbar lesions, 27.7 percent lubosacral, 9.9 percent thoracolumbar, 8.6 percent 
sacral, 7.5 percent thoracic, 3.7 percent cervical and 0.44 percent anterior.
89
 Approximately 
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90 percent of the time the protruding sac contains elements of spinal cord and/or nerves, also 
known as meningomyelocele.
45
 The remaining cases of spina bifida are considered 
meningoceles.    
Meningocele, a form of spina bifida, occurs when a defect in the closure of vertebral 
bones results in a protruding fluid filled sac containing abnormal meninges and cerebral 
spinal fluid.
45
 The underlying spinal cord is usually intact; however, it may also protrude into 
the sac, although not to the extent of a meningomyelocele.  Normal skin usually covers the 
sac.  To distinguish this malformation from meningomyelocele, the sac should be 
transilluminated or undergo magnetic resonance imaging at birth.  Meningoceles are often 
asymptomatic at birth, however it may be associated with serious co-morbidities including 
diastematomyelia (a division of the spinal cord) and various tumors.
45, 95
   
Cases of spina bifida are often difficult to diagnosis using direct sonographic 
visualization.  The sensitivity and specificity of these scans vary depending on the underlying 
risk of the population.
96
 Indirect methods of visualization have been developed to help make 
sonographic diagnoses.  Infants with spina bifida who undergo ultrasound at 24 weeks of 
gestation frequently have a bilateral, concave, frontal contour of the cranium (the lemon sign) 
and cerebellar hemispheres with anterior curves with loss of the cisterna magna (the banana 
sign).
45
 These signs have been shown in a large cohort of high risk pregnancies to have 
positive and negative predictive values of 92 percent and 99.8 percent for the lemon sign and 
100 percent and 99.7 percent for cerebellar anomalies for the banana sign.
97
 
Prognosis for patients with spina bifida is variable.  Significant morbidity and mortality 
often depends on the severity and location of the lesion. Approximately 90 percent of infants 
with spina bifida are live births, and those without other life-threatening malformations 
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typically experience very high survival rates once beyond the first year of life.
45
 Loss of renal 
function and shunt complications are the usual causes of death in older patients but many 
patients can lead relatively normal lives.
90
 Population based data from British Columbia 
found 1, 5 and 10 year survival to be 67, 65 and 64 percent respectively.
98
 Treatment with 
primary closure of the lesion has been reported to increase long term survival rates in some 
cohorts, while having only marginal impact in others.
45, 99-102
  
C. Prenatal Diagnostic And/Or Screening Tests:  
1. Alpha-fetoprotein 
 
The primary method for screening for NTDs is testing for the presence of alpha-
fetoprotein (AFP) in maternal serum.  AFP is the principal fetal plasma protein early in 
gestation and remains so until the fetal liver matures and albumin becomes the primary 
plasma protein.
103
 Amniotic fluid AFP (see below) passes through the placental barrier into 
the maternal circulation and levels are measurable early in the first trimester.  When a fetus 
has an open neural tube lesion, high concentrations of AFP build up in amniotic fluid 
subsequently leading to increased maternal serum concentrations.
103, 104
     
Maternal serum AFP (MSAFP) levels rise through the first and second trimesters of 
gestation in unaffected pregnancies, so gestational age must be considered when interpreting 
results.
104
 MSAFP for prenatal screening purposes should be performed between the 15
th
 and 
20
th
 weeks of gestation and results should be expressed in multiples of the median (MoM) for 
gestational age.
103
 A result of 2.5 MoM in single gestations and 4.5 MoM in twin gestations 
is considered elevated enough to perform additional diagnostic testing.
103
 Sensitivity of 
MSAFP screening has been determined in a number of trials, but depends on the NTD under 
evaluation.  When used to evaluate anencephaly, MSAFP has a reported sensitivity between 
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88 and 92 percent depending on the underlying risk in the population.
105, 106
  Sensitivity to 
MSAFP testing for spina bifida is lower, but depending upon the type of lesion involved, it is 
still between 64 and 76 percent.
105, 106
   
Because of the possibility of overlap of MSAFP level in affected and unaffected NTD 
cases at different gestational ages, elevated MSAFP should not be considered diagnostic.
104
 
However, elevated MSAFP levels have been shown to be highly predictive of NTDs in a 
number of trials. In a series of studies by Drugan et al, MSAFP levels of 2.5 to 2.9 MoM are 
associated with NTDs 3.4 percent of the time, while defects occurred 40.3% of the time with 
a MoM of greater than 7. 
107, 108
    Other studies indicate that level of MSAFP greater than 5 
MoM can be associated with ultrasound confirmed defects as much as 71 percent of the 
time
109
,  while levels greater than 8 MoM are most commonly associated with large structural 
defects and/or fetal death prior to 20 weeks of gestation.
110
  
The UK Collaborative AFP Study, the first major study to determine the parameters of 
association between AFP and NTDs, produced detection rates for anencephaly of 98.2 
percent and open spina bifida of 97.6 percent.
111
 False positives do occur when fetal blood 
contaminates the sample.  Fetal blood contains 100 to 200 times the AFP per milliliter that 
amniotic fluid does at a given gestational age, and will thus give false results.
104
 The 
diagnostic cut off for AFP varies by gestational age between 2.5 at 13-15 completed weeks to 
4.0 for 22-24 completed weeks.
104
   
2. Amniocentesis 
 
Amniocentesis is the collection of amniotic fluid from the amniotic sac of a developing 
fetus through an abdominal needle aspiration.
112
 This screening procedure is normally 
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performed between the 15
th
 and 20
th
 week of gestation to aide in the determination of fetal 
karyotyping.
113
 Although the procedure is extremely accurate in the screening and diagnosis 
of certain genetic disorders and NTDs, it is not without risk.  Tabor et al conducted a 
randomized controlled trial and found that the risk of spontaneous abortion after 
amniocentesis was approximately 1 percent.
114
 Roper et al found a similar cumulative fetal 
loss rate of 1.2 percent, but the rate was variable dependent upon the gestational age at 
amniocentesis.
115
 When the amniocentesis was performed before 14 weeks, the fetal loss rate 
was 1.0 percent, while the rate increased to 3.1 percent after 18 weeks of gestation.  As these 
rates are generally higher than some of the observed rates of the genetic disorders and NTDs 
that amniocentesis is meant to detect, less invasive and less risky tests are preferred in 
populations at low risk for the underlying defect.  
Amniocentesis can also be used to detect the presence of acetylcholinesterase enzymes 
(AChE) in the amniotic fluid.  While non-specific cholinesterase enzymes are present in the 
amniotic fluid, AChE are normally only found in the cerebrospinal fluid and within red blood 
cell membranes.
104
 When an open NTD occurs, AChE can be detected in the amniotic 
fluid.
116
 Between the 13
th
 and 24
th
 weeks of gestation, a group of confirmed open NTDs with 
a high amniotic fluid AFP (>99.6 percentile) had a positive amniotic fluid AChE in 99.5 
percent of cases.
117
 The Second Report of the Collaborative AChE Study recommended that 
the best policy for use of the AChE test was in the analysis of amniotic fluid samples with 
AFP results greater than 2.0 MoM.
118
 This approach was predicted to yield a true positive 
rate for open spina bifida of 96 percent and a false positive rate of 0.14 percent.
104, 118
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3. Ultrasonography 
 
Ultrasonography is considered the primary diagnostic technique for prenatal 
identification of NTDs.  This technology, first utilized in 1958, has been demonstrated to 
provide accurate diagnostic information for gestational age and fetal anomalies.
119-122
 
Prenatal ultrasonography is a complex technology which uses sound waves to produce 
images of the developing fetus.
113
 These images of the developing fetus allow the direct 
visualization of anencephaly and cephaloceles. 
45, 103, 123
 Anencephaly was the first 
malformation to be diagnosed by ultrasound.
124
 Campbell et al determined that ultrasound 
could be used between the 14
th
 and 15
th
 week of gestation to determine a diagnosis of 
anencephaly.
123, 125
    Accuracy of diagnosis of anencephaly by prenatal ultrasound has been 
shown to approach 100 percent.
105, 126, 127
   
In the case of spina bifida, direct visualization is often difficult, thus indirect visualization 
methods have been devised.
45
 Infants with spina bifida who undergo ultrasound at 24 weeks 
of gestation frequently have a bilateral, concave, frontal contour of the cranium (the lemon 
sign) and cerebellar hemispheres with anterior curves with loss of the cisterna magna (the 
banana sign).
45
 One of the first studies to confirm the utility of ultrasonography in spina 
bifida affected pregnancies was that of Nicolaides et al.
128
 The authors retrospectively 
analyzed the ultrasounds of 70 fetuses between 16 and 24 weeks of gestation that were 
diagnosed with open spina bifida lesions.  Their work confirmed the use of indirect signs, 
such as the “lemon” sign and the “banana” sign in the diagnosis of NTDs.
45
 Van den Hof et 
al were able to detect 98 percent of spina bifida cases in a cohort of 1561 high risk mothers, 
however, rates of 55 to 60 percent detection have been reported by others.
105, 129
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While the diagnostic ability of ultrasound for spina bifida may not approach that of 
anencephaly, when combined with other maternal screening approaches, diagnostic ability is 
improved.  Nadel et al showed that the use of ultrasound in mothers with elevated MSAFP 
decreased the need for amniocentesis to confirm the diagnosis of a NTD.
130
 Lennon et al 
examined a group of 2257 patients at high risk for an open NTD either because of a family 
history of NTDs or a positive MSAFP.
131
 2053 patients were given an ultrasound with 55 
NTDs occurring in this cohort.  All of the NTDs in this cohort were detected prenatally.  The 
sensitivity and specificity of ultrasound in the identification of NTDs was 97 and 100 percent 
respectively.  The positive predictive value was 100 percent and the negative predictive value 
was 99.9 percent. 
4. Current UK Guidelines For NTD Screening 
 
The Royal College of Obstetricians and Gynecologists and the National Institute for 
Clinical Excellence have proposed routine antenatal care for pregnant women.
132
 Women 
should be scheduled for between seven and ten antenatal appointments for uncomplicated 
pregnancies.  Ultrasound testing is recommended for all pregnant women between the 10
th
 
and 13
th
 week of pregnancy to determine gestational age, detect multiple pregnancies, and 
improve the performance of screening procedures for Down’s syndrome and other anomalies. 
In addition, women should be offered an additional ultrasound scan between week 18 and 20 
to detect congenital anomalies. The Guideline recommends standard screening for Down’s 
syndrome between 11 and 20 weeks of gestation through the performance of nuchal 
translucency as well as several combined tests.  The recommendations are as follows: 1) 
Gestational age from 11 to 14 weeks - Nuchal translucency (NT) or the combined test (NT, 
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hCG and PAPP-A); 2) Gestational age from 14 to 20 weeks - the triple test (hCG, AFP and 
uE3) or the quadruple test (hCG, AFP, uE3, inhibin A); 3) Gestational age from 11 to 14 
weeks and 14 to 20 weeks - the integrated test (NT, PAPP-A + hCG, AFP, uE3, inhibin A) or 
the serum-integrated test (PAPP-A + hCG, AFP, uE3, inhibin A).  The “Triple”, 
“Quadruple”, “Integrated” and “Serum-integrated” tests all incorporate tests for alpha-
fetoprotein thus also serving as a screening tool for NTDs. 
Nuchal translucency (NT) testing may have some utility in the detection of NTDs.  NT 
testing is conducted using a transvaginal ultrasound device to measure the normal 
subcutaneous space between the skin and the cervical spine in the fetus early (12
th
 to 14
th
 
week) in pregnancy.  A space less than 3 mm has been associated with increased risk for 
Down’s syndrome, 18, 13 and triploidy and Turner syndrome.
133
  As this screening 
ultrasound occurs much earlier than diagnostic ultrasounds for other abnormalities (NTDs for 
example), researchers have assessed if these early ultrasound can be used to identify other 
abnormalities. McAuliffe and colleagues determined that while NT can identify some serious 
structural abnormalities (i.e. anencephaly), the 18 to 20 week ultrasound should remain the 
gold standard.
134
 
 
D. NTD Monitoring In The UK 
 
Historically, the UK has had some of the highest recorded rates of NTDs. Prevalences of 
anencephaly and spina bifida were as high as 60/10,000 births in the 1940’s and      
1950’s.
135, 136
 Increased awareness of NTDs, folic acid supplementation and general UK 
population trends (such as increased immigration, changes in birth rate) may be related to the 
fall in NTD prevalences from those early numbers to 36/10,000 births in the 1970’s and 
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roughly 8/10,000 births in the 1990’s.
137
 Table 2.1 describes the current rates of NTDs in the    
UK.
138-141
  
 
Table 2.1 – Data for NTDs (anencephaly, all spina bifida and encephalocele) from ONS for 
the UK between 1999 and 2002.  
  1999 2000 2001 2002 Totals: 
Live Births 67 88 71 83 309 
Still Births 31 36 29 34 130 
Induced Abortions 295 331 288 255 1,169 
Total Cases 393 455 388 372 1,608 
Total Live Births & Stillbirths 624,862 607,304 597,506 599,279 2,428,951 
Prevalence/10,000 (L&S) 1.57 2.04 1.67 1.95 1.81 
 
These historically high rates of occurrence, in addition to the thalidomide tragedy of the 
1960s created the impetus within the UK for a continuous monitoring system for congenital 
anomalies.   
1. The National Congenital Anomaly System 
 
The Office of National Statistics initiated the National Congenital Anomaly System 
(NCAS) in 1964. The England and Wales National Congenital Anomaly System collects data 
from birth registries throughout the UK and reports data to the Office of National Statistics 
on a continuous basis.  Data are collected from birth notifications by local health care 
authorities in all regions of the UK using a standardized case report form that is completed 
and sent to the Office of National Statistics.   Data are collected on live and stillbirths, and 
reporting is conducted on a voluntary basis.  Some local congenital anomaly registries also 
report information to the NCAS.
141
 
Rather than attempt to estimate the prevalence of various anomalies, the goal of the 
NCAS is to detect changes in the frequency of reporting of particular anomalies or groups of 
anomalies. Although the NCAS does not produce true prevalences of any abnormality 
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because of the voluntary nature of data reporting, the reported rates may offer important 
estimates of the prevalence of these conditions. The database is a valuable tool for detecting 
possible signals for further investigation; however, increases in notification may be due to 
changes in the reporting practices rather than true changes in prevalence.   
Limitations of the data are due to the reliance on passive surveillance techniques for case 
ascertainment, lack of collection of information on spontaneous abortions and limited 
information on elective terminations of pregnancy.  Although not collected directly through 
the NCAS, data on elective terminations and their association with a potential congenital 
anomaly is available through other National Health Service data.  This data is captured and 
presented along with the data from live and stillbirths collected through the passive reporting 
system. The NCAS does collect some basic exposure information (such as mother’s and 
father’s occupation), but the data have limited utility for research on risk factors for 
congenital anomalies. 
2. The European Concerted Action On Congenital Anomalies And Twins 
 
The EUROCAT (European Concerted Action on Congenital Anomalies and Twins) 
program was set up in 1974 to monitor epidemiologic information on congenital 
anomalies.
142
 The aim of EUROCAT is to carry out epidemiologic surveillance of congenital 
anomalies in Europe.  As of 2003, data from 41 member registries from 20 countries are 
collected and transmitted to a central registry in the UK.    Eight registries from the UK are 
currently full member registries, transmitting case data on all congenital anomaly cases in 
their region.  Each member registry transmits core variables that are recorded using a 
common coding system. Biannually updated prevalence data tables for 80 congenital 
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anomaly subgroups between 1980 and 2003 are available to researchers through the 
EUROCAT website (www.eurocat.ulster.ac.uk). Core variables reported to the EUROCAT 
include date of birth, gender of fetus/infant, number of fetuses/infants delivered, type of birth 
(including spontaneous abortions), gestational age, demographic information on the mother 
and syndromal and malformation details. In EUROCAT prevalence calculations, numerators 
include cases identified from live birth, fetal deaths from 20 weeks gestation (stillbirths and 
spontaneous abortions) and induced abortions.  A baby/fetus with several anomalies is 
counted once within each class of anomaly. The number in different classes of cases cannot 
be added to reach a total number of babies/fetuses. A baby is counted once only in any given 
prevalence.  Current data on NTD prevalence with denominators including live births, fetal 
deaths and induced abortions are presented in Table 2.2. 
Table 2.2 – Data for NTDs (anencephaly, encephalocele, spina bifida and iniencephaly) from 
EUROCAT for the UK between 2000 and 2003. 
  2000 2001 2002 2003 Totals: 
Live Births 37 31 45 20 171 
Fetal Deaths (>= 20 weeks) 9 8 14 8 52 
Induced Abortions 212 207 201 134 960 
Total Cases 258 246 260 162 1183 
Total Live Births & Stillbirths 204,693 192,117 192,785 111,765 904,886 
Prevalence/10,000 12.6 12.8 13.49 14.49 13.07 
 
Produced using EUROCAT Website Database: http://eurocat.ulster.ac.uk/pubdata/report8tab.html (accessed 6/13/05) 
 
3. Differences Between NCAS And EUROCAT Systems 
 
The importance of the differences in the utility of each database for the surveillance of 
congenital anomalies should not be overlooked.  Boyd et al compared the NCAS to four of 
the UK registries that report to the EUROCAT.
143
 Isolated cases were derived from similar 
locales to the four UK registries and created a ratio of cases identified by the national register 
to those in the local registry files.  Overall, the ascertainment rate for the NCAS was 40 
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percent of the cases identified by the four registries when terminations of pregnancy were 
excluded, and 27 percent when terminations of pregnancies were included.  The lowest 
ascertainment was for NTDs, with only 11 percent ascertainment when terminations were 
included and 68 percent ascertainment when terminations were excluded. The authors note 
that although the stated goal of the NCAS is for signal monitoring, the degree to which it can 
meet this goal is hindered by the uncertainty of the magnitude of under-ascertainment.   If 
under-ascertainment is constant, signals can be detected.  If, however, it is not constant, there 
is no way of knowing if any increase in reporting is due to increased ascertainment or to a 
true increase in prevalence. 
A primary advantage of the development of a cohort population in our proposed study is 
the ability to determine various prevalence estimates. While the prevalence from the ONS 
and the EUROCAT were determined using different methodologies, they are both likely 
representative of the decline in occurrence compared to historical highs.
41, 137, 144
 The 
disparity is indicative of a number of issues with the study of NTD prevalence.  Improvement 
in folic acid use, both from supplementation and fortification of foods, has been identified as 
a cause for the decline in rates of NTDs.
33, 87, 145-152
 However, it is believed that only a portion 
of NTDs are due to folic acid deficiency, thus the decline in rates is unlikely due entirely to 
the benefits of folic acid.
12, 153
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E. The GPRD 
1. Introduction 
 
The GPRD was initiated in 1987 and is the world’s largest anonymized patient electronic 
medical records database.  The Medicines and Healthcare products Regulatory Agency 
(MHRA), formerly Medicines Control Agency (MCA), manages the GPRD in the UK.  
Approximately 35 million patient years of data representing 8.9 million unique patients 
are currently available from the database.
154
 Over 350 general practices are currently 
submitting data to the GPRD on 3 million patients or five percent of the UK 
population.
154, 155
   
The GPRD has a makeup similar to the population of the UK.  The practitioners are 
geographically dispersed, with a tendency to be part of larger rather than smaller group 
practices. The age distribution of the GPRD is similar to the UK’s distribution and is reported 
in Table 3.  Race within the GPRD is similar to that of the UK population.  In 2001 the UK 
population was predominantly white (92.1 percent of the total population) with Asian or 
Asian British representing the largest portion of the minority population (50.2 percent of the 
minority population).
156
 Sex is evenly distributed within the GPRD with 50.7 percent 
female.
157
 This ratio is roughly equivalent to the UK population with 51.4 percent female.
158
 
The age groups of less than or equal to 9 years old are less and greater than 80 years old are 
more represented in GPRD, compared to national statistics.  Combined, these aspects make 
prevalences from the GPRD generalizable to the UK population and allow us to achieve our 
second aim. 
Extensive outcome information is available within the GPRD.  Patient demographics, 
including age, height, weight and sex, are available.  All medical diagnoses, including 
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comments by the physician using OXMIS and/or Read coding systems are recorded.  
Records of referrals to hospitals, hospital treatment outcomes and hospital discharge reports 
are also located within the patient records.  Detailed information on pregnancies is essential 
for epidemiologic study of congenital anomalies.  The GPRD provides details on deliveries, 
stillborn and live born births and elective pregnancy terminations.  Spontaneous abortions are 
also recorded in the database, although the completeness of this data and that for elective 
terminations is limited to those events that the physician was aware of and recorded in the 
database.  
Since a long-term goal is to better identify potential teratogens, the information on 
exposures is equally important. GP’s prescriptions, including details on formulation, strength, 
quantity prescribed, dosing instructions, indication for treatment and events leading to 
withdrawal of a drug treatment are recorded.  Actual prescription dispensation is not 
recorded.  Although there is a moderate dispensing fee incurred by all patients for each 
prescription, most patients fill their prescriptions indicated by a greater than 90 percent 
concordance between the records of prescriptions in the GPRD and those of the UK’s 
prescription Pricing Authority.
159
 Information on over the counter medications is not 
recorded in the database. Lab test results, immunization records and alcohol and smoking 
habits are also available for some patient records. This information will provide vital 
information regarding exposures and confounders that are generally not available in US 
claims data.    
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2. The Mother-Baby Linkage 
 
 The inability to link mothers and offspring has been identified as a major limitation 
for the use of electronic databases in birth defect research.
160, 161
 The GPRD mother-baby link 
provides the opportunity to link the medical record of the mother with that of her newborn so 
that maternal exposures and infant outcomes can be assessed.  A schematic of this linkage 
process is presented 
below to illustrate the 
relationship between 
the mother’s record 
and the infant’s 
record. The link is 
created in three steps.  
Potential mothers are 
identified from those 
women who are 
categorized as an acceptable patient (having met GPRD Quality Control standards), are 
between 15 and 45 years of age and have a record of delivery(s) or birth(s) at any point in 
time following the certification that the practice has met data quality standards (the up to 
standard (UTS) date).  To identify multiple births with the same mother, births with >=210 
days between episodes are considered separate deliveries.  Potential newborns are identified 
from the cohort of patients who have a birth date after 1987, have a registration date within 6 
months of the date of birth, are categorized as an acceptable patient, and are registered at any 
Figure 2.1 – The GPRD Mother-Baby Linkage 
 
60 Days
>= 40 Weeks
Up To Standard Delivery
Date of Birth
Time
Dates in Mothers Record
Baby’s Record
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point in time after the practices UTS date.  Utilizing the mother and infant registration details 
and medical records, a mother-baby link is created when a potential mother and infant match 
on practice-specific family number, and when the infant’s date of birth and the mother’s 
delivery/birth records are within 60 days of each other.  In addition the registration date and 
practice UTS date of the mother is at least 40 weeks before the date of birth of the infant.   
The family ID number is a practice-specific identifier assigned to patients at their 
registration to the practice and is instrumental in the linkage process.  In the old Value Added 
Medical Products system, now integrated into the GPRD, a family number was automatically 
generated at the time of registration, based upon the registrant’s home address and house 
number.  Patients with the same address would automatically be assigned the same family 
number. This method could produce inconsistencies in family ID numbers when the 
registrant was living in a large block of flats (apartment buildings for example) or if an 
extended family was living at the same address. 
In the Vision system, the family ID number is proactively assigned at registration by the 
practice staff in consultation with the patient.  At registration, the patient (or his/her mother if 
this is an infant) is asked if he/she is a member of an existing family at the practice. The 
family ID is assigned accordingly. Therefore, if a mother brings a newborn to her same 
general practice physician, the practice administrator assigns the family ID number of the 
mother to the newborn.  The family ID number will remain the same as long as the mother 
and child remain in the same practice.  If the mother or infant transfers to a non-GPRD 
provider, the mother-baby pair is lost to follow-up. 
The mother-baby link within the GPRD makes the database ideally suited for the study of 
NTDs.  As mentioned in the discussion above on the biology of the neural tube, closure takes 
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place within the 3
rd
 to 4
th
 week of gestation.
2, 3
  Thus neural tube closure may occur prior to a 
pregnancy diagnosis.
162
 The mother-baby link allows the capture of data for this time period.  
In addition to detailed information about maternal exposures captured in the database the 
linkage can provide substantial benefits for the study of NTDs and related teratogens. 
3. Previous Birth Defect Research In The GPRD 
There have been over 400 research articles, editorials, general articles and review articles 
reporting results from the GPRD.
163
 Research articles have focused on a variety of topics and 
issues including disease prevalence, drug safety and the validity of using electronic medical 
records systems for epidemiologic research.  For a full bibliography of published literature 
please consult the GPRD web site (www.gprd.com). 
There have been a number of published articles using the GPRD to evaluate congenital 
anomalies.  Jick and Terris published the first work in 1997.
164
 Citing evidence that the 
prevalence of congenital malformations is higher in infants of women with epilepsy, they 
used the GPRD to perform a matched cohort study of women who took anticonvulsant drugs 
during their first trimester.  The outcome of interest was any major congenital anomaly that 
could be identified around the time of birth and that could be drug-induced.
165, 166
  Ten 
congenital anomalies were found in the epileptic women treated with anticonvulsants, versus 
six in the matched controls (RR 3.3; 95 percent CI 1.2-9.2).  No anomalies occurred in 
women who did not have epilepsy, or who were non-epileptic yet treated with 
anticonvulsants.  Interestingly, the authors validated the congenital anomalies found in their 
study, finding 100 percent concordance between information recorded on the computer and 
that received from a questionnaire sent to the GP.  However, the authors did not attempt to 
evaluate outcomes resulting from spontaneous abortions or elective terminations. 
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Jick conducted another evaluation of pregnancies after maternal exposure to 
fluconazole.
167
 They conducted a matched cohort study of 234 women exposed to oral 
fluconazole in their first trimester, 580 exposed to other topical and oral azole preparations 
and 1629 unexposed to any of these agents.  Congenital anomalies in the infant were 
identified by a review of the computer records, and confirmed by an examination of the GPs 
clinical records.  Although not clearly defined, the congenital anomalies of interest appear to 
be those present at birth that resulted in surgery or treatment.  The prevalence of disorders 
was similar in the fluconazole group (4/234 or 17.1/1000 births) and the non-exposed group 
(26/1629 or 16.0/1000 births).  The relative risks for congenital anomalies for first trimester 
users of fluconazole, other oral azoles and topical azoles versus non-users were 1.1 (95 % CI: 
0.4-3.3), 2.1 (95 % CI: 0.7-6.8) and 0.6 (95 % CI: 0.2-1.6) respectively.   
Ruigomez et al used the GPRD to assess pregnancies associated with the use of 
cimetidine, omperazole and ranitidine during pregnancy.
168
 They conducted a cohort study of 
all pregnant women less than 45 years old who received a prescription for one of the three 
acid suppressing drugs between January 1991 and October 1996.  In a cohort of 1179 
pregnancies, 68 malformations were identified at birth.  The overall malformation prevalence 
in the cohort was 4.4 percent (95 % CI 3.6-5.3).  The relative risks for malformations 
associated with first trimester cimetidine, omperazole and ranitidine use were 1.2, 0.9 and 1.4 
respectively. The case definitions of pregnancy is also worthy of mention.  Either a 
pregnancy loss at 28 weeks or an elective termination of pregnancy due to a diagnosed 
malformation was considered a stillbirth.  Congenital malformations were thus only those 
that resulted in a birth (live or still) with a structural defect detected either prenatally, at the 
time of birth or within one year after birth.  This was an improvement over previous works, 
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but a substantial number of NTDs are likely to have resulted in a pregnancy loss prior to the 
28
th
 week of pregnancy.  This could result in an underestimation of the results. 
Wurst and colleagues published a study examining the prevalence of congenital heart 
defects found in the GPRD to those of other UK national monitoring systems.
169
  They found 
that the prevalence ratio of these defects was between 2.20 and 2.79 the prevalence of the 
NCAS between 2001 to 2003 and was between 1.29 and 1.48 the prevalence of the 
EUROCAT.  While preliminary, the authors report that the overall positive predictive value 
of their group of congenital heart defect codes was 93 percent.   
Only one study has been published to date using data from the GPRD examining NTDs.  
Lawrenson et al examined the prevalence and mortality of patients with spina bifida, 
hydrocephalus, meningocele and meningomyelocele in the GPRD between 1994 and 1997.
170
 
Case definitions and details on the specific codes used to identify patients with one of these 
disorders were not included in the published article.  Mean age standardized prevalence were 
9.0 to 9.4 per 10,000 females and 7.9 to 8.4 per 10,000 males between 1994 and 1997.  Rates 
for each disorder were not presented.   
Lawrenson’s inclusion of hydrocephalus as a NTD is problematic.  Hydrocephalus, 
although often associated with spina bifida, meningocele and meningomyelocele, is not a 
NTD.  Congenital hydrocephalus is also a frequently occurring central nervous system 
anomaly. Between 1994 and 1997, ONS estimates that the rate of congenital hydrocephalus 
in births (live or still) alone were 1.0 to 1.2 per 10,000 births.
171
 This represents between 28 
and 31 percent of all reported central nervous system defects during this time frame.  
Additional information would be necessary to compare the results found in this report to 
prevalence reported in other sources. 
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4. Previous Pregnancy Research Using The GPRD 
While not developed in the GPRD, Manson et al. developed an approach to detect 
pregnancies using a health maintenance organization database.
162
  In approximately 10,000 
women with any record of pregnancy care or a pregnancy outcome, the authors identified 
potential pregnancies first by identifying outcomes and looking back up to 9 months for a 
marker of pregnancy care, then by identifying all individuals with a PCM and looking 
forward up to 9 months for a pregnancy outcome.  Their approach led to accuracy in 
identifying a pregnancy outcome in the automated database compared with medical records 
of 99 percent and 73 percent when identifying pregnancy-care-markers without a pregnancy 
outcome. 
Building upon the work of Manson et al., Hardy et al. developed an alternative approach 
for identifying pregnancies in the Value Added Medical Products (VAMP) based GPRD.
172
 
Using the GPRD records of 266,976 women between 15 and 44 years of age between 1991 
and 1999, the authors created a computer algorithm which matched PCMs with a 
corresponding pregnancy care outcome creating a record of the recorded time between the 
first PCM and the outcome of pregnancy.   Using this approach in the VAMP-GPRD 
database identified 297,082 pregnancies.  Because of the extensive number of codes available 
in the various systems used in the UK and no applied method to address codes that have an 
ambiguous interpretation, over 21 percent of the pregnancies were categorized as an 
unknown outcome type (i.e. the delivery was either live or dead).   
Hardy et al. used this approach for identifying pregnancies and attempted to create a 
mother-baby linkage for each live birth pregnancy.
173
   The authors created the link by 
matching records based upon the GPRD’s family identification code, the GP’s practice 
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identification code, the year of practice registration, and the year of birth for the child and 
delivery for the mother.  When these criteria were met and the birth record and delivery 
record where within 30 days of each other, a linkage was formed between that mother’s 
pregnancy and that child.   After randomly selecting one pregnancy per woman, the authors 
were able to create 122,198 matched pairs of mother and child.   Of these matched pairs, 
81,975 pairs had at least 7 months of prenatal data in the mother’ profile and at least 2 health 
records in the baby’s profile.  From this group the authors were able to summarize 
information on medication exposure during pregnancy.    
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III. STATEMENT OF SPECIFIC AIMS 
A. Hypotheses 
Congenital anomalies have diverse etiologies and complicated clinical definitions.  In 
addition, the circumstances of their occurrence, such as spontaneous abortions or elective 
terminations, make detailed information often difficult to obtain.  These challenges make it 
difficult to use any medical database to study the adverse outcomes of drug use during 
pregnancy. The GPRD is one of the premier databases for performing 
pharmacoepidemiologic research.  The GPRD has been used for evaluations of birth defects 
following the use of certain medications during pregnancy,
164, 168, 174
 but some experts have 
argued that databases cannot provide sufficiently detailed information for the valid 
identification of congenital anomalies and related exposures.
175
 One area of research in 
which a database may be useful is in the identification of NTDs. 
B. Rationale 
Although preventing the exposure of women to teratogenic agents seems an implicit goal 
of prenatal care, it may be one of the most difficult objectives to achieve. While 
medications such as thalidomide and isotretinoin are readily recognized to cause birth 
defects by providers and regulators, many medications with risks that are simply 
unknown are used in pregnancy.
175
 This poses an extremely difficult situation for women 
and their clinicians, as they are often faced with the decision of exposing an unborn child 
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to a potentially dangerous medication or diminishing the maternal benefit from a 
medication.   
 The reasons for this lack of knowledge are complex. Ethical and regulatory barriers 
are in place that prevents pregnant women from taking part in approval trials.  If women 
inadvertently become pregnancy while enrolled, they are typically withdrawn from the 
study.  Medications are rarely studied using clinical trial populations that could be at risk 
of pregnancy, thus preventing any direct knowledge of the risks for teratogenicity in 
humans. Manufacturers frequently test products in animal models for teratogenic activity, 
but these models often have poor predictive values for known teratogens.
176
 Frequently 
exposure registries have been used to prospectively and retrospectively follow the use of 
various medications, but many are limited by self referral bias and loss to follow-up.
161
 
The identification of specific birth defects has proven difficult in many of the larger 
US claims databases. Grisso et al discovered several epidemiologic pitfalls in a case-
control study of CNS birth defects using Medicaid data.
177
 Cases were identified using 
electronic records and confirmed using paper medical records.  The authors found 
substantial misclassification of outcomes (70 percent) and under reporting of diagnostic 
tests (25 percent).  Although Grisso and colleagues point out that some of these problems 
may be unique to the data under study, many may be due to the limitations of claims data. 
Large databases have been used with some success in epidemiologic studies of birth 
defects,
165, 178
 but even databases with records of over 100,000 pregnancies have limited 
use if information linking the mother to the offspring are not adequately recorded.
160
  
Epidemiologic studies are the most commonly used approach to assess teratogenic 
risk. Electronic medical records databases allow researchers to conduct case-control 
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surveillance studies while avoiding the potential limitations from recall bias that can 
occur with maternal interviews.
161
 Epidemiologic studies using databases have their 
disadvantages, sometimes being plagued with a variety of methodological problems.  One 
methodological difficulty often seen in research of birth defects is the rarity of events.  
Depending on the birth defect under study, the risk of occurrence ranges from 1 per 1000 
live births for oral cleft palate to 1 or fewer per 10,000 live births for hemimelia (limb 
development abnormality).
161
 The rarity of events can lead to sample size difficulties, as 
often the number of outcomes as well as the number of exposed pregnancies can be 
small. 
Case-control surveillance program methods, such as those utilized by Mitchell and 
colleagues,
179-181
 have been shown to be able to over come some important issues.  Small 
numbers of cases can largely be avoided for more common malformations when active 
case ascertainment programs are in place.  The early studies by the now Slone 
Epidemiology unit were able to evaluate several important and controversial exposure 
outcome relationships related to Benedictine (pyloric stenosis
180
, oral clefts and cardiac 
defects
179
) and diazepam (oral clefts
181
) because of their large number of cases of a 
variety of malformations.  These authors also used closed ended questionnaires to reduce 
the amount of recall bias on exposure information.  In the case of Benedictine, this 
method allowed them to produce exposure rates in cases and controls that closely 
matched expected exposure rates based on the general population. 
Some authors have attempted to overcome the problem of small sample size by 
combining outcomes into a larger group of “birth defects”.
182
 This approach is 
problematic as the mechanisms for most birth defects, while often unknown, frequently 
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result from exposures that affect specific cell types.
161
 Problems with the development of 
these cell types are then related to very specific birth defects, which should preclude 
investigators from grouping together general categories of “birth defects” to overcome 
sample size issues.  For this reason we focused this research on four specific NTDs. 
An additional challenge to epidemiologic study of teratogenic risk is the choice of 
medication. To be appropriate for study of an association with NTDs, a medication 
should have certain characteristics.  The medication would likely have pharmacologic 
properties that make it likely to alter the mechanical or metabolic processes involved in 
the closure of the neural tube.  Most of these processes involve folic acid or 
homocysteine, presenting two targets for medications to alter through pharmacokinetic or 
pharmacodynamic processes.  Medications to be studied should also be used to treat 
conditions affecting women of childbearing age and be used on a routine or long-term 
basis to treat the conditions affecting these women.  Women requiring such medications 
are at particularly high risk of medication-induced NTDs as they are often unaware of 
their pregnancy prior to the closure of the neural tube. This trait in particular makes 
longitudinal data on medication history of particular importance for the accurate 
ascertainment of exposure.   
The preferred study design and data source for evaluating potential teratogenicity are 
dependent on certain properties of the medication and the outcome.  Medications with 
low exposure rates with potentially high risk for the outcome may be best identified using 
a cohort approach.  Identification of exposed women and following them using a 
prospective cohort registry approach allows for the thorough evaluation of the presence 
or absence of a malformation.  When studying a medication with a high exposure rate and 
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a low probability of an effect that requires large numbers of cases, a case-control 
approach may be recommended.
183
   
Study designs should also consider the public health importance of the outcome.    
Medications with the potential for causing major malformations (thalidomide and 
isotretinoin) can pose a significant risk to large numbers of individuals.  These medications 
should be monitored then with public health resources and using government regulatory 
authority.  The registry-based risk management plans for both thalidomide and isotretinoin 
are both mandated by the FDA.  For medications that may increase the risk of specific 
defects in limited numbers, the case-control surveillance programs may be the optimal 
approach. Our goal is to support all of these approaches by developing an algorithm to detect 
pregnancies and by developing an algorithm to identify cases of NTDs in the GPRD. 
C. Research Questions And Specific Aims 
The primary research questions for this study are: 
Question 1:  Can electronic medical records and associated medical codes be used to 
accurately identify cases of NTDs within the GPRD? 
and 
Question 2:  Can the GPRD provide prevalence estimates of NTDs that are of similar 
accuracy to existing monitoring systems in the UK?   
 
We believe that these questions can be answered through the following specific aims: 
Specific Aim 1: Identify and validate cases of NTDs within the GPRD.  To achieve this aim 
we created electronic case definitions of specific NTDs and use these definitions to identify 
potential cases.  We then validated these cases through querying GPs using a short 
 - 42- 
assessment form and determine the positive predictive value of our electronic case 
definitions. 
 
Specific Aim 2:  Determine the prevalence of NTDs within the population that makes up the 
GPRD.  Prevalence was determined using the following definition: 
  
Prevalence –  
# Cases (from live births, stillbirth, terminations & spontaneous abortions) 
# Potential Births (live births, stillbirth, terminations & spontaneous abortions or an 
appropriate combination of these events) 
 
To determine this prevalence we created electronic case definitions for pregnancies and 
use these definitions to determine the number of annual pregnancies.  Using this information 
in combination with our validated annual cases we determined the prevalence of NTDs 
within the GPRD.  
 
Specific Aim 3:  Compare our prevalence of NTDs to other congenital anomaly monitoring 
systems at work in the UK.  Through a comparison to monitoring systems using different 
mechanisms, we determined if our proposed monitoring approach produces similar results, 
while producing gains in efficiency. 
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IV. METHODS 
A. Overview Of Methods Used 
 
We have conducted a validation study and a retrospective cohort analysis to achieve our 
study aims.   To meet our first aim (Aim 1: Identify and validate cases of NTDs within the 
GPRD), we identified all cases of NTDs within the GPRD between 1987 and 2004 in both 
children’s and adult women’s records. A questionnaire was sent to all the potential case’s GP 
using the Verification Service provided by the GPRD Division at MHRA. The questionnaire 
is presented in Appendix A.   We asked the practitioner to verify the NTD case through a 
series of questions focusing on method of verification and diagnosis.  In addition, when the 
case was identified in a child’s patient record (for example in a non-fatal NTD), we identified 
the linked mother and ask the GP to verify the linkage. 
Upon receipt of all questionnaires from the Verification Service, the positive predictive 
value of the operational case definitions was determined. Based upon the positive predictive 
value of our definitions, alternate cases counts were created by multiplying the PPV by the 
identified number of cases.   
The second aim (Aim 2: develop a means to determine the prevalence of NTDs within 
the population that makes up the GPRD) was met through the creation of a series of annual 
pregnancy cohorts. Using the annual pregnancy cohorts and the number of estimated NTDs, 
we determined the annual prevalence for NTDs.  Prevalence estimates were created for all 
NTDs using stillbirth, live birth, and elective terminations as the denominator. As with most 
studies of birth outcomes, we were unable to capture all possible outcomes, thus we could 
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not determine the incidence of these NTDs.  Using the prevalences created from 
comprehensive annual pregnancy denominators we determined estimates and made informal 
comparisons to the monitoring sources available in the UK. 
B. Data Used  
The GPRD was initiated in 1987 and is the world’s largest anonymized, longitudinal 
patient electronic medical records database providing clinical information based on GP 
records.  The GPRD data contain approximately 46 million patient years of follow-up 
representing 10.11 million unique patients.
184 Over 460 general practices in the UK are 
currently submitting data to the GPRD on 3.23 million patients or approximately five percent 
of the UK population.
154, 155, 184
 The patient population is representative of the regional, age 
and gender distribution of the UK population.
184
   
Members of the UK’s National Health Service (NHS) act as the main means of access to 
and record holder for all forms of health care provision within the NHS. Practitioners in the 
GPRD tend to be part of larger rather than smaller practices.  Practitioners enrolled in the 
GPRD must follow a recording protocol ensuring that significant clinical contacts are entered 
into the computer record.  These contacts include all events resulting in hospitalization or 
referral to any specialist.  The outcome of the referral is also recorded.  Any significant test 
results are recorded in the GPRD.  All events resulting in a prescription or withdrawal of 
treatment are recorded.   Any events that the patient will consult with the practitioner on 
more than one occasion (childhood diseases, pregnancy) are often recorded multiple times by 
the practitioner.
185
 
 The MHRA has put in place specific recommendations regarding recording of 
pregnancies in the GPRD.  The mother’s profile should include a record of the identification 
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of the pregnancy when known.  This includes positive pregnancy test results and any referral 
for ante-natal care.  Additional information concerning significant abnormalities or 
complications of the mother or her fetus detected during pregnancy are also recorded.  The 
outcome of the pregnancy, including the date of delivery, any congenital malformations of 
the baby, and where relevant, a record of neonatal death, are recorded.
185
 Free text may be 
recorded by GPs to further detail the patient’s medical conditions.  Diagnoses are recorded 
using Read Codes (1996-current) and a modified version of the Oxford Medical Information 
System (OXMIS: 1987-1999).  For this project data were selected from calendar years 1987 
through September 2004, and thus require both the OXMIS and Read Code systems. 
GPs code clinical information for their practices using the greater than 80,000 Read 
Codes which cover a wide range of topics in categories such as signs and symptoms, 
treatments and therapies, investigations, occupations, diagnoses, drugs and appliances.  
However, the GPRD also uses the 18,000 codes from the Oxford Medical Information 
System (OXMIS). Because these two coding systems co-exist within the GPRD, a cross-
classification variable was developed called the GPRD Medical Code that allows 
investigators to query the system using Read, OXMIS or these GPRD Medical codes, with 
the latter being the most efficient for research purposes. The GPRD Medical codes allow for 
consistency over time in defining disease outcomes and thus they were used to conduct all 
analyses for this dissertation. 
We created a data file containing all electronic patient records with a NTD code within 
the GPRD between January 1987 and September 2004. All the clinical, referral, diagnostic 
and screening test (and results), immunization and therapy events for this cohort were 
downloaded. The data set was created using the GPRD Business Objects data acquisition 
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system at the RTI-Health Solutions London, UK office and is in the form of tab delimited 
text files that were then converted into SAS datasets. The SAS datasets were used for all 
analyses.  The medical code listings we used to identify NTD patients are listed in Appendix 
B. As many NTDs are associated with a variety of syndromes and often known by a variety 
of names, GPRD Medical codes were searched using a list of key words developed through 
an extensive review of the literature in addition to work by Jones
40
 and Moore.
81
 This list of 
codes is meant to be inclusive of all codes for anencephaly, craniorachischisis, 
encephalocele, encephalomyelocele, meningocele and spina bifida.  
Pregnancy codes were identified through a key word search of the GPRD medical code 
dictionary.  Codes were divided into two categories: End-of-pregnancy (EOP) events and 
pregnancy-care-markers (PCMs). EOP events are those events that represent the final 
outcome of a pregnancy, such as live births, stillbirths, miscarriages, spontaneous abortions, 
elective terminations, multi-fetus deliveries and pre- or post-term deliveries.  PCMs include 
any event that describes the delivery of care relating to pregnancy prior to an EOP event.  
Examples include positive pregnancy tests, alpha-fetoprotein tests, obstetric ultrasounds, 
amniocenteses, visits related to pregnancy, pregnancy complications, threatened abortions, 
abortion referrals or counseling, and obstetric hospitalizations.   
In addition to the keyword search of the code dictionaries, we created longitudinal patient 
histories for a subset of 10,000 women with at least one EOP code and visually reviewed 
them for previously undiscovered pregnancy related codes.  These methods resulted in a total 
of 5,266 codes that were potentially associated with pregnancies (Appendix C). Our final list 
of codes consisted of two subsets of codes: one containing 1,691 PCMs codes (Appendix D), 
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and another containing 1,059 EOP codes (Appendix E).  We excluded the remaining 2,516 
codes as they represented post-natal care, or were deemed non-specific.  
C. Procedure For Pregnancy Identification 
1. Overview 
 
The challenge in identifying pregnancies within GPRD electronic medical records is that 
there is no consistent indicator of the occurrence of a pregnancy. To overcome this limitation 
we defined a pregnancy as the occurrence of at least one code in the GPs’ record for an end- 
of-pregnancy event (i.e. an outcome of pregnancy). EOP (EOP) events included live births, 
stillbirths, spontaneous abortions and elective terminations. All codes for the above-
mentioned EOP events are found in Appendix E. 
In the GPRD, clinical contacts are recorded continuously in the patient’s record and 
several records may be associated with a single event. In addition, women can become 
pregnant multiple times. To address these scenarios, we took a series of steps to identify 
separate pregnancies within a woman’s clinical record. In addition to identifying all of the 
EOP events within a woman’s clinical record, we had to determine gaps in time between the 
EOP codes for each EOP event type.  At times, there were conflicting EOP event types 
within a very short period of time.  For example, there might be a code of live birth and two 
days later, a stillbirth code.  We developed a decision rule that handled these conflicts and 
eliminated redundancy between different types of EOP events within each woman’s record. 
This process is described in detail and visually in the figures below.  All descriptions use 
fictitious identification numbers and event dates. 
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2. Operational Procedure 
a. Step1 – Identification Of All Patients With Pregnancy Records 
 
Figure 4.1 – Steps 1 Through 3 Of EOP Event Identification Process. 
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EOP events were identified from the GPRD data set using the core clinical file that 
contains the clinical events recorded for patients as part of their routine care by the GP, the 
laboratory file that contains records of the performance of any laboratory tests and the 
referral record portions of the GPRD that contain records of any outside clinical care reported 
to the GP. From this large data file, a sub-set data file (main.clinreflab_all) of all patient 
event records for any individual in the data set with at least one pregnancy related clinical or 
referral code was created. The final list of 5266 GPRD medical codes is found in the file 
Appendix C. These codes were identified through the process described in “Data Used” 
section of this chapter.  
• PID – The unique patient identification number 
• EVENTID – The unique identification number for each recorded clinical event 
• EVENTCODE – The GPRD code for the particular event associated with the EVENTID 
• EVENTDATE – The date of record for the particular event associated with the 
EVENTID 
• TEXTID – The unique identification number for a text note associated with an 
EVENTID 
 
From this file (main.clinreflab_all) a new data set (clinref_preg1) was created consisting 
of only those records indicating a pregnancy event or a PCM (codes are found in Appendix 
D). In addition, each record that could be considered an EOP event (i.e. a live birth, stillbirth, 
termination or spontaneous abortion) or a PCM was marked with an indicator variable. 
Registration, demographic and practice details for each patient were added to each event 
record by merging them into the clinref_preg1 file, with only those records that were 
originally in the clinref_preg1 file maintained in the new file clinref_preg1_du.  In addition 
to the above-mentioned variables, the following variables were added to the new file: 
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• PRACTICEID – the unique general practice identification number 
• BIRTHYEAR – the patient’s year of birth (available for all patients) 
• BIRTHMONTH – the patient’s month of birth (available for individuals less than 15 
years old) 
• FAMILYNUM – a practice-assigned family identification number 
• GENDER – the gender of the patient 
• REGDATE – the date the patient was registered at a specific practice 
• SMOKE – history of smoking (yes/no) 
• DRINK – history of drinking (yes/no) 
• HEIGHT & WEIGHT – height and weight at visit 
• BMI – calculated BMI based upon height and weight 
• TRANSOUTDATE – date in which a patient transfers out of a practice 
• TRANSOUTREASON – reason for which a patient transfers out of a practice 
• UTSDATE – date which practice met all GPRD data quality standards 
 
b. Step 2 – Apply Exclusions To Pregnancy Event File 
 
A total of three exclusion criteria were placed on the file clinref_preg1_d. The first 
exclusion criterion was to remove the records of those individuals who were 1) female and 2) 
between the ages of 15 and 45 at any point up to September 2004 (the last month of data 
collection for our study). The gender restriction was applied by removing all records with a 
male gender variable. The age restriction was applied by requiring the birth year of the 
female to be between 1942 (earliest year in which individual could be 45 as of 1987) and 
1989 (latest year in which individual could be 15 by the end of the study period). Only the 
birth year is available for individuals over the age of 15, thus precluding us from knowing the 
exact birth date for any individual. Although the use of the year 1942 caused some 45 year-
olds to be excluded from the data (those born in September – December) and the choice of 
1989 caused some 14 year olds (those born in September – December) to be included, these 
year choices were considered more conservative. Once these criteria were applied, a new 
data set was created named clinref_preg2. Those records that came from a male or were 
outside our age range were collected and placed in a new file named remove_2. 
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The second exclusion was the removal of records with event dates prior to 1/1/1987 or 
after 9/14/2004. The GPRD was launched as a database in on 1/1/1987. Any dates before 
1/1/1987 are events that have been recorded by a GP as part of the patient’s medical history. 
Any dates after 9/14/2004 (the last date of data gathered from the GPRD for this project) are 
either data entry errors or default dates (the year 2500) when no year is entered by the GP. 
The source file was clinref_preg2 and the output files were clinref_preg2a and remove_2a. 
The third exclusion we performed was the removal of records with event dates prior to 
the woman’s registration date or the practice up to standard date, whichever came first. If one 
considers the registration date as the date of first contact with a patient by the GP, all dates 
before that should be considered patient history references or errors in data entry. The 
practice up to standard date is considered the first date in which records should be used in a 
physician’s practice and a more reliable date by the MHRA for record integrity as compared 
to the patient registration date. The source file for this exclusion step was clinref_preg2a and 
the output files was clinref_preg2b and remove_2b. 
c. Step 3 – Remove Historical Event Records 
 
At times a GP may want to record the occurrence of an event in the patient’s medical 
history. The physician can chose to override the date associated with the visit so that a date 
from the past can be entered.  Events that may have occurred prior to when the woman 
registered with the practice may be clinically important.  GPs enter this information as a 
historical reference.  Unfortunately, it is often not clear when the GP has done this, as there is 
no code that identifies when this occurred. While not optimal, we assumed that the patient 
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was under the physicians care at that time (i.e. after their registration date with that practice), 
resulting in a minimal likelihood that the entry is based upon unreliable data.   
There are other record entries that tend to be more suspect. At times a GP may want to 
record an event in the patient’s medical history while only knowing the year in which that 
event occurred. The default month and day for a record of this type is January 1st of a given 
year. As records on “1/1/YEAR” can be historical records or actual care delivered on January 
1st, we excluded those records that are not proximal to a pregnancy related record (codes 
found in Appendix C).  Using the data set clinref_preg_2b, we created an indicator variable 
for all records on 1/1/YEAR of any given year and produced a new data set named 
clinref_preg3. Using clinref_preg3, all records that have an pregnancy related record within 
30 days of the 1/1/YEAR date, were considered an actual event of interest. If events with a 
1/1/YEAR event date were not within 30 days of an pregnancy related record they were 
removed. We performed sensitivity analyses on the 30-day cut off to see if it materially 
affects our results. The output files for this step was clinref_preg3a, clinref_preg3b, and 
remove_3b. 
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d. Step 4 – Identification And Ranking Of EOP Events 
Figure 4.2 – Steps 4 Through 5 of EOP Event Identification Process. 
 
 
After steps 2 and 3 were completed, the remaining data set contained any pregnancy 
related event that was not excluded.  Step 4 began the process of identifying our final group 
of EOP events.  Using the data file clinref_preg3b, we created a new file clinref_preg4a that 
labeled all records as one of seven EOP event categories. All other records were PCM 
records, and were removed to file remove4a.  The seven categories or ranks are: 
1) Stillbirths  
2) Stillbirths at the same time as a live birth 
3) Elective terminations 
4) Spontaneous abortions or miscarriages 
5) Multiple live births 
6) Pre-term or Post-term live births 
7) Normal term live births 
 
The GPRD medical codes for each of these categories are found in Appendix E. After a 
careful review of the first 10,000 patients with a pattern of EOP events, we identified the 
above listed rank order as likely to result in appropriate classification of EOP events.  This 
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rank order is necessary as codes were frequently recorded out of sequence, thus preventing a 
researcher from considering the first code in a series as the ultimate diagnosis. An example of 
this problem is illustrated with the sample patient record in the figure below.   
Figure 4.3 – Example For Step 4 of EOP Event Identification Process. 
PID EVENTID EVENTCODE EVENTDATE TEXTID 
978158 1869703 Normal Delivery 4/30/94 18907 
978158 2871349 Birth Details 4/30/94 167946 
978158 3032970 Stillbirth 5/08/94 186234 
972185 5042965 Birth Details 6/3/94 192310 
978158 7042969 Birth Details 6/3/94 192309 
 
In the example above, we can see that there was a normal delivery code on 4/30/94 
followed by a stillbirth code on 5/08/94, 8 days later. If a researcher took only the first 
indicator of an EOP event, this event may have been misclassified as a live birth, when in all 
likelihood it was a stillbirth.  
e. Step 5 – Removal Of Duplicate EOP Events Within Event Categories 
 
Once event ranks were assigned, the clinical records were sorted by patient identifier, 
event rank and by event date. This sorting allowed us to analyze individual patient profiles 
for codes of interest and to establish a chronology of pregnancy events for each patient. The 
establishment of event chronology occurred in two steps for each patient: 1) within each EOP 
event type (occurs in this step); 2) between EOP event types (Step 6). 
For each woman with pregnancies in our GPRD data set, we set up a count variable to 
determine the maximum number of each type of EOP event.  This count variable (num_rank) 
is continuous and allows us to compare events both between EOP events of the same type 
(termination vs. termination) but also between EOP types (termination vs. live birth). This 
allows the determination of ranks that are needed for establishing the seminal pregnancy 
event for each woman’s available GPRD reproductive history.    
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We describe step 5 using an example of an elective termination. After determining the 
maximum number of events in any single individual within any rank, we determined that no 
patient had more than 3 stillbirths alone or in combination with a live birth, no more than 7 
elective terminations, 10 spontaneous terminations, no more than 2 multiple live births, 3 
pre-term or post-term births and no more than 10 normal term live births.  We created a count 
variable to be used in the process of comparing events. Based upon our ranks and the 
maximum number of events in any single individual within any rank the num_rank variable 
was assigned as follows: 
1) Stillbirths – num_ranks 1 to 3  
2) Stillbirths at the same time as a live birth – num_ranks 4 to 6 
3) Elective terminations – num_ranks 7 to 13  
4) Spontaneous abortions or miscarriages – num_ranks 14 to 23 
5) Multiple live births – num_ranks 24 and 25 
6) Pre-term or post-term births – num_ranks 26 to 28 
7) Normal term live births – num_ranks 29 to 38 
 
The first normal live birth event that is found in a patient record, regardless if it is actually 
the first or the last event found would be given the num_rank value of 29. Similarly, the first 
spontaneous abortion or miscarriage would be given a num_rank value of 14.  The example 
in the figure below shows how we implemented the ranking process using an elective 
termination where the first event indicative of an elective termination was given a num_rank 
value of 7. 
 
Figure 4.4 – Example 1 for Step 5 of EOP Event Identification Process 
PID EVENTID EVENTCODE EVENTDATE TEXTID Num_rank 
9858 869703 Screening - general 7/30/00 18907 0 
9858 871349 [D]Abdominal colic 7/30/00 167946 0 
9858 1032970 Screening - general 8/28/00 186234 0 
9285 1042965 Anencephalus 10/3/00 192310 0 
9858 1042969 Therapeutic abortion 10/3/00 192309 7 
9858 1042971 Therapeutic abortion 10/3/00 192312 7 
9858 1042989 Therapeutic abortion 10/5/00 192567 7 
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Because a similar or identical code referring to the same event may be entered multiple 
times in the patient’s record for each woman, we created a new variable that represents the 
number of days between the two records (var=T_gap) and set the start value to 0.   We only 
increased the variable num_rank when the gap in days (var=T_gap) exceeded a certain 
predefined value.  In the case of spontaneous abortions and terminations we set this required 
gap in days to 60. The use of a 60 day cut off between spontaneous abortion or termination 
events was based upon an estimate of the number of days after a pregnancy termination but 
before a women is likely to be diagnosed as pregnant again.
162
 In the case of a live birth or a 
stillbirth, the required gap in days was 210.  The 210 day gap is consistent with the gap used 
by the GPRD for identifying separate pregnancies for linkages between mothers and 
infants,
186
 and is sufficient to detect pre-term as well as post-term live births.  
In the example below we see that a code for a therapeutic abortion is recorded on 10/3 
and then again on 10/8 creating a T_gap of 5.  As this does not exceed the predefined value 
of 60 days for terminations, our num_rank variable remains at the starting value of 1.  Please 
note that as the variable num_rank is a retained variable, the value remains in place even for 
the event codes “Anencephalus” and “Grief reaction”.  The count variable can be thought of 
as a cumulative count of events that have occurred in the patient's medical record up to that 
point.   
 - 57- 
 
Figure 4.5 – Example 2 for Step 5 of EOP Event Identification Process 
PID EVENTID EVENTCODE EVENTDATE TEXTID Num_rank T_Gap 
9858 869703 Screening - general 7/30/00 18907 0  
9858 871349 [D]Abdominal colic 7/30/00 167946 0  
9858 1032970 Screening - general 8/28/00 186234 0  
9858 1042969 Anencephalus 10/3/00 192310 0  
9858 1042970 Therapeutic abortion 10/3/00 192309 7 0 
9858 1042971 Anencephalus 10/3/00 192310 7  
9858 1042972 Therapeutic abortion 10/8/00 192311 7 5 
9858 1043269 Grief reaction 10/8/00 192209 7  
 
 
In the next illustration we see that the GP has entered a termination code on 5/19 of the 
following year.  Because the variable t_gap now exceeds 60 (it is 200 in this case), we 
consider this termination code unrelated to the previous codes and representative of a new 
event.  The num_rank variable is thus increased by 1 and now stands at 8. 
Figure 4.6 – Example 3 for Step 5 of EOP Event Identification Process 
PID EVENTID EVENTCODE EVENTDATE TEXTID Num_rank T_Gap 
9858 869703 Screening - general 7/30/00 18907 0  
9858 871349 [D]Abdominal colic 7/30/00 167946 0  
9858 1032970 Screening - general 8/28/00 186234 0  
9858 1042969 Anencephalus 10/3/00 192310 0  
9858 1042970 Therapeutic abortion 10/3/00 192309 7 0 
9858 1042971 Anencephalus 10/3/00 192310 7  
9858 1042972 Therapeutic abortion 10/8/00 192311 7 5 
9858 1043269 Grief reaction 10/8/00 192209 7  
9858 1063569 Termination of 
pregnancy NEC 
5/19/01 192921 8   200 
 
Each patient event record (pregnancy and non-pregnancy related) was analyzed with the 
num_rank carried over until the next EOP event. This process continued for terminations 
until the last patient event record was analyzed.  The next woman’s records were then 
examined with the count variables and gap variables reset to zero. 
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Figure 4.7 – Example 4 for Step 5 of EOP Event Identification Process.  
 
 
 
PID EVENTID EVENTCODE EVENTDATE TEXTID Num_rank T_gap 
9858 1255355664 Dyspepsia 1/21/03 902651002 8  
9858 1255358167 [D]Abdominal pain 2/27/03 902653765 8  
13573 1132367 O/E - height 10/11/02 284356 0 0 
13573 1144814 Dietary history 10/11/02 298239 0  
13573 1145251 
Child exam.: 
genitalia 10/11/02 298680 0 
 
 
As the most critical information arising from this step is the identification of additional 
pregnancies in the same woman as indicated by EOP events separated by appropriate time 
windows, we needed to set up two new variables: rank# (event date) and eid# (event ID). The 
rank# captures the date of the event that corresponds to a given rank and the eid# corresponds 
to the event identification number for the event of a given rank#. The procedure for assigning 
the eid# variables occurs in unison with the rank# variables, so to simplify description we 
only describe the process for the rank# variables. To illustrate the process we consider a 
record with a stillbirth, a termination and a live birth. The new variables Rank1, Rank7, 
Rank8, Rank9 and Rank26 are created.   
Figure 4.8 – Example 5 for Step 5 of EOP Event Identification Process 
  
EVENTID EVENTCODE EVENT 
DATE 
Num_rank Rank1 Rank7 Rank8 Rank9 Rank26 
1037118 Stillbirth 8/4/97 1 8/4/97     
1042969 
Therapeutic 
abortion 
10/3/00 7  10/3/00    
1043569 
Termination of 
pregnancy 
NEC 
5/19/01 8   5/19/01   
1047289 
Premature 
delivery 
3/2/02 26     3/2/02 
1049971 
Therapeutic 
abortion 
1/8/03 9    1/8/03  
 
 In our above example the num_rank value for the first event was 1, and thus the rank 
variable for this stillbirth was assigned “rank1” and it was given the event date for its value.  
End of PID 9858 
Records 
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If there were a second stillbirth recorded, it’s rank variable would have been “rank2”.   
Because the next record was the first of a series of elective terminations and is the first event 
that is a member of the category of event ranks from 7 to 13, the rank variable “rank7” was 
assigned the event date for this record.  Because the next event was also a termination, but at 
a future date (greater than 60 days) from the previous one, it was assigned to “Rank8” with 
the event date recorded as its value.  Following the sequence of the clinical records, we then 
assigned a “rank#” to the first in a potential series of live births.  Although the fourth actual 
event, the first available rank for a premature live birth is “Rank26” and thus the variable 
“Rank26” was assigned the premature live birth’s event date as its value.  Finally, we come 
to the final event of this profile, another termination.  As this was the third termination for 
this patient, it was assigned the “Rank9” spot and the variable “Rank9” was assigned the 
event date.   
To summarize, while looking at all potential event dates within each category, by moving 
between subsequent categories in our hierarchy, the rank variable is increased by one each 
time there is a new event within a category.  The rank variables are assigned below. 
1) Stillbirths – Rank1 to Rank3 
2) Stillbirths at the same time as a live birth – Rank4 to Rank6 
3) Elective terminations – Rank7 to Rank13  
4) Spontaneous abortions or miscarriages – Rank14 through Rank23 
5) Multiple live births – Rank24 and Rank25 
6) Pre-term or post-term births – Rank26 to Rank28 
7) Normal term live births – Rank29 to Rank38 
 
After all the clinical data indicating an EOP event was examined for each woman, we 
created seven new files representing each type of EOP event (Stillbirth, stillbirth at the same 
time as a live birth, etc) (file names: clinref_preg5a through clinrer_preg5g) to establish the 
within-patient chronology of all EOP event categories. These new files contained the PID, 
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the event date, the appropriate num_rank corresponding with the EOP types and all rank# 
and eid# variables. 
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f. Step 6 – Removal Of Duplicate EOP Events Between Event Categories 
 
Figure 4.9 – Step 6 Of EOP Event Identification Process. 
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After we assigned ranks to each of the dates and event identification numbers, we were 
able to compare dates that were in close proximity to each other by not only their event dates, 
but also their rank.  As explained earlier in step 4, EOP events are not necessarily recorded in 
a chronological fashion conducive to easy identification.  To overcome this problem, we 
considered the sensitivity of certain categories of codes as better than others, allowing us to 
select the correct codes although they occur chronologically later than the first EOP code.  
This was achieved through a comparison of each event date to the newly created date value 
for each of the rank variables. 
This process began by merging the files created in the previous step (clinref_preg5a – 
preg5g) into two new files.  The first file, clinref_preg6, contained all EOP records in 
clinref_preg5a – preg5g meeting the inclusion criteria set forth to this point.  The dates for 
each event and each rank were retained through each iteration of the data step allowing the 
last event of a patient’s record to have all of the event dates for a given individual in the form 
of all of the rank variables. 
Figure 4.10 – Example 1 for Step 6 of EOP Event Identification Process 
 
 
 
PID EVENTID EVENTDATE Num_rank Rank1 Rank7 Rank8 Rank9 Rank29 Rank30 
9858 1037118 8/4/97 1 8/4/97      
9858 1042969 10/3/00 7 8/4/97 10/3/00     
9858 1043569 5/19/01 8 8/4/97 10/3/00 5/19/01    
9858 1047289 3/2/02 29 8/4/97 10/3/00 5/19/01  3/2/02  
9858 1049971 1/8/03 9 8/4/97 10/3/00 5/19/01 1/8/03 3/2/02  
11098 1907531 4/27/94 29     4/27/94  
11098 4969836 4/29/94 1 4/29/94    4/27/94  
11098 5332504 8/3/00 30 4/29/94    4/27/94 8/3/00 
13573 1144814 10/11/02 7  10/11/02     
27023 5249852 7/3/00 29     7/3/00  
27023 5250025 8/9/02 30     7/3/00 8/9/02 
57323 1145251 9/10/95 7  9/10/95     
57323 1145320 9/15/96 8  9/10/95 9/15/96    
57323 1289061 7/08/97 9  9/10/95 9/15/96 7/08/97   
 
The second file created from clinref_preg5a – preg5g was the last record for each PID.  
This new file, clinref_preg6a, was used in the next part of step six.  The file clinref_preg6 
• End of PID 9858 Records 
• Contains all prior dates as ranks 
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was then reformatted to create a new file (clinref_preg6b).  This file consists of a new record 
for each event date, its rank and the event identification number.  This file was then merged 
with clinref_preg6a to create another new file (clinref_preg6c) that contains each event date, 
rank number and all of the patients’ rank# variables. Even though most rank# variables do 
not have a value, each record contains all 38 rank# variables.  The file contents are illustrated 
below.  To simplify illustration, only the rank# variables that are in use are shown in this 
example. 
Figure 4.11 – Example 2 for Step 6 of EOP Event Identification Process 
 
PID EVENTID EVENTDATE Num_rank Rank1 Rank7 Rank8 Rank9 Rank29 Rank30 
9858 1037118 8/4/97 1 8/4/97      
9858 1042969 10/3/00 7 8/4/97 10/3/00     
9858 1043569 5/19/01 8 8/4/97 10/3/00 5/19/01    
9858 1047289 3/2/02 29 8/4/97 10/3/00 5/19/01  3/2/02  
9858 1049971 1/8/03 9 8/4/97 10/3/00 5/19/01 1/8/03 3/2/02  
11098 1907531 4/27/94 29     4/27/94  
11098 4969836 4/29/94 1 4/29/94    4/27/94  
11098 5332504 8/3/00 30 4/29/94    4/27/94 8/3/00 
13573 1144814 10/11/02 7  10/11/02     
27023 5249852 7/3/00 29     7/3/00  
27023 5250025 8/9/02 30     7/3/00 8/9/02 
57323 1145251 9/10/95 7  9/10/95     
57323 1145320 9/15/96 8  9/10/95 9/15/96    
57323 1289061 7/08/97 9  9/10/95 9/15/96 7/08/97   
 
Starting with file clinref_preg6c, each record date was compared to all other EOP record 
dates for the patient.  This occurs using three arrays that evaluate all of our event types (i.e. 
ranks) with criteria similar to those used in step five.  Stillbirths, live births, pre-term and 
post-term births and multiple births must be at least 210 days from other events to be 
considered valid, while elective terminations and miscarriages must be at least 60 days from 
other events to be considered valid.   
For example, in the case of PID 11098 events with ranks 1 through 6 (stillbirths alone or 
in combinations with live births) are first compared to all other events with a criteria that they 
must be more than 210 days from a higher ranked event to be considered valid.    As few 
events are ranked higher than those ranked 1 through 6, few of these events are considered 
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invalid.   In the example below there is an event two days before the event with a rank of 1, 
but because it is a higher rank, the event on 4/29 is considered valid. 
Figure 4.12 – Example 3 for Step 6 of EOP Event Identification Process 
 
 
PID EVENTID EVENTDATE Num_rank Rank1 Rank7 Rank8 Rank9 Rank29 Rank30 
9858 1037118 8/4/97 1 8/4/97      
9858 1042969 10/3/00 7 8/4/97 10/3/00     
9858 1043569 5/19/01 8 8/4/97 10/3/00 5/19/01    
9858 1047289 3/2/02 29 8/4/97 10/3/00 5/19/01  3/2/02  
9858 1049971 1/8/03 9 8/4/97 10/3/00 5/19/01 1/8/03 3/2/02  
11098 1907531 4/27/94 29     4/27/94  
11098 4969836 4/29/94 1 4/29/94    4/27/94  
11098 5332504 8/3/00 30 4/29/94    4/27/94 8/3/00 
13573 1144814 10/11/02 7  10/11/02     
27023 5249852 7/3/00 29     7/3/00  
27023 5250025 8/9/02 30     7/3/00 8/9/02 
57323 1145251 9/10/95 7  9/10/95     
57323 1145320 9/15/96 8  9/10/95 9/15/96    
57323 1289061 7/08/97 9  9/10/95 9/15/96 7/08/97   
 
When comparing the event on 4/27 and the event on 4/29, because this event is a live 
birth (its rank is between 29 and 38), it also must be at least 210 days from another event to 
be considered valid.  Because this live birth event is 2 days before the stillbirth event and the 
rank of the stillbirth event is lower than the live birth event, the live birth event is identified 
as suspect allowing the event date and event ID to be removed.  The stillbirth is the event 
selected. 
The first of the final series of files for this stage of step 6 was clinref_preg6d. The arrays 
used to create this file produce a very large number of records (for the base case: 387,712 x 
38 x 3 = 44,199,168 records created) making it difficult to illustrate. Most of the records in 
clinref_preg6d do not identify suspect dates, thus in order to later remove only those records 
that are suspect they are isolated. Once isolated to file clinref_preg6e, an additional stage is 
required to ensure that individuals who have multiple invalid records have all invalid records 
removed. 
 Once all suspect dates were identified, a series of new data files (clinref_preg6ew to ez) 
were created that contain only patient identification number and the variables indicating a 
Event on 4/29 is valid 
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suspect record – datebad1 – datebad3. This new file, clinref_preg6f now contains all event 
dates, event IDs and event ranks along with a new series of variables indicating the suspect 
records – bdate1 through bdate38. 
These suspect dates are similar to the rank# variables used earlier in step 6, but there are 
only a potential of 38 (sum of maximum number of EOP events for each case type) suspect 
dates that any record could have. The file clinref_preg6f was then created to remove all 
records for each PID that were suspect. We used an array to evaluate all event dates and 
suspect dates. When a given event date’s rank was equal to the suspect date’s rank it was 
labeled for removal by setting the new variable “bad” to 1.  
To complete step 6 the file clinref_preg6g was merged with clinref_preg6c so that the 
final removal of suspect dates could occur. The new file, clinref_preg6gy, then had all event 
dates, event identification numbers, event ranks and the “bad” variables. When the event rank 
equaled the “bad” variable that particular event record was removed to remove_6g. The final 
list of correct EOP event dates and event identification numbers was then contained in the 
file clinref_preg6h. Event codes and any additional information about the patient could then 
be added back into the file for future analysis. 
g. Step 7 – Identification Of All Patients With Complete Pregnancy Profiles 
 
After the completion of the identification of the most likely EOP events, we next 
identified the first pregnancy-care-marker (PCM) for that EOP event in the patient's record.  
Identification of the first PCM is important for determining the recognition of pregnancy and 
potentially estimating the date of the last menstrual period.  The process for identifying 
PCMs is described in detail below and presented visually in the figures below.  The same 
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process is applied to the identification of screening and diagnostic tests.  This allows us to 
identify the first occurrence of a specific screening and diagnostic test for each pregnancy. 
1. Sub-Step 1 – Identification Of Women With A PCM 
 
Pregnancy-care-markers are diagnoses and procedure codes that define the delivery of 
care for a pregnant woman.  These codes can be used to help identify the initiation of care at 
the beginning of a pregnancy or are indicative of care during an ongoing pregnancy.  Prior to 
beginning this database search, relevant key words and codes that indicate PCMs were 
identified. Examples of some potential PCMs are listed in the table below: 
Table 4.1 – Potential PCMs Used in the GPRD. 
• Pregnancy test / hCG test 
• Alpha-fetoprotein test 
• Obstetric ultrasound 
• Amniocentesis 
• Rh screen  
• Chorionic villus sampling 
• AZ test  
• Antenatal blood group screen 
• Antenatal syphilis screen 
 
• Visits related to pregnancy (antenatal care/booking) 
• Basic pregnancy codes (pregnant, pregnancy)  
• Pregnancy complications (anemia pregnancy, 
pregnancy bleeding) 
• Other (prenatal lifestyle advice etc.) 
• Threatened abortion  
• Abortion referral/counseling 
• Obstetric hospitalization (obstetric admission, 
obstetric discharge summary) 
Source: List adapted from Hardy et al.172 and Manson et al.162  
To identify these PCM codes we systematically searched OXMIS and Read Code 
codebooks using keywords.  We also merged codes provided by Dr. Janet Hardy that 
represented a subset of codes used in her early work with a similar data set.
172
 Additionally, 
the profiles of a group of 10,000 women with suspected pregnancy records were visually 
searched to identify additional and previously undiscovered codes.  The final list of 1,691 
PCM codes is found in Appendix D.   
We searched for all PCMs utilizing the same large automated data file as described in 
step 1 of this operational procedure (main.clinreflab_all).  Each PCM record was then 
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labeled with an indicator variable that could then be used to identify the records in future 
steps.  All file names and variables are the same as those mentioned in the pregnancy 
identification process at this point.  The final file for step one was clinref_preg1_du. 
2. Sub-Step 2 – Selecting Valid Occurrences Of PCMs 
 
Using the same procedures as step 2 in the pregnancy identification process, we applied a 
series of exclusion criteria on the file clinref_preg1_du. The first exclusion criterion was to 
restrict the records to those individuals who were 1) female and 2) between the ages of 15 
and 45 as of September 2004 (the last month of data collection for our study).  The gender 
restriction was applied by removing all records with a male gender variable.  The age 
restriction was applied by requiring the birth year of the female to be between 1942 and 
1989.  Only the birth year is available for individuals over the age of 15, thus precluding us 
from determining the exact birth date for any individual.  Although the use of the year 1942 
caused some 45 year-olds to be excluded from the data (those born in September – 
December) and the choice of 1989 caused some 14 year olds (those born in September – 
December) to be included, these year criteria were considered more conservative.   Once 
these criteria were applied, a new data set was created named clinref_preg2.  The records that 
came from a male or were outside our age range were collected and placed in a new file 
named remove_2.   
We next removed records with event dates prior to 1/1/1987 or after 9/14/2004.  The 
GPRD was launched as a database in on 1/1/1987.  Any dates before 1/1/1987 are events that 
have been recorded by a GP as part of the patient’s medical history.  Any dates after 
9/14/2004 (the last date of data gathered from the GPRD for this project) are either data entry 
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errors or default dates (the year 2500) when no year is entered by the GP.   The source file 
was clinref_preg2 and the output files were clinref_preg2a and remove_2a. 
The third exclusion we performed was the removal of records with event dates prior to 
the individual’s registration date or the practice up to standard date whichever is first. 
Because the registration date represents the GPs first contact with a patient, all dates before 
those were considered patient history references or errors in data entry. The practice up-to-
standard date is considered the first date in which records should be used in a physician’s 
practice and a more reliable date then the patient registration date. The source file for this 
exclusion step is clinref_preg2a and the output files are clinref_preg2b and remove_2b. 
3. Sub-Step 3 – Create ID Variable For Events On 1/1/YEAR 
 
After implementing the previous exclusions, we began the third step: identification and 
removal of historical event records after the patient’s registration date. At times a GP may 
want to record the occurrence of an event in the patient’s medical history.  The physician can 
chose to override the date of visit at any time, thus allowing her to enter a date from the past.  
Dates entered after registration, but entered as a historical reference, are not labelled 
specifically as historical records.  While not optimal, we assumed that the patient was under 
the physician’s care at that time (i.e. after their registration date with that practice), resulting 
in a minimal likelihood that the entry is based upon unreliable data.   
There are other record entries that tend to be more suspect.  At times a GP may want to 
record an event in the patient’s medical history while only knowing the year in which that 
event occurred.  The default month and day for a record of this type is January 1
st
 of a given 
year.  Using the data set clinref_preg_2b, we created an indicator variable for all records on 
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1/1/YEAR of any given year and produced a new data set named clinref_preg3. As records 
on “1/1/YEAR” lack specific information, we excluded those 1/1/YEAR records that are not 
proximal to a PCM or an EOP record.  Using clinref_preg3, all records that have an EOP 
record within 30 days of the 1/1/YEAR date, were considered an actual event of interest.  If 
events with a 1/1/YEAR event date were not within 30 days of a PCM or an EOP event they 
were removed. The output files for this step are clinref_preg3a, clinref_preg3b, and 
remove_3b. 
4. Sub-Step 4 – Identifying First PCMs 
 
After all valid PCMs where identified, we began the process of determining the number 
of days between each PCM and each EOP event. As many codes are replicated throughout a 
patient’s record of care, it is necessary to select a point in time that a PCM must not exceed 
to be considered part of a given EOP event.  For any given EOP event, only markers that 
occur during the 280 days prior to the EOP event were analyzed.  If another end-or-
pregnancy event occurs within 280 days, such as a miscarriage proceeded by an elective 
termination, the number of days between the prior EOP event and EOP event being analyzed 
serves as the cut off for assessing PCMs.  The two approaches and the steps used to analyze 
each are described in detail and depicted visually in the figures below. 
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Identifying patients with pregnancies within 280 days of another 
Figure 4.13 – PCM Identification Process: Part 1 
 
Starting with the final pregnancy file from Step 6 (pwip.clinref_preg7), we created a 
count variable within each patient identifier indicating the number of days between each EOP 
event.  This new file was named marker1. Once the number of days between each EOP event 
was calculated, we put records for those patient identifiers that had at least one EOP event 
within 280 days of the previous EOP event into another file.  This file is named marker2.  All 
EOP events for these patients were then tagged with an indictor variable indicating that one 
of their pregnancies was within 280 days of a prior pregnancy.    All EOP events were then 
subdivided into two groups, those with all pregnancies at least 280 days apart (file name: 
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marker4a) and those with at least one pregnancy within 280 days of another (file name: 
marker4b).  The approach used to identify the first PCM is different for these two groups.  
We describe each approach separately.  
 
Group 1: First PCMs when all pregnancies are at least 280 days apart 
Figure 4.14 – PCM Identification Process: Part 2 
 
At this point, file marker4a contains only the EOP event records of those individuals that 
had no pregnancies within 280 days of another pregnancy.  We then combined the EOP 
events with the PCMs identified through Step 4 as described above.  This created the file 
named marker5.  The file now contains an indicator of pregnancies which are greater than or 
less than 280 days apart. The following steps where then used to identify the first PCM in 
this group. 
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The file marker5 contains two general types of records, PCMs and EOP events.  All EOP 
events in file marker5 were labeled as such in the new file, marker6.  PCMs are now 
identifiable as those records that are not EOP events.  A new variable was created named 
“EOPDATE” for each of the EOP events in marker6.  All PCM records have a missing value 
for the EOPDATE variable.  The file name at this stage is marker7. 
In order to compare each possible PCM to all other pregnancies, we created multiple 
EOPDATE variables from the file marker7 using PROC TRANSPOSE creating the file 
marker8.  One variable was created for each pregnancy. There were up to 10 EOPDATE 
variables created named EOPDATE1 through EOPDATE10 in file marker8.  Individuals 
who did not have 10 EOP events were given missing values for those EOPDATE values.   At 
this stage we also created multiple event identification number variables in file maker8a.  
These variables named EID1 through EID10 represent the event identification numbers for 
up to 10 EOP events in a patient’s record.   
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Figure 4.15 – PCM Identification Process: Part 3 
 
The multiple EOPDATE and EID variables in marker8a were then merged into marker6 
containing all records of EOP events and PCMs to create the new file marker9.  An 
additional file, maker9a, was then created containing only the patient identifier and the 
multiple EOPDATE and EID variables.  Because PCM records for patients not contained in 
marker4a remain in the file, we removed them at this point and renamed the file marker10.  
Each record (PCM as well as EOP events) is now compared to each EOPDATE variable.  
The number of days between each record and each EOPDATE is calculated using an array.  
This new file is named marker11. 
The previous file, marker11, now contains many extraneous records.  All records that 
have a calculated difference in days that is missing were deleted.  These records represent a 
comparison between a marker’s date and a missing value for the EOPDATE value.  As most 
EOPDATE values were missing (i.e. most patients have less than 10 EOP events), this 
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represents the majority of records in our file marker11.  Records with a calculated difference 
in days of less than zero were deleted.  This difference occurs when the PCM occurs after a 
given EOP event.  As there are many patients with multiple pregnancies, this is also a 
common scenario.  When the difference was greater than 280, the PCM was being compared 
to an EOP event other than the one actually associated with the PCM (i.e. a future 
pregnancy).  When this occurred the record was deleted.  Finally, we deleted all records 
where the comparison was between an EOP event and the EOPDATEs.  The file now only 
contained PCM records that could represent the first PCM for any given pregnancy.  The file 
name at this stage is marker12. 
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Figure 4.16 – PCM Identification Process: Part 4 
 
To determine the first PCM for any given pregnancy, we sorted the file marker12 by 
patient identification number, number of EOP events (calculated in file marker11), and the 
number of days between the PCM and its respective EOP event.  As there are likely multiple 
PCMs for each pregnancy, this sorting allowed us to select the PCM that is the furthest back 
in the patient’s history without exceeding our limit of 280 days.  The file marker13 contains 
only the PCMs that are considered the first PCM for each of their respective pregnancies.  A 
new variable, FPMDATE, is created that is equal to the event date found in the file 
marker13.  The new file is marker14. 
Each patient identifier number now has multiple first PCMs associated with multiple 
pregnancies.  We then created a new variable representing each of these FPMDATE 
variables labeled FPMDATE1 through FPMDATE10.  This new file is marker15.  The final 
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step in this part of the process is to create a single record for each patient identification 
number that contains all EOP events, all of those EOP event identification numbers and the 
first PCM dates.  This is accomplished by merging the files marker15 and marker9a.  The 
final file for this stage is pwip.marker16. 
Group 2: First PCMs when at least one pregnancy is within 280 days of another 
Figure 4.17 – PCM Identification Process: Part 5 
 
 
The approach used to address PCMs when there is at least one pregnancy within 280 days 
of another is similar to the previous procedure.  We start with the file marker4b, which 
contains only the EOP event records of those individuals that have at least one pregnancy 
within 280 days of another pregnancy.  Because these records cannot use a maximum cut 
point of 280 days for their first PCM for all of their pregnancies, additional steps must occur 
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to determine an alternate maximum for those pregnancies that occur within 280 days of 
another pregnancy.   
Starting with marker4b, we create a new variable named “TARGET”.  This variable 
serves as the cut point for the number of days before an EOP event that a PCM can reach.  
The new file is named marker17. The default value for the variable TARGET is 280 days, 
but this will later be replaced for those specific pregnancies that are less than 280 days before 
another pregnancy. 
The file marker2 contains the EOP records of patients that were less than 280 days after a 
prior EOP and was then merged into marker17 by record event identification number.  We 
then created a new file named marker19.  The variable TARGET was then replaced for those 
records in which the EOP event from the file marker2 was less than 280 days.  Now the 
variable TARGET is the actual number of days between each pregnancy with the maximum 
cut point of 280 days.  This new file is named marker20. So that we can later use the 
different cut points for each unique EOP event, we created a new series of variables named 
TARGET1 through TARGET14.  Additionally we created event identification number 
variables for each EOP event named EID1 through EID14.  This new file is named 
marker20d.   
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Figure 4.18 – PCM Identification Process: Part 6 
 
As before, we combined the EOP events from marker4b with the PCMs identified 
through step three as described earlier in the marker identification process.  This created the 
file named marker21.  The newly created TARGET variables from marker20d were then 
merged into all of the records from file marker21.  This new file is named marker22. 
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The records in marker22 are both PCMs and EOP events.  So that we can identify and 
later remove the EOP events, we label them as such at this time.  The new file is named 
marker23. A new variable was created named “EOPDATE” for each of the EOP events in 
marker23.  All PCM records have a missing value for the EOPDATE variable.  The file 
name at this stage is marker24. In order to compare each possible PCM to all pregnancies, 
we created multiple EOPDATE variables from the file marker24.  One variable was created 
for each pregnancy. There were up to 14 EOPDATE variables created named EOPDATE1 
through EOPDATE14 in file marker25. 
We then merged all EOPDATE and TARGET variables for each patient identification 
number onto each PCM record.  We then removed the PCM records that are associated with 
a patient with no pregnancies within 280 days of another (these records were evaluated in the 
previous step). The file marker27 now contains only records of patients with at least one 
pregnancy that occurs less than 280 days from the prior pregnancy.  Each event record date 
in marker27 is then compared with each EOPDATE variable using an array.  A difference 
value is calculated and a new file, marker28, is then created.  
 - 80- 
Figure 4.19 – PCM Identification Process: Part 7 
 
As before, the array results in a large number of uninformative records that need to be 
removed. All records that have a calculated difference in days that is missing were deleted.  
These records represent a comparison between a marker date and a missing value for the 
EOPDATE value.  As most EOPDATE values were missing (i.e. most patients have less than 
14 EOP events), this represents the majority of records in our file marker28.  Records with a 
calculated difference in days of less than zero were deleted.  This difference occurs when the 
PCM occurs after a given EOP event.  As there are many patients with multiple pregnancies, 
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this was also a common scenario.  When the difference was greater than 280, the PCM was 
compared to an EOP event other than the one actually associated with the PCM.  When this 
occurred the record was deleted. Finally, we deleted all records where the comparison was 
between an EOP event and the EOPDATES.  This leaves us with a file that only contains 
PCM records that could represent the first PCM for any given pregnancy.  The file name at 
this stage is marker29. [NOTE additional records are deleted in the next step using the 
TARGET variables.] 
Using the file marker29, we compare the difference variable calculated in file marker28 
and compare it to the TARGET variables using an array.  When the difference variable is 
greater than the TARGET variable for a given pregnancy it is deleted.  This has the effect of 
limiting PCM variables to those that are less than or equal to the number of days between 
two pregnancies without exceeding the maximum number of days for a unique pregnancy.  
The new file is named marker29a. 
To determine the first PCM for any given pregnancy, we sorted the file marker29a by 
patient identification number, number of EOP events (calculated in file marker28), and the 
number of days between the PCM and its respective EOP event.  As there are likely multiple 
PCMs for each pregnancy, this sorting allowed us to select the PCM that was the farthest 
back in the patient’s history without exceeding our pregnancy specific limit (280 days or 
less).  The file marker30 then contained only the PCMs that were considered the first PCM 
for each of their respective pregnancies.  A new variable, FPMDATE, was created that is 
equal to the event date found in the file marker30.  The new file is marker31. 
Each patient identifier number now has a single first PCM associated with each EOP 
event.  We then created a new variable representing each of these FPMDATE variables 
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labeled FPMDATE1 through FPMDATE10.  This new file is marker32.  The final step in 
this part of the process is to create a single record for each patient identification number that 
contains all of their EOP events, all of those EOP event identification numbers and the first 
PCM dates.  This is accomplished by merging the files marker32, marker25 and marker22.  
The final file for this stage is pwip.marker33. 
Combining the first PCM into the final pregnancy file 
Figure 4.20 – PCM Identification Process: Part 8 
 
To complete the first PCM identification process, we combined the final files for the two 
scenarios described above.  By combining files pwip.marker16 and pwip.marker33 we 
created the file marker34. Using this file we performed another array to create multiple 
records per patient identifier number.  Each record now represents a single EOP event, its 
 - 83- 
first PCM date and the event identification number of the EOP event.   After the creation of 
two transitional files, marker35 and marker36, the file marker37 is then sorted by the event 
identification number and the new variable FPM (first PCM) is merged onto the final 
pregnancy file pwip.clinref_preg7.  The new final file is named pwip.clinref_preg8.  This file 
now contains all end-of-pregnancy events and when available, the first PCM date and event 
ID. 
D. Procedure For NTD Identification 
1. Overview 
 
We analyzed the complete medical record profile for any individual in the GPRD with at 
least one NTD code between January 1, 1987 and September 14, 2004. The NTDs of interest 
in this study are anencephaly, encephalocele, meningocele and spina bifida. Our goal was to 
identify new cases of NTDs that occurred within the time frame of our available data from 
the database (January 1, 1987 to September 14, 2004).   
To begin the identification process, we first identified potential mothers and children.  
Separate exclusion criteria were applied to each of these types of records.  We considered all 
individuals as potential mothers if they were female and had a birth year between 1942 and 
September 1989 (between 15 and 45 as of 1987).  Individuals were potential children if their 
birth year was between 1987 and 2004.   
To avoid identifying records in which the mother herself had a NTD, we excluded NTD 
records in a mother’s profile that were not within 210 days of another record indicating that 
the woman was pregnant. We also excluded records dated January 1
st
 of a given year (used 
for recording historical information) if they were not within 30 days of any record indicating 
the woman was pregnant.  Finally, to rule out the duplicate recording of a single NTD in a 
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woman’s record, we selected the first NTD in a mother’s profile and excluded all future 
records of NTDs recorded for a period of 60 days.  When conflicts between two types of 
NTDs existed (i.e. a record for both meningocele and spina bifida was present), we selected 
the first record as the correct diagnosis. 
We applied a separate series of exclusion criteria to the NTD codes identified in 
children’s profiles.  We analyzed the first 365 days of data available for a child after their 
estimated date of birth (the 15
th
 of their birth month) and selected the first record of a NTD as 
the primary NTD diagnosis. All future records of NTD for that child were excluded.  If the 
first NTD record was dated January 1
st
 of a given year, it was excluded if not within 30 days 
of the child’s estimated birth date.   
The use of a link between the children’s and mother’s records was necessary to rule out 
duplication of events between profiles.  To avoid double counting, we utilized the GPRD’s 
mother-baby linkage.  Once linked, the date of the first occurrence of a NTD diagnosis in the 
child’s profile was compared to the date (or dates) of any NTD diagnosis in a mother’s 
profile.  If any NTD diagnosis in a mother’s profile was within 180 days of the date in the 
linked child’s profile, the record in the mother’s profile was excluded.  When the GPRD’s 
mother-baby linkage was not able to provide us with a matching mother or child’s 
identification number, we ruled out duplication by comparing GP Practice Identification 
numbers and NTD event dates.  When GP Practice Identification numbers were the same, we 
considered a NTD to be a duplicate if it was the same NTD diagnosis and the event codes 
were within 90 days of each other.  
Once all NTD cases were identified, a questionnaire was sent to the GP for each 
identified NTD using the Verification Service provided by the GPRD Division at the 
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Medicines and MHRA.  Each questionnaire consisted of at least three questions: 1) Can you 
confirm the NTD diagnosis and date, 2) What source was reviewed to confirm the diagnosis 
and date, and 3) If the NTD was confirmed, what type of examination was performed to 
determine the diagnosis.  When the record was part of a mother’s profile, we asked the GP to 
indicate if the diagnosis was the mother’s own condition or if the diagnosis was for the 
mother’s fetus or offspring.  When the mother-baby linkage linked a case, we asked the GP 
to verify the linkage.   
2. Operational Procedure 
 
The following is a detailed description of the case identification process starting with a 
description of the data that were used. After reviewing the data files used in case 
identification, we describe our three-step identification process. Although explained in text 
below, flow charts were created (see below) to aid in the description of this process. 
The GPRD provided all demographic information, clinical event records, diagnostic tests, 
laboratory tests, and immunization records from January 1, 1987 through September 14, 
2004 for all individuals in the data set with either a NTD code (see Appendix B) or a 
pregnancy related code (see Appendix C).  Data was gathered for practices that met the 
GPRD’s up-to-standard quality assurance standards.  All files were delivered separately as 
tab delimited text files and in the case of the clinical event files, unique files were available 
for each year.  All files were then merged into SAS data sets.   
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Figure 4.21 – Initiation Of Case Identification Process.  
 
 
For the purposes of identifying cases, a single file clinref_all was created from four of 
our original data request files: clinfiles_all (combined file for clinical files from 1987 to 
2004), refer_97_04 (referral files from 1997 to 2004), refer_upto97 (referral files up to 
1997), diag_clin (clinical files of possible NTD patients not in clinfiles_all) and ntd_referral 
(referral files of possible NTD patients not in the other referral files). The contents of this file 
include the following variables: 
• PID – The unique patient identification number 
• EVENTTYPE – Text variable indicating type of event record (clinical, referral, etc) 
• EVENTID – The unique identification number for each recorded clinical event 
• EVENTCODE – The GPRD Medical Code for the event associated with the 
EVENTID 
• EVENTDATE – The date of record for the particular event associated with the 
EVENTID 
• TEXTID – The unique identification number for a text note associated with an 
EVENTID 
• SOURCE – A categorical variable indicating which original data file each record 
came from 
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Once these files were combined, the PID’s for any individual with at least one code for a 
NTD (see Appendices 2a-2d) where identified.  Upon identification of these individuals, four 
new files where created from the contents of clinref_all:   clinref_anenceph (all records from 
clinref_all for those individuals with at least one anencephaly code), clinref_ceph (all records 
from clinref_all for those individuals with at least one cephalocele code) ,clinref_menin (all 
records from clinref_all for those individuals with at least one meningocele code), and 
clinref_spina (all records from clinref_all for those individuals with at least one spina bifida 
code).  At this point there were four files that contained all clinical and referral records for 
any potential case in the GPRD database.  The variables were the same as those listed above 
for the file clinfiles_all.   For the purpose of simplifying the following discussion, we refer to 
the four files clinref_anenceph, clinref_ceph, clinref_menin, and clinref_spina in the generic 
format clinref_diagnosis.   
At this point the clinref_diagnosis files do not contain any demographic information 
about the individual.  In order to start the process of identifying the actual cases we added 
this information to the files.  The files preg_demog and ntd_demog contain demographic 
information on all patients with either a code indicating a pregnancy or a NTD code.  Upon 
addition of this data, the contents of this file includes the following variables in addition to 
those mentioned above: 
• PRACTICEID – the unique general practice identification number 
• BIRTHYEAR – the patient’s year of birth (available for all patients) 
• BIRTHMONTH – the patient’s month of birth (for individuals less than 15 years old) 
• FAMILYNUM – a practice assigned family identification number 
• GENDER – the gender of the patient 
• REGDATE – the date the patient was registered at a specific practice 
• SMOKE – history of smoking (yes/no) 
• DRINK – history of drinking (yes/no) 
• HEIGHT & WEIGHT – height and weight at visit 
• BMI – calculated BMI based upon height and weight 
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• TRANSOUTDATE – date in which a patient transfers out of a practice 
• TRANSOUTREASON – reason for which a patient transfers out of a practice 
 
The files clinref_diagnosis_d where the starting point for our identification of cases and 
all subsequent files have the above-mentioned variables.  Once updated with the 
demographic information, we were able to begin applying our exclusion criteria.  The case 
identification process has three stages: Step 1 – application of universal exclusions and 
creation of mother and child files, Steps 2 a & b – continued application of exclusion criteria 
and identification of cases in mother’s and children’s records, and Step 3 – combining of 
mother’s and children’s records and removal of duplicates.  These three steps are described 
in the process below. 
a. Step 1 – Universal Exclusions And Creation Of Mother And Child Files 
 
The first two exclusion criteria were universally applied to all records within the 
clinref_diagnosis_d files with the intent of removing patient history references and records 
entered with the incorrect date (data entry errors).  These steps are described below.  Each 
step includes the name of the generic source file and output files. 
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Figure 4.22 – Step 1 Of Case Identification Process 
 
The first step was the removal of records with event dates prior to 1/1/1987 or after 
9/14/2004.  The GPRD was launched as a database in on 1/1/1987.  Any dates before 
1/1/1987 are events that have been recorded by a GP as part of the patient’s medical history.  
Any dates after 9/14/2004 (the last date of data gathered from the GPRD for this project) are 
either data entry errors or default dates when no year is entered by the GP.   The source file 
was clinref_diagnosis_d and the output files were clinref_diagnosis_1 and 
remove_1_diagnosis. 
The second step was the removal of records with event dates prior to the individual’s 
registration date.  If one considers the registration date as the date of first contact with a 
patient by the GP, all dates before that should be considered patient history references or 
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errors in data entry. The source file was clinref_diagnosis_1 and the output files was 
clinref_diagnosis_2 and remove_2_diagnosis. 
After removing these records, we began the third step: the process of identifying children 
and mothers’ records.   Potential children records are the records of those individuals less 
than 18 years old as of September 14, 2004 (last date of data collection in this study). 
Children are defined as an individual that had a birth year after 1987. As the exact date of 
birth is not available, we estimated the birth date as the 15
th
 of the month in which the child 
was born (birth month is available for individuals born after 1987).  
All records with a birth year before 1987 were considered adult records.  Because we 
were only interested in finding new cases, we restricted adult records to females that may 
have had a pregnancy associated with a NTD.  Females born after 1942 and before 1987 
(between 1 and 44 years old as of 1987) were considered potential mothers. Males born 
before 1987 (more than 17 years old as of 2004) and women born before 1942 (over 44 years 
old) were not of interest in this study.  The source files for this step are clinref_diagnosis_2 
and the output files are clinref_diagnosis_3.  
To review, the electronic definition of a child’s record is: 
• a record that has a birth year after 1987; 
and the electronic definition of a mother’s record is: 
• a record of a female, and 
• a record with a birth year between 1942 and 1986. 
The determination of whether a record was a child’s or a mother’s was necessary to rule 
out identification of the same NTD in both records.  A non-fatal NTD may be recorded in a 
mother’s record on or about the date of a live birth.  As the infant is alive, a new patient 
identification number is generated for the infant when first seen by the GP.  This presents the 
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opportunity for the same NTD to be recorded and counted in a mother’s and child’s record.  
To avoid this double counting we utilized the mother-baby linkage to link potential mothers 
and infants.  We discuss the use of the mother-baby link further at the end of the case 
identification process.  
We applied a number of exclusion criteria to the general data in the files 
clinref_diagnosis_3.   These exclusion criteria had slight differences based upon the type of 
record (mother or child) and thus are described separately (Step 2a and 2b). 
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b. Step 2a – Identification Of Cases Within A Mother’s Records 
Figure 4.23 – Step 2a Of Case Identification Process In Mother’s Records: Part 1. 
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Figure 4.24 – Step 2a Of Case Identification Process In Mothers Records: Part 2. 
 
 
The following are details as to how cases are identified in a mother’s record.  These 
details are depicted in the figures above.  At each step that results in the removal of records, 
we created separate files containing the removed data.  This data was reviewed to ensure that 
only the intended data was present.  
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The first step was the identification of all the records from females born between 1942 
and 1987 (between 17 and 44 years old) in the file clinref_diagnosis_3 and created new files 
containing all clinical and referral records for mothers.  The source files are 
clinref_diagnosis_3 and the output files are clinref_diagnosis_4m. 
Next we identified all records with at least one NTD code (Appendix B) and created an 
indicator variable for each possible case type (i.e. anencephaly, cephalocele, meningocele, 
and spina bifida).  These new variables allowed us to create counts of separate cases and 
assign records a series of “case dates” for use in future steps.  The source files are 
clinref_diagnosis_4m, clinref_diagnosis_5m, and clinref_diagnosis_6m (_5m and _6m are 
also output files for this step).  The output files are clinref_diagnosis_5m, 
clinref_diagnosis_6m and clinref_diagnosis_7m.  No records were removed at this step.  
Next we identified records related to a pregnancy, captured the individual dates, and 
compared these dates to each of the “case dates” described above.  Records related to a 
pregnancy are any record that has an event code listed in Appendix C.  If any/all of the case 
dates preceded a pregnancy related record by 0 to 210 days, a new indicator variable was 
created and set to 1.  This new variable, wi_seven#, indicates that a specific NTD record 
(identified by a particular case date) was within 210 days of at least one pregnancy related 
record.  The source files for this step are clinref_diagnosis_7m, clinref_diagnosis_8m and 
clinref_diagnosis_9m (files _8m and _9m are also output files in this step).  The output files 
were clinref_diagnosis_8m, clinref_diagnosis_9m and clinref_diagnosis_10m.  No records 
are removed in this step. 
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The fourth step was similar to the previous step, but focused on potential case records 
that may indicate a patient history record.   At times a GP may want to record the occurrence 
of an event in the patient’s medical history, while only knowing the year in which that event 
occurred.  The default month and day for an entry into the patient’s record without a specific 
date is January 1
st
 of a given year.  As records on “1/1/YEAR” are often historical references 
that lack specific information, we excluded records that were not in close proximity to the 
date of a pregnancy related record.  Any events that occur on 1/1/YEAR that have a 
pregnancy related record in the 30 days before were considered potential cases.  To test the 
assumption of 30 days, we performed a number of alternate analyses on the 30-day cut off to 
see if they materially affected our results.  If a potential case record was up to 30 days after a 
pregnancy related record, the new indicator variable wi_thirty# was set to 1. The source files 
for this step were clinref_diagnosis_10m, clinref_diagnosis_11m, clinref_diagnosis_12m, 
clinref_diagnosis_13m, clinref_diagnosis_14m and clinref_diagnosis_15m (files _11m 
through _15m are also output files in this step).  The output files were 
clinref_diagnosis_11m, clinref_diagnosis_12m, clinref_diagnosis_13m, 
clinref_diagnosis_14m and clinref_diagnosis_15m.  No records were removed in this step. 
In summary: potential case records that were 210 days before or after of a pregnancy 
record, and if on 1/1 of a given year no more than 30 days after a pregnancy record, had the 
variables wi_seven# and/or wi_thirty# set to one.  All other records (regardless of whether the 
are related to pregnancy or case status) had these two variables set to zero. 
The next step was to select all of the records that meet our exclusion criteria.  We 
considered all NTD records potential cases if they were within 210 days of a pregnancy event 
or if on 1/1 of a given year were within 30 days of a pregnancy event.  All other records were 
 - 96- 
removed.   The source file for this step was clinref_diagnosis_15m and the output files were 
clinref_diagnosis_16m and remove_16_diagnosis.   
The last step in this stage was to assign date differences between potential case records to 
determine if separate potential cases existed.  If a potential case occurs >=60 days from 
future cases within a mother’s record, the future record was considered a separate case.  If it 
was < 60 days from another code, it was considered a duplicate record and was removed.  
The use of the 60 day cut off between two potential case records was based upon an estimate 
of the number of days that would be required to elapse after a pregnancy termination but 
before a women is likely to be diagnosed as pregnant again.
162
 After this amount of time a 
women could potentially become pregnant and experience another NTD.  As this 60 day cut 
point potentially had a large impact on our the number of cases, we performed alternate 
analyses by cutting this range to 15 and 30 days, as well as raise to 90, 180 and 365 days. 
The source files for this step were clinref_diagnosis_16m and the output files were 
clinref_diagnosis_final_m and remove_diagnosis_final_m.   
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c. Step 2b – Identification Of Cases Within A Children’s Records 
Figure 4.25 – Step 2b Of Case Identification Process In Children’s Records: Part 1. 
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Figure 4.26 – Step 2b Of Case Identification Process Part 2. 
 
We next identified cases in children’s records.  The process is depicted in the figures 
above.  The first step was to identify all records that had a birth year after 1987 but before 
2005 from clinref_diagnosis_3 and create new files containing all valid clinical and referral 
records for mothers.  This created our group of potential children.  The source files are 
clinref_diagnosis_3 and the output files are clinref_diagnosis_4c. 
We then identified all records with at least one NTD code from Appendix B and create an 
indicator variable for each possible case type (i.e. anencephaly, cephalocele, meningocele, 
and spina bifida).  These new variables then allowed us to create counts of separate cases and 
assign records a series of case dates for use in future steps.  The source files were 
clinref_diagnosis_4c, clinref_diagnosis_5c, and clinref_diagnosis_6c (_5c and _6c are also 
output files for this step).  The output files were clinref_diagnosis_5c, and 
clinref_diagnosis_6c.  No records were removed at this step.  
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Next we identified records on “1/1/YEAR” and selected those records that were within 
30 days of the child’s estimated date of birth. All records with dates of 1/1/Year that are not 
within 30 days of the date of birth were removed. The use of the child’s estimated birth date 
is a potential source of bias in this criteria, thus we performed alternate analyses on the 30-
day cut off to see if it materially affected our results. The source files for this step were 
clinref_diagnosis_6c, clinref_diagnosis_7c, clinref_diagnosis_8c and clinref_diagnosis_9c 
(files _7c through _9c are also output files in this step).  The output files were 
clinref_diagnosis_7c, clinref_diagnosis_8c, clinref_diagnosis_9c, and 
remove_diagnosis_9_c. 
Next we identified case records, captured the dates, and compared these dates to the 
estimated birth date of each patient.  Potential case records that are between 0 and 365 days 
from the patient’s date of birth were considered potential cases, and those that were not 
within this range were removed. The source files for this step were clinref_diagnosis_9c, 
clinref_diagnosis_10c, clinref_diagnosis_11c and clinref_diagnosis_12c (files _10c, _11c 
and _12c are also output files in this step).  The output files were clinref_diagnosis_10c, 
clinref_diagnosis_11c, clinref_diagnosis_12c and remove_diagnosis_12_c. 
The last step in this stage was to identify the first potential case record for each patient.  
As the case type cannot be repeated in a patient (i.e. each patient only represents a single 
possible case), the first occurrence of each NTD type was considered the only one.  Please 
note that the possibility that the same child may have two separate diagnoses still exists at 
this point.  Ruling out alternate diagnoses will take place in the next step of case 
identification.  The source files for this step was clinref_diagnosis_12c and the output files 
were clinref_diagnosis_final_c and remove_diagnosis_final_c.   
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d. Step 3 – Merging Mothers’ And Child’s Records And Eliminating Duplicates 
Figure 4.27 – Step 3 Of Case Identification Process. 
 
 
In the final step of case identification (depicted above) we combined our potential cases 
identified from the record of a mother or child and compared them for potential duplication.  
Each of the files generated from the case identification process for mothers 
 - 101- 
(clinref_anenceph_final_m, clinref_ceph_final_m, clinref_menin_final_m, and 
clinref_spina_final_m) was recombined to form a single file: clinref_ntd_m.  For each 
patient, if a case occurrence is within 60 days of another case occurrence, the case type that 
occurs first was considered the final case type.  This allowed a mother’s record to contain 
multiple different case types, but rules out the possibility that the same case (i.e. within 60 
days of each other) are counted twice in our case counts.   
A similar approach was applied to the children’s records.  Like a mother’s record, the 
files generated from the case identification process for children (clinref_anenceph_final_c, 
clinref_ceph_final_c, clinref_menin_final_c, and clinref_spina_final_c) were combined to 
form a single file: clinref_ntd_c.  However, as the case type cannot legitimately change 
throughout the child’s life, we considered the first recorded case type to be the only case type 
for the child.  This prevents the child’s record from containing multiple different case types.  
As potential cases are removed in this step, a new file, remove_ntd_c, was created and 
reviewed. 
The final step (recombining the case files and finalizing the list of cases) required the use 
of the mother-baby linkage.  A detailed description of the methods used for the mother-baby 
linkage is provided in the Chapter II, Part E, Section 2.  The possibility exists that a non-fatal 
NTD case could exist both in a mother’s record (the record of the event associated with a 
birth) and as part of a child’s record (within the first 12 months of life).  In order to rule out 
these duplications, we used the mother-baby linkage to identify all the offspring of the 
mothers with a NTD record, and all the mothers of children with a NTD record. Once linked, 
the date of the first occurrence of a NTD diagnosis in the child’s record was compared to the 
date (or dates) of any NTD diagnosis in a mother’s record.  If any NTD diagnosis in a 
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mother’s record was within 180 days of the date in the linked child’s record, the diagnosis in 
a mother’s record was removed from the file clinref_ntd_all and placed in the file 
remove_ntd_all for further evaluation.  The source files for clinref_ntd_all were 
clinref_ntd_m and clinref_ntd_c. 
As this step is dependent on the reliability of the mother-baby linkage and our decision to 
call records that occur within 180 days of each other duplicates, we conducted several 
additional analyses. We conducted alternate analyses utilizing 90 days and 210 days as the 
cut points for designating mother-baby linked cases duplicates.  To test the reliability of the 
mother-baby linkage we also analyzed all NTD cases (regardless of diagnosis) that occur 
within 14 days of each other.  The family identification number and the practice 
identification numbers were compared.  If the family identification number or the practice 
identification number match, the cases were copied to the file suspect_ntd_final and 
considered a possible duplication.  
3. Validation Of Outcomes 
 
The verification service provided by the GPRD Division at MHRA was used to distribute 
a GP Questionnaire for all NTD cases.  The GP questionnaire was designed by 
epidemiologists with input from a dysmorphologist to provide as much insight as possible 
into the appropriateness of the diagnosis that is listed in the computer records.  The GP 
questionnaire was submitted to the GPRD Scientific and Ethical Advisory Group (SEAG) for 
their input and approval.  The SEAG assesses all questionnaires for appropriate content, time 
to completion and accessibility of the requested data. The SEAG approved GP Questionnaire 
may be found in Appendix A.  A case that met our operational case definition of 
anencephaly, encephalocele, meningocele, or spina bifida and was confirmed by a physician 
 - 103- 
through the GP questionnaire was considered a validated case. In order to validate the 
linkage between mother and offspring we also asked the GP to confirm the personal 
identification number of the suspected mother of a case when a mother for the case could be 
identified using the mother-baby linkage. 
E. Quality Assurance/Quality Control 
1. GPRD Quality Assurance Practices 
 
The MHRA utilizes a robust data quality program to ensure that the data utilized in any 
study is of the most reliable quality. Data quality indicators are available for individual 
patient records and each GPRD practice. 
187
 Individual patient records are considered to be of 
“acceptable” quality if no event records exist prior to birth year, the estimated age of the 
patient is less than 115 years old, the gender is recorded as either male, female or 
indeterminate, and the patient is in one of three acceptable registration status categories: 1) 
the patient is registered as ‘Applied’, ‘Permanent’ or ‘Transferred Out’; 2) the patient 
registration year is after or equal to the patient birth year, and 3) for a patient registered as 
‘Permanent’ or ‘Applied’ there is no transferred out date and reason, or for a patient 
registered as ‘Transferred Out’ there is a valid reason for transferring out and the date that the 
patient transfers out is after the registration date.  
GPRD practices that meet GPRD data quality standards are considered up-to-standard 
(UTS).  To be considered up-to-standard the practice must meet continuity of data checks 
that insure that there are no gaps in the reporting of patient record information and pass a 
series of time series analyses that evaluate the practices records for major data entry flaws.  
We only used data from patients in practices with an up-to-standard rating.  
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2. Data Management Quality Assurance Practices 
 Quality assurance criteria were also applied to the data sets received from the GPRD. 
The text files created from the GPRD data management software were converted to SAS 
data sets.  To insure that the SAS data sets were correctly converted, variable and 
observation counts were compared to values created from the GPRD data management 
software.  Once the integrity of the SAS data sets was confirmed, we verified that the 
data used for analysis met our inclusion and exclusion criteria.  This was accomplished 
by conducting range checks for the variables of birth year, birth month and gender and 
verifying that we only used records that met acceptable patient registration status criteria 
and were from practices that are considered up to standard.  
 The author and the dissertation advisor, Dr. Suzanne West, reviewed the entire 
medical profile for each NTD record.  Based upon our definition of a NTD, we 
determined if multiple records occurred or if illogical combinations of diagnoses exist 
(i.e. anencephaly followed by additional codes indicating additional health services).  
While we found no illogical combinations of diagnoses, the review did however lead to 
the addition of the question determining if the record was the mother’s own condition or 
the condition of her offspring or fetus. 
3. Programming Quality Assurance Practices 
  
 As this project was computer programming intensive, the quality and integrity of the 
programming was essential.  We conducted two quality assurance procedures to insure all 
programming was correct.  The first procedure was the detailed documentation of all 
programming.  SAS was the primary analytic software program used in the analysis.  
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SAS was used to construct all data files, conduct range checks, determine frequencies, 
counts and conduct all statistical analyses.  All SAS data step editor files and SAS log 
files were retained. Comments were used throughout the coding to describe the 
programming with the intent of meeting the second quality assurance procedure 
described below.  Log files were generated and retained in their original form for each 
days programming.   
 The second procedure for quality assurance was the review of select coding and log 
files by a second investigator, Dr. Suzanne West.  Dr. West reviewed code and log files 
with the intent of determining the accuracy of the coding steps and outputs.  Although Dr. 
West did not repeat the data analysis, major errors in coding could be found through this 
review.   
F. Analysis Plans 
1. Pregnancy Identification 
Our primary analytic output for the pregnancy identification process was annual counts of 
pregnancies. Upon identification, key characteristics of all women with pregnancies were 
described.  The age of the woman, and the age at first pregnancy was determined and 
categorized into six groups: <=20 years old, >20 to 25 years old, >25 to 30 years old, >30 to 
35 years old, >35 to 40 years old and >40 years old (45 is upper limit of our records). 
Screening and diagnostic methods for NTDs (AFP, Amniocentesis and Ultrasound) used in 
any pregnancy and the availability of smoking and alcohol use information were determined.    
In addition to these primarily descriptive analyses, we also conducted a series of detailed 
electronic record reviews, assessments of variables used at various stages and alternate 
analyses in order to evaluate our identification algorithm.  To find potential errors in our 
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algorithm we reviewed records of women with extremely short or long periods of time 
between their first and last identified pregnancies as well as women with eight or more 
pregnancies.   
Several reviews of variables created by the algorithm were also conducted.  The length of 
time between events within pregnancy categories impacts the number of EOP events that we 
identified.  We conducted multiple alternate analyses varying the required time between 180 
and 280 days for stillbirths, live births, pre-term and post-term births and multiple births and 
between 30 and 120 days for elective terminations and spontaneous abortions.  We also 
assessed our assumptions of the length of time between events of different pregnancy event 
categories by varying the required time from 210 days to between 180 and 280 days for 
stillbirths, live births, pre-term and post-term births and multiple births and from 60 days to 
between 30 and 120 days for elective terminations and spontaneous abortions.   
The time between potential EOP events was plotted and assessed to determine if our 
assumptions concerning required gaps were appropriate for the data.  We also plotted and 
assessed the number of days between the first identifiable PCM and its associated EOP event 
to determine if the beginning and ending of a pregnancy were consistent with those found in 
other data sources.
162, 172
   
We conducted alternate analyses using all records regardless of their relationship to 
registration or practice up-to-standard dates, or only the patient registration date as the 
beginning of records to ascertain the impact of these exclusions.  Additionally, we evaluated 
our assumption that a PCM or EOP event found on a 1/1/YEAR date that was within 30 days 
was valid by varying this number between 15 days and up to 120 days.  Finally, we assessed 
our assumption that pregnancy markers could be no more than 280 days prior to an EOP 
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event by plotting the number of days between each pregnancy marker and any EOP event in 
the patients record.   
2. NTDs 
One of the primary analytic outputs from the NTD validation study was the determination 
of annual NTD prevalences. It has been historically difficult to determine the incidence of 
NTDs, as many pregnancies do not result in a live birth, but rather in a stillbirth or an elective 
or spontaneous termination.  Many monitoring programs, including the CDC’s programs, 
have been limited to live births and stillbirths of >20 weeks of gestation.  The CDC 
concluded in 1995 that estimation of the prevalence of NTDs at birth should include those 
cases that were electively terminated.
188
 In several studies of the subject, prenatal diagnostic 
testing has resulted in increased terminations.
87, 188-194
 With the increase in prenatal screening 
and the high degree of variability in reporting and surveillance of elective terminations, some 
under reporting of terminations may result in artificially low rates of NTDs.  For these 
reasons, we only report the prevalence of NTDs in our analyses. 
Upon the completion of each of the above-mentioned pregnancy identification analyses, 
we were able to determine annual prevalences. The numerators and denominators used to 
calculate key prevalence outputs are summarized below.  
Annual Prevalence –  
# Cases in Year (from live births, stillbirth, & terminations) 
# Potential Pregnancies in Year (live births, stillbirth, & terminations) 
Using positive predictive value adjusted case counts of NTDs as well as totals from the 
annual pregnancies, the prevalence for all NTDs were calculated and presented per 10,000 
pregnancies.   
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To evaluate the internal robustness of our NTD identification algorithm, we conducted a 
number of alternate analyses.  To evaluate some of our baseline assumptions for evaluating 
the mothers’ records for NTDs, we varied both the number of days a pregnancy related 
record (Appendix C) must precede a normally recorded NTD diagnosis as well as one that 
may represent a historical reference.  For children’s records, we varied the number of days 
from the child’s date of birth that a potential historical record may be recorded, and we 
extended the number of days past the estimated birth date that the first NTD diagnosis could 
be recorded.  Because many NTDs may be recorded in close proximity to the patient’s GP 
registration date, we determined the number of additional cases that could be identified if we 
looked in various time frames before the registration date.  Finally, we varied the required 
number of days between the first NTD record and any subsequent records used to see if it 
influenced the number of cases identified by the algorithm. 
The cases identified by the NTD algorithm and the cases from the returned GP 
questionnaires were compared.  Those cases in which the GP confirmed the presence of a 
NTD were considered validated cases. We determined the positive predictive value (PPV) of 
our algorithm for the validated cases.  Sensitivity and specificity of our algorithm cannot be 
determined because the number of true cases and non-cases could not be determined.  We 
determined a priori that if our validated PPV was less than 70 percent, we would revise our 
electronic case definitions. If our validated positive predictive values exceeded 70 percent we 
would determine alternate case counts based upon the validated positive predictive values. 
Alternate case counts were calculated by multiplying the annual observed case counts by the 
positive predictive value determined for validated cases. 
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Using the alternate case counts, we determined annual prevalences of NTDs in the GPRD 
for the years 1991 through 2003.  We restricted our calculations to these years, as our data on 
pregnancies was most complete for this time frame.  The annual prevalence was calculated 
by dividing the number of alternate cases by the number of live births, stillbirth, and 
terminations. Annual prevalences were standardized to the age distribution of women giving 
birth in the UK. To aid in comparing our results to those of surveillance systems in the UK, 
we charted our age standardized annual prevalences with those of the UK’s National 
Congenital Anomaly System.   
To establish our ability to avoid duplicate counting of NTD records in both a mother’s 
and a child’s record we determined the accuracy of the GPRD mother-baby linkage for those 
NTD cases that we were able to link.  The linkage between a mother and her offspring was 
considered correct by a positive response to a question on the GP’s questionnaire. When the 
linkage between mother and offspring was confirmed, we described details of the mother at 
the time that the NTD was identified. 
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V. RESULTS 
A. Additional Results 
1. Review of NTD Cases With Changes In Diagnosis During 1st Year  
Duplicate records of medical diagnoses are common place within the GPRD.  Because 
the care delivered to a child with a NTD is likely to take place over the course of many visits 
to the GP, medical event codes signifying the NTD as the problem relating to care can and 
should be recorded several times throughout the patient’s profile.  As the GP has freedom to 
utilize any code, the possibility exists that different NTD codes can occur in the record over 
time.  This becomes problematic when the actual category of NTD appears to change within 
the patient’s record.  This change can be due to a change in the GP’s opinion of the diagnosis 
or by the feeling that some codes can be used interchangeably.  In order to develop an 
algorithm to identify NTD diagnoses, we selected the first diagnosis by date, and in the case 
of a tie, by the first event identification number.  We chose the first diagnosis based upon the 
assumption that the initial diagnosis may be the most likely to be determined by a specialist 
rather than the GP. 
The following is a brief discussion on the five instances in which our identification 
algorithm found two potential NTD types within a child’s record.  Although the possibility 
exists that duplication could have occurred in a mother’s record, we found no instances of 
this eventuality in the cases identified.   
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a. Description Of Identified Cases With Changes In Diagnoses 
 
We identified five NTD cases with two different categories of NTD within the first year 
of the child’s life.  All five of the cases were identified from the primary clinical event files.  
No referral files were used to identify these cases.  A brief summary of each case is presented 
in table 5.1 below.  The first case for each individual was considered the final case. 
Table 5.1 – Summary of Cases Which Changed Diagnosis Within the First Year 
Event 
Code 
Event Code 
Description 
Event 
Date 
DOB Gender Reg 
Date 
Case 1      
304969 Meningocele 3/17/97 3/15/97 Female 3/17/97 
304968 Spina Bifida 6/13/97 3/15/97 Female 3/17/97 
Case 2      
299389 Meningomyelocele 2/27/98 1/15/98 Female 2/9/98 
208117 Spina Bifida with 
hydrocephalus 
2/27/98 1/15/98 Female 2/9/98 
Case 3      
262689 Spina Bifida 7/29/02 6/15/02 Female 7/22/02 
277162 Closure of spinal 
myelomeningocele 
12/3/02 6/15/02 Female 7/22/02 
Case 4      
277162 Closure of spinal 
myelomeningocele 
12/23/03 10/15/03 Female 12/18/03 
262689 Spina Bifida 1/7/04 10/15/03 Female 12/18/03 
Case 5      
280988 Spina bifida with 
hydrocephalus, 
unspecified 
8/7/90 5/15/90 Male 6/6/90 
280993 Spinal meningocele 8/25/90 5/15/90 Male 6/6/90 
 
b. Validation Results 
 
We reviewed the results of the validation questionnaire to determine if the GP confirmed the 
diagnosis for the cases we submitted.  Three of the five GP questionnaires were returned.  
The GP confirmed the date and diagnosis of each of the three cases.  The results of the 
validation questionnaires are summarized in the table below. 
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Table 5.2 – Summary of Validation Responses for Cases Which Changed Diagnosis Within the First 
Year. 
Event Code 
Description 
Event 
Date 
GP 
Quest  
Returned 
Diag 
Validated 
Source Reviewed Exam Performed 
Case 1      
Meningocele 3/17/97 No n/a n/a n/a 
Case 2      
Meningomyelocele 2/27/98 Yes Yes EMR, Letter from 
Spec 
Other (No access to 
maternal AN records) 
Case 3      
Spina Bifida 7/29/02 Yes Yes EMR Ultrasound, MRI 
Case 4      
Closure of spinal 
myelomeningocele 
12/23/03 No n/a n/a n/a 
Case 5      
Spina bifida with 
hydrocephalus, 
unspecified 
8/7/90 Yes Yes EMR, Letter from 
Spec, Paper Chart 
Physical Exam by 
Ped/OB 
 
c. Conclusions 
Because of the limited number of cases with changes in diagnoses, it is difficult to reach 
any definitive conclusion as to the appropriateness of our assumption that using the first 
diagnosis identified.  There are several points that are encouraging.  The first are the 
validation results.  All three of the returned questionnaires confirmed both the date and the 
diagnosis of the NTD in question and two of the three confirmed this using a letter from a 
specialist physician.  As we expected the first diagnosis to be based upon the opinion of a 
specialist, these responses were reassuring.  The second point is that all of the changes in 
diagnosis were related to cases of spina bifida or meningocele.  As these two case types have 
a number of similarities in presentation and meningocele is often considered a type of spina 
bifida, some physicians may interchange these codes.  Based upon these two points, we are 
comfortable with maintaining the assumption that the first identified diagnosis is the correct 
diagnosis. 
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2. Pregnancy Identification Alternate Analyses 
Few of our reviews or alternate analyses described in our analysis section resulted in any 
substantive changes in our final results, demonstrating that our initial assumptions resulted in 
a fairly robust algorithm.  We reviewed the records of the five women with four or more 
pregnancies that had the shortest and the longest length of time between their first and last 
pregnancy.  All five of the women with the least amount of time between their first and last 
recorded pregnancy experienced three or more miscarriages in relatively short order.  The 
women with the longest time between the first and last pregnancy exhibited no discernable 
patterns. 
The records of the forty-one women with eight or more pregnancies were reviewed. We 
identified no reason to believe that any of the reviewed records were inaccurate.  One of 
these women had seven live births, eight had six live births, five had five live births, twelve 
had four live births, and fifteen women had less than four live births.  One woman had nine 
miscarriages over a three-year period.  The miscarriages were no less than 70 days apart, 
with five of the nine greater than 140 days apart. Based on the low number of multiple 
pregnancies, the retention or elimination of these records would have minimal impact on the 
final number of pregnancies. 
We altered the required number of days between events from our baseline of 210 days to 
between 180 and 280 days for stillbirths, live births, pre-term or post-term births and multiple 
births and from 60 days to between 30 and 120 days for elective terminations and 
spontaneous abortions.  These analyses reliably added pregnancies as compared to baseline 
when criteria were relaxed and lost pregnancies when criteria were constricted.  Changing the 
number of days between events to 280 and 120 resulted in up to 4,755 fewer pregnancies, 
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whereas reducing the number of days to 180 and 30 resulted in up to 1,271 additional 
pregnancies.    
We performed an additional check on our baseline choices that if an EOP event were 
greater than 210 days (for stillbirths, multi-births, pre/post-term births and live births) or 60 
days (spontaneous abortions or miscarriages and elective terminations), it would represent a 
separate event. We present histograms of the time between EOP events in the figure below.   
Figure 5.1 – Days Between Stillbirth Event Codes In The GPRD Between 1987 and 2004. 
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Figure 5.2 – Days Between Live Birth Stillbirth Event Codes In The GPRD Between 1987 
and 2004. 
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Figure 5.3 – Days Between Elective Termination Event Codes In The GPRD Between 1987 
and 2004. 
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Figure 5.4– Days Between Spontaneous Termination Event Codes In The GPRD Between 
1987 and 2004. 
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Figure 5.5 – Days Between Multiple Birth Event Codes In The GPRD Between 1987 and 
2004. 
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Figure 5.6 – Days Between Pre-term and Post-term Event Codes In The GPRD Between 
1987 and 2004. 
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Figure 5.7 – Days Between Live Birth Event Codes In The GPRD Between 1987 and 2004. 
 
 
These histograms in the figures above show that time is generally less than 30 days, 
indicating that most duplicate codes are recorded within 30 days of the first code of that 
event type in the patients record.  This reaffirms the above assumptions indicating that there 
is little impact upon the final number of cases if we were to change our 60-day and 210-day 
cut points for separating pregnancy outcomes. Varying our choice of requiring a pregnancy 
related code (Appendix C) to be with 30 days of an event on January 1 of a given year had 
only minor effects on our final results. 
Finally, we reviewed our baseline assumption that 280 days was the maximum length of 
time that should elapse between the patient’s first PCM and the EOP event.  This baseline 
was chosen based on the typical length of full gestation.  The figure below indicates the 
distribution of the number of days between pregnancies in our EOP event cohort.   
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Figure 5.8 – Number Of Days Between End Of Pregnancy Events For All Identified 
Pregnancies In The GPRD Between 1987 And 2004. 
 
The number of days gradually increases after 210 days with the majority time between 
pregnancies exceeding our 280-day maximum.  Based upon the results of these alternate 
analyses, we feel that our initial algorithm assumptions were robust and any change in these 
assumptions would have produced similar results. 
3. NTD Identification Alternate Analyses 
While we conducted multiple alternate analyses (see analysis plan section), only two 
produced results that had any substantive impact on the final number of NTD cases.  We 
elaborate on these alternate analyses in the sections below. 
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a. Alternate Analyses On Time Searched Past Birth Criteria 
Not all NTDs are identified at the time of birth.  Many are only identified after the 
appearance of complications that are common with the defects and through additional 
physical examination. Although our primary analysis focused on the first year after birth, we 
conducted a number of alternate analyses to explore the number of additional cases that may 
be gained by looking 180, 548, 730, 1000, and 2000 days after the estimated date of birth.  
The results of our alternate analyses are presented in the table below. 
Table 5.3 – Primary Results Of Sensitivity Analysis On Time Past Birth Criteria. 
 
Change NTD to birth date 
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%? 
from 
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case 
180             
Identified in Children’s 
Records 50 0.72 1 0.50 3 0.60 14 0.82 32 0.71 
BASELINE (365)           
Identified in Children’s 
Records 69 1.0 2 1.0 5 1.0 17 1.0 45 1.0 
548             
Identified in Children’s 
Records 79 1.14 2 1.00 5 1.00 21 1.24 51 1.13 
730             
Identified in Children’s 
Records 87 1.26 2 1.00 5 1.00 21 1.24 59 1.31 
1000             
Identified in Children’s 
Records 96 1.39 2 1.00 5 1.00 21 1.24 68 1.51 
2000             
Identified in Children’s 
Records 113 1.64 2 1.00 5 1.00 24 1.41 82 1.82 
 
Table 5.3 provides a review of the results of the sensitivity analysis and provides the 
percentage increase in the number of each case type versus the base line results.  For all case 
types, as the number of days beyond the estimated birth date increases, the more cases are 
identified.  The number of cases increases by approximately 64% for the entire group when 
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the range is extended through 2000 days, with the impact coming only from the diagnoses of 
spina bifida and meningocele.  No cases of anencephaly or cephalocele were added in this 
sensitivity analyses.   
In addition to these changes in case counts, we examined the effects of using records 
prior to registration on other variables. Tables 5.4 through 5.8 provide additional details 
about the 18 additional cases that are identified by extending the cut off to 730 days (2 
years).  Table 5.4 describes the case make-up of the 18 cases that were identified up to 2 
years after the date of birth.  More than three quarters of these cases were spina bifidas.  
Table 5.5 describes the gender break down of the individuals who had a case record.  As all 
of these records were from a suspected child’s record, each gender should represent the 
actual case.  No substantial gender predominance was noted; however, the small sample size 
should limit our interpretation of these results. 
Table 5.6 describes the difference between event date and estimated birth date.  No 
patterns are noted.  Table 5.7 indicates that 45 percent of all cases were originally identified 
from the pregnancy group clinical records; whereas 55 percent were identified from the 
group that had no history of a pregnancy related event in their clinical files.  Table 5.8 
indicates the year in which the event was recorded.  No unusual patterns were seen.   
Table 5.4 – Outcome Breakdown Of Additional Cases Added In Sensitivity Analysis On 
Extension Of Time Past Birth To 730 Days. 
 
Cumulative Cumulative  
Outcome 
Frequency Percent 
Frequency Percent 
Anencephaly 0 0.0% 0 0.0% 
Cephalocele 0 0.0% 0 0.0% 
Meningocele 4 22.2% 4 22.2% 
Spina Bifida 14 77.8% 18 100.0% 
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Table 5.5 – Gender Of Case Event Record In Sensitivity Analysis On Extension Of Time 
Past Birth To 730 Days. 
 
Current Gender (Current) 
Cumulative Cumulative Case 
Gender 
Frequency Percent 
Frequency Percent 
Female 8 44.44 8 44.44 
Male 10 55.56 18 100.00 
 
Table 5.6 – Number Of Days Between Case Event Date And Estimated Birth Date In 
Sensitivity Analysis On Extension Of Time Past Birth To 730 Days. 
 
Cumulative Cumulative Difference Between 
Event Date And 
Estimated Birth Date 
Frequency Percent 
Frequency Percent 
369 1 5.88 1 5.88 
378 1 5.88 2 11.76 
408 1 5.88 3 17.65 
409 1 5.88 4 23.53 
461 1 5.88 5 29.41 
463 1 5.88 6 35.29 
488 1 5.88 7 41.18 
500 1 5.88 8 47.06 
513 1 5.88 9 52.94 
559 1 5.88 10 58.82 
568 1 5.88 11 64.71 
589 1 5.88 12 70.59 
601 1 5.88 13 76.47 
612 1 5.88 14 82.35 
622 1 5.88 15 88.24 
679 1 5.88 16 94.12 
683 1 5.88 17 100.00 
 
 
Table 5.7 – Original Source File Of Case Event Record In Sensitivity Analysis On Extension 
Of Time Past Birth To 730 Days. 
 
Cumulative Cumulative Source Frequency Percent 
Frequency Percent 
NTD Referral File 3 16.67 3 16.67 
NTD Clinical File 7 38.89 10 55.56 
Main Clinical Files 7 38.89 17 94.44 
Main Referral 97 to 
2004 
1 5.56 18 100.00 
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Table 5.8 – Year Of Case Event Record In Sensitivity Analysis On Extension Of Time Past 
Birth To 730 Days. 
 
Cumulative Cumulative Year of NTD 
Event Record 
Frequency Percent 
Frequency Percent 
1990 2 11.11 2 11.11 
1992 4 22.22 6 33.33 
1994 2 11.11 8 44.44 
1997 2 11.11 10 55.56 
1998 1 5.56 11 61.11 
2000 1 5.56 12 66.67 
2001 5 27.78 17 94.44 
2003 1 5.56 18 100.00 
 
 
After a careful review of each of these cases with a dysmorphologist, it was 
recommended that most of the cases of spina bifida occulta be excluded as there is 
uncertainty as to their relationship to open spina bifida.
3
 Five of these cases did appear to 
have sufficient information to support their inclusion as cases (five spina bifida’s a 
meningocele).  Other cases did not have enough information in the records to support the 
case status.  This complicating factor may require that spina bifida studies utilize additional 
follow-up data for identifying and verifying potential cases.   
b. Alternate Analyses On Registration Date Criteria 
The date on which events are recorded in a patient’s record can be automatic as well as 
manually entered by the GP.  As there is some flexibility in the entry of dates, situations arise 
that patient events may be given dates prior to the date on which a patient is first registered 
with a physician.  Typically these dates are considered of questionable validity, as they are 
not entered on dates that comprise the longitudinal care history of the patient.  However, 
records of children pose additional challenges for the recording of dates.  Children are not 
always registered into a physicians practice on the date of a child’s birth, thus the record of 
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an event prior to the patients registration date may be the only method of capturing 
information determined at birth.  Although our primary analysis maintained the standard 
approach of utilizing only records entered after the registration date, we conducted a number 
of alternate analyses to explore the number of additional cases that may be gained by looking 
30, 60 and 180 days prior to registration. The results of our alternate analyses are presented 
in the table below. 
Table 5.9 – Primary results of Alternate Analysis on Registration Date Criteria. 
 
Change in days prior to 
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BASELINE           
Identified in Children’s 
Records 69 1.00 2 1.00 5 1.00 17 1.00 45 1.00 
30             
Identified in Children’s 
Records 84 1.22 3 1.50 7 1.40 24 1.41 50 1.11 
90             
Identified in Children’s 
Records 89 1.29 3 1.50 8 1.60 26 1.53 52 1.16 
180             
Identified in Children’s 
Records 90 1.30 3 1.50 8 1.60 27 1.59 52 1.16 
 
Table 5.9 provides a review of the results of the alternate analysis and provides the 
percentage increase in the number of each case type versus the base line results.  For all case 
types, as the number of days prior to registration that we allow cases to be considered valid is 
allowed to increase, the more cases are identified.  The number of cases increases by 
approximately 30% for the entire group when the cut off is extended through 180 days, with 
the impact being most dramatic for the diagnoses of cephalocele and meningocele.  Few 
cases of spina bifida were added in this sensitivity analyses.   
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In addition to these changes in case counts, we examined the effects of using records 
prior to registration on other variables. Tables 5.10 through 5.15 provide details about the 22 
additional cases that are identified by extending the cut off to 180 days.  Table 5.10 describes 
the case make-up of the 22 cases that were identified prior to registration.  More than three 
quarters of these cases were either meningoceles or spina bifidas.  An important point to 
interpreting this sensitivity analysis is that while there are up to 22 additional cases 
identified, many of these cases (3 spina bifida, 3 meningoceles and 1 cephalocele) were later 
identified by codes that were recorded after the patient’s registration date.  Table 5.11 
describes the gender break down of the individuals who had a case record.  As all of these 
records were from a suspected child’s record, each gender should represent the actual case.  
This female predominance is consistent with the literature; however, the small sample size 
should limit our interpretation of these results. 
Tables 5.12 and 5.13 describe the differences between event date and registration date 
and event date and estimated birth date respectively.  These data indicate that the almost 
three quarters of event dates are within 14 days of date of birth, and more than one half of the 
event dates are recorded within the 30 days prior to registration date.  Table 5.14 indicates 
that 60 percent of all cases were originally identified from the pregnancy group clinical 
records; whereas 40 percent were identified from the group that had no history of a 
pregnancy related event in their clinical files.  Table 5.15 indicates the year in which the 
event was recorded.  No unusual patterns were seen.   
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Table 5.10 – Outcome Breakdown Of Additional Cases Added In Sensitivity Analysis on 
Registration Date Criteria. 
 
Cumulative Cumulative Outcome Frequency Percent 
Frequency Percent 
Anencephaly 1 4.5% 1 4.5% 
Cephalocele 4 18.2% 5 22.7% 
Meningocele 7 31.8% 12 54.5% 
Spina Bifida 10 45.5% 22 100.0% 
 
Table 5.11 – Gender of Case Event Record From Sensitivity Analysis On Registration Date 
Criteria. 
 
Current Gender (Current) 
Cumulative Cumulative Case 
Gender 
Frequency Percent 
Frequency Percent 
Female 13 59.09 13 59.09 
Male 9 40.91 22 100 
 
Table 5.12 – Number Of Days Between Case Event Date And Estimated Birth Date From 
Sensitivity Analysis On Registration Date Criteria. 
 
Cumulative Cumulative Difference between 
Event date and 
Estimated Birth Date 
Frequency Percent 
Frequency Percent 
1 1 4.76 1 4.76 
3 1 4.76 2 9.52 
7 4 19.05 6 28.57 
8 1 4.76 7 33.33 
9 3 14.29 10 47.62 
10 1 4.76 11 52.38 
11 2 9.52 13 61.9 
12 1 4.76 14 66.67 
14 1 4.76 15 71.43 
15 2 9.52 17 80.95 
16 1 4.76 18 85.71 
17 1 4.76 19 90.48 
24 1 4.76 20 95.24 
72 1 4.76 21 100 
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Table 5.13 - Number Of Days Between Case Event Date And Registration Date From 
Sensitivity Analysis On Registration Date Criteria. 
 
Cumulative Cumulative Time Delay 
Between NTD 
Event Date and 
Registration Date 
Frequency Percent 
Frequency Percent 
-100 1 4.55 1 4.55 
-85 1 4.55 2 9.09 
-48 1 4.55 3 13.64 
-44 2 9.09 5 22.73 
-41 1 4.55 6 27.27 
-40 1 4.55 7 31.82 
-39 1 4.55 8 36.36 
-38 1 4.55 9 40.91 
-31 1 4.55 10 45.45 
-29 1 4.55 11 50 
-26 1 4.55 12 54.55 
-21 1 4.55 13 59.09 
-14 1 4.55 14 63.64 
-12 1 4.55 15 68.18 
-10 1 4.55 16 72.73 
-8 1 4.55 17 77.27 
-6 2 9.09 19 86.36 
-4 1 4.55 20 90.91 
-3 2 9.09 22 100 
 
Table 5.14 – Original Source File Of Case Event Record From Sensitivity Analysis On 
Registration Date Criteria. 
 
Cumulative Cumulative Source Frequency Percent 
Frequency Percent 
NTD Referral File 1 4.55 1 4.55 
NTD Clinical File 8 36.36 9 40.91 
Main Clinical Files 12 54.55 21 95.45 
Main Referral Up To 97 1 4.55 22 100 
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Table 5.15 – Year Of Case Event Record From Sensitivity Analysis On Registration Date 
Criteria. 
 
Cumulative Cumulative Year of NTD 
Event Record 
Frequency Percent 
Frequency Percent 
1987 2 9.09 2 9.09 
1989 2 9.09 4 18.18 
1990 3 13.64 7 31.82 
1992 2 9.09 9 40.91 
1993 1 4.55 10 45.45 
1994 1 4.55 11 50 
1995 2 9.09 13 59.09 
1998 3 13.64 16 72.73 
1999 1 4.55 17 77.27 
2001 2 9.09 19 86.36 
2002 1 4.55 20 90.91 
2003 2 9.09 22 100 
 
In conclusion, while adding 22 additional cases, the hazards of data inaccuracy should 
temper thoughts of including these cases in our analysis.  These cases could be an important 
opportunity for future validation.   
4. Dataset Quality Assurance Analyses 
The following table summarizes the comparison of record counts between the received 
ASCII Text files and the converted SAS data sets. 
Table 5.16 – Comparison of record counts between received data and converted SAS data sets. 
Rows  Text File (*.txt) SAS File Name (.sas7bdat) Observations Difference 
2476 
Diagnosis 
cohort_smok_drink_Historic GPRD.N_SMOKE_DRINK 2417 59 
4261 Diagnosis cohort_BMI_Historic GPRD.N_BMI 4180 81 
5151965 Test00_01 GPRD.TEST00_01 5151956 9 
 
Three files had small differences in record counts.  On each occasion these were 
determined to be null value rows in the original text files, and thus were not converted to 
SAS records. 
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B. The Identification Of Pregnancies Within The GPRD 
1. Introduction 
 
Large automated electronic medical records databases are extremely valuable for the 
study of medication use during pregnancy and several recent studies have highlighted their 
use.
195, 196
 For these databases to be useful for pharmacoepidemiologic studies, they must 
provide comprehensive medication and healthcare information about women before and 
during pregnancy and at delivery.  Often a challenge exists for researchers because the time 
period in which a woman is pregnant is not easily identifiable in the database, requiring 
researchers to develop algorithmic approaches to identify these records.  
The General Practice Research Database (GPRD) is the world’s largest electronic 
medical records database
155
 and has been found to be a complete and accurate source of 
health care data.
197, 198
 An algorithm for the identification of pregnancies in the GPRD would 
provide researchers with the opportunity to use its extensive data regarding pregnancy and 
birth outcomes in a variety of research areas. We present a detailed report on an approach to 
identifying pregnancies in the GPRD. In addition, we describe aspects of the pregnancy data 
in the GPRD to highlight its potential for use in future pharmacoepidemiologic studies.    
 
2. Methods 
a. Data And Study Population  
 
The GPRD was initiated in the United Kingdom (UK) in 1987 to provide research 
information based on general practitioner (GP) records.  The GP serves as the gatekeeper for 
all health care in the UK. GPRD data contain approximately 46 million patient-years of 
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follow-up, representing approximately 10.1 million unique patients.
184
 More than 460 general 
practices in the UK currently submit data to the GPRD on 3.2 million patients, or 
approximately five percent of the UK population.
154, 155, 184
 The patient population is 
representative of the region, age and gender distribution of the UK population.
184
 
GPs enrolled in the GPRD utilize the Vision system to enter data as a comprehensive 
electronic medical record.  They follow a recording protocol to ensure that significant clinical 
contacts are entered into the computer record.  Such contacts include all hospitalizations or 
visits to specialists, any significant test results, events resulting in a prescription or treatment 
withdrawal, adverse reactions to a medication, and any other events which result in multiple 
consults.
185
 Free text may be recorded to further detail the patient’s medical conditions.  A 
modified version of the Oxford Medical Information System (OXMIS) medical codes was 
used from 1987 to 1999.  OXMIS codes were phased out starting in 1996 and replaced with 
Read codes.     
The Vision data are transformed by the GPRD division of the Medicines and Healthcare 
products Regulatory Agency into the database known as the FF-GRPD.  All patient contacts 
are recorded and multiple health records are often generated when care for a condition is 
continued over a period of time, as in the case of pregnancy.  Sorting through these multiple, 
and often duplicate, records makes the identification of distinct pregnancies a challenge. 
 The recording protocol for the GPRD makes specific recommendations regarding the 
amount of detail that should be entered for each pregnancy.
185
 The mother’s profile should 
include a record of the identification of the pregnancy, such as a positive pregnancy test 
result.  It should also include any referral for ante-natal care, significant maternal or fetal 
abnormalities or complications detected during pregnancy, the outcome of the pregnancy, the 
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date of delivery (when appropriate), any congenital malformations of the baby, and where 
relevant, a record of neonatal death.  
Among those registered in the GPRD, we searched for indicators of pregnancy in all 
women between the ages of 15 and 45 as of January 1, 1987.  We then excluded any of the 
following: 1) records that occurred outside the study period of January 1, 1987 to September 
14, 2004 (the last data collection date for our study); 2) records that occurred during the 
study period but prior to the individual’s registration with the GPRD general practitioner or 
the date the GPRD practice achieved a sufficient data recording standard (the up-to-standard 
date), whichever was first; and 3) records that represented historical events recorded during 
the study period but not within 30 days of any pregnancy-related code.  
b. Pregnancy Medical Codes 
 
Pregnancy codes were identified through a key word search of the Read and OXMIS 
medical code dictionaries.  Codes were divided into two categories: EOP events and PCMs. 
EOP event codes indicate the final outcome of a pregnancy, such as full-term, preterm, or 
post-term live births, stillbirths, miscarriages, spontaneous abortions, elective terminations, 
and multi-fetus live births.  PCMs include any event that describes the delivery of care 
relating to pregnancy prior to an EOP event.  Examples include positive pregnancy tests, 
alpha-fetoprotein tests, obstetric ultrasounds, amniocenteses, visits related to pregnancy, 
pregnancy complications, threatened abortions, abortion referrals or counseling, and obstetric 
hospitalizations.    
In addition to the keyword search of the code dictionaries, we created longitudinal patient 
histories for a subset of 10,000 women with at least one EOP code and visually reviewed 
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them for previously undiscovered pregnancy-related codes.  These methods resulted in a total 
of 5,266 codes that were potentially associated with pregnancies. Our final list of codes 
consisted of two subsets of codes: one containing 1,691 PCM codes, and another containing 
1,059 EOP codes.  We excluded the remaining 2,516 codes because they represented post-
natal care or were too non-specific. 
c. Identification Of Pregnancies 
 
We designed a computer-based (SAS V9.1.3, SAS Institute, Cary, NC) three-step 
pregnancy identification algorithm to handle the complexities of identifying pregnancies in 
the GPRD data.  The first step identified and removed duplicate EOP codes for each woman.  
The second step used a hierarchical coding scheme to select the final pregnancy outcome for 
each pregnancy.  The third step used the final pregnancy outcome to determine the first 
pregnancy-care marker for each pregnancy.  These steps are described in more detail below. 
When we were able to identify an EOP medical code and match it with a PCM, we 
considered this a complete pregnancy profile. 
1. Step 1 – Removal Of Duplicate Pregnancy Codes  
 
Starting with our entire study population, all records of EOP codes were grouped into 
three categories: 1) stillbirths (38 codes), 2) elective terminations (74 codes) and spontaneous 
abortions or miscarriages (229 codes), and 3) normal full-term births/deliveries (652 codes), 
pre-term and post-term births (25 codes), and multiple live births (41 codes).  The actual 
codes are available upon request from the authors.  For the purposes of this study, we 
considered multi-fetus pregnancies as one pregnancy.  
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Because of the frequent recording of event codes that represent the same pregnancy, 
duplicate EOP codes had to be removed. For each woman, duplicate records were addressed 
within each of the three pregnancy categories by designating her earliest EOP code within a 
category as the index event, then disregarding all subsequent EOP codes in that same 
category within a predetermined time frame, 60 days.  This time frame represented the 
minimum number of days after a pregnancy termination that subsequent pregnancies were 
likely to be diagnosed.
162
 Similarly we used a 210-day span for live births or stillbirths to 
capture potential pre-term births in addition to full-term and post-term births.  Within the 
three event categories, each subsequent EOP code that was beyond these time frames was 
considered a new pregnancy and was compared to future pregnancies in a similar fashion.  
This resulted in a group of potential pregnancies for each pregnancy category for each 
woman. 
2. Step 2 – Selection Of Final Pregnancy Outcome 
 
In addition to duplication, records can be recorded out of chronological order or contain 
conflicting information, making it difficult to determine the true outcome of interest.  While 
codes indicating a normal live birth and delivery are correct for the majority of the mothers, 
there are some notable exceptions as illustrated in Figure 5.3. For patient 1, a stillbirth code 
occurs after a “breech delivery” code, the latter code often accompanying a full-term live 
birth.  Another example, again illustrated in Figure 5.3, is the recording of a miscarriage 
before a “birth details” code.  The birth details code may be entered in error, or it may be 
entered to describe aspects of the miscarriage. It is not possible for a woman to miscarry and 
then have a live birth 27 days later, so we must choose a pregnancy outcome based on the 
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most plausible biological scenario for these EOP codes.  These two examples demonstrate 
that the correct outcome may occur somewhere within a cluster of codes with similar dates, 
requiring special approaches to identify the correct outcome. 
Figure 5.9 – Example of Selection Challenges for Final Pregnancy Records in the GPRD. 
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To address these conflicting EOP codes, we developed a hierarchical decision rule based 
on the pregnancy code and the date in which the GP entered the code into the GPRD.  We 
ordered each woman’s codes chronologically and then ranked them based on the pregnancy 
categories developed in Step 1: stillbirths (category 1), spontaneous and elective terminations 
(category 2) and live births and deliveries (category 3).  Each EOP record date was compared 
to every other EOP record in the mother’s profile.  When a pregnancy in category 1 was 
within 210 days of a pregnancy in category 2 or 3, the EOP record in category 1 was 
considered the actual pregnancy outcome. All other EOP codes within 210 days were 
deleted. When an EOP code from category 2 was within 60 days of a diagnosis code in 
category 3, the category 2 EOP code was selected as the final outcome and the remaining 
codes were disregarded. Pregnancy codes in category 3 were considered correct only when 
they were not in conflict with EOP codes in categories 1 or 2.     
3. Step 3 – Identifying The First PCM 
 
The determination of the beginning of pregnancy in an electronic database poses 
additional challenges because the data files do not routinely contain the most clinically 
relevant marker of pregnancy initiation, the last menstrual period.  Many researchers attempt 
to overcome this by looking back a fixed number of days from the conclusion of pregnancy 
indicated by a delivery or birth outcome code.  After counting back a set number of days, 
they use the first PCM code in the woman’s record to signify the initiation of pregnancy 
care.
162, 172, 195, 196
 This method is appropriate when looking at stillbirths or live births, as 
many go to full-term, but is less effective when researchers consider spontaneous and 
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elective terminations or preterm births.  Outcomes other than full-term births can and do 
occur with variable intervals between the PCM and the EOP event and can appear to overlap 
with other pregnancies when a fixed-day approach is used.   
Our algorithm takes a flexible approach to identifying the first PCM.  For each EOP code 
identified after applying steps 1 and 2, we looked back a maximum of 280 days. If another 
EOP code occurred within 280 days (e.g. an elective termination occurring 170 days after a 
full-term pregnancy), the number of days between the first and second EOP codes served as 
the maximum number of days to look back for assigning a first PCM. The marker that was 
farthest from the EOP code without exceeding the maximum number of days as described 
above was labeled as the first PCM.  With this first pregnancy-care-maker identified, it and 
its matched EOP code create a complete pregnancy profile. 
d. Evaluation Of Identification Algorithm 
 
Because direct validation of our pregnancy identification algorithm using GP 
questionnaires was not financially feasible, we conducted a number of internal assessments 
and alternate analyses for evaluation.  First, we reviewed electronic records of women with 
extremely short or long periods of time between their first and last identified pregnancies as 
well as women with what appeared to have had 8 or more pregnancies.  We then varied the 
length of time assigned in the algorithm for developing the pregnancy categories in step 1 
and selecting the EOP records in step 2.  Alternate analyses were conducted using a range of 
180 to 280 days for stillbirths, live births, pre-term and post-term births and multiple births, 
and 30 to 120 days for elective terminations and spontaneous abortions.  We plotted and 
assessed the time between pregnancies to determine if assumptions concerning required gaps 
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were appropriate for the data.  Additionally, we evaluated our step-3 assumption that PCMs 
could be no more than 280 days prior to a pregnancy by plotting the number of days between 
the matched PCM and the EOP code for each pregnancy in the patient’s record.   
3. Results 
 
Between January 1, 1987 and September 14, 2004 there were a total of 98,922,326 
records from 980,474 individuals with one of the 5,315 pregnancy-related medical codes in 
the GPRD. Our algorithm identified a total of 255,400 women who had 374,878 pregnancies. 
Our alternate analyses did not produce any substantive changes in our final results, 
suggesting that the initial assumptions resulted in a robust approach.  Figure 5.4 provides the 
number of records remaining at each point in the pregnancy identification process, with 
special focus on how steps 1-3 influenced the final number of records, and ultimately, the 
final number of pregnancies used in our analyses.   
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Figure 5.10 – Record Counts In GPRD Through Pregnancy Identification Process. 
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We identified 271,613 full-term live births (72.5% of pregnancies), 2,106 pre- or post-
term births (0.6% of pregnancies), 1,191 multi-fetus deliveries (0.3%), 55,614 spontaneous 
abortions or miscarriages (14.8%), 43,264 elective terminations (11.5%), and 1,090 stillbirths 
or fetal deaths (0.3%).  Stratification by year is presented in Figure 5.5, and the distribution 
of pregnancies per woman is presented in Table 5.17.  
Figure 5.11 – End of Pregnancy Event Counts By Outcome Type In The GPRD Between 
1987 and 2004. 
 
Table 5.17 – Distribution of pregnancy in women age 15 to 45 in the GPRD between January 
1, 1987 and September 14, 2004. 
Number of 
Pregnancies 
Women w/ 
Pregnancies 
Pregnancies by 
These Women 
1 169869 (66.5) 169869 (45.3) 
2 60930 (24.0) 121860 (32.5) 
3 17879 (7.0) 53637 (14.3) 
4 4839 (2.0) 19356 (5.1) 
5 1353 (0.5) 6765 (1.8) 
6 383 (0.1) 2298 (0.6) 
7 106 (0.0) 742 (0.2) 
8 26 (0.0) 208 (0.0) 
9 7 (0.0) 63 (0.0) 
10 8 (0.0) 80 (0.0) 
Total 255400 (100.0) 374878(100.0) 
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The mean number of pregnancies per woman was 1.5, with a median of 1 and a 
maximum of 10.  Of the women who had at least one pregnancy, less than 1% had more than 
4 pregnancies.  Of the women with more than four pregnancies, the mean and median 
number of years between the first pregnancy and the last pregnancy was 7.7 and 7.5 years 
respectively, with a range of 1.2 years to 14.5 years.   
By fixing a maximum of 280 days between an EOP record and PCM, we were able to 
create complete pregnancy profiles for 88.1% of 374,878 pregnancies.  This percentage 
varied by pregnancy category.  Among the 271,613 full-term live births, 92.6% had at least 
one PCM whereas 74.1% of the 43,264 elective terminations and 76.5% of the 55,614 
spontaneous abortions had at least one PCM.  The 10 most common PCM codes from all 
pregnancies, representing 74.3% of the total, are presented in Table 5.18.  Six of the 10 of 
these most common markers, representing 53.5% of the total, indicate the patient is pregnant. 
Table 5.18 – Top Ten PCM Codes Identified Within The GPRD Between 1987 and 2004. 
 
 
 
 
The mean and median number of days in a complete pregnancy profile was 170 days and 
216 days, respectively.  The distribution of the number of days within complete 
pregnancy profiles is presented in Figure 5.6.  
 OXMIS/  Percent 
Event Code Read Code Frequency Of Total 
Patient Pregnant 62...00 44208 13.4 
Delivery Booking Place 62B..00 40342 12.2 
Pregnancy Y60 39600 12.0 
Pregnant Y60 AA 32907 10.0 
Urine Pregnancy Test 465..00 25370 7.7 
Maternity Care 62...12 18711 5.7 
Pregnancy Test L 134 17898 5.4 
Pregnancy Test Positive L 134P 10812 3.3 
Urine Pregnancy Test Positive 4654 8635 2.6 
Antenatal Care 62...11 6722 2.0 
Patient Pregnant 62...00 44208 13.4 
 - 143- 
Figure 5.12 – Time Between First PCM And Its Matched EOP Event Within The GPRD 
Between 1987 And 2004. 
 
 
When we stratified results by pregnancy category, the mean and median number of 
days was predictably different across categories (see Table 5.19). Because the amount of 
maternal medical history available prior to the first PCM is important for 
pharmacoepidemiology research, Table 5.20 summarizes the number of women with at 
least 30, 60, 90, 180 and 360 days of data before the start of each complete pregnancy 
profile.  The mean number of days prior data began prior to the first PCM was 2,608, and 
the median was 1,469. 
Table 5.19 – Summary Statistics Of The Time Between First PCM And Matched EOP 
Events In GPRD Between 1987 And 2004. 
 
 
Number of 
Events w/ FPM Missing FPM 
Mean 
Number 
of Days 
Median 
Number of 
Days 
Interquartile 
Range 
All EOP Events 330153 (88.1) 44725 (11.9) 170 216 149 
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Table 5.20 – Pregnancies With Between 30 And 360 Days Of Data Available Prior To The 
First PCM In The GPRD Between 1987 And 2004. 
 
 
Stillbirths 981 (90.0) 109 (10.0) 163 170 92 
Elective Terminations 32056 (74.1) 11208 (25.9) 45 21 24 
Spontaneous Abortions 42547 (76.5) 13067 (23.5) 46 26 33 
Multiple Live Births 1085 (91.1) 106 (8.9) 188 203 44 
Pre/Post-term Births 1942 (92.2) 164 (7.8) 185 197 67 
Live Births 251542 (92.6) 20071 (7.4) 207 226 39 
FPM - First PCM     
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4. Discussion 
 
Our pregnancy identification algorithm builds off the work of others.  Manson et al. 
developed and evaluated an approach to detect pregnancies and pregnancy markers using a 
health maintenance organization database.
162
 This approach was adapted to the Value Added 
Medical Products based GPRD by Hardy et al. 
172
 Manson’s general approach of identifying 
a pregnancy outcome and looking backward a fixed number of days for PCMs has been used 
by other researchers in a variety of data sets.
195, 196
 Because of the similarities of our 
approach and our data source to that of Hardy’s, consistencies in both results should be 
noted. For example, the distribution of the number of pregnancies among identified women 
was similar.  Specifically, both studies found that 66.5 percent of women had only one 
pregnancy and similar distributions for other pregnancy frequencies were observed.  
Additionally, the mean number of weeks between the first PCM and a live birth was 30 
weeks in our data compared to approximately 31-35 weeks in Hardy’s study.  
Our pregnancy identification algorithm and the pregnancies that it identified in the GPRD 
offer several strengths.  We identified a large number of pregnancies in a 17.5 year period of 
the GPRD.  These pregnancies have a rich assortment of medical care data associated with 
them.  At least one pregnancy care record was available for 88 percent of all pregnancies, and 
78 percent of the identified pregnancies had records accessible going back at least 300 days 
from the pregnancy outcome.  With these records, researchers can identify treatments and 
care delivered during critical windows of fetal development and throughout the pregnancy.  
Additionally, over 78 percent of the complete pregnancy profiles had medical history records 
going back at least 180 days before the first PCM.  With records within the six months prior 
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to the first PCM, details on chronic conditions, health-services utilization and medication 
orders are available.  
This rich dataset also gives researchers the ability to estimate the last menstrual period 
(LMP) date associated with each pregnancy. The LMP date is important for determining the 
timing of medication exposure during very early gestation, but is often estimated because it is 
generally not available in an electronic database.  It is possible to estimate LMP using data 
developed by Manson et al. for the Kaiser-Permanente database. They found that the LMP 
was on average 40 days prior to the first PCM in the case of fetal deaths, and within 57 days 
of the first PCM for live births.
162
 We evaluated our data using the time points from the 
Manson et al. study to determine the number of pregnancies for which we could estimate an 
LMP date.  Among the aggregated stillbirths, elective terminations and spontaneous 
terminations, we found that ninety-three percent of those with a complete pregnancy profile 
had at least 40 days of medical records prior to the first PCM.  Of the live births and 
deliveries with complete pregnancy profiles, eighty-five percent had at least 57 days of 
records prior to the first PCM.   If we defined an LMP date as 57
 
days prior to the first PCM 
regardless of outcome type, we would be able to estimate the LMP date for 86 percent of the 
330,153 pregnancies with complete profiles.  
An additional strength of our algorithm is its ability to reduce the chance of selecting an 
indeterminate pregnancy outcome as the final EOP code by detecting outcomes that were out 
of order in the mother’s record.  Because we were able to detect specific codes (i.e. those for 
a stillbirth or an elective termination) even when they were not the first in a series of codes, 
we did not have unknown outcome codes.  For example, if a fetal death or stillbirth was 
recorded after a code broadly applied in most patients (e.g. normal delivery or birth details), 
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the outcome was categorized as a fetal death and rather than an unknown outcome.  While 
this approach relies upon accurate recording of fetal deaths and stillbirths, the reliability of 
recording by the GP has been shown to be excellent.
198-201
   
Finally, a strength of both the algorithm presented here and the GPRD is the ability to 
identify recorded spontaneous abortions.  Spontaneous abortions composed approximately 
fifteen percent of the identified EOP outcomes.  This conforms with estimates of twelve to 
fifteen percent from other sources.
202, 203
 Because we are able to identify multiple pregnancy 
outcome types, particularly spontaneous abortions, pharmacoepidemiologic studies using the 
GPRD data will not be restricted to pregnancies with full-term outcomes.  
However, researchers should use caution when including these spontaneous abortions.  
There will be an unknown number of spontaneous abortions that are not detected by the 
mother or the GP.  Many go unnoticed or are mistaken as part of a woman’s normal 
menstrual cycle. Because of these unidentified spontaneous abortions, developing specific 
rates for this outcome would be ill advised; however, the GPRD still offers information about 
spontaneous abortions that is not commonly available in other large electronic databases and 
these data can be useful for addressing other objectives.  
There are several limitations to our pregnancy algorithm and the identifiable pregnancies 
in the GPRD.  The first is the potential for the incomplete ascertainment of pregnancies.  In 
addition to the unrecorded spontaneous abortions mentioned above, the GPRD may not 
contain records of all elective terminations. These procedures occur at health care facilities 
other than the GP office and may not be recorded in the medical record, either by omission or 
at the woman’s request.   
GPs may fail to record all pregnancy care and outcomes in the database as we noted when 
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evaluating maternal data for evidence of diagnostic and screening tests.  We found that only 
15 percent of all pregnancies had any record of a possible 149 common diagnostic or 
screening tests codes relevant for pregnancy.  This would limit the database utility in 
examining pregnancy complications as outcomes. The Royal College of Obstetricians and 
Gynecologists and the National Institute for Clinical Excellence,
132
 have established 
guidelines for pregnancy diagnostic and screening tests.  The NHS has also put in place 
financial incentives to ensure that these tests are done.
204
 For this reason, we believe that 
these tests are likely being performed but do not exist in the discrete data portion of the 
mother’s electronic health record.  The GP has the opportunity to record information as free 
text comments and this may be where they place information on pregnancy diagnosis and 
screening tests.  We did not search this free text information as the costs involved were 
outside of the planned budget of this project. 
Additionally, at the time of patient registration with the GP, information on pregnancies 
that occurred prior to the patient’s registration is frequently incomplete.  Even though many 
of these pregnancies are often recorded in the GPRD as historical data, we did not include 
them in our analysis.  There is also the potential that a woman could leave a physician’s 
practice prior to delivery.  We found that there were 13,812 women with a PCM within 90 
days of transferring out of the practice and without an accompanying EOP event record.  
Because not all GP practices are part of the GPRD and records are not linked from one GP 
practice to the next, it was not feasible to track these outcomes. 
Another limitation is the potential for misclassification of our pregnancy outcomes. The 
correct classification of pregnancies was an expressed goal of our algorithm.  Although we 
believe misclassification was minimized through the use of recognized pregnancy codes, 
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physicians have the ability to use codes as they judge appropriate.  The potential lack of 
consistency within and across GPs and the reality that many codes within the OXMIS and 
Read Coding dictionaries may have multiple uses complicate any attempt to avoid 
misclassification. Our approach of ranking pregnancy categories and selecting the final 
outcome using a hierarchical approach, rather than identifying the first available pregnancy 
outcome code and excluding all others within a fixed time period, should minimize 
misclassification. In our analyses, 12,834 pregnancies with the potential of being 
misclassified were ultimately identified and removed using a hierarchical pregnancy category 
approach.  We will continue to refine this approach and hope to continue to minimize 
misclassification.    
We believe that the algorithm for identifying pregnancies described here gives 
researchers the opportunity to utilize the GPRD for pharmacoepidemiologic research 
projects. Electronic medical records databases, such as the GPRD, allow researchers to 
conduct case-control surveillance studies while avoiding the potential limitations from 
recall bias that can occur with maternal interviews.
161
 Because of the ability to link 
details of a mother to her offspring, including information on potential exposures in a 
mother prior to and during all stages of pregnancy, and potential pregnancy outcomes not 
limited to live births, the GPRD can now provide detailed records on a sample of 
pregnancies large enough to detect rare events   This resource should prove valuable for 
future research on pregnancy outcomes.  
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C. Validation Of NTD In The GPRD 
1. Introduction 
 
The study of birth defects is complicated by a number of factors. There are diverse 
hypothesized etiologies and complicated clinical definitions for most birth defects.  In 
addition, the context of their identification, such as spontaneous abortions or elective 
terminations, can make detailed information difficult to obtain. Neural tube defects (NTDs) 
are a group of severe central nervous system birth defects that occur when the neural tube 
fails to close during early embryonic development.
1
 Neural tube formation and closure are 
complex events of embryogenesis,
2
 requiring 10 days to complete and occurring during the 
3
rd
 to 4
th
 week post-fertilization.
2, 3
 NTDs are generally defined by the area of central nervous 
system that they affect: anencephaly is the absence of brain material, encephalocele is an 
opening in skull, and spina bifida is an opening along the spinal cord. While the birth 
prevalence of NTDs in the United Kingdom and Ireland, having declined from 45 per 10,000 
live and stillbirths in 1980 to 10 to 15 per 10,000 in the 1990s through 2000, NTDs remain a 
common congenital anomaly.
205
 
Although the associations of NTDs with medications affecting folic acid activity are well 
documented,
10, 62, 71, 72
 the mechanisms in which other medications may cause NTDs are 
unknown.  It is of great importance to understand a medication’s potential role in NTD 
occurrence, as many women may not know they are pregnant during early gestation, 
potentially exposing their growing fetus to a harmful medication.
162
  
The General Practice Research Database (GPRD) is one of the most widely used 
databases for pharmacoepidemiologic research.  The GPRD has been used for evaluating the 
association between birth defects and use of certain medications during pregnancy,
164, 168, 174
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but some experts have argued that large automated databases cannot provide sufficiently 
detailed information for the valid identification of specific congenital anomalies and related 
exposures.
175
 Researchers need a reliable means to study rare outcomes such as NTDs in 
large populations that may have uncommon medication exposures.  The purpose of this study 
is to determine if the GPRD can be used to accurately identify NTDs. 
2. Methods 
 
The GPRD, currently managed by the United Kingdom’s (UK) Medicines and Healthcare 
Products Regulatory Agency (MHRA), was initiated in 1987 and is the world’s largest 
anonymized, longitudinal patient electronic medical records database.  It provides clinical 
information based on general practitioner (GP) records.  The GPRD data contain 
approximately 46 million patient-years of follow-up representing 10.1 million unique 
patients.
184
 Over 460 general practices in the UK are currently submitting data to the GPRD 
on 3.2 million patients or approximately five percent of the UK population.
154, 155, 184
 The 
patient population is representative of the regional, age and gender distribution of the UK 
population.
184
 
 Practitioners enrolled in the GPRD must follow a recording protocol ensuring that 
significant clinical contacts related to patients’ medical care are entered into the computer 
record.  These contacts include all events resulting in hospitalization or referrals to any 
specialist, the outcome of referrals, any significant test results, all events resulting in a 
prescription or treatment withdrawal including the indication for the medication, all adverse 
reactions to a medication, and any other events which result in multiple consults with the 
practitioner (childhood diseases, pregnancy).
185
 Free text may also be recorded by GPs to 
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detail further the patient’s medical conditions.  Diagnoses have been recorded using Read 
codes since 1996 and a modified version of the Oxford Medical Information System 
(OXMIS: 1987-1999).  Most of the Read codes used in this study are found in Chapter P 
(Congenital Anomalies), and OXMIS codes include 740 through 7439.  A complete list of 
codes is available from the authors.  
a. Identification And Validation Of NTD Cases 
 
Our goal was to identify new cases of NTDs that occurred within the time frame of 
available data from the database (January 1, 1987 to September 14, 2004). The NTDs of 
interest in this study are anencephaly, encephalocele, meningocele and spina bifida.  We 
analyzed the complete medical record profile for any individual in the data set with at least 
one NTD code between January 1, 1987 and September 14, 2004. 
We first identified potential mothers and children and applied separate exclusion criteria 
to each of these types of records.  We considered all individuals as potential mothers if they 
were female and had a birth year between 1942 and September 1989 (between 15 and 45 as 
of 1987).  Individuals were potential children if their birth year was between 1987 and 2004.   
To avoid identifying records in which the mother herself had a NTD, we excluded any 
NTD record in a mother’s profile that was not within 210 days of another record indicating 
that the woman was pregnant. We also excluded records dated January 1
st
 of a given year 
(system default used for recording historical information when the date was unknown) if they 
were not within 30 days of any record indicating the woman was pregnant.  Finally, to avoid 
double counting of duplicate records of a single NTD in a woman’s record, we selected the 
first NTD diagnosis listed in a mother’s profile and excluded NTDs recorded during the next 
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60 days.  When two different types of NTDs were recorded (i.e. a record for both 
meningocele and spina bifida was present), we selected the first record as the correct 
diagnosis. 
We applied a separate series of exclusion criteria to the NTD codes identified in 
children’s profiles.  From the first 365 days following the estimated date of birth for each 
child (the 15
th
 of their birth month) we selected the first record of a NTD as the primary NTD 
diagnosis as it should not change.  All future records of NTD for that child were excluded.  If 
the first NTD record was dated January 1
st
 of a given year, it was excluded if not within 30 
days of the child’s estimated birth date.   
The use of a link between the children’s and mother’s records was necessary to rule out 
duplication of events.  To avoid double counting, we utilized the GPRD’s mother-baby 
linkage.
206
 Once linked, the date of the first occurrence of a NTD diagnosis in the child’s 
profile was compared to the date (or dates) of any NTD diagnosis in a mother’s profile.  If 
any NTD diagnosis in a mother’s profile was within 180 days of the date in the linked child’s 
profile, the record in the mother’s profile was not counted.  When the GPRD’s mother-baby 
linkage was not able to provide a matching mother or child’s identification number, we ruled 
out duplication in mother and child records by comparing GP Practice Identification numbers 
and NTD event dates among all NTDs identified in mother and child records.  When GP 
Practice Identification numbers were the same for a mother and child NTD record, we 
considered the NTD to be a single NTD if woman and child had the same NTD diagnosis and 
the event codes were within 90 days of each other.  
Once all NTD cases were identified, a questionnaire was sent to the general practitioner 
for each identified NTD using the Verification Service provided by the GPRD.  Each 
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questionnaire consisted of at least three questions: 1) Can you confirm the NTD diagnosis 
and date, 2) What source was reviewed to confirm the diagnosis and date, and 3) If the NTD 
was confirmed, what type of examination was performed to determine the diagnosis.  When 
the record was part of a mother’s profile, we asked the GP to indicate if the diagnosis was the 
mother’s own condition or if the diagnosis was for the mother’s fetus or offspring.  When the 
mother-baby linkage linked a case, we asked the general practitioner to verify the linkage.   
b. Analyses 
 
The cases identified by the NTD algorithm and the cases confirmed by general 
practitioner responses to questionnaires were compared.  Those cases in which the general 
practitioner confirmed the presence of a NTD were considered validated cases.  We 
determined the positive predictive value (PPV) of our algorithm for the validated NTD cases.  
Sensitivity and specificity of our algorithm cannot be determined because the number of true 
cases and non-cases could not determined.  We determined a priori that if our validated PPV 
was less than 70 percent, we would revise our electronic case definitions. If our validated 
positive predictive values exceeded 70 percent we would determine adjusted case counts 
based upon the validated positive predictive values. Adjusted case counts were calculated by 
multiplying the annual observed case counts by the positive predictive value determined for 
validated cases. 
Because the GPRD mother-baby linkage can be used to avoid duplicate counting of NTD 
records in both a mother’s and a child’s record, the GP questionnaire included a question 
about the identification of the mother and the baby.  With this information, we determined 
the accuracy of the GPRD mother-baby linkage for those NTD cases that we were able to 
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link.  The linkage between a mother and her offspring was considered correct if there was a 
positive response to a question on the general practitioner’s questionnaire. For NTD cases 
confirmed by the GP to have correct linkage between mother and offspring, we summarized 
maternal characteristics at the time that the NTD was identified. 
Using the adjusted case counts, we determined annual prevalences of NTDs in the GPRD 
for the years 1991 through 2003.  We restricted our calculations to these years, as our data on 
pregnancies were most complete for this time frame.  The annual prevalence was calculated 
by dividing the number of adjusted case counts by the number of live births, stillbirth, and 
terminations. Annual prevalences were standardized to the age distribution of women giving 
birth in the United Kingdom. The method used for defining live births, stillbirth, & 
terminations is described in detail elsewhere.
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 To aid in comparing our results to those of a 
surveillance system in the United Kingdom, we charted our annual prevalences along with 
those of the UK’s National Congenital Anomaly System.
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To evaluate the robustness of our NTD identification algorithm, we conducted a number 
of alternate analyses.  To evaluate the impact of some of our assumptions about NTDs in 
mothers’ records, we varied the requirement that a pregnancy record precede a recorded NTD 
diagnosis by no more than 210 days as well as the requirement that a pregnancy record 
precede a reference to a past medical history record (i.e. 1/1/Year) by no less than 30 days.  
For children’s records, we varied the required 30 days between the child’s date of birth and 
the date of a potential medical history record, and we extended the 365-day time window past 
the estimated birth date for acceptable first NTD diagnosis.  Because many NTDs in 
children’s records may be recorded in close proximity to their GP registration date, we 
determined the number of additional cases that could be identified if we used various time 
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frames before the registration date of the child.  Finally, we varied the required number of 
days used to rule out duplicate records between the NTD records in a mother’s record and 
any subsequent records to see if it impacted the number of cases identified associated with 
each woman. 
3. Results 
 
We analyzed 98,922,326 records from 980,474 individuals and identified 2,117 
individuals associated with 3,178 records with a NTD code.  457 individuals with a NTD 
record were excluded because the event date was outside the study period, 492 were 
excluded because the event was prior to the patients registration date, and 460 were excluded 
because they were found in men >17 years old or in women who were >45 years old.  After 
these exclusions and application of our identification process, we identified 217 unique NTD 
cases associated with 214 individuals.  148 cases were found within a mother’s record and 69 
cases were found in a child’s record.  We found no evidence of duplicate NTD records in 
both the mother’s and the child’s record. 183 cases were identified from general practitioner 
clinical records, and 34 were identified from referral records. With two exceptions, our 
alternate analyses on our identification algorithm resulted in only moderate changes in the 
initial number of algorithm-identified NTDs.  When we included records up to 90 days prior 
to the patient’s GP registration date as opposed to using only records found after registration, 
we found an additional 21 NTD cases in children’s records.  Additionally, when we extended 
the acceptable time from birth to the first occurrence of a NTD diagnosis from one year to 
the first two years of life, we found an additional 18 NTD cases in children’s records.  We 
sent validation questionnaires to the general practitioners of all 217 identified cases in 
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August of 2006.  Figure 5.7 describes the progression of records through the validation 
procedure.   
Figure 5.13 – Progression of Records For Validated Neural Tube Defects in The General 
Practice Research Database Between 1987 and 2004. 
 
  
Of the 217 requests, we received responses from general practitioners for 165 cases (76 
percent) as of January 2007.   Responses for 121 cases from mother’s records and 44 cases 
from children’s records were returned. Questionnaire return rates differed across NTD 
diagnoses (MH ?2= 4.1, df=1, p=0.04), with anencephaly having the greatest overall response 
rate (86 percent) and cephalocele having the worst (60 percent).  More responses were 
 - 158- 
received for NTDs found in mother’s records (82 percent, 95% CI: 88 – 76 percent) than in 
children’s records (64 percent, 95% CI: 52 – 75 percent).  Although 80 percent (95% CI: 72 
– 86 percent) of questionnaires for cases occurring after 1994 were returned versus 70 
percent (95% CI: 58 – 79 percent) before 1994, the year of event had little impact on whether 
the questionnaire was returned. 
The GP responses validated a NTD diagnosis for 117 of the 165 cases, yielding a positive 
predictive value of 0.71 for our algorithm (?2 = 28.9, df=1, p <0.001).  Validation of the 
NTD did not vary by whether the case came from a mother’s record (69 percent, 95% CI: 60 
– 78 percent) or a child’s record (75 percent, 95% CI: 60 – 87 percent), or by the number of 
repeat NTD codes in a case’s complete record (MH?2 =0.49, df=1 p=0.48).  Percentage 
validation of cases was not influenced by the year in which the NTD occurred. 
There were 14 cases that the GP questionnaire indicated that the date or the specific NTD 
code identified was not accurate.  If we do not count these cases as validated, the positive 
predictive value drops to 0.61.  As the presence of a NTD was confirmed in these cases, we 
considered them validated.  The PPV of the identification algorithm varied depending on the 
specific NTD diagnoses. The PPV for our algorithm was 0.81 for anencephaly codes, 0.83 
for cephalocele codes, 0.64 for meningocele codes, and 0.47 for spina bifida codes. A list of 
these codes as well as their individual success in validation is presented in Table 5.21.  
Although the number of each specific NTD code was often small, when grouped, codes for 
spina bifida occulta proved the most unreliable.  
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Table 5.21 – Neural Tube Defect Codes And Positive Predicative Values Based Upon 
Validation of Records in The GPRD. 
     
Description 
GPRD 
Medical Code  
OXMIS/Read 
Code 
Validated 
Code Total PPV 
Anencephaly 257028 740 AD 22 28 0.79 
Spina Bifida 304968 7419 14 28 0.5 
Anencephalus 290126 P00..00 17 21 0.81 
Spina bifida 262689 P1...00 7 16 0.44 
Spina Bifida Occulta 304970 7419CO 5 14 0.36 
Suspect fetal anencephaly 216610 L250.11 10 12 0.83 
Spina bifida occulta 253735 PG17.00 1 9 0.11 
Suspect fetal spina bifida 225710 L250.13 6 7 0.86 
Meningocele 304969 7419B 3 5 0.6 
Encephalocele 238579 7430E 3 4 0.75 
Spinal meningocele 280993 P113.00 2 4 0.5 
Spina bifida NOS 281001 P1z..00 3 4 0.75 
Spina bifida with hydrocephalus, 
unspecified 
280988 P100000 
2 3 0.67 
Spina Bifida Meningocele 
Hydrocephalus 
202515 7410D 
1 1 1 
Meningocele - cranial 217100 P203.11 1 1 1 
Closed spina bifida with Arnold-Chiari 
malformation 
226205 P101.11 
0 1 0 
Encephalocele 226217 P20..00 1 1 1 
Spinal meningocele NOS 244311 P113z00 1 1 1 
Meningocele - cerebral 244315 P203.00 0 1 0 
Occipital encephalocele 253512 P20z000 1 1 1 
Meningomyelocele Closure 266599 K027 C 1 1 1 
Acrania 290127 P000.00 1 1 1 
Meningomyelocele 299389 P114.00 1 1 1 
      
Total   103 165 0.62 
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A summary of the methods used by the GP to confirm or refute the NTD diagnoses is 
presented in Tables 5.22 and 5.23.   
Table 5.22 – Source Used To Confirm Or Refute NTD Diagnosis From Analysis Of General 
Practitioner Questionnaires 
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Returned Questionnaires 130 79% 77 47% 28 17% 4 2% 165 
Anencephaly 48 77% 36 58% 12 19% 2 3% 62 
Cephaloceles 6 100% 2 33% 0 0% 0 0% 6 
Meningoceles 8 57% 5 36% 1 7% 0 0% 14 
Spina Bifidas 68 82% 34 41% 15 18% 2 2% 83 
          
Validated Cases 96 82% 62 53% 19 16% 2 2% 117 
Anencephaly 45 79% 35 61% 12 21% 1 2% 57 
Cephaloceles 5 100% 1 20% 0 0% 0 0% 5 
Meningoceles 8 73% 5 45% 0 0% 0 0% 11 
Spina Bifidas 38 86% 21 48% 7 16% 1 2% 44 
 
 
 
Table 5.23 – Diagnostics And Screening Tests Used In NTD Diagnosis From Analysis Of 
General Practitioner Questionnaire. 
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Returned 
Questionnaires 66 40 32 19 24 15 11 7 35 21 1 1 17 10 165 
Anencephaly 42 68 9 15 8 13 0 0 16 26 0 0 3 5 62 
Cephaloceles 1 17 1 17 1 17 0 0 1 17 0 0 2 33 6 
Meningoceles 2 14 4 29 4 29 5 36 1 7 0 0 2 14 14 
Spina Bifidas 21 25 18 22 11 13 6 7 17 20 1 1 10 12 83 
                               
Validated Cases 61 52 27 23 24 21 10 9 23 20 0 0 12 10 117 
Anencephaly 39 68 7 12 8 14 0 0 15 26 0 0 3 5 57 
Cephaloceles 0 0  1 20 1 20 0 0 1 20 0 0 2 40 5 
Meningoceles 2 18 4 36 4 36 5 45 1 9 0 0 2 18 11 
Spina Bifidas 20 45 15 34 11 25 5 11 6 14 0 0 5 11 44 
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For 32 percent (n=52) of our returned questionnaires, the only source reviewed to 
confirm the diagnosis was the GPRD electronic medical records. Electronic medical records 
were used alone or in combination with other records 79 percent of the time.  The methods 
used by the GPs were similar for cases identified in the mother’s records and children’s 
records.    
The GP indicated that an examination, diagnostic or screening technique was used to 
confirm or refute the NTD diagnosis 81 percent of the time.  The most common technique 
was an ultrasound examination.  40 percent of all returned questionnaires and 59 percent of 
validated cases listed ultrasound as one of the techniques that were used by a clinician for 
determining the NTD diagnosis.  Among cases identified in mother’s records, ultrasound was 
the most common method (49 percent), while among cases identified in children’s records a 
physical exam by an obstetrician or pediatrician was the most common method (41 percent). 
Of the original 69 NTD cases identified in a child’s record, we matched 51 children to a 
mother using the mother-baby linkage.  Questionnaire responses confirmed that the mother 
baby linkage accurately identified the mother of a NTD case 89 percent of the time. When 
we looked at the 117 validated NTD cases, 87 cases were either in a mother’s record (n=71) 
or correctly linked to a mother and confirmed by the general practitioner (n=16).   
Among the 87 NTD cases in a mother’s record or with valid mother-baby links, the mean 
and median maternal age was 28 and 29 respectively, with an age range of 16 to 38. The 
NTD pregnancy was the first pregnancy for 67 percent of the mothers. 34 percent of NTD 
cases had a diagnostic or screening test commonly associated with a NTD diagnosis recorded 
in their profile in the period prior to the end of their pregnancy. All pregnancy outcomes 
associated with the 87 validated NTD cases are presented in Table 5.24.  45 percent of the 
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NTD cases were associated with an elective termination.  Spontaneous abortions were the 
second most commonly associated pregnancy outcome. 
Table 5.24 – Neural Tube Defects by Linked Pregnancy Outcomes* for Validated NTDs 
In The GPRD. 
  
 Pregnancy Event Type Matched To NTD   
 Stillbirth Termination Miscarriage 
Pre/Post 
term 
Live Birth 
/Delivery Total % 
Anencephaly 0 27 15 0 2 44 50.6 
Cephalocele 0 2 1 0 1 4 4.6 
Meningocele 0 1 0 0 5 6 6.9 
Spina Bifida 2 9 8 1 13 33 37.9 
Total 2 39 24 1 21 87  
% 2.3 44.8 27.6 1.2 24.1   
*Linked pregnancy outcomes are those from a mother’s record, and those in a child’s record with a linked 
mother with a confirmed mother-baby linkage. 
 
Because the positive predictive value of the validated NTD cases exceeded 0.70, we 
calculated adjusted annual case counts of NTDs.  Adjusted counts of NTDs by year of 
occurrence are presented in Figure 5.14.    
Figure 5.14 – Corrected Counts of Neural Tube Defect Cases in the General Practice 
Research Database Between 1991 and 2003. 
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      Annual prevalences ranged from 5.4 per 10,000 pregnancies (live births, stillbirths and 
elective terminations) in 1994, to 1.38 per 10,000 pregnancies in 1991.  These prevalences, 
as well as the annual prevalences of NTDs from the National Congenital Anomaly System 
(NCAS),
208
 are presented in Figure 5.15. 
Figure 5.15 – Age Standardized Annual Prevalence Of Neural Tube Defects From Corrected 
Case Counts Of Neural Tube Defects From The GPRD And The UK National Congenital 
Anomaly System Between Jan 1, 1991 And Dec 31, 2003.   
 
 
 
 
4. Discussion 
 
We were able to identify and subsequently confirm a large number of NTDs in the GPRD 
that may be useful in investigating maternal exposures and NTD outcomes. We believe our 
study has several benefits for future pharmacoepidemiologic research. 
Our study confirms the need for continued use of validation of diagnoses within the 
GPRD. The added information gathered by our questionnaire allowed us to determine the 
means by which the physician verified the diagnosis of a NTD. The manual validation 
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procedure also allowed us to determine additional information exceeding that available solely 
through the electronic data. While a substantial number of the returned questionnaires 
reported that the physician confirmed the NTD by using only the electronic medical records 
(the records that we used to identify the case), the majority of cases used other means of 
verification, alone or in combination with the electronic medical record.  
Additionally, this collection of validated cases available in the GPRD offers a potential 
source for case-control studies of maternal exposures and NTDs. Using our adjusted counts 
of NTDs, we would expect at least 137 NTDs available for research in the GPRD in the study 
time period.  With 137 cases and a control to case ratio of 10:1, a researcher has 80 percent 
power to detect an odds ratio of 2.0 when exposure prevalence exceeds 10 percent.  The 
power would be reduced for the analysis of specific categories of NTDs.  We present 
minimum detectable odds ratios with exposure prevalences in the range of those found in 
pregnant women identified in the GPRD in Table 5.25.
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Table 5.25 – Minimum Detectable Odds Ratio With 80 Percent Power Using 10:1 Control To 
Case Ratio. 
 
 Exposure Prevalence 
Cases 0.01 0.025 0.05 0.075 0.1 0.15 0.2 
50 7.8 5.0 3.8 3.2 3.0 2.7 2.5 
75 6.3 4.0 3.1 2.7 2.5 2.3 2.1 
100 5.3 3.5 2.8 2.5 2.3 2.1 2.0 
125 4.8 3.3 2.5 2.3 2.1 1.9 1.9 
150 4.3 3.0 2.4 2.1 2.0 1.8 1.8 
200 3.8 2.7 2.2 1.9 1.8 1.7 1.6 
 
 
We were also reassured by the accuracy of the GPRD’s mother-baby linkage.  In addition 
to the success in linking a child’s record to the mother, we also found that the linkage was 
successful in linking a mother to all of her offspring 72 percent of the time.   Linkage 
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between mothers and children allows ascertainment of detailed pre- and peri-natal exposure 
information for mothers of cases that is not prone to recall bias. However, several questions 
still remain about the role of the GPRD’s mother-baby linkage in research, primarily the 
completeness of the linkage.  While only 13 percent of the cases of NTD identified in a 
child’s record were not linked to a mother’s record, 28 percent of women with at least one 
recorded pregnancy were not linked to a child’s record.  While our sample of children with 
NTDs and their mothers is not likely representative of the greater population of mothers and 
children in the linkage, it does indicate that further research could prove valuable in 
determining the completeness of the linkage.  
There are several potential limitations of this study. Other researchers have documented 
that estimates for a variety of congenital anomalies may be underestimated by the NCAS.
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The prevalences we estimated from GPRD and those from NCAS are comparable in the later 
years; yet appear quite different in the early years.  There are several potential reasons for 
these apparent differences.   We did not identify a large number of cases, which added 
significant imprecision to our prevalence estimates, as reflected by the wide 95 percent 
confidence intervals.  All of our prevalence estimates have confidence intervals that contain 
the NCAS estimate.  Additionally, our search methodology may not have ascertained all of 
the NTD cases that are actually in the GPRD population.  Cases could be recorded in text 
notes, or in un-identifiable referral letters.  There is also the possibility that some NTD cases 
were not captured in the GP records.  If a practitioner other than the GP terminates a NTD 
pregnancy and that termination is not reported back to the GP, we would not capture that 
case.  All of these scenarios would result in an underestimate of the NTD prevalence, which 
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in turn would limit the GPRD’s ability to be a resource for use in monitoring overall NTD 
trends in the UK.  
An additional limitation was our algorithm’s inability to adequately differentiate cases in 
which the mother had spina bifida from new cases of spina bifida in offspring. While 18 
percent of NTD diagnoses identified in the mother’s records were determined by the GP to 
be the mother’s, 37 percent of spina bifida diagnoses represented the mother’s own 
condition. These false positives had a negative impact on the overall PPV of our study.  If we 
exclude all spina bifida codes, the algorithm’s PPV improves to 0.78, but 38 percent of 
confirmed NTDs are eliminated.  If we exclude only spina bifida codes associated with spina 
bifida occulta (OXMIS/Read Codes: PG17.00 and 7419CO) the PPV increases to 0.68, with 
only 6 percent of confirmed NTDs lost. Because of the potential for misclassification of case 
status, especially in the case of spina bifida, additional means, such as text notes or additional 
validation questionnaires should be used to minimize the possibility of identifying women 
with incident NTD cases. 
 Finally, there were fewer prenatal diagnostic tests in mothers’ records than we would 
have expected based upon the frequency of NTD pregnancy terminations and the established 
guidelines for antenatal care from The Royal College of Obstetricians and Gynecologists and 
the National Institute for Clinical Excellence.
132
 More physician-reported diagnostic 
techniques were used to confirm a clinical diagnosis of a NTD than we were able to identify 
using computer codes.  As most of these tests are performed in hospitals or hospital-based 
obstetric clinics, results may not be reported to or recorded by the general practitioner into 
the GP record. It is also possible that some of these diagnostic and screening tests are being 
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recorded in the form of free text information in patient visit electronic free-text notes. Due to 
cost restraints our study did not attempt to review this information  
Despite these limitations, we believe that our study has shown that the number of NTD 
cases in the GPRD provides an excellent opportunity for research into maternal exposures 
and this important outcome.  We intend to continue to improve our identification approach 
for cases of spina bifida and provide this information to other researchers that wish to utilize 
the GPRD for this purpose. 
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VI. CONCLUSIONS 
A. Recapitulation Of Overall Study Aims, Findings And Degree To Which The 
Standards And Expectations For Doctoral Research Have Been Met. 
 
 This doctoral research project was initiated with three specific aims.  The first aim was to 
identify and validate cases of NTDs within the GPRD.  We achieved this aim by creating 
electronic case definitions of specific NTDs and used these definitions to identify potential 
cases.  We then validated these cases through querying GPs using a short assessment form 
and determined the positive predictive value of our electronic case definitions.  We found 
that our electronic case definitions performed well overall, but had significant shortcomings 
for identification of cases of spina bifida (PPV = 0.47) and to a lesser extent, meningocele 
(PPV = 0.64).   
Our second specific aim was to determine the annual prevalence of NTDs within the 
population that makes up the GPRD.  In order to determine these prevalences we created 
electronic case definitions for pregnancies and used these definitions to determine the 
number of annual pregnancies. The procedure produced results that were consistent with 
previous studies using similar databases. In order to make this important procedure available 
to other researchers, we made this effort a primary focus of one of the two manuscripts that 
are contained in this dissertation.  Using this information, in combination with our validated 
annual cases, we determined the annual prevalence of NTDs within the GPRD.  Although the 
overall number of NTDs was less than expected in our initial estimates, they were of 
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sufficient quantity to provide researchers opportunity to address research questions were 
power is adequate. 
 Our third and final specific aim was to compare our prevalence of NTDs to other 
congenital anomaly monitoring systems in the UK.  Through a comparison to monitoring 
systems using different mechanisms, we determined if our proposed monitoring approach 
produces similar results, while producing gains in efficiency.  We were not able to compare 
our prevalences to those of the European Concerted Action on Congenital Anomalies and 
Twins (EUROCAT) database.  Age specific counts of NTDs were not publicly available at 
the time of this dissertation. We were able to do an informal comparison of NTD rates from 
the UK’s National Congenital Anomaly System (NCAS).  We found that our prevalences 
matched favorably with the NCAS during certain years, but unfavorably during others.  This 
could be expected based upon the different methodologies used by the NCAS and previous 
studies indicating that the NCAS may provide underestimates of many congenital 
anomalies.
143
  
 This dissertation meets the four departmental expectations for doctoral research.  
Originality was shown through its innovation in the development of methods for identifying 
pregnancies and NTDs in the GPRD.  Other researchers have not covered these areas.  These 
procedures and algorithms add valuable research tools to the research community. This 
dissertation meets the expectation of depth through its sophisticated approach to prevention 
of pregnancy misclassification.  This approach offers significant improvements to previous 
methodologies used in the field.  With regard to scholarship, the specific aims for this 
dissertation addressed gaps in the field of pharmacoepidemiology discovered during the 
research process.  Finally, this dissertation meets the expectation of demonstrable writing 
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skills.  Evidence of these skills is provided in the dissertation document itself and two 
manuscripts that are of a standard for submission to a peer-reviewed journal. 
B. Strengths & Limitations 
1. Pregnancy Identification Strengths and Limitations 
 
Our pregnancy identification algorithm and the pregnancies that it identified in the GPRD 
offer several strengths.  We identified a large number of pregnancies in a 17.5-year period of 
the GPRD.  These pregnancies have a rich assortment of medical care data associated with 
them.  At least one PCM was available for 88 percent of all pregnancies, and 78 percent of 
the identified complete pregnancy profiles had records accessible going back at least 300 
days prior to the EOP event.  Using the electronic definitions, researchers can identify 
treatments and care delivered during critical windows of fetal development and throughout 
the pregnancy.  Additionally, over 78 percent of the complete pregnancy profiles had medical 
history records going back at least 180 days before the first PCM.  Using the records for the 
six months prior to the first PCM can provide details on chronic conditions, health-services 
utilization and medication orders.  
This rich dataset also gives researchers the ability to estimate the last menstrual period 
(LMP) date associated with each pregnancy. The LMP date is important for determining the 
timing of medication exposure during very early gestation, but is often estimated because it is 
generally not available in an electronic database.  It is possible to estimate LMP using data 
developed by Manson et al. for the Kaiser-Permanente database. They found that the LMP 
was on average 40 days prior to the first PCM in the case of fetal deaths, and within 57 days 
of the first PCM for live births.
162
 We evaluated our data using the time points from the 
Manson et al. study to determine the number of pregnancies for which we could estimate an 
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LMP date.  Among the aggregated stillbirths, elective terminations and spontaneous 
terminations, we found that ninety-three percent of those with a complete pregnancy profile 
had at least 40 days of medical records prior to the first PCM.  Of the live births and 
deliveries with complete pregnancy profiles, eighty-five percent had at least 57 days of 
records prior to the first PCM.   If we defined an LMP date as 57
 
days prior to the first PCM 
regardless of outcome type, we would have data as far back as the LMP date for 86 percent 
of the 330,153 pregnancies with complete profiles.  
An additional strength of our pregnancy algorithm is its ability to reduce the chance of 
selecting an indeterminate pregnancy outcome as the final EOP code by detecting outcomes 
that were out of order in the mother’s record.  Because we were able to detect specific codes 
(i.e. those for a stillbirth or an elective termination) even when they were not the first in a 
series of codes, we did not have unknown outcomes.  For example, if a fetal death or 
stillbirth was recorded after a code broadly applied in most patients (e.g. normal delivery or 
birth details), the outcome was categorized as a fetal death rather than as an unknown 
outcome.  While this approach relies upon accurate recording of fetal deaths and stillbirths, 
the reliability of recording by the GP has been shown to be excellent.
198-201
   
Finally, a strength of both the algorithm presented here and the GPRD is the ability to 
identify recorded spontaneous abortions.  Spontaneous abortions composed approximately 
fifteen percent of the identified EOP outcomes.  This conforms with estimates of twelve to 
fifteen percent from other sources.
202, 203
 Because we are able to identify multiple pregnancy 
outcome types, particularly spontaneous abortions, pharmacoepidemiologic studies using the 
GPRD data are not be restricted to pregnancies with full-term outcomes.  
 - 172- 
However, researchers should use caution when including these spontaneous abortions.  
There will be an unknown number of spontaneous abortions that are not detected by the 
mother or the GP.  Many go unnoticed or are mistaken as part of a woman’s normal 
menstrual cycle. Because of these unidentified spontaneous abortions, developing specific 
rates for this outcome would be ill advised; however, the GPRD still offers information about 
spontaneous abortions that is not commonly available in other large electronic databases and 
these data can be useful for addressing other objectives.  
There are several limitations to our pregnancy algorithm and the identifiable pregnancies 
in the GPRD.  The first is the potential for the incomplete ascertainment of pregnancies.  In 
addition to the unrecorded spontaneous abortions mentioned above, the GPRD may not 
contain records of all elective terminations. These procedures occur at health care facilities 
other than the GP office and may not be recorded in the medical record, either by omission or 
at the woman’s request.   
GPs may fail to record all pregnancy care and outcomes in the database.  This was noted 
by the incomplete matching of a PCM to each EOP event and when evaluating maternal data 
for evidence of diagnostic and screening tests.  Although we could not expect to have 
complete matching of a PCM for certain outcomes such as miscarriages because women may 
not know they are pregnant until the time of the miscarriage, it would not explain the 
approximately 8 percent of full-term pregnancies that we could not locate a PCM.  As many 
aspects of pregnancy care are performed outside a GPs office, it is possible that information 
is not being conveyed to or entered by the GP in a format that is readily searchable (i.e. non-
descript text entries). 
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Additionally, we found that only 15 percent of all pregnancies had any record of a 
possible 149 common diagnostic or screening tests codes relevant for pregnancy.  This would 
limit the database utility in examining pregnancy complications as outcomes. The Royal 
College of Obstetricians and Gynecologists and the National Institute for Clinical 
Excellence,
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 have established guidelines for pregnancy diagnostic and screening tests.  The 
NHS has also put in place financial incentives to ensure that these tests are done.
204
 For these 
reasons, we believe that these tests are likely being performed but do not exist in the discrete 
data portion of the mother’s electronic health record.  The GP has the opportunity to record 
information as free text comments and this may be where they place information on 
pregnancy diagnosis and screening tests. We did not search this free text information as the 
costs involved were outside of the planned budget of this project. 
An additional limitation is that information on pregnancies that occurred prior to the 
patient’s registration is frequently incomplete.  Even though many of these pregnancies are 
often recorded in the GPRD as historical data, this data may be incomplete or missing in 
some women, so we did not include them in our analysis.  There is also the potential that a 
woman could leave a physician’s practice prior to delivery.  We found that there were 13,812 
women with a PCM within 90 days of transferring out of the practice and without an 
accompanying EOP event record .  Because not all GP practices are part of the GPRD and 
records are not linked from one GP practice to the next, it was not feasible to track these 
outcomes. 
There is also the potential for misclassification of pregnancy outcomes. Although we 
believe misclassification was minimized through the use of recognized pregnancy codes, 
physicians have the ability to use codes as they judge appropriate.  The potential lack of 
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consistency within and across GPs and the reality that many codes within the OXMIS and 
Read Coding dictionaries may have multiple uses complicate any attempt to avoid 
misclassification. Our approach of ranking pregnancy categories and selecting the final 
outcome using a hierarchical approach, rather than identifying the first available pregnancy 
outcome code and excluding all others within a fixed time period, should minimize 
misclassification. In our analyses, 12,834 pregnancies with the potential of being 
misclassified were ultimately identified and removed using a hierarchical pregnancy category 
approach. 
2. NTD Identification Strengths And Limitations 
 
This collection of validated cases available in the GPRD offers a potential source for 
case-control studies of maternal exposures and NTDs. Using our adjusted counts of NTDs, 
we would expect at least 137 NTDs available for research in the GPRD in the study time 
period.  With 137 cases and a control to case ratio of 10:1, a researcher has 80 percent power 
to detect an odds ratio of 2.0 when exposure prevalence exceeds 10 percent.  The power 
would be reduced for the analysis of specific categories of NTDs.  We present minimum 
detectable odds ratios with exposure prevalences in the range of those found in pregnant 
women identified in the GPRD in the table below.
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Table 6.1 – Minimum Detectable Odds Ratio With 80 Percent Power Using 10:1 Control To 
Case Ratio. 
 
 Exposure Prevalence 
Cases 0.01 0.025 0.05 0.075 0.1 0.15 0.2 
50 7.8 5.0 3.8 3.2 3.0 2.7 2.5 
75 6.3 4.0 3.1 2.7 2.5 2.3 2.1 
100 5.3 3.5 2.8 2.5 2.3 2.1 2.0 
125 4.8 3.3 2.5 2.3 2.1 1.9 1.9 
150 4.3 3.0 2.4 2.1 2.0 1.8 1.8 
200 3.8 2.7 2.2 1.9 1.8 1.7 1.6 
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We were also reassured by the accuracy of the GPRD’s mother-baby linkage.  In addition 
to the success in linking a child’s record to the mother, we also found that the linkage was 
successful in linking a mother to all of her offspring 72 percent of the time.   Linkage 
between mothers and children allows ascertainment of detailed pre- and peri-natal exposure 
information for mothers of cases that are not prone to recall bias. However, several questions 
still remain about the role of the GPRD’s mother-baby linkage in research, primarily the 
completeness of the linkage.  While only 13 percent of the cases of NTD identified in a 
child’s record were not linked to a mother’s record, 28 percent of women with at least one 
recorded pregnancy were not linked to a child’s record.  While our sample of children with 
NTDs and their mothers is not likely representative of the greater population of mothers and 
children in the linkage, it does indicate that further research could prove valuable in 
determining the completeness of the linkage.  
There are several potential limitations of this study. Other researchers have documented 
that estimates for a variety of congenital anomalies may be underestimated by the NCAS.
143
 
As illustrated in Figure 6.1 below, the prevalences we estimated from GPRD and those from 
NCAS are comparable in the later years; yet appear different in the early years, particularly 
in 1994.     
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Figure 6.1 – Age Standardized Annual Prevalence Of NTDs From Corrected Case Counts Of 
NTDs From The GPRD And The UK National Congenital Anomaly System Between Jan 1, 
1991 And Dec 31, 2003.   
 
 
 
 
We used corrected case counts to generate the annual prevalence estimates in the figure 
above.  To correct cases counts we applied the PPV of 0.71 from the NTD validation to the 
annual total number of NTDs and created age standardized prevalence and confidence 
interval estimates. To determine if our method for correcting case counts had an impact on 
our annual prevalences comparability to NCAS estimates we utilized an alternative approach.   
Rather than apply the overall PPV of 0.71, we used our NTD type specific PPVs of 0.81 for 
anencephaly, 0.83 for cephalocele, 0.64 for meningocele and 0.47 for spina bifida and 
created new age standardized annual prevalence estimates and confidence intervals using 
these new counts.   We present these results in the figure below.  
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Figure 6.2 – Age Standardized Annual Prevalence Of NTDs From Event Type Specific 
Corrected Case Counts Of NTDs From The GPRD And The UK National Congenital 
Anomaly System Between Jan 1, 1991 And Dec 31, 2003. 
 
Predictably this approach results in lower annual estimates of NTD prevalence, however, 
it does not change any of the overall impressions of comparability.  In both scenarios there is 
a pronounced difference in prevalence in between 1992 and 1996, save 1995.  One possible 
reason for the steep decline in NTD prevalence in 1995 and there after was the 1995 to 1998 
effort by the UK Health Education Authority to educate patients and physicians on the peri-
conceptual folic acid supplimentation.
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  However, the education effort does not explain the 
increase in 1994.  
There are several additional potential reasons for these apparent differences.   We did not 
identify a large number of cases, which added significant imprecision to our prevalence 
estimates, as reflected by the wide 95 percent confidence intervals.  All of our prevalence 
estimates have confidence intervals that contain the NCAS estimate.  Additionally, our 
search methodology may not have ascertained all of the NTD cases that are actually in the 
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GPRD population.  Cases could be recorded in text notes, or in un-identifiable referral letters.  
There is also the possibility that some NTD cases were not captured in the GP records.  If a 
practitioner other than the GP terminates a NTD pregnancy and that termination is not 
reported back to the GP, we would not capture that case.  All of these scenarios would result 
in an underestimate of the NTD prevalence, which in turn would limit the GPRD’s ability to 
be a resource for use in monitoring overall NTD trends in the UK.  
An additional limitation was our algorithm’s inability to adequately differentiate cases in 
which the mother had spina bifida from new cases of spina bifida in offspring.  While 18 
percent of all NTD diagnoses identified in the mother’s records were determined by the GP 
to be the mother’s own condition, 37 percent of spina bifida diagnoses represented the 
mother’s own condition. These false positives had a negative impact on the overall PPV of 
our study.  If we exclude all spina bifida codes, the algorithm’s PPV improves to 0.89, but 38 
percent of validated NTDs are eliminated.  If we exclude only spina bifida codes associated 
with spina bifida occulta (OXMIS/Read Codes: PG17.00 and 7419CO) the PPV increases to 
0.78, with only 5 percent of validated NTDs lost. Because of the potential for 
misclassification of case status, additional means, such as text notes or additional validation 
questionnaires should be used to minimize the possibility of identifying women with incident 
cases of spina bifida. 
  Finally, there were fewer prenatal diagnostic tests in mothers’ records than we would 
have expected based upon the frequency of NTD pregnancy terminations and the established 
guidelines for antenatal care from The Royal College of Obstetricians and Gynecologists and 
the National Institute for Clinical Excellence.
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 Based upon the results of the GP 
questionnaire we found that more physician-reported diagnostic techniques were used to 
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confirm a clinical diagnosis of a NTD than we were able to identify using computer codes.  
As most of these tests are performed in hospitals or hospital-based obstetric clinics, results 
may not be reported to or recorded by the GP into the GP record. It is also possible that some 
of these diagnostic and screening tests are being recorded in the form of free text information 
in patient visit electronic free-text notes. Our study did not attempt to review this 
information. 
C. Future directions 
1. Pregnancy Identification 
 
There are several areas for future work with the pregnancy identification algorithm. 
Although we did achieve a high percentage of complete pregnancy profiles (i.e. PCM and 
matched EOP event), we were unsuccessful in matching over 40,000 EOP events to a PCM.  
These events were less likely to be associated with a full-term delivery; however, there were 
still a large number of full-term deliveries that did not have a matched PCM.  Additional 
review of the text records for these events may provide additional information that could 
increase our ability to match additional EOP events to a PCM.   
There is also a need to explore text records to identify evidence of the performance of 
screening and diagnostic tests.  As noted in the results, an unexpectedly small number of 
screening and diagnostic codes were identified in the primary analyses of both the pregnancy 
identification algorithm and the NTD identification algorithm.  The standard of care in the 
UK indicates that more than approximately 15 percent of pregnancies should have a 
screening or diagnostic code associated with them.  The system of providing healthcare to a 
pregnant woman in the UK may provide some insight into why these numbers are so low.  
Much of the care delivered during pregnancy is performed by members of the healthcare 
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team other than the GP (i.e. mid-wives, OB/GYNs).   Because this care is not being delivered 
by the GP, the information may not be recorded in the GP records or it may be recorded in 
the text notes of a visit code that is associated with pregnancy.  A careful examination of the 
text notes of a sub-set of individuals who are similar to those with diagnostic and screening 
records may provide some insight into this matter.   
2. NTD Identification 
 
Our NTD identification algorithm for the GPRD will continue to be refined.  As noted in 
the results section above, our algorithm did not perform as well in the identification of new 
cases of spina bifida and to a lesser extent, meningocele.  Although many incident cases were 
identified and not selected for validation, many cases were discovered to be incident by 
validation despite the use of an appropriate NTD code. Much of this can be explained by the 
poor performance of just two codes for spina bifida occulta.  There may also be limitations of 
relying completely on medical codes rather than an approach that also uses free-text 
information. The ability to review certain free-text records for each of NTD cases could 
prove helpful in decreasing the number of false positives.   
Another area of work could focus on the development of a regularly updated case count 
for NTDs and other congenital anomalies by the GPRD.  As the database matures, we would 
expect the number of NTD cases to increase.  The periodic updating of the counts of NTDs 
would build the credibility of the GPRD to support case-control studies involving NTDs.  As 
each additional case is added and additional exposure time is potentially added, the power to 
detect associations will improve thus increasing the attractiveness of the data for research. 
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Finally, there is a need for more research into the linkage between mothers and their 
offspring developed by the GPRD.  Our study was successful in utilizing the mother-baby 
linkage, but many questions remain as to the accuracy and completeness of the linkage for 
the entire population of mothers and offspring.  This truly unique feature of the GPRD has 
many important uses and will surely be an area of future research. 
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APPENDICES 
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Version 1 – NTD Identified In Mother’s Record  
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Version 2 – NTD Identified In Child’s Record 
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Appendix B – NTD Codes   
 
GPRD 
Medical 
Codes GP Medical Term Type 
202512 Absence brain Anencephaly 
208116 Anencephalus and similar anomalies NOS Anencephaly 
216610 Suspect fetal anencephaly Anencephaly 
238577 Acrania Anencephaly 
238578 Absence skull bone with anencephalus Anencephaly 
244302 Hemianencephaly Anencephaly 
244303 Other specified anencephalus Anencephaly 
253500 Craniorachischisis Anencephaly 
257028 Anencephaly Anencephaly 
262688 Anencephalus and similar anomalies Anencephaly 
275382 Acephalia Anencephaly 
280987 Anencephalus NOS Anencephaly 
290126 Anencephalus Anencephaly 
290127 Acrania Anencephaly 
304966 Acephalus Anencephaly 
202514 Meningocoele with hydrocephalus Meningocele 
202516 Meningomyelocele with hydrocephalus Meningocele 
202517 Meningocele Meningocele 
208118 Myelocele with hydrocephalus Meningocele 
208121 Cervical spinal hydromeningocele Meningocele 
208122 Cervical meningomyelocele Meningocele 
208123 Lumbar myelocele Meningocele 
208126 Syringomyelocele Meningocele 
208128 Syringomyelocele Meningocele 
211851 Meningocoele closed Meningocele 
217100 Meningocele - cranial Meningocele 
226210 Lumbar spinal meningocele Meningocele 
226211 Lumbar meningomyelocele Meningocele 
226212 Thoracic myelocele Meningocele 
240476 Closure of spinal meningocele Meningocele 
244309 Spinal hydromeningocele Meningocele 
244310 Cervical spinal meningocele Meningocele 
244311 Spinal meningocele NOS Meningocele 
244312 Myelocele NOS Meningocele 
244315 Meningocele - cerebral Meningocele 
253503 Hydromyelocele Meningocele 
253504 Lumbar hydromyelocele Meningocele 
253505 Cervical myelocele Meningocele 
257371 Repair meningocele spinal Meningocele 
262695 Spinal hydromeningocele NOS Meningocele 
262696 Hydromyelocele of unspecified site Meningocele 
262697 Meningomyelocele NOS Meningocele 
262698 Myelocele of unspecified site Meningocele 
266594 Repair meningocele cerebral Meningocele 
266599 Meningomyelocele closure Meningocele 
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271962 Spinal hydromeningocele, unspecified Meningocele 
271963 Thoracic spinal hydromeningocele Meningocele 
271964 Hydromyelocele NOS Meningocele 
277162 Closure of spinal myelomeningocele Meningocele 
280990 Hydromyelocele with hydrocephalus Meningocele 
280992 Cervical hydromyelocele Meningocele 
280993 Spinal meningocele Meningocele 
280994 Spinal meningocele of unspecified site Meningocele 
280995 Meningomyelocele of unspecified site Meningocele 
280996 Thoracic meningomyelocele Meningocele 
280997 Myelocele Meningocele 
290134 Thoracic spinal meningocele Meningocele 
299388 Thoracic hydromyelocele Meningocele 
299389 Meningomyelocele Meningocele 
299394 Hydromeningocele - cranial Meningocele 
304969 Meningocele Meningocele 
202856 Repair meningoencephalocele Cephalocele 
208130 Meningoencephalocele Cephalocele 
217101 Nasofrontal encephalocele Cephalocele 
220566 Absence skull bone with hydrocephalus Cephalocele 
226217 Encephalocele Cephalocele 
226218 Encephalocele of other specified site Cephalocele 
229981 Repair encephalocele Cephalocele 
238579 Encephalocele Cephalocele 
253508 Hydroencephalocele Cephalocele 
253511 Encephalocele NOS Cephalocele 
253512 Occipital encephalocele Cephalocele 
262955 [X]Encephalocele of other sites Cephalocele 
271967 Frontal encephalocele Cephalocele 
277152 Repair of meningoencephalocele Cephalocele 
290139 Encephalomyelocele Cephalocele 
293615 Absence skull bone with encephalocele Cephalocele 
202515 Spina bifida meningocoele hydrocephalus Spina bifida 
204328 Repair of spina bifida NOS Spina bifida 
208117 Spina bifida with hydrocephalus Spina bifida 
208119 Cervical spina bifida with hydrocephalus - closed Spina bifida 
208120 Other spina bifida with hydrocephalus NOS Spina bifida 
208125 Cervical spina bifida without hydrocephalus - closed Spina bifida 
217094 Other specified spina bifida with hydrocephalus Spina bifida 
217098 Thoracic spina bifida without hydrocephalus - open Spina bifida 
220565 Spina bifida occulta Spina bifida 
225710 Suspect fetal spina bifida Spina bifida 
226205 Closed spina bifida with Arnold-Chiari malformation Spina bifida 
226207 Sacral spina bifida with hydrocephalus - open Spina bifida 
226208 Lumbar spina bifida with hydrocephalus - closed Spina bifida 
226209 Lumbar spina bifida without mention of 
hydrocephalus Spina bifida 
226214 Spina bifida without hydrocephalus - open Spina bifida 
226215 Cervical spina bifida without hydrocephalus - open Spina bifida 
226216 Lumbar spina bifida without hydrocephalus - open Spina bifida 
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231472 Repair of spina bifida Spina bifida 
235305 Thoracic spina bifida with hydrocephalus - closed Spina bifida 
235306 Spina bifida with stenosis of aqueduct of Sylvius Spina bifida 
235307 Unspecified spina bifida without hydrocephalus - 
open Spina bifida 
235308 Other specified spina bifida without hydrocephalus Spina bifida 
244304 Lumbar spina bifida with hydrocephalus Spina bifida 
244305 Lumbar spina bifida with hydrocephalus - open Spina bifida 
244306 Dandy - Walker syndrome with spina bifida Spina bifida 
244307 Spina bifida with hydrocephalus NOS Spina bifida 
244308 Spina bifida without mention of hydrocephalus Spina bifida 
244313 Spina bifida without hydrocephalus - open NOS Spina bifida 
247777 Spina bifida meningocoele no hydrocephal Spina bifida 
249657 Other specified repair of spina bifida Spina bifida 
253502 Thoracic spina bifida without mention of 
hydrocephalus Spina bifida 
253506 Lumbar spina bifida without hydrocephalus - closed Spina bifida 
253735 Spina bifida occulta Spina bifida 
262689 Spina bifida Spina bifida 
262690 Thoracic spina bifida with hydrocephalus - open Spina bifida 
262691 Spina bifida with hydrocephalus - open NOS Spina bifida 
262692 Spina bifida with hydrocephalus - closed NOS Spina bifida 
262693 Spina bifida with hydrocephalus of late onset Spina bifida 
262694 Unspecified spina bifida without hydrocephalus NOS Spina bifida 
262699 Sacral spina bifida without hydrocephalus - open Spina bifida 
262956 [X]Unspecified spina bifida with hydrocephalus Spina bifida 
271960 Unspecified spina bifida with hydrocephalus Spina bifida 
271961 Cervical spina bifida without mention of 
hydrocephalus Spina bifida 
271965 Thoracolumbar spina bifida without hydrocephalus - 
closed Spina bifida 
280988 Spina bifida with hydrocephalus, unspecified Spina bifida 
280989 Thoracic spina bifida with hydrocephalus Spina bifida 
280991 Unspecified spina bifida with hydrocephalus - closed Spina bifida 
280999 Spina bifida without hydrocephalus - closed Spina bifida 
281001 Spina bifida NOS Spina bifida 
284487 Spina bifida Spina bifida 
284864 Spina bifida repair Spina bifida 
290130 Spina bifida with hydrocephalus NOS Spina bifida 
290132 Cervical spina bifida with hydrocephalus - open Spina bifida 
290133 Sacral spina bifida with hydrocephalus - closed Spina bifida 
290137 Unspecified spina bifida without hydrocephalus - 
closed Spina bifida 
290138 Sacral spina bifida without hydrocephalus - closed Spina bifida 
295434 Insertion of Halber valve for spina bifida Spina bifida 
299380 Cervical spina bifida with hydrocephalus Spina bifida 
299381 Spina bifida with hydrocephalus - open Spina bifida 
299383 Unspecified spina bifida with hydrocephalus - open Spina bifida 
299384 Spina bifida with hydrocephalus - closed Spina bifida 
299385 Thoracolumbar spina bifida with hydrocephalus - 
closed Spina bifida 
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299386 Spina bifida without mention of hydrocephalus, 
unspecified Spina bifida 
299387 Spina bifida without hydrocephalus, site unspecified Spina bifida 
299391 Thoracic spina bifida without hydrocephalus - closed Spina bifida 
299392 Spina bifida without hydrocephalus - closed NOS Spina bifida 
299393 Spina bifida without mention of hydrocephalus NOS Spina bifida 
304968 Spina bifida Spina bifida 
304970 Spina bifida occulta Spina bifida 
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Appendix C: All Pregnancy Codes 
 
GPRD 
Medical 
Codes 
Gp medical term 
201581 Umbilical sepsis 
201912 Birthmark angiomatous 
201997 Pregnancy depression 
202338 Pregnancy multiple 
202339 Pregnancy disproportion 
202340 Premature labour undelivered 
202341 Pregnancy weight gain excessive 
202342 Pyelitis puerperium 
202343 Urinary infection pregnancy 
202344 Pregnancy albuminuria 
202345 Syndrome nephrotic pregnancy 
202348 Delivery antepartum haemorrhage 
202349 Malpresentation at delivery breech 
202350 Labour difficult atony uterus 
202351 Perineal laceration at delivery 
202352 Pregnancy complicated delivery 
202360 Galactorrhoea 
202376 Abscess umbilicus newborn 
202607 Placental insufficiency (baby) 
202609 Haemolytic disease newborn without 
kerni 
202611 Decreased foetal movements 
202612 Hospital confinement (baby) 
202613 Skin haemorrhage newborn 
202615 Breech birth (baby) 
202616 Birth no details 
202645 Pregnancy delusions 
202664 Jaundice increasing 
202715 Handicapped since birth 
203004 Midwifery sister 
203221 Midwife attends 1 - 10 days post 
discharge 
203250 Pregnancy benefits 
203268 Patient pregnant 
203297 No history of miscarriage 
203298 H/O: 5 miscarriages 
203299 H/O: termination 
203308 Vaginal irritation 
203493 O/E - fetal movements NOS 
203651 Edinburgh postnatal depression scale 
203769 Alpha-feto protein normal 
204044 U-S scan - fetal cephalometry 
204045 U-S scan - fetal maturity 
204046 U-S scan - fetal presentation 
204047 Viability US scan 
204048 Antenatal ultrasound result received 
204049 Antenatal ultrasound confirms ectopic 
pregnancy 
204088 Antenatal care 
204089 Pregnant - ? Planned 
204090 A/N care: H/O stillbirth 
204091 A/N care: poor A/N attender 
204092 Delivery booking place 
204093 Delivery booking - place NOS 
204094 Feeding intention -baby 
204095 Feeding intention - not known 
204096 AFP blood test not wanted 
204097 Static weight gain pregnancy 
204098 Pregnancy prolonged - 41 weeks 
204099 Mother currently breast feeding 
204100 Maternal P/N exam. Defaulted 
204101 Postnatal examination minor problem 
found 
204102 Triple test 
204103 Double test offered 
204104 Triple test not wanted 
204105 Downs screen blood test abnormal 
204106 Birth details 
204107 Baby premature 36-38 weeks 
204108 Baby premature 39 weeks 
204109 Baby premature 36 weeks 
204110 Baby BW = 3% - 9% (2500-2849g) 
204111 Birth HC = 75th-89th centile 
204112 Apgar at 1 minute NOS 
204113 Apgar at 10 minutes = 8 
204114 Mother < 20 years old 
204115 H.V.: mother not managing well 
204116 Labour details 
204117 Normal labour 
204234 Preg. Termination counselling 
204235 Fertility counselling 
204242 Infant feeding advice 
204243 Pregnancy alcohol advice 
204244 Preg. Prescription exempt adv. 
204946 Total abdominal hysterectomy NEC 
204950 Hysterotomy and termination of 
pregnancy 
204953 Termination of pregnancy NEC 
204957 Introduction of abortifacient into uterine 
cavity 
204989 Therapeutic fetoscopic operation NOS 
204990 Foetoscopic examination foetus and 
sampling of foetal blood 
204991 Therapeutic percutaneous operations 
on fetus 
204992 Other operation on amniotic cavity NOS 
204993 Removal of Shirodkar suture 
204994 Other specified operation on gravid 
uterus 
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204995 Surgical induction of labour 
204996 Hind water rupture of amniotic 
membrane 
204997 Low forceps cephalic delivery 
204998 Kielland forceps cephalic delivery with 
rotation 
204999 Piper forceps delivery 
205000 Episiotomy to facilitate delivery 
205001 Induction and delivery operations NOS 
205002 Normal delivery of placenta 
205003 Other operation on delivered uterus 
NOS 
205004 Other specified immediate repair of 
obstetric laceration 
205005 Other obstetric operations NOS 
205093 Open instillation sclerosing substance 
to peritoneal cavity 
205674 Referral to antenatal clinic 
205717 Full post-natal examination 
205718 HSA1-therap. Abort. Green form 
205775 Lss 24 wk inv risk inj phys/men hlth ext 
child preg wom fmly 
207529 Fallopian tube pregnancy 
207530 Other ectopic pregnancy 
207531 Mesenteric pregnancy 
207532 Spontaneous abortion unspecified 
207533 Complete spontaneous abortion + other 
specified complication 
207534 Complete spontaneous abortion + no 
mention of complication 
207535 Inevitable miscarriage unspecified 
207536 Unspecified inevitable miscarriage with 
unspec complication 
207537 Inevitable miscarriage incomp 
207538 Termination of pregnancy 
207539 Unspecified legal abortion + 
delayed/excessive haemorrhage 
207540 Unspecified legal abortion with no 
mention of complication 
207541 Surgical abortion - incomplete 
207542 Complete legal abortion + damage to 
pelvic organs or tissues 
207543 Complete legal abortion NOS 
207544 Unspecified illegal abortion with shock 
207545 Incomplete illegal abortion with 
metabolic disorder 
207546 Unspecified abortion with other 
specified complication 
207547 Unspecified abortion complete 
207548 Endometritis following abortive 
pregnancy 
207549 Septicaemia NOS following abortive 
pregnancy 
207550 Bowel damage following abortive 
pregnancy 
207551 Cervix damage following abortive 
pregnancy 
207552 Periurethral tissue damage following 
abortive pregnancy 
207553 Renal tubular necrosis following 
abortive pregnancy 
207554 Uraemia following abortive pregnancy 
207555 Shock following abortive pregnancy 
207556 Readmission for retained produc of 
concept, illegal abortion 
207557 Failed medical abortion complic by 
genital tract/pelvic infn 
207558 Failed medical abortion comp by 
delayed/excessive haem'ge 
207559 Threatened abortion - delivered 
207560 Other haemorrhage in early pregnancy 
- delivered 
207561 Placenta praevia with haemorrhage 
unspecified 
207562 Ablatio placentae 
207563 Antepartum haemorrhage with 
coagulation defect NOS 
207564 Antepartum haemorrhage with uterine 
leiomyoma NOS 
207565 Renal hypertension in 
pregnancy/childbirth/puerp unspecified 
207566 Other pre-exist hypertension in 
preg/childb/puerp-not deliv 
207567 Gestational hypertension 
207568 Mild or unspecified pre-eclampsia - not 
delivered 
207569 Eclampsia in labour 
207570 Eclampsia NOS 
207571 Pre-eclampsia or eclampsia with pre-
existing hypertension 
207572 Pre-eclampsia or eclampsia with 
hypertension + p/n comp 
207573 Unspecified hypertension in 
preg/childb/puerp unspecified 
207574 Hyperemesis gravidarum with metabolic 
disturbance unsp 
207575 Other pregnancy vomiting - not 
delivered 
207576 Other pregnancy vomiting NOS 
207577 Other threatened labour - not delivered 
207578 Premature delivery 
207579 Other pregnancy complication NEC 
207580 Papyraceous fetus - delivered 
207581 Unspecified renal disease in pregnancy 
unspecified 
207582 Peripheral neuritis in pregnancy - not 
delivered 
207583 Asymptomatic bacteriuria in pregnancy 
unspecified 
207584 Infections of the genital tract in 
pregnancy 
207585 Glycosuria during pregnancy - delivered 
207586 Maternal syphilis in puerperium - baby 
delivered 
207587 Maternal syphilis during pregnancy - 
baby not yet delivered 
207588 Maternal gonorrhoea during 
pregnancy/childbirth/puerperium 
207589 Infections of bladder in pregnancy 
207590 Other mat.infective/parasitic dis in 
pregnancy - delivered 
207591 Mat infect/parasitic dis NOS in 
puerperium - baby delivered 
207592 Diabetes mellitus during pregnancy - 
baby delivered 
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207593 Diabetes mellitus in puerperium - baby 
delivered 
207594 Gestational diabetes mellitus 
207595 Postpartum thyroiditis 
207596 Congenital heart disease in pregnancy 
207597 Congenital cardiovasc dis in puerp - 
baby delivered 
207598 Other cardiovascular diseases in 
pregnancy/childbirth/puerp 
207599 Heart disease during pregnancy 
207600 Other cardiovascular dis in pregnancy - 
baby not delivered 
207601 Other cardiovascular disease in 
pregnancy/childb/puerp NOS 
207602 Abnormal glucose tolerance test in 
pregnancy/childb/puerp 
207603 Dis of the digestive sys comp preg 
childbirth and puerp 
207604 Dis of the skin and subcut tis comp preg 
childbrth puerp 
207605 Medical condition NOS in puerperium - 
baby delivered 
207606 Twin pregnancy unspecified 
207607 Triplet pregnancy unspecified 
207608 Multiple delivery, all spontaneous 
207609 Unstable lie NOS 
207610 Breech presentation unspecified 
207611 Oblique lie - delivered 
207612 Brow presentation with antenatal 
problem 
207613 Multiple pregnancy with 
malpresentation - delivered 
207614 Compound presentation 
207615 Fetal malposition and malpresentation 
NOS 
207616 Disproportion - major pelvic abnormality 
unspecified 
207617 Outlet pelvic contraction NOS 
207618 Other disproportion NOS 
207619 Bicornuate uterus affecting obstetric 
care 
207620 Uterine operation scar in 
pregnancy/childb/puerp + a/n prob 
207621 Other uterine/pelvic floor abnormality - 
baby delivered 
207622 Rectocele - delivered with postpartum 
complication 
207623 Rectocele complicating postpartum 
care - baby delivered prev 
207624 Cervical incompetence unspecified 
207625 Other cervical abnormality affecting 
obstetric care 
207626 Polyp of cervix complicating a/n care- 
baby not delivered 
207627 Stenosis of vagina complicating a/n 
care- baby not delivered 
207628 Stenosis of vagina complicating p/n 
care - baby deliv prev 
207629 Vulval abnormality in 
pregnancy/childbirth/puerperium NOS 
207630 Persistent hymen in 
pregnancy/childbirth/puerperium NOS 
207631 Rigid perineum in 
pregnancy/childbirth/puerperium NOS 
207632 Pelvic soft tissue abnormality in 
preg/childb/puerp unspec 
207633 Known or suspected fetal abnormality 
207634 Fetus with central nervous system 
malformation - delivered 
207635 Suspect fetal damage from maternal 
toxoplasmosis 
207636 Fetus with radiation damage 
207637 Fetus with radiation damage NOS 
207638 Fetus with other damage NEC 
207639 Other fetal and placental problems 
207640 Fetal acidosis 
207641 Fetal tachycardia 
207642 Fetal distress with antenatal problem 
207643 Maternal care for reduced fetal heart 
rate during pregnancy 
207644 Small-for-dates with antenatal problem 
207645 Small-for-dates NOS 
207646 Suspected macroscopic fetus 
207647 Feto-placental problems NOS, 
unspecified 
207648 Polyhydramnios and hydramnios 
207649 Hydramnios 
207650 Polyhydramnios unspecified 
207651 Polyhydramnios NOS 
207652 Oligohydramnios 
207653 Oligohydramnios unspecified 
207654 Premature rupture of membranes with 
antenatal problem 
207655 Prolonged spontaneous or unspecified 
rupture of membranes 
207656 Chorioamnionitis 
207657 Amniotic fluid leaking 
207658 Other problem of amniotic cavity and 
membranes NOS 
207659 Unspecified maternal pyrexia during 
labour NOS 
207660 Elderly primigravida - delivered 
207661 Other problems affecting labour 
unspecified 
207662 Abnormal findings on antenatal 
screening of mother 
207663 Abnormal cytological finding on 
antenatal screen of mother 
207664 Abnormal radiological finding on 
antenatal screen of mother 
207665 Obstructed labour due abnormality of 
maternal pelv organs 
207666 Shoulder dystocia NOS 
207667 Locked twins 
207668 Other failed forceps, unspecified 
207669 Other failed forceps - delivered 
207670 Obstructed labour NOS with antenatal 
problem 
207671 Abnormality of forces of labour NOS - 
delivered 
207672 Abnormality of forces of labour NOS 
with antenatal problem 
207673 Prolonged first stage unspecified 
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207674 Prolonged second stage - delivered 
207675 Prolapse of cord - delivered 
207676 Prolapse of cord NOS 
207677 Cord tight round neck with antenatal 
problem 
207678 Cord tight round neck NOS 
207679 Cord tangled or knotted with 
compression 
207680 Knot in cord 
207681 Other cord entanglement 
207682 Short cord with antenatal problem 
207683 Vasa praevia - delivered 
207684 Umbilical cord complications NOS - 
delivered 
207685 First degree perineal tear during 
delivery with p/n problem 
207686 Labial tear during delivery 
207687 First degree perineal tear during 
delivery NOS 
207688 Second degree perineal tear during 
delivery NOS 
207689 Fourth degree perineal tear during 
delivery with p/n problem 
207690 Vulval and perineal haematoma during 
delivery NOS 
207691 Ruptured uterus before labour 
207692 Rupture of uterus before labour - 
delivered 
207693 Rupture of uterus during/after labour - 
deliv with p/n prob 
207694 Rupture of uterus during/after labour 
with postnatal problem 
207695 Rupture of uterus during and after 
labour NOS 
207696 Inversion of uterus - obstetric 
207697 Obstetric high vaginal laceration with 
postnatal problem 
207698 Obstetric pelvic haematoma unspecified 
207699 Other obstetric trauma with postnatal 
problem 
207700 Other obstetric trauma NOS 
207701 Obstetric trauma NOS - delivered 
207702 Postpartum haemorrhage (PPH) 
207703 Bleeding postpartum 
207704 Postpartum coagulation defects NOS 
207705 Mendelson's syndrome 
207706 Obstetric anaesthesia with cardiac 
comp with postnatal prob 
207707 Spinal/epidural anesth-induced 
headache dur labour/delivery 
207708 Other complications of obstetric 
anaesthesia -del + p/n prob 
207709 Obstetric anaesthetic complications 
NOS 
207710 Obstetric anaesthetic complications 
NOS - deliv + p/n prob 
207711 Obstetric shock unspecified 
207712 Other complications of labour and 
delivery unspecified 
207713 Complications of labour and delivery 
NOS 
207714 Puerperal septicaemia 
207715 Varicose veins of legs in pregnancy 
207716 VV's of perineum/vulva in 
pregnancy/puerperium + a/n comp 
207717 Superficial thrombophlebitis in 
pregnancy and the puerperium 
207718 DVT - deep venous thrombosis, 
antenatal 
207719 Haemorrhoids in pregnancy and 
puerperium with p/n comp 
207720 Cerebral venous thrombosis in the 
puerperium 
207721 Puerperal pyrexia of unknown origin 
with p/n complication 
207722 Obstetric pulmonary embolus 
207723 Obstetric air pulm embolism - delivered 
+ p/n complication 
207724 Obstetric pulmonary embolism NOS, 
unspecified 
207725 Obstetric perineal wound disruption 
207726 Other complication of obstetric surgical 
wound NOS 
207727 Other complications of the puerperium 
with p/n complication 
207728 Complications of the puerperium NOS 
with postnatal comp 
207729 Complications of the puerperium NOS 
207730 Obstetric nipple infection - delivered 
207731 Obstetric nipple infection with antenatal 
complication 
207732 Obstetric nipple infection with postnatal 
complication 
207733 Obstetric breast abscess 
207734 Obstetric breast abscess unspecified 
207735 Obstetric breast abscess with antenatal 
complication 
207736 Obstetric nonpurulent mastitis - 
delivered 
207737 Obstetric nonpurulent mastitis NOS 
207738 Retracted nipple in 
pregnancy/puerperium/lactation - deliv 
207739 Breast engorgement in pregnancy, the 
puerperium or lactation 
207740 Breast engorgement in 
pregnancy/puerp/lact - del + p/n comp 
207741 Other breast disorder in 
pregnancy/puerperium/lactation 
207742 Failure of lactation - delivered with 
postnatal complication 
207743 Other disorders of lactation 
207744 Other disorder of lactation unspecified 
207745 Maternal care for poor fetal growth 
207746 [X]Additional preg,cldbirth+puerperium 
diseas clssfctn terms 
207747 [X]Other specified abnormal products of 
conception 
207748 [X]Maternal care for other 
malpresentation of fetus 
207749 [X]Obstructed labour due/other 
malposition+malpresentation 
207750 [X]Obstructd labour due to oth maternal 
pelvic abnormalities 
207751 [X]Complication of anaesthesia during 
labour and deliv unsp 
207752 [X]Other single spontaneous delivery 
207753 [X]Other obstetric embolism 
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207754 [X]Infection of caesarian section wound 
following delivery 
207755 [X]Oth infctns wth predomin sexual 
mode/transmissn complicat 
207756 [X]Other viral diseases complicating 
preg,cldbirth+puerperum 
208411 Fetal and neonatal conditions 
208412 Fetus/neonate affected by maternal 
problem unrelated to preg 
208413 Fetus or neonate affected by maternal 
hypertensive disease 
208414 Fetus/neonate affected-plac./breast 
transfer anticoagulant 
208415 Fetus/neonate affected by placental 
damage-amniocentesis 
208416 Fetus/neonate affected by feto-maternal 
transplacental trans 
208417 Fetus or neonate affected by knot in 
cord 
208418 Fetus or neonate affected by short cord 
208419 Fetus/neonate affected 
malpos/malpres/disprop - lab/deliv OS 
208420 Fetus/neonate affected by 
malposition/disproportion NOS 
208421 Fetus/neonate affected by maternal 
anaesthetic/analgesia NOS 
208422 Fetus or neonate affected by hypertonic 
labour 
208423 Fetus/neonate affected by uterine 
inertia in labour/delivery 
208424 Fetus or neonate affected by 
instrumental delivery 
208425 Fet newborn affect nox influenc transmit 
placent breast milk 
208426 Fetus/newborn affected maternal use of 
antihypertensive drug 
208427 Fetal malnutrition, no mention light or 
small for gest age 
208428 Extreme immaturity 
208429 Disorders relating to long gestation and 
high birthweight 
208430 Intracerebral haemorrhage in fetus or 
newborn 
208431 Scalp injuries due to birth trauma 
208432 Caput succedaneum due to birth 
trauma 
208433 Other specified scalp injury due to birth 
trauma 
208434 Fracture of radius or ulna due to birth 
trauma 
208435 Spine fracture due to birth trauma 
208436 Erb-Duchenne paralysis 
208437 Subcutaneous fat necrosis due to birth 
injury 
208438 Birth injury NOS 
208439 Other and unspecified perinatal 
atelectasis 
208440 Perinatal chronic respiratory disease 
NOS 
208441 Perinatal apnoeic spells NOS 
208442 Umbilical sepsis NOS 
208443 Ophthalmia neonatorum - 
staphylococcal 
208444 Neonatal candidiasis of perineum 
208445 Neonatal candidiasis of lung 
208446 Intra-amniotic fetal infection, 
unspecified 
208447 Sepsis of newborn due to Escherichia 
coli 
208448 Congenital viral disease, unspecified 
208449 Fetal and neonatal haemorrhage 
208450 Fetal blood loss from cut co-twin's cord 
208451 Fetal placental blood loss 
208452 Fetal blood loss from vasa praevia 
208453 Perinatal gastrointestinal haemorrhage 
NOS 
208454 Perinatal cutaneous ecchymoses 
208455 Haemorrhage of fetus and newborn 
NOS 
208456 Haemolytic disease due to rhesus 
isoimmunisation 
208457 Rhesus isoimmunisation of the newborn 
208458 Hydrops fetalis due to other+unspcfd 
haemolytic disease 
208459 Breast feeding inhibitors causing 
neonatal jaundice 
208460 Inspissated bile syndrome 
208461 Newborn physiological jaundice NOS 
208462 Other newborn transient coagulation 
defect 
208463 Transient neonatal neutropenia 
208464 Feeding problems in newborn 
208465 Slow feeding in newborn 
208466 Vomiting in newborn 
208467 Bottle feeding problem in the newborn 
208468 Grey syndrome of newborn 
208469 Neonatal cerebral leukomalacia 
208470 Other specified perinatal conditions 
208471 Stillbirth NEC 
208472 Other specified perinatal conditions 
208473 [X]Fetus and newborn affected by other 
maternal conditions 
208474 [X]Haemorrhagic+haematolog disorders 
of fetus and newborn 
208475 [X]Other fetal blood loss 
208476 [X]Trans disorder carbohydrate metab 
of fet and newborn unsp 
208477 Perinatal conditions NOS 
209589 Accident due to abandonment of 
newborn 
210188 [V]Other normal pregnancy supervision 
210189 [V]Pregnancy with history of infertility 
210202 [V]Twin, born in hospital, mate stillborn 
210284 [V]Pregnancy not (yet) confirmed 
210352 Ventouse extraction delivery (baby) 
210353 Repair uterus obstetric 
210421 Version external 
210444 Placental function test abnormal 
210514 Pregnancy test done 
210605 Pregnancy high risk 
210713 Newborn infant examination- normal 
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210745 Prenatal care normal pregnancy 
210747 Examination well baby normal 
210748 Well baby/child care 
210965 Cannabis ingestion in pregnancy 
211355 Pregnancy bicornate uterus 
211356 Pyelitis pregnancy 
211357 Pregnancy nephritis 
211359 Induced abortion legal 
211361 Inevitable abortion 
211362 Incomplete abortion 
211363 Placenta praevia delivered 
211364 Disproportion cephalopelvic 
211365 Delivery crossbirth (mother) 
211366 Malpresentation at delivery face 
211367 Uterus atony 
211368 Delivery bicornate uterus 
211369 Laceration perineal at delivery slight 
211371 Delivery sudden death (mother) 
211373 Postabortion bleeding 
211613 Twin conjoined 
211615 Paralysis brachial plexus due birth inju 
211616 Asphyxia antenatal 
211621 Neonatal convulsion 
211709 Disabled since birth 
212193 Midwife attends 17 - 20 days post 
discharge 
212194 Midwife attends 25 - 28 days post 
discharge 
212269 Due to deliver - EDC 
212275 H/O: abortion NOS 
212276 H/O: delivery no details 
212282 H/O: prolonged labour 
212351 Delusions 
212398 O/E - accessory resp.m's.used 
212739 Serum pregnancy test equivocal 
213053 U-S scan - obstetric, diagn. 
213054 Antenatal ultrasound confirms intra-
uterine pregnancy 
213085 Pregnant, IUD failure 
213093 Patient currently pregnant 
213094 Unplanned pregnancy 
213095 A/N care: uncertain dates 
213096 A/N care: primip. < 17 years 
213097 A/N - shared care 
213098 Home delivery booked 
213099 Deliv.booking - length of stay 
213100 Feeding intention - bottle 
213101 A/N amniocentesis wanted 
213102 A/N amnio. For ? Neural tube 
213103 A/N U/S scan not wanted 
213104 A/N U/S scan abnormal 
213105 Rh screen - 2nd preg. Sample 
213106 Rh - 6/12 after anti-D sample 
213107 A/N Rh antibody screen NOS 
213108 Alpha-feto protein blood test 
213109 AFP test - antenatal 
213110 AFP blood test NOS 
213111 Rubella screen offered 
213112 Rubella screen NOS 
213113 Antenatal sickle cell screen 
213114 A/N sickle cell screen NOS 
213115 A/N 20 week examination 
213116 A/N 28 week examination 
213117 A/N 39 week examination 
213118 A/N 40 week examination 
213119 P/N care refused 
213120 P/N - seventh day visit 
213121 Postnatal exam. - maternal 
213122 Maternal P/N exam. Done 
213123 Triple test offered 
213124 Double test not offered 
213125 Length of labour 
213126 1 male + 1 female baby 
213127 2 male + 1 female babies 
213128 Premature baby 
213129 Baby extremely prem.28-32 week 
213130 Birthweight of baby 
213131 Baby BW = 10 - 24% (2850-3149g) 
213132 Baby BW = 90 - 96% (4050-4399g) 
213133 Baby BW = 1.5-2.0kg 
213134 Baby BW = above 2.5kg 
213135 Birth HC = > 97th centile 
213136 Birth length 
213137 Birth length=50th-74th centile 
213138 Birth length=75th-89th centile 
213139 Apgar at 1 minute = 3 
213140 Apgar at 1 minute = 7 
213141 Apgar at 1 minute = 10 
213142 Heterozygous twin 
213143 Placental details 
213144 Placenta diameter 
213145 Birth details not known 
213162 Baby normal at birth 
213184 Child 8 week exam. Normal 
213258 Pregnancy advice NOS 
213942 Introduction of gamete into uterine 
cavity 
213943 Implantation of fertilised egg into uterus 
213966 Diagnostic endoscopic examination 
fetus using fetoscope NOS 
213967 Selective destruction of fetus NOS 
213968 Percutaneous sampling of foetal blood 
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213969 Lower uterine segment caesarean 
section (LSCS) NEC 
213970 Extraperitoneal caesarean section 
213971 Other specified other breech delivery 
213972 Normal delivery 
213973 Other method of delivery NOS 
213974 Other obstetric operations 
213975 Instrumental removal products of 
concep delivered uterus NOS 
213976 Crede placental expression 
213977 Pack to control postnatal haemorrhage 
213978 Repair of ruptured uterus 
213979 Fetal heart monitoring in labour 
214389 Gas and air analgesia in labour 
214625 Post-natal exercises 
214674 Refuse procedure-after thought 
214712 Maternity services admin. 
214715 Part post-natal care-2 visits 
214774 Unborn child at risk physi/ment 
abnormal serious handicap 
214994 Neonatal gonococcal conjunctivits 
215630 Neurotic depression reactive type 
216494 Habitual aborter-not pregnant 
216507 Abdominal pregnancy 
216508 Unspecified spontaneous abortion with 
shock 
216509 Unspecified spontaneous abortion with 
embolism 
216510 Incomp spontaneous abortion + genital 
tract/pelvic infection 
216511 Unspec inev abor comp by genital tract 
and pelvic infect 
216512 Unspecified inevitable abortion with OS 
complication 
216513 Incomp inev abor comp by genital tract 
and pelvic infection 
216514 Incomplete inevitable abortion 
complicated by embolism 
216515 Incomplete inevitable abortion with OS 
complication 
216516 Inevitable abortion complete 
216517 Elective abortion 
216518 Unspecified legal abortion with 
metabolic disorder 
216519 Incomplete legal abortion with shock 
216520 Incomplete legal abortion with 
embolism 
216521 Complete legal abortion with other 
specified complication 
216522 Incomplete illegal abortion with 
complication NOS 
216523 Complete illegal abortion NOS 
216524 Unspecified abortion with genital tract 
or pelvic infection 
216525 Unspecified abortion with no mention of 
complication 
216526 Unspecified complete abortion + pelvic 
organ/tissue damage 
216527 Unspecified complete abortion + no 
mention of complication 
216528 Delayed/excess haemorrhage NOS 
following abortive pregnancy 
216529 Pelvic organ or tissue damage following 
abortive pregnancy 
216530 Embolism following abortive pregnancy 
216531 Fat embolism following abortive 
pregnancy 
216532 Other haemorrhage in early pregnancy 
- not delivered 
216533 Early pregnancy haemorrhage NOS 
216534 Antepartum bleeding 
216535 Placenta praevia without haemorrhage - 
delivered 
216536 Placenta praevia with haemorrhage - 
delivered 
216537 Placenta praevia with haemorrhage 
NOS 
216538 Placental abruption unspecified 
216539 Antepartum haemorrhage with uterine 
fibroid 
216540 Benign essential hypertension in 
preg/childb/puerp unspec 
216541 Renal hypertension in 
pregnancy/childbirth/puerp - delivered 
216542 Renal hypertension in preg/childb/puerp 
+ p/n complication 
216543 Other pre-existing hypertension in 
preg/childbirth/puerp 
216544 Other pre-existing hypertension in 
preg/childb/puerp unspec 
216545 Severe pre-eclampsia - delivered with 
postnatal complication 
216546 Unspecified hypertension in 
preg/childb/puerp - delivered 
216547 Unspecified hypertension in 
preg/childb/puerp with p/n comp 
216548 Mild hyperemesis gravidarum 
216549 Late pregnancy vomiting unspecified 
216550 Late pregnancy vomiting - delivered 
216551 Other pregnancy vomiting 
216552 Threatened premature labour 
216553 Threatened premature labour NOS 
216554 Early onset of delivery unspecified 
216555 Post-term pregnancy 
216556 Oedema or excessive weight gain in 
pregnancy, delivered 
216557 Oedema/excess weight gain preg - 
delivered + postnatal compl 
216558 Albuminuria in pregnancy without 
hypertension 
216559 Nephropathy NOS in pregnancy without 
hypertension 
216560 Unspecified renal disease in pregnancy 
with p/n complication 
216561 Peripheral neuritis in pregnancy 
216562 Peripheral neuritis in pregnancy 
unspecified 
216563 Genitourinary tract infection in 
pregnancy NOS 
216564 Liver disorder in pregnancy unspecified 
216565 Herpes gestationis unspecified 
216566 Glycosuria during pregnancy 
unspecified 
- 195- 
216567 Gestational oedema with proteinuria 
216568 Excessive weight gain in pregnancy 
216569 Pregnancy complication NOS 
216570 Infective/parasitic disease in 
preg/childbirth/puerperium 
216571 Maternal syphilis in 
pregnancy/childbirth/puerperium NOS 
216572 Maternal tuberculosis in 
pregnancy/childbirth/puerperium 
216573 Maternal tuberculosis in pregnancy - 
baby not yet delivered 
216574 Maternal malaria during pregnancy - 
baby not yet delivered 
216575 Viral hepatitis comp pregnancy, 
childbirth & the puerperium 
216576 Other maternal viral dis. In 
pregnancy/childbirth/puerp. NOS 
216577 Mat infect/parasitic dis NOS in puerp-
baby previously deliv 
216578 Diabetes mellitus - unspec whether in 
pregnancy/puerperium 
216579 Anaemia in the puerperium - baby 
previously delivered 
216580 Drug dependence during pregnancy - 
baby delivered 
216581 Drug dependence in puerperium - baby 
previously delivered 
216582 Mental disorder - unspec whether in 
pregnancy/puerperium 
216583 Cardiomyopathy in the puerperium 
216584 Dis nervous syst complic 
pregnancy,childbirth and puerperium 
216585 Medical condition NOS in pregnancy - 
baby not yet delivered 
216586 Twin pregnancy NOS 
216587 Triplet pregnancy 
216588 Cephalic version NOS - delivered 
216589 High head at term with antenatal 
problem 
216590 Other fetal malposition and 
malpresentation unspecified 
216591 Fetal malposition and malpresentation 
NOS with a/n problem 
216592 Disproportion - major pelvic abnormality 
216593 Disproportion - major pelvic abnormality 
with antenatal prob 
216594 Conjoined twins causing disproportion 
216595 Other disproportion with antenatal 
problem 
216596 Disproportion NOS, unspecified 
216597 Uterine fibroids in pregnancy, childbirth 
and the puerperium 
216598 Cystocele affecting obstetric care 
216599 Cystocele complicating antenatal care - 
baby not delivered 
216600 Other uterine/pelvic floor abn in 
preg/childb/puerp NOS 
216601 Polyp of cervix - baby 
delivered+postpartum complication 
216602 Stenosis of cervix - baby 
delivered+postpartum complication 
216603 Other cervical abn complicating a/n 
care- baby not delivered 
216604 Other cervical abn complicating p/n 
care - baby deliv prev 
216605 Stenosis of cervix in 
pregnancy/childbirth/puerperium NOS 
216606 Septate vagina complicating p/n care - 
baby delivered prev 
216607 Pelvic soft tissue abnormality in 
pregnancy/childbirth/puerp 
216608 Pelvic soft tissue abnorm in 
preg/childb/puerp with a/n prob 
216609 Pelvic soft tissue abnorm in 
preg/childb/puerp with p/n comp 
216610 Suspect fetal anencephaly 
216611 Suspect cystic fibrosis fetus 
216612 Fetus with hereditary disease with 
antenatal problem 
216613 Fetus with suspected rubella damage 
via mother 
216614 Fetus with viral damage via mother 
NOS 
216615 Fetus with damage due to IUCD - 
delivered 
216616 Rhesus isoimmunisation 
216617 Rhesus isoimmunisation with antenatal 
problem 
216618 Rhesus isoimmunisation NOS 
216619 Fetal bradycardia 
216620 Labour+delivery complicatd by biochem 
evidence/fetal stress 
216621 Maternal care for fetal acidosis during 
pregnancy 
216622 Small-for-dates - delivered 
216623 Large-for-dates - delivered 
216624 Other placental conditions unspecified 
216625 Placental infarction 
216626 Ragged placenta 
216627 Reduced fetal movements 
216628 Lithopaedian 
216629 Other feto-placental problems - 
delivered 
216630 Polyhydramnios 
216631 Polyhydramnios with antenatal problem 
216632 Premature rupture of membranes 
unspecified 
216633 Prolonged spontaneous/unspecified 
rupture of membranes NOS 
216634 Placentitis 
216635 Amniotic cavity infection - delivered 
216636 Other amniotic/membrane problem with 
antenatal problem 
216637 Failed mechanical induction unspecified 
216638 Failed mechanical induction - delivered 
216639 Septicaemia during labour unspecified 
216640 Grand multiparity unspecified 
216641 Elderly primigravida with antenatal 
problem 
216642 Vaginal delivery following previous 
caesarean section 
216643 Other problems affecting labour 
216644 Problems affecting labour NOS 
unspecified 
216645 Other specified risk factors in 
pregnancy 
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216646 Obstructed labour caused by bony 
pelvis unspecified 
216647 Obstructed labour due to pelvic inlet 
contraction 
216648 Deep transverse arrest (DTA) 
216649 Persistent occipitopost/occipitoant 
position + a/n problem 
216650 Impacted shoulders 
216651 Obstructed labour NOS - delivered 
216652 Other uterine inertia - delivered 
216653 Precipitate labour unspecified 
216654 Hypertonic uterine inertia 
216655 Contraction ring (dystocia) 
216656 Uterine or cervical spasm 
216657 Abnormality of forces of labour NOS 
unspecified 
216658 Other cord entanglement NOS 
216659 Short cord NOS 
216660 Vasa praevia NOS 
216661 Vascular lesions of cord unspecified 
216662 Other umbilical cord complications 
unspecified 
216663 Other umbilical cord complications - 
delivered 
216664 Umbilical cord complications NOS with 
antenatal problem 
216665 Vaginal tear 
216666 First degree perineal tear during 
delivery - delivered 
216667 Vulval/perineal trauma during delivery 
NOS with p/n problem 
216668 Rupture of uterus before labour NOS 
216669 Obstetric inversion of uterus 
unspecified 
216670 Obstetric high vaginal laceration 
unspecified 
216671 Obstetric trauma damaging pelvic joints 
and ligaments 
216672 Obstetric damage to pelvic joints and 
ligaments + p/n prob 
216673 Obstetric damage to pelvic joints and 
ligaments NOS 
216674 Obstetric pelvic haematoma - delivered 
with p/n problem 
216675 Other obstetric trauma - delivered 
216676 Obstetric trauma NOS with postnatal 
problem 
216677 Third-stage postpartum haemorrhage 
unspecified 
216678 Third-stage postpartum haemorrhage - 
deliv with p/n problem 
216679 Postpartum coagulation defects 
216680 Retained portion of placenta or 
membranes - no haemorrhage 
216681 Complications of anaesthesia during 
labour and delivery 
216682 Obstetric anaesthesia with pulmonary 
complications unsp 
216683 Obstetric anaesthesia with cardiac 
complications 
216684 Obstetric anaesthesia with cardiac 
comp with antenatal prob 
216685 Complication of anaesthesia during 
labour and deliv unsp 
216686 Obstetric anaesthetic complications 
NOS - delivered 
216687 Obstetric anaesthetic complications 
NOS 
216688 Maternal distress with postnatal 
problem 
216689 Obstetric shock with postnatal problem 
216690 Maternal hypotension syndrome 
unspecified 
216691 Other complications of obstetric 
procedures unspecified 
216692 Other complications of obstetric 
procedures with p/n problem 
216693 Ventouse delivery 
216694 Breech extraction 
216695 Other complications of labour and 
delivery - delivered 
216696 Other complications of labour and 
delivery with a/n problem 
216697 Other complications of labour and 
delivery with p/n problem 
216698 Vaginal discomfort postnatal 
216699 Intrapartum haemorrhage, unspecified 
216700 Complications of labour and delivery 
NOS 
216701 Major puerperal infection 
216702 Major puerperal infection NOS, 
unspecified 
216703 Perineal varices in pregnancy 
216704 Thombophlebitis of legs in the 
puerperium 
216705 Postnatal deep vein thrombosis NOS 
216706 Piles - obstetric 
216707 Haemorrhoids in pregnancy and 
puerperium - deliv + p/n comp 
216708 Haemorrhoids in the puerperium 
216709 Obstetric cerebral venous thrombosis 
216710 Venous complication 
pregnancy/puerperium NOS - del +p/n 
comp 
216711 Venous complication of pregnancy and 
puerperium NOS 
216712 Amniotic fluid pulmonary embolism 
NOS 
216713 Obstetric blood-clot pulmonary 
embolism 
216714 Obstetric pyaemic and septic pulm 
embolism - deliv +p/n comp 
216715 Other obstetric pulmonary embolism 
NOS 
216716 Cerebrovascular disorders in the 
puerperium 
216717 Puerperal cerebrovascular disorder - 
delivered with p/n comp 
216718 Puerperal cerebrovascular disorder with 
antenatal comp 
216719 Caesarean wound disruption 
unspecified 
216720 Obstetric perineal wound disruption 
unspecified 
216721 Other complication obstetric surg 
wound -delivered +p/n comp 
216722 Other complications of the puerperium 
NOS 
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216723 Obstetric nipple infection 
216724 Other obstetric breast infection NOS 
216725 Retracted nipple in 
pregnancy/puerperium/lactation unspec 
216726 Failure of lactation - delivered 
216727 Galactorrhoea in pregnancy and the 
puerperium NOS 
216728 Hypogalactia 
216729 Galactocele - obstetric 
216730 Other disorder of lactation with 
antenatal complication 
216731 Other disorder of lactation with 
postnatal complication 
216732 Maternal care for compound 
presentation 
216733 [X]Failed medical abortion,wth 
other+unspcfied complications 
216734 [X]Abnormal finding on antenatal 
screening of mother 
216735 [X]Maternal care for other 
isoimmunization 
216736 [X]Labour+delivery complicated by 
other cord complications 
216737 [X]Other genitourinary tract infections 
following delivery 
216738 [X]Other obstetric conditions, not 
elsewhere classified 
216739 [X]Oth d/bld+bld-form org+c d inv im 
mch cm preg,cldbir+puer 
216740 [X]Oth spcf dis+conditns complicat 
preg,childbirth+puerperum 
217378 Fetus/neonate affected by other chronic 
mat CVS/RS dis NOS 
217379 Fetus/neonate affected-placental/breast 
transfer unsp poison 
217380 Fetus/neonate affected by 
placental/breast transfer narcotic 
217381 Fetus/neonate affected - poison transfer 
placenta/breast NOS 
217382 Fetus or neonate affected by maternal 
polyhydramnios 
217383 Fetus affected by maternal death 
217384 Fetus or neonate affected by abruptio 
placentae 
217385 Fetus or neonate affected by torsion of 
cord 
217386 Fetus or neonate affected by varices of 
cord 
217387 Fetus or neonate affected by vasa 
praevia of cord 
217388 Fetus or neonate affected by cord 
problems NOS 
217389 Fetus and newborn afect by mat use of 
nutritional chem subs 
217390 Fetal malnutrition 
217391 Other "large-for-dates" infant 
217392 Birth trauma 
217393 Tentorial tear due to birth trauma 
217394 Massive epicranial subaponeurotic 
haemorrhage-birth trauma 
217395 Fracture of clavicle due to birth trauma 
217396 Other skeleton injury due to birth 
trauma 
217397 Other fractures due to birth trauma 
217398 Other birth fracture 
217399 Birth fracture of radius 
217400 Fracture due to birth trauma NEC 
217401 Fracture of nose due to birth trauma 
217402 Spine dislocation due to birth trauma 
217403 Spinal cord laceration due to birth 
trauma 
217404 Other cranial or peripheral nerve palsy 
due to birth trauma 
217405 Laryngeal injury due to birth trauma 
217406 Liveborn with prelabour fetal distress 
217407 Liveborn with prelabour abnormal heart 
beat 
217408 Liveborn with labour fetal distress 
217409 Liveborn with labour abnormal heart 
beat 
217410 Liveborn with labour hypoxia 
217411 Liveborn with labour fetal distress NOS 
217412 Hyaline membrane disease 
217413 Congenital pneumonia due to group B 
haemolytic streptococcus 
217414 Congenital pneumonia due to 
pseudomonas 
217415 Congenital pneumonia NOS 
217416 Perinatal interstitial emphysema and 
related conditions 
217417 Perinatal pulmonary haemorrhage NOS 
217418 Perinatal pulmonary collapse NOS 
217419 Wet lung syndrome in newborn 
217420 Cyanotic attacks of the newborn 
217421 Other perinatal respiratory problems 
NOS 
217422 Grunting baby 
217423 Tetanus neonatorum 
217424 Tetanus neonatorum, unspecified 
217425 Neonatal dacryocystitis/conjunctivitis 
due to staphylococcus 
217426 Ophthalmia neonatorum - viral 
217427 Other specified neonatal dacryocystitis 
or conjunctivitis 
217428 Congenital septicaemia 
217429 Umbilical haemorrhage after birth NOS 
217430 Intracerebral (nontraumatic) 
haemorrhage of fet and newborn 
217431 Haemolytic disease due to ABO 
isoimmunisation 
217432 ABO isoimmunisation of the newborn 
217433 Neonatal jaundice - deficiency enzyme 
for bilirubin conjug. 
217434 Perinatal jaundice due to other 
specified cause 
217435 Perinatal jaundice NOS 
217436 Neonatal hypocalcaemia 
217437 Hypocalcaemic tetany in newborn 
217438 Disturbances of sodium balance of 
newborn 
217439 Perinatal endocrine or metabolic 
problem NOS 
217440 Fetal and newborn blood disorders 
217441 Trans neonatal thrombocyto due to 
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idopath matern thrombocyto 
217442 Anaemia of prematurity 
217443 Neonatal isoimmune neutropenia 
217444 Other perinatal digestive system 
disorder NOS 
217445 Other newborn temperature regulation 
disorders 
217446 Newborn environmental pyrexia 
217447 Perinatal skin disorder NOS 
217448 Umbilical polyp of newborn 
217449 Jittery baby 
217450 Megalencephaly 
217451 [X]Fetus+newborn affected/oth 
maternal complicatns/pregnancy 
217452 [X]Fetus+newbrn affect/oth spcf 
complication/labour+delivery 
217453 [X]Birth trauma 
217454 [X]Other specified brain damage due to 
birth injury 
217455 [X]Congenital pneumonia due to other 
bacterial agents 
217456 [X]Other umbilical haemorrhages of 
newborn 
217457 [X]Neonatal jaundice from other 
specified causes 
217458 [X]Other transient neonatal disorders of 
coagulation 
217459 [X]Neonatal goitre, not elsewhere 
classified 
217460 [X]Other specified intestinal obstruction 
of newborn 
217461 [X]Other disorders of muscle tone of 
newborn 
217462 [X]Other specified conditions originat in 
perinatal period 
219233 [V]Personal history of perinatal 
problems 
219251 [V]Pregnancy with history of abortion 
219255 [V]Twins, both stillborn 
219256 [V]Other multiple birth, all stillborn 
219257 [V]Other specified outcome of delivery 
219262 [V]Twin, not hospitalised, mate stillborn 
219264 [V]Other multiple birth,born before 
hospital,mates stillborn 
219265 [V]Other multiple birth, unspecified 
219388 Delivery assisted breech 
219389 Termination pregnancy caesarean 
section 
219390 Caesarean sterilisation 
219391 Repair obstetric laceration 
219491 Az test positive 
219551 Referred to antenatal clinic 
219680 Rhesus anti-d given 
219689 Child born 
219701 Counselling abortion 
219702 Requests abortion 
219722 Labour induction nonsurgical 
219746 Pregnancy unmarried 
219747 Problem unmarried pregnancy 
219750 Decided against termination pregnancy 
219785 Screening baby abnormal 
219786 Screening newborn examination 
abnormal 
219798 Newborn clinic attendance 
219833 Antenatal booking 
219834 Foetal movements normal 
219836 Postnatal examination minor problem 
219837 Postnatal examination normal 
219838 Well baby examination 
220413 Pregnancy placenta praevia 
220414 Pregnancy haemorrhage 
220416 Possible labour 
220417 Toxaemia pregnancy 
220419 Abortion with sepsis 
220420 Normal labour 
220421 Delivery continuous monitoring 
220422 Delivery epidural 
220423 Placenta abruptio complicating delivery 
220424 Postpartum haemorrhage immediate 
220425 Disproportion at delivery 
220426 Malpresentation at delivery brow 
220427 Malpresentation at delivery face to pube 
220428 Twins non identical delivered 
220505 Rheumatoid arthritis juvenile 
220506 Juvenile arthritis 
220654 Asphyxia due mucus aspiration 
newborn 
220656 Foetal movements not felt 
220658 Dysmaturity newborn 
220659 Domiciliary confinement (baby) 
220662 Haemorrhagic disease newborn 
220666 Low apgar rating 
220668 Normal birth (baby) 
220708 Jaundice fluctuating 
221207 Labourer NOS 
221259 Midwife attends 14 - 16 days post 
discharge 
221281 Teenage pregnancy 
221364 H/O: premature delivery 
221369 H/O: ante-partum haemorrhage 
221370 H/O: perinatal fetal loss 
221558 O/E - breech presentation 
222137 U-S scan -placental localisatn 
222138 U-S scan - fetal abnormality 
222139 U-S obstetric diagn. Scan NOS 
222174 Pregnant - on abdom. Palpation 
222175 Antenatal care: multip 
222176 A/N care: precious pregnancy 
222177 A/N care: social risk 
222178 A/N care from consultant 
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222179 G.P. unit delivery booking 
222180 Parent craft classes 
222181 Parent craft class NOS 
222182 A/N U/S scan for ? Abnormality 
222183 Spontaneous membrane rupture 
222184 Breast changed to bottle feed 
222185 Infant weaned 
222186 Postnatal care provider 
222187 P/N - shared care 
222188 P/N - tenth day visit 
222189 P/N care <48hrs after birth 
222190 Postnatal visit NOS 
222191 Triple test wanted 
222192 Triplet birth 
222193 Outcome of delivery NOS 
222194 Birth of child 
222195 Male baby 
222196 Postmature baby 
222197 Baby maturity NOS 
222198 Baby BW = 50 - 74% (3450-3749g) 
222199 Baby BW = 75 - 89% (3750-4049g) 
222200 Apgar at 1 minute = 9 
222201 Apgar at 5 minutes 
222202 Apgar at 5 minutes NOS 
222203 Apgar at 10 minutes = 0 
222204 Apgar at 10 minutes = 1 
222205 Apgar at 10 minutes = 4 
222206 Apgar at 10 minutes = 6 
222207 Risk of non-accidental injury 
222208 Difficult to establish feeding 
222209 One of triplets 
222216 Birth exam abn. - on treatment 
222225 Child 8 week exam. Not offered 
222288 Folic acid advice - pre-pregnancy 
222291 Termination counselling 
222293 Postnatal support group 
222924 Hysterotomy & evacuation retained 
products conception NEC 
222929 Dilation cervix uteri & curettage 
products conception uterus 
222934 Other specified introduction of gamete 
into uterine cavity 
222950 Excision of ectopic ovarian pregnancy 
222953 Removal of ectopic pregnancy from 
fallopian tube 
222969 Fetoscopic blood transfusion of fetus 
222970 Fetoscopic examination of fetus and 
biopsy of fetus 
222971 Diagnostic endoscopic examination 
fetus using fetoscope OS 
222972 Selective destruction of fetus 
222973 Percutaneous blood transfusion of fetus 
222974 Diagnostic percutaneous examination 
of fetus 
222975 Diagnostic percutaneous examination 
of fetus NOS 
222976 Spontaneous breech delivery 
222977 High forceps cephalic delivery with 
rotation 
222978 Vacuum delivery 
222979 Trial of vacuum delivery 
222980 Other specified vacuum delivery 
222981 Water birth delivery 
222982 Instrument removal retained products 
conception deliv uterus 
222983 Immediate repair of obstetric laceration 
NOS 
223676 Discharged from hospital within 6 hours 
of delivery 
223694 Private referral to obstetrician 
223710 FP58 - newborn registration 
223737 Part post-natal care-3 visits 
223838 Normal delivery 
225610 Tubal abortion 
225611 Mural pregnancy 
225612 Other ectopic pregnancy NOS 
225613 Incomplete spontaneous abortion NOS 
225614 Complete spontaneous abortion + 
pelvic organ/tissue damage 
225615 Unspec inevit abortion comp by delayed 
or excessive haemorr 
225616 Unspecified inevitable abortion with 
unspec complication 
225617 Incomplete inevitable miscarriage 
without complication 
225618 Complete inevitable miscarriage without 
complication 
225619 Legal abortion unspecified 
225620 Incomplete legal abortion + genital 
tract/pelvic infection 
225621 Incomplete legal abortion with no 
mention of complication 
225622 Complete legal abortion with 
delayed/excessive haemorrhage 
225623 Illegal abortion unspecified 
225624 Unspecified illegal abortion with 
embolism 
225625 Incomplete illegal abortion + other 
specified complication 
225626 Complete illegal abortion + genital 
tract/pelvic infection 
225627 Complete illegal abortion with no 
mention of complication 
225628 Unspecified abortion with renal failure 
225629 Unspecified abortion with metabolic 
disorder 
225630 Unspecified incomplete abortion 
+genital tract/pelvic infect 
225631 Unspecified incomplete abortion + 
pelvic organ/tissue damage 
225632 Unspecified complete abortion with 
embolism 
225633 Parametritis following abortive 
pregnancy 
225634 Defibrination syndrome following 
abortive pregnancy 
- 200- 
225635 Cardiac arrest following abortive 
pregnancy 
225636 Urinary tract infection following abortive 
pregnancy 
225637 Placenta praevia without haemorrhage 
NOS 
225638 Placental abruption - delivered 
225639 Placental abruption NOS 
225640 Antepartum haemorrhage with trauma 
NOS 
225641 Antepartum haemorrhage with uterine 
leiomyoma 
225642 Antepartum haemorrhage with fibroid 
225643 Placenta praevia 
225644 Antepartum haemorrhage NOS 
225645 Benign essential hypertension in 
pregnancy/childbirth/puerp 
225646 Benign essential hypertension in 
preg/childb/puerp NOS 
225647 Other pre-exist hypertension in 
preg/childb/puerp + p/n comp 
225648 Transient hypertension of pregnancy - 
not delivered 
225649 Pre-eclampsia, unspecified 
225650 Severe pre-eclampsia - delivered 
225651 Pre-exist 2ndry hypertens comp preg 
childbth and puerperium 
225652 Mild hyperemesis-not delivered 
225653 Unspecified pregnancy vomiting 
225654 Other threatened labour unspecified 
225655 Post-term pregnancy - not delivered 
225656 Papyraceous fetus NOS 
225657 Oedema or excessive weight gain in 
pregnancy no hypertension 
225658 Unspecified renal disease in pregnancy 
- delivered 
225659 Habitual aborter NOS 
225660 Peripheral neuritis in pregnancy with 
postnatal complication 
225661 Liver disorder in pregnancy - delivered 
225662 Gestational proteinuria 
225663 Other pregnancy complications 
225664 Other pregnancy complication 
unspecified 
225665 Maternal gonorrhoea in puerperium - 
baby delivered 
225666 Maternal rubella in pregnancy, childbirth 
and the puerperium 
225667 Maternal rubella in 
pregnancy/childbirth/puerperium NOS 
225668 Other mat.viral dis. In puerperium-baby 
previously delivered 
225669 Other mat. Infective/parasitic disease in 
preg/puerp unspec 
225670 Other medical condition in 
pregnancy/childbirth/puerperium 
225671 Thyroid dysfunction in 
pregnancy/childbirth/puerperium NOS 
225672 Mental disorder during pregnancy - 
baby not yet delivered 
225673 Congenital cardiovasc dis - unsp 
whether in preg/puerperium 
225674 Congenital cardiovasc dis in pregnancy 
- baby delivered 
225675 Other cardiovasc dis in puerperium - 
baby delivered 
225676 Orthopaedic disorder during pregnancy 
- baby delivered 
225677 Abnormal GTT in 
pregnancy/childbirth/puerperium NOS 
225678 Medical condition NOS in 
pregnancy/childbirth/puerperium 
225679 Spontaneous vaginal delivery 
225680 Twin pregnancy with antenatal problem 
225681 Quadruplet pregnancy NOS 
225682 Multiple pregnancy NOS 
225683 Malpresentation of fetus 
225684 Cephalic version NOS 
225685 Breech presentation with antenatal 
problem 
225686 Face presentation with antenatal 
problem 
225687 Brow presentation - delivered 
225688 Multiple pregnancy with 
malpresentation unspecified 
225689 Other fetal malposition and 
malpresentation with a/n prob 
225690 Cephalo-pelvic disproportion 
225691 Generally contracted pelvis 
225692 Mixed feto-pelvic disproportion - 
delivered 
225693 Hydrocephalic disproportion 
225694 Hydrocephalic disproportion unspecified 
225695 Cong abnorm uterus complic p/n care - 
baby previously deliv 
225696 Tumour of uterine body affecting 
obstetric care 
225697 Uterine fibroid affecting obstetric care 
225698 Retroverted incarcerated gravid uterus 
NOS 
225699 Rectocele complicating antenatal care - 
baby not delivered 
225700 Other uterine/pelvic floor abn - baby 
delivered previously 
225701 Polyp of cervix in pregnancy, childbirth 
and the puerperium 
225702 Other cervical abnormality - baby 
delivered+postpartum compl 
225703 Stenosis of cervix complicating p/n care 
- baby deliv prev 
225704 Septate vagina in pregnancy, childbirth 
and the puerperium 
225705 Vaginal abnormality affecting obstetric 
care 
225706 Stenosis of vagina - baby delivered 
225707 Vaginal abnormality - baby 
delivered+postpartum complication 
225708 Septate vagina in 
pregnancy/childbirth/puerperium NOS 
225709 Rigid perineum complicating a/n care - 
baby not delivered 
225710 Suspect fetal spina bifida 
225711 Maternal care for CNS malformation in 
fetus 
225712 Suspect mongol fetus 
225713 Fetus with damage due to other 
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maternal disease - delivered 
225714 Fetus with damage due to other 
maternal disease + a/n prob 
225715 Fetus with damage due to other 
maternal disease NOS 
225716 Fetus with damage due to intra-uterine 
contraceptive device 
225717 Fetus with damage due to IUCD 
unspecified 
225718 Fetus with damage due to IUCD with 
antenatal problem 
225719 Fetus with other damage NEC NOS 
225720 Fetus with damage NOS, unspecified 
225721 Other blood-group isoimmunisation with 
antenatal problem 
225722 Meconium stained liquor 
225723 Fetal distress unspecified 
225724 Maternal care for fetal tachycardia 
during pregnancy 
225725 Intrauterine death 
225726 Intrauterine death unspecified 
225727 Other fetal problems 
225728 Other placental conditions NOS 
225729 Other fetal problems 
225730 Feto-placental problems NOS 
225731 Amniotic cyst 
225732 Ragged membranes 
225733 Failed mechanical induction 
225734 Failed medical induction of labour 
225735 Elderly primigravida unspecified 
225736 Obstructed labour due to breech 
presentation 
225737 Obstructed labour due to deformed 
pelvis 
225738 Obstructed labour due to generally 
contracted pelvis 
225739 Obstructed labour caused by pelvic soft 
tissues NOS 
225740 Deep transverse arrest NOS 
225741 Persistent 
occipitoposterior/occipitoanterior 
position NOS 
225742 Shoulder dystocia - delivered 
225743 Locked twins with antenatal problem 
225744 Locked twins NOS 
225745 Other failed trial of labour with antenatal 
problem 
225746 Failed forceps unspecified 
225747 Other failed ventouse extraction with 
antenatal problem 
225748 Failed ventouse extraction NOS 
225749 Other causes of obstructed labour NOS 
225750 Primary uterine inertia unspecified 
225751 Secondary uterine inertia - delivered 
225752 Hourglass uterine contraction 
225753 Prolonged first stage - delivered 
225754 Prolonged first stage with antenatal 
problem 
225755 Unspecified prolonged labour with 
antenatal problem 
225756 Prolonged labour NOS 
225757 Cord tight round neck - delivered 
225758 Other umbilical cord complications with 
antenatal problem 
225759 Vulval tear during delivery 
225760 Third degree perineal tear during 
delivery - delivered 
225761 Fourth degree perineal tear during 
delivery, unspecified 
225762 Unspecified perineal laceration during 
delivery 
225763 Tear of cervix - obstetric 
225764 Obstetric laceration of cervix NOS 
225765 Other obstetric pelvic organ damage 
unspecified 
225766 Pubic symphysis separation 
225767 Symphysis pubis separation 
225768 Obstetric damage to pelvic joints and 
ligaments - delivered 
225769 Obstetric trauma causing pelvic 
haematoma NOS 
225770 Third-stage postpartum haemorrhage 
with postnatal problem 
225771 Retained placenta or membranes with 
no haemorrhage 
225772 Placenta accreta without haemorrhage 
225773 Retained products with no 
haemorrhage with postnatal problem 
225774 Obstetric anaesthesia with pulmonary 
comp with a/n problem 
225775 Obstetric anaesthesia with pulmonary 
comp with p/n problem 
225776 Obstetric anaesthesia with CNS 
complications unspecified 
225777 Obstetric anaesthesia with CNS 
complications - delivered 
225778 Obstetric anaesthetic complications 
NOS with p/n problem 
225779 Maternal hypotension syndrome with 
postnatal problem 
225780 Caesarean delivery following previous 
Caesarean delivery 
225781 Postnatal vaginal discomfort 
225782 Puerperal endometritis - delivered with 
postnatal comp 
225783 Puerperal peritonitis unspecified 
225784 Puerperal septicaemia with postnatal 
complication 
225785 Vulval obstetric varicose veins 
225786 Perineal varices in the puerperium 
225787 Superficial thrombophleb in 
preg/puerperium - del + p/n comp 
225788 Postnatal deep vein thrombosis with 
postnatal complication 
225789 Other phlebitis/thrombosis in 
preg/puerperium + a/n comp 
225790 Other phlebitis in the puerperium 
225791 Haemorrhoids in pregnancy 
225792 Other venous complication of 
pregnancy/puerperium -delivered 
225793 Venous complication in the puerperium, 
unspecified 
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225794 Puerperal pyrexia NOS 
225795 Obstetric pulmonary embolism 
225796 Amniotic fluid pulm embolism - 
delivered + p/n complication 
225797 Other obstetric pulmonary embolism 
225798 Fat embolism - obstetric 
225799 Stroke in the puerperium 
225800 Placental polyp with postnatal 
complication 
225801 Obstetric breast abscess - deliv with 
postnatal complication 
225802 Obstetric nonpurulent mastitis with 
antenatal complication 
225803 Other obstetric breast infection - deliv 
with p/n comp 
225804 Other obstetric breast infection with 
postnatal complication 
225805 Obstetric breast infection NOS 
225806 Obstetric breast infection NOS, 
unspecified 
225807 Obstetric breast infection NOS - deliv 
with p/n complication 
225808 Cracked nipple in pregnancy, the 
puerperium or lactation 
225809 Breast engorgement in 
pregnancy/puerperium/lactation unspec 
225810 Agalactia 
225811 Galactorrhoea in pregnancy and the 
puerperium - delivered 
225812 Disorders of lactation NOS 
225813 [X]Maternal care/other(suspected)fetal 
abnormality+damage 
225814 [X]Other disorders of amniotic fluid and 
membranes 
225815 [X]Other intrapartum haemorrhage 
225816 [X]Other and unspecified forceps 
delivery 
225817 [X]Complications predominantly related 
to the puerperium 
225818 [X]Other specified puerperal infection 
225819 [X]Other+unspcf disorders/breast 
associated with childbirth 
226474 Fetus and newborn affected by 
maternal use of alcohol 
226506 Fetus/neonate affect-plac./breast transf 
hypoglycaemic agent 
226507 Fetus/neonate affected - poison transfer 
placenta/breast OS 
226508 Fetus or neonate affected by maternal 
medical problem NOS 
226509 Fetus or neonate affected by multiple 
pregnancy 
226510 Fetus or neonate affected by 
unspecified multiple pregnancy 
226511 Fetus/neonate affected by 
malpresentation before labour OS 
226512 Fetus/neonate affected by materno-fetal 
transplacental trans 
226513 Fetus or neonate affected by vacuum 
extraction delivery 
226514 Fetus or neonate affected by hypertonic 
labour 
226515 Fetus/neonate affected by 
labour/delivery complication OS 
226516 Fetus+newborn affected/other maternal 
noxious influences 
226517 Maternal problems unrelated preg 
affecting fetus/neonate OS 
226518 Short gestation and unspecified low 
birthweight problems 
226519 Low birthweight 
226520 Disorders slow fetal growth, low and 
high birthweight NOS 
226521 Birth trauma, asphyxia and hypoxia 
226522 Subdural or cerebral haemorrhage due 
to birth trauma NOS 
226523 Scalp abrasions due to birth trauma 
226524 Electrode injury to scalp during birth 
226525 Fracture of humerus due to birth trauma 
226526 Skeleton injury due to birth trauma NOS 
226527 Birth injury to phrenic nerve 
226528 Phrenic nerve palsy in newborn 
226529 Cerebral oedema due to birth injury 
226530 Fetal death due to prelabour anoxia 
226531 White asphyxia 
226532 Other specified birth trauma, asphyxia 
or hypoxia 
226533 Fetus and newborn respiratory 
conditions 
226534 Respiratory distress syndrome 
226535 Aspiration of blood in newborn 
226536 Perinatal pneumothorax 
226537 Perinatal partial atelectasis 
226538 Other specified perinatal chronic 
respiratory disease 
226539 Other perinatal respiratory problems 
226540 Perinatal respiratory distress NOS 
226541 Congenital rubella 
226542 Congenital falciparum malaria 
226543 Neonatal dacryocystitis due to 
staphylococcus 
226544 Neonatal conjunctivitis due to other 
bacteria 
226545 Neonatal inclusion blenorrhoea 
226546 Neonatal dacryocystitis or conjunctivitis 
NOS 
226547 Pseudomonas pyocyaneus congenital 
infection 
226548 Sepsis of newborn due to 
Staphylococcus aureus 
226549 Other specified perinatal infection NOS 
226550 Perinatal infections NOS 
226551 Perinatal melaena 
226552 Perinatal cutaneous petechiae 
226553 Perinatal purpura 
226554 Other fetal and newborn haemorrhage 
226555 Perinatal pseudomenses 
226556 Perinatal transient vaginal bleeding 
226557 Neonatal rectal haemorrhage 
226558 Hydrops fetalis due to isoimmunisation 
226559 Perinatal jaundice from bruising 
226560 Perinatal jaundice from maternal 
transmission drug or toxin 
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226561 Other neonatal jaundice - delayed 
conjugation other cause 
226562 Delayed conjugation causing neonatal 
jaundice, unspecified 
226563 Neonatal jaundice with Crigler-Najjar 
syndrome 
226564 Neonatal jaundice with Dubin-Johnson 
syndrome 
226565 Neonatal jaundice with congenital 
hypothyroidism 
226566 Neonatal jaundice with Rotor's 
syndrome 
226567 Delayed conjugation causing neonatal 
jaundice OS 
226568 Fetal and neonatal jaundice, 
unspecified 
226569 Cow's milk hypocalcaemia 
226570 Other specified transitory neonatal 
electrolyte disturbance 
226571 Iatrogenic neonatal hypoglycaemia 
226572 Other specified transient neonatal blood 
disorder 
226573 Perinatal digestive system disorders 
226574 Congenital faecoliths causing 
obstruction 
226575 Intestinal obstruction in newborn due to 
faecoliths 
226576 Transitory fever of newborn 
226577 Non-immune hydrops fetalis 
226578 Panniculitis in newborn 
226579 Perinatal skin or temperature regulation 
disorder NOS 
226580 Rumination in newborn 
226581 Underfeeding in newborn 
226582 Difficulty in feeding at breast 
226583 [X]Macerated stillbirth 
226584 Neonatal cardiac failure 
226585 [X]Fetus+newborn affectd/other 
abnormalities/chorion+amnion 
226586 [X]Oth intracranial 
laceratns+haemorrhages due/birth 
injury 
226587 [X]Other birth injuries to scalp 
226588 [X]Other chronic resp diseases 
originating/perinatal period 
226589 [X]Other specified infections 
specific/perinatal period 
226590 [X]Intracranial nontraumatic 
haemorrhage fetus newborn unsp 
226591 [X]Other neonatal hypoglycaemia 
226609 [D]Jaundice (not of newborn) NOS 
228321 [V]Other specified pregnant state 
228322 [V]Pregnancy with history of 
hydatidiform mole 
228323 [V]Supervisn/pregnancy wth history 
insufficnt antenatal care 
228325 [V]Admission for termination of 
pregnancy 
228333 [V]Birth - type 
228334 [V]Single live birth 
228335 [V]Newborn receiving special care 
228337 [V]Healthy liveborn infants according to 
type of birth 
228376 [V]Illegitimate pregnancy 
228415 [V]Postnatal screening for chromosomal 
anomalies 
228423 [X]Other multiple births, some liveborn 
228460 Dilatation & curettage with cautery 
228474 Termination pregnancy d & c 
228475 Amniocentesis 
228476 High foetal forceps delivery 
228477 Rotation foetal head forceps 
228478 Hysterectomy with caesarean section 
228479 Placenta manual removal 
228480 Vaginorrhaphy obstetric 
228481 Repair perineum obstetric 
228592 Human placental lactogen level 
abnormal 
228634 Seen in postnatal clinic 
228644 Referred to postnatal clinic 
228838 Iucd failed 
228930 Prenatal examination 
228931 Breast exam abnormal- recheck 
228932 Postpartum care normal 
228933 Twin 
228934 Twin (non identical) 
229070 Diabetes pregnancy 
229500 Tubal abortion 
229502 Praevia placenta 
229503 Pregnancy macrocytic anaemia 
229504 Hyperchromic anaemia pregnancy 
229505 Varicose veins pregnancy 
229506 Pregnancy milk leg 
229507 Small for dates (foetus) 
229508 Urinary infecion puerperium 
229509 Termination of pregnancy requested 
229510 Top (termination of pregnancy) 
229511 Complete abortion 
229512 Complicated abortion 
229513 Premature separation placenta 
229515 Labour difficult 
229517 Delivery obstetric trauma 
229519 Delivery death due anaesthetic 
229522 Vaginal discomfort postnatal 
229523 Postpartum galactocele 
229738 Toxaemia pregnancy affecting 
foetus/newb 
229739 Pyelitis newborn 
229742 Erythroblastosis neonatorum 
229743 Foetal distress 
229745 Baby normal at birth 
229746 Infant condition normal 
229783 Laboured breathing 
229798 Jaundice decreasing 
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229850 Invalid (disabled) since birth 
229940 Syndrome battered baby/child 
230252 Pipe/sheet metal labourer 
230273 Light labourer NOS 
230421 Para 3 
230423 Past pregnancy outcome 
230424 H/O: 1 miscarriage 
230425 H/O: 4 miscarriages 
230426 H/O: 1 abortion 
230631 O/E - fetal movements seen 
230992 Urine pregnancy test equivocal 
231213 U-S obstetric scan normal 
231214 Antenatal scan unable to confirm 
pregnancy 
231247 Patient pregnant 
231248 Pregnancy confirmed 
231249 A/N care: gynae. Risk 
231250 Delivery: no place booked 
231251 Delivery booking place changed 
231252 Parent craft classes offered 
231253 Parent craft - group class 
231254 A/N U/S scan awaited 
231255 Antenatal ultrasounds scan at 4-8 
weeks 
231256 Rubella screen wanted 
231257 Antenatal syphilis screen NOS 
231258 A/N blood group screen done 
231259 A/N blood group screen NOS 
231260 A/N 34 week examination 
231261 Antenatal examination NOS 
231262 Misc. Antenatal data 
231263 Misc. Antenatal data NOS 
231264 Double test wanted 
231265 Downs screening - blood sent 
231266 Home delivery planned 
231267 Born before arrival 
231268 Twin birth 
231269 Triplets - all live born 
231270 Triplets -2 live+ 1 still born 
231271 Baby premature 26-28 weeks 
231272 Baby premature 37 weeks 
231273 Birthweight 
231274 Weight - baby 
231275 Baby BW = below 751gm 
231276 Birth HC = 25th-49th centile 
231277 Birth length=25th-49th centile 
231278 Apgar at 5 minutes = 0 
231279 Apgar at 10 minutes = 10 
231294 Birth exam. Abnormal -referred 
231398 Maternity benefit advice 
231989 Intravesical instill of therapeutic agent 
for benign disease 
232074 Vacuum termination of pregnancy 
232075 Dilation and curettage removal of 
missed abortion 
232078 Intracervical artificial insemination 
232107 Obstetric operations 
232108 Feticide 
232109 Late selective feticide 
232110 Other specified selective destruction of 
fetus 
232111 Percutaneous insertion of fetal 
vesicoamniotic shunt 
232112 Percutaneous sampling of fetal blood 
232113 Operations on gravid uterus 
232114 Operation on gravid uterus NOS 
232115 Other specified operations on fetus or 
gravid uterus 
232116 Fetus and gravid uterus operations 
NOS 
232117 Labour operations 
232118 Fore water rupture of amniotic 
membrane 
232119 Other specified surgical induction of 
labour 
232120 Other induction of labour 
232121 Other caesarean delivery 
232122 Breech extraction delivery with version 
232123 Manip cephalic vaginal deliv abnorm 
pres head without instrm 
232124 Nonmanip cephal vagin deliv abnorm 
pres head without instrum 
232125 Cephalic vagin deliv abnorm pres head 
without instrument OS 
232126 Other specified normal delivery 
232127 Destructive operation to facilitate 
delivery 
232128 Symphysiotomy to facilitate delivery 
232129 Pubiotomy to facilitate delivery 
232130 Other specified induction or delivery 
operations 
232131 Instrumental removal products of 
concep delivered uterus OS 
232132 Pack to control postpartum 
haemorrhage 
232133 Immediate repair of obstetric laceration 
232134 Other obstetric operations 
232135 Secondary repair of obstetric laceration 
232136 Fetal monitoring 
232137 Foetal monitoring 
232138 Other specified obstetric operations 
232139 Other specified obstetric operations 
232442 Neonatal exchange blood transfusion 
232506 Entonox analgesia in labour 
232730 Iron supplement in pregnancy 
232871 Complete post-natal care 
232872 Part post-natal care-1 visit 
232941 Seen in postnatal clinic 
232952 Seen in antenatal clinic 
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233712 Congenital Heinz-body anaemia 
233783 Fear of pregnancy 
234265 Ectopic beats unspecified 
234385 Asp pneumonitis due to anaesthesia 
during labour and deliv 
234712 Habitual aborter - non pregnant state 
234723 Other abnormal product of conception 
234724 Ectopic pregnancy 
234725 Intraligamentous pregnancy 
234726 Unspecified spontaneous abortion with 
complication NOS 
234727 Incomp spontaneous abortion + 
delayed/excessive haemorrhage 
234728 Incomplete spontaneous abortion with 
complication NOS 
234729 Complete spontaneous abortion with 
embolism 
234730 Unspecified inevitable miscarriage 
complicated by embolism 
234731 Complete inevitable abor comp by 
delayed or excessive haem 
234732 Complete inevitable miscarriage with 
unspecified comp 
234733 Incomplete legal abortion with renal 
failure 
234734 Incomplete legal abortion with 
metabolic disorder 
234735 Incomplete legal abortion with 
complication NOS 
234736 Surgical abortion - complete 
234737 Complete legal abortion with shock 
234738 Unspecified illegal abortion with no 
mention of complication 
234739 Unspecified illegal abortion NOS 
234740 Illegal abortion incomplete 
234741 Incomplete illegal abortion with renal 
failure 
234742 Complete illegal abortion with renal 
failure 
234743 Complete illegal abortion with metabolic 
disorder 
234744 Complete illegal abortion with shock 
234745 Unspec incomplete abortion with other 
specified complication 
234746 Failed attempted abortion with 
metabolic disorder 
234747 Pelvic peritonitis following abortive 
pregnancy 
234748 Afibrinogenaemia following abortive 
pregnancy 
234749 Renal failure following abortive 
pregnancy 
234750 Soap embolism following abortive 
pregnancy 
234751 Readmis for retain products of concept, 
spontaneous abortion 
234752 Failed medical abortion, complicated by 
embolism 
234753 Other specified pregnancy with abortive 
outcome 
234754 Antepartum haemorrhage with uterine 
leiomyoma unspecified 
234755 Other antepartum haemorrhage - not 
delivered 
234756 Other antepartum haemorrhage NOS 
234757 Renal hypertension in preg/childb/puerp 
-deliv with p/n comp 
234758 Mild or unspecified pre-eclampsia 
234759 Toxaemia NOS 
234760 Eclampsia 
234761 Eclampsia - not delivered 
234762 Pre-eclampsia or eclampsia with 
hypertension - delivered 
234763 Moderate pre-eclampsia 
234764 Hyperemesis gravidarum with metabolic 
disturbance NOS 
234765 Unspecified pregnancy vomiting - not 
delivered 
234766 Early onset of delivery 
234767 Post-term pregnancy 
234768 Unspecified renal disease in pregnancy 
234769 Habitual aborter - delivered 
234770 Asymptomatic bacteriuria in pregnancy 
- not delivered 
234771 Asymptomatic bacteriuria in pregnancy 
NOS 
234772 Genitourinary tract infection in 
pregnancy with p/n comp 
234773 Fatigue during pregnancy - delivered 
234774 Herpes gestationis - delivered 
234775 Abdominal pain in pregnancy 
234776 Maternal gonorrhoea during pregnancy 
- baby delivered 
234777 Other maternal venereal dis. In 
pregnancy-baby not delivered 
234778 Maternal tuberculosis in 
pregnancy/childbirth/puerperium NOS 
234779 Other maternal viral dis.in pregnancy-
baby not yet delivered 
234780 Mat infect/parasitic dis NOS in 
pregnancy - baby delivered 
234781 Pregnancy and drug dependence 
234782 Mental disorders in pregnancy, 
childbirth and the puerperium 
234783 Congenital cardiovasc dis in puerp - 
baby previously deliv 
234784 Other cardiovascular dis - unsp whether 
in preg/puerperium 
234785 Orthopaedic disorder in 
pregnancy/childbirth/puerperium NOS 
234786 Complications specific to multiple 
gestation 
234787 Continuing pregnancy after abortion of 
one fetus or more 
234788 Quadruplet pregnancy - delivered 
234789 Multiple delivery, all by forceps and 
vacuum extractor 
234790 Other multiple pregnancy NOS 
234791 Fetus - unstable lie 
234792 Cephalic version NOS with antenatal 
problem 
234793 Oblique lie with antenatal problem 
234794 Transverse lie - delivered 
234795 Transverse lie with antenatal problem 
234796 Transverse lie NOS 
234797 Fetal malposition and malpresentation 
NOS, unspecified 
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234798 Generally contracted pelvis with 
antenatal problem 
234799 Inlet pelvic contraction unspecified 
234800 Outlet pelvic contraction unspecified 
234801 Outlet pelvic contraction - delivered 
234802 Mixed feto-pelvic disproportion 
234803 Mixed feto-pelvic disproportion NOS 
234804 Hydrocephalic disproportion NOS 
234805 Disproportion NOS 
234806 Cong abnorm uterus complicating a/n 
care, baby not delivered 
234807 Bicornuate uterus in pregnancy, 
childbirth or puerperium NOS 
234808 Tumour of uterine body - baby delivered 
234809 Tumour of uterine body complicating 
a/n care, baby not deliv 
234810 Uterine fibroid complicating a/n care, 
baby not delivered 
234811 Tumour of uterine body complic p/n 
care, baby prev delivered 
234812 Uterine fibroid complicating p/n care - 
baby delivered prev 
234813 Uterine operation scar in 
pregnancy/childbirth/puerp NOS 
234814 Retroverted incarcerated gravid uterus 
with postnatal comp 
234815 Rectocele - baby delivered 
234816 Other uterine/pelvic floor abnormal - 
baby not yet delivered 
234817 Cervical incompetence with antenatal 
problem 
234818 Cervical incompetence with postnatal 
complication 
234819 Vulval abnormality affecting obstetric 
care 
234820 Vulval abnormality - baby delivered 
234821 Rigid perineum - baby delivered 
234822 Fetus with central nervous system 
malformation NOS 
234823 Fetus with drug damage unspecified 
234824 Maternal care for (suspected) damage 
to fetus from alcohol 
234825 Fetus with radiation damage with 
antenatal problem 
234826 Maternal care for fetal abnormality and 
damage, unspecified 
234827 Fetal-maternal haemorrhage with 
antenatal problem 
234828 Other blood-group isoimmunisation 
234829 Labour and delivery complicated by 
fetal heart rate anomaly 
234830 Maternal care for fetal hypoxia 
234831 Labour and delivery complic by 
meconium in amniotic fluid 
234832 Small-for-dates unspecified 
234833 Maternal care for intrauterine growth 
retardation 
234834 Large-for-dates unspecified 
234835 Other feto-placental problems NOS 
234836 Amniotic cavity infection with antenatal 
problem 
234837 Amniotic cavity infection NOS 
234838 Amnion nodosum 
234839 Other problem of amniotic cavity and 
membranes - delivered 
234840 Amniotic cavity and membrane problem 
NOS with a/n problem 
234841 Amniotic cavity and membrane problem 
NOS 
234842 Unspecified maternal pyrexia during 
labour - delivered 
234843 Grand multiparity 
234844 Problems affecting labour NOS 
234845 Abnormal ultrasonic finding on 
antenatal screening of mother 
234846 Abnormal chromosomal and genet 
find/antenat screen of mother 
234847 Low weight gain in pregnancy 
234848 Malnutrition in pregnancy 
234849 Persistent occipitopost/occipitoant 
position, unspecified 
234850 Shoulder dystocia 
234851 Failed ventouse extraction unspecified 
234852 Dystocia NOS 
234853 Primary uterine inertia NOS 
234854 Secondary uterine inertia with antenatal 
problem 
234855 Bandl's retraction ring 
234856 Incoordinate uterine action 
234857 Abnormality of forces of labour NOS 
234858 Abnormality of forces of labour NOS 
234859 Prolonged second stage with antenatal 
problem 
234860 Prolonged labour NOS 
234861 Cord tight round neck unspecified 
234862 Cord tangled or knotted with 
compression NOS 
234863 Velamentous insertion of cord 
234864 First degree perineal tear during 
delivery, unspecified 
234865 Vulval and perineal haematoma during 
delivery 
234866 Other vulval and perineal trauma during 
delivery 
234867 Rupture of uterus during and after 
labour unspecified 
234868 Obstetric high vaginal laceration 
234869 Obstetric high vaginal laceration NOS 
234870 Other obstetric pelvic organ damage 
NOS 
234871 Obstetric trauma causing pelvic 
haematoma 
234872 Obstetric pelvic haematoma - delivered 
234873 Other obstetric trauma OS 
234874 Other obstetric trauma - delivered with 
postnatal problem 
234875 Other immediate postpartum 
haemorrhage with postnatal prob 
234876 Other immediate postpartum 
haemorrhage NOS 
234877 Retained placenta or membranes with 
no haemorrhage NOS 
234878 Obstetric anaesthesia with pulmonary 
complications 
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234879 CNS comps of anaesthesia during 
labour and delivery 
234880 Other complications of obstetric 
anaesthesia + p/n problem 
234881 Obstetric shock with antenatal problem 
234882 Simpson's forceps delivery 
234883 Forceps delivery - delivered 
234884 Low forceps delivery 
234885 Caesarean delivery unspecified 
234886 Other complications of labour and 
delivery NOS 
234887 Complications of labour and delivery 
NOS - del + p/n problem 
234888 Puerperal septicaemia - delivered with 
postnatal comp 
234889 Puerperal septicaemia NOS 
234890 Varicose veins of legs in 
pregnancy/puerperium -del+p/n comp 
234891 VV's of perineum/vulva in 
pregnancy/puerperium unspecified 
234892 Vulval varices in pregnancy 
234893 Superficial thrombophlebitis in the 
puerperium 
234894 Superficial thrombophlebitis in 
pregnancy and puerperium NOS 
234895 Antenatal deep vein thrombosis with 
antenatal complication 
234896 Other phlebitis/thrombosis in 
pregnancy/puerperium - deliv 
234897 Other venous complication of 
pregnancy/puerperium unsp 
234898 Gestational phlebitis NOS 
234899 Puerperal pyrexia of unknown origin - 
delivered + p/n comp 
234900 Obstetric air pulmonary embolism 
234901 Obstetric blood-clot pulmonary 
embolism unspecified 
234902 Obstetric pyaemic and septic pulm 
embolism + p/n comp 
234903 Obstetric pulmonary embolism NOS - 
delivered 
234904 Obstetric pulmonary embolism NOS 
with antenatal complication 
234905 Obstetric pulmonary embolism NOS 
with postnatal complication 
234906 Puerperal cerebrovascular disorder 
unspecified 
234907 Caesarean wound disruption with 
postnatal complication 
234908 Other complication of obstetric surgical 
wound unspecified 
234909 Placental polyp - delivered with 
postnatal complication 
234910 Blood dyscrasia puerperal 
234911 Complications of the puerperium NOS, 
unspecified 
234912 Obstetric nipple infection - delivered 
with p/n complication 
234913 Cracked nipple in pregnancy/puerp/lact 
- deliv + p/n comp 
234914 Breast engorgement in 
pregnancy/puerperium/lact + p/n comp 
234915 Other breast disorder in 
pregnancy/puerperium/lactation NOS 
234916 Failure of lactation with postnatal 
complication 
234917 Galactorrhoea in pregnancy and the 
puerperium 
234918 Other disorder of lactation - delivered 
with p/n comp 
234919 Disorder of lactation NOS 
234920 Maternal care/known or suspected fetal 
problem,unspecifd 
234921 [X]Oth+unspc fail induc 
abortn,complict/delay/exces h'morrhg 
234922 [X]Oth venous complicatns follow 
abortn+ectopic+molr pregncy 
234923 [X]Other vomiting complicating 
pregnancy 
234924 [X]Other venous complications in 
pregnancy 
234925 [X]Maternal care relat to fetus+amniotic 
cavity+deliv prob 
234926 [X]Other multiple gestation 
234927 [X]Maternal care/oth spcf known or 
suspected fetal problems 
234928 [X]Other antepartum haemorrhage 
234929 [X]Complications of labour and delivery 
234930 [X]Labour+delivery complicat/oth 
evidence of fetal distress 
234931 [X]Oth pulmonary 
complicatns/anaesthesia during 
lab+delivery 
234932 [X]Other and unspecified disorders of 
lactation 
235073 Juvenile rheumatoid arthritis - Still's 
disease 
235326 Newborn glaucoma 
235580 Fetus or neonate affected by maternal 
urinary disease 
235581 Fetus/neonate affected by other chronic 
maternal CVS/RS dis 
235582 Fetus/neonate affected by other chronic 
maternal CVS disease 
235583 Fetus/neonate affected by maternal 
complication of pregnancy 
235584 Fetus or neonate affected by abdominal 
ectopic pregnancy 
235585 Fetus/neonate affected placental 
separation/haemorrhage NOS 
235586 Fetus affected by cord problems 
235587 Fetus or neonate affected by 
membranitis 
235588 Fetus/neonate affected other 
abnormalities of chorion/amnion 
235589 Fetus or neonate affected by breech 
delivery and extraction 
235590 Fetus/neonate affect persistent occip-
posterior - labour/del 
235591 Fetus/neonate affected by mat general 
anaesthesia - lab/del 
235592 Fetus or neonate affected by abnormal 
uterine contractions 
235593 Fetus or neonate affected by uterine 
inertia or dysfunction 
235594 Fetus/neonate affected by uterine 
dysfunction in labour/del 
235595 Destruction of fetus to facilitate delivery 
235596 Fetus/neonate affected by complic 
labour/delivery NOS 
235597 Fetus small-for-dates with signs of 
malnutrition 
235598 Fetus small-for-dates (SFD) with signs 
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of malnutrition 
235599 Extremely low birth weight infant 
235600 Birth weight 999 g or less 
235601 Subdural haemorrhage unspecified, 
due to birth trauma 
235602 Scalpel wound due to birth trauma 
235603 Birth injury to face 
235604 Trunk injury NEC due to birth trauma 
235605 Intrauterine hypoxia and birth asphyxia 
235606 Labour fetal anoxia 
235607 Liveborn with prelabour hypoxia 
235608 Liveborn with unspecified fetal distress 
NOS 
235609 Pulmonary hypoperfusion syndrome of 
newborn 
235610 Other fetal and newborn respiratory 
conditions 
235611 Congenital pneumonia due to 
Chlamydia 
235612 Massive aspiration syndrome 
235613 Meconium aspiration syndrome 
235614 Perinatal interstitial emphysema or 
related condition NOS 
235615 Perinatal atelectasis, unspecified 
235616 Primary sleep apnoea of newborn 
235617 Snuffles 
235618 Other perinatal conditions 
235619 Neonatal dacryocystitis due to other 
bacteria 
235620 Neonatal viral dacryocystitis or 
conjunctivitis 
235621 Fetal blood loss NOS 
235622 Perinatal epistaxis 
235623 Lucy - Driscoll syndrome 
235624 Unspecified fetal or neonatal jaundice 
NOS 
235625 Neonatal diabetes mellitus 
235626 Hypomagnesaemic tetany in newborn 
235627 Transitory neonatal hypernatraemia 
235628 Transitory neonatal hypokalaemia 
235629 Syndrome of infant of mother with 
gestational diabetes 
235630 Transitory neonatal endocrine disorder, 
unspecified 
235631 Other transitory neonatal endocrine and 
metabolic problem 
235632 Transient neonatal thrombocytopenia 
235633 Trans neonatal thrombocytopenia due 
to exchange transfusion 
235634 Other specified transient neonatal 
thrombocytopenia 
235635 Polycythaemia neonatorum NOS 
235636 Newborn swallowing maternal blood - 
haematemesis/melaena 
235637 Transitory ileus of newborn 
235638 Meconium plug syndrome 
235639 Thermal injury in newborn NEC 
235640 Oedema of newborn unspecified 
235641 Erythroderma neonatorum 
235642 Other and ill-defined perinatal 
conditions 
235643 Convulsions in newborn 
235644 Newborn feeding problem, unspecified 
235645 Neonat withdrawal symptom from mat 
use of drug of addiction 
235646 Fetal death due to termination of 
pregnancy 
235647 [X] stillbirth 
235648 [X]Fresh stillbirth 
235649 Transient myocardial ischaemia of 
newborn 
235650 [X]Additional perinatal disease 
classification terms 
235651 [X]Fetus+newbrn affct/oth 
malprsntn,malpsitn+disprop/lab+del 
235652 [X]Other specified congenital 
infectious+parasitic diseases 
235653 [X]Other infections specific to the 
perinatal period 
235654 [X]Other neonatal gastrointestinal 
haemorrhage 
235655 [X]Other neonatal hypocalcaemia 
235656 [X]Oth specif condition of integument 
specif to fetus/newb 
236304 Nutritional maltreatment of child 
237316 [V]Normal level of neonatal care 
237317 [V]Twin, mate stillborn, NOS 
237318 [V]Other multiple birth, born before 
hospital, mates live 
237319 [V]Other multiple birth, mates stillborn, 
NOS 
237320 [V]Other multiple birth, born in hospital, 
mates live+still 
237321 [V]Other multiple birth, not hospitalised, 
mates live+still 
237322 [V]Unspecified birth, born before 
admission to hospital 
237381 [V]Pregnancy examination and test 
237401 [X]Supervision of other normal 
pregnancy 
237450 Forceps extraction high 
237451 Forceps extraction midcavity with episio 
237452 Forceps breech extraction 
237453 Dilatation cervix in labour 
237454 Retained products conception removed 
237550 Pregnancy test negative 
237689 Violence with spouse 
237710 Housing unsatisfactory very poor quality 
237712 Housing problem poor facilities 
237790 Pregnancy/birth extramarital 
237791 Problem pregnancy unmarried 
237816 Screening newborn examination 
237854 Rubella contact in pregnancy 
237874 Pregnancy 
237875 Pregnancy normal 
237876 Instruction antenatal given 
237877 Examination prenatal 
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237878 Breast exam nad- recheck 
237879 Breast screening examination normal 
237881 Twin (identical) 
238418 Placenta praevia central 
238420 Pregnancy anaemia hypochromic 
238421 Pregnancy malposition foetus 
238423 Primigravida elderly 
238424 Rhesus incompatibility 
pregnancy/puerper 
238425 Intrauterine growth retardation 
238426 Pyelocystitis pregnancy 
238427 Puerperal cystitis 
238429 Pregnancy terminated medical reasons 
238431 Pregnancy normal delivery 
238432 Labour 
238433 Normal birth (confinement) 
238434 Delivery after antepartum haemorrhage 
238437 Delivery abnormal bony pelvis 
238438 Foetopelvic disproportion complicating 
d 
238439 Brow presentation 
238440 Transverse lie delivery 
238441 Delay 2nd stage (labour) 
238442 Laceration perineal at delivery extensiv 
238443 Laceration bladder complicating 
delivery 
238480 Pruritus of pregnancy 
238657 Pregnancy accident affecting baby 
238658 Palsy erb's 
238659 Trauma birth 
238660 Abnormal erythrocytes newborn with 
kerni 
238661 Rhesus incompatibility newborn without 
k 
238662 Asphyxia birth 
238663 Premature delivery (child) 
238664 Infant condition- required resusitation 
238665 Infant condition- apgar score 
238666 Face presentation birth (baby) 
238670 Physiological jaundice newborn 
238671 Stillbirth 
238871 Neglected baby malnutrition 
239094 Photographer (still camera) 
239283 FH: Raised B.P. in pregnancy 
239403 H/O: birth trauma 
239425 Estimated date of delivery 
239429 H/O: 2 miscarriages 
239430 H/O: 3 miscarriages 
239431 H/O: 6 miscarriages 
239432 H/O: abortion 
239440 H/O: post-partum haemorrhage 
240180 Fetal U-S scan 
240181 Ultra-sound scan - obstetric 
240212 Pregnant, diaphragm failure 
240216 Pregnancy care 
240217 Pregnant - on history 
240218 Pregnant - unplanned - wanted 
240219 Pregnant -unplanned-not wanted 
240220 Patient ? Pregnant 
240221 Patient pregnant NOS 
240222 Antenatal care: primigravida 
240223 Antenatal care: 3rd pregnancy 
240224 Antenatal care: gravida NOS 
240225 A/N care: obstetric risk 
240226 A/N care: grand multip 
240227 A/N care: H/O trophoblast.dis. 
240228 Ante-natal care: not offered 
240229 Ante-natal care: not attended 
240230 No ante-natal care NOS 
240231 Full stay delivery booking 
240232 Parent craft not wanted 
240233 Feeding intention - unsure 
240234 Antenatal amniocentesis 
240235 Antenatal amniocentesis NOS 
240236 Rh screen - 1st preg. Sample 
240237 Rh - random, non-preg. Sample 
240238 Alpha-feto protein test - A/N 
240239 AFP blood test not offered 
240240 AFP blood test wanted 
240241 Rubella screen 
240242 Rubella screen not wanted 
240243 Antenatal syphilis screen 
240244 A/N syphilis screen-blood sent 
240245 Antenatal blood group screen 
240246 A/N 38 week examination 
240247 Fetal maturity: dates not=size 
240248 Initial booking of patient 
240249 Infant feeding method 
240250 Infant feeding method NOS 
240251 P/N - fourth day visit 
240252 P/N - sixth day visit 
240253 P/N - ninth day visit 
240254 P/N care >48hrs after birth 
240255 Maternal P/N 6 week exam. NOS 
240256 Puerperal depression 
240257 Misc. Post natal data NOS 
240258 Barts test 
240259 Downs screen blood test normal 
240260 Downs screening blood test NOS 
240261 Sex of baby 
240262 2 male babies 
- 210- 
240263 Baby full term maturity 
240264 Baby premature 38 weeks 
240265 Baby BW = 751g-1kg 
240266 Birth head circumference 
240267 Birth HC = < 3rd centile 
240268 Birth length=10th-24th centile 
240269 Apgar at 1 minute = 2 
240270 Apgar at 1 minute = 5 
240271 Apgar at 5 minutes = 2 
240272 Apgar at 5 minutes = 10 
240273 Apgar at 10 minutes = 5 
240274 Baby misc. "at-risk" factors 
240275 Monozygous twin 
240276 Baby "at-risk" factors NOS 
240277 Placental weight 
240278 Placental abnormality 
240279 Placenta incomplete 
240290 6 week exam.abnormal -for obs. 
240310 Child 8 week exam. Not wanted 
240390 Procreat/fertility counselling 
240393 Pregnancy exercise advice 
240394 Maternity milk/vits advice 
241094 Curettage of products of conception 
from uterus NEC 
241095 Dilation cervix & vacuum aspirat 
products conception uterus 
241096 Evacuation of products of conception 
from uterus NEC 
241126 Puerperium operations 
241127 Therapeutic endoscopic operations on 
fetus 
241128 Diagnost endoscopic examination 
foetus using foetoscope NOS 
241129 Therapeutic percutaneous operation on 
fetus NOS 
241130 Electrode applied to fetal scalp 
241131 Diagnostic amniocentesis 
241132 Amniocentesis NEC 
241133 Biopsy of placenta NEC 
241134 Arm 
241135 Other specified other induction of labour 
241136 Elective upper uterine segment 
caesarean delivery 
241137 Failed forceps delivery 
241138 Repositioning of inverted delivered 
uterus 
241139 Instrumental exploration of delivered 
uterus NEC 
241140 Immediate repair of obstetric tear 
241141 Immediate suture of obstetric laceration 
241926 Part post-natal care-4 visits 
241927 Part post-natal care-5 visits 
241983 BAAF B1/2-adopt:birth history 
242794 Acquired neutropenia in newborn 
242838 Postnatal depression 
243026 Neonatal myoclonic epilepsy 
243738 Pregnancy with abortive outcome 
243742 Angular pregnancy 
243743 Spontaneous abortion with heavy 
bleeding 
243744 Unspecified spontaneous abortion NOS 
243745 Incomplete spontaneous abortion with 
shock 
243746 Complete spontaneous abortion + 
genital tract/pelvic infect 
243747 Complete spontaneous abortion with 
renal failure 
243748 Incomplete inevitable abortion without 
complication 
243749 Therapeutic abortion 
243750 Unspecified legal abortion with renal 
failure 
243751 Unspecified illegal abortion with 
metabolic disorder 
243752 Unspecified illegal abortion with 
complication NOS 
243753 Incomplete illegal abortion + pelvic 
organ/tissue damage 
243754 Incomplete illegal abortion with shock 
243755 Illegal abortion complete 
243756 Unspecified abortion with delayed or 
excessive haemorrhage 
243757 Unspecified abortion with embolism 
243758 Unspecified complete abortion NOS 
243759 Failed attempted abortion with 
embolism 
243760 Failed attempted abortion with 
complication NOS 
243761 Sepsis NOS following 
abortion/ectopic/molar pregnancy 
243762 Broad ligament damage following 
abortive pregnancy 
243763 Renal shutdown following abortive 
pregnancy 
243764 Renal failure NOS following abortive 
pregnancy 
243765 Air embolism following abortive 
pregnancy 
243766 Readmission for retained products of 
conception (NHS codes) 
243767 Haemorrhage in early pregnancy 
243768 Threatened abortion NOS 
243769 Other haemorrhage in early pregnancy 
243770 Early pregnancy haemorrhage NOS - 
not delivered 
243771 Placenta praevia with haemorrhage - 
not delivered 
243772 Antepartum haemorrhage with trauma - 
delivered 
243773 Other antepartum haemorrhage 
243774 Hypertension complicating 
pregnancy/childbirth/puerperium 
243775 Transient hypertension of pregnancy 
unspecified 
243776 Transient hypertension of pregnancy 
243777 Mild or unspecified pre-eclampsia 
unspecified 
243778 Severe pre-eclampsia NOS 
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243779 Eclampsia in pregnancy 
243780 Morning sickness 
243781 Early or threatened labour 
243782 Threatened premature labour 
unspecified 
243783 Early onset of delivery NOS 
243784 Genitourinary tract infection in 
pregnancy - delivered 
243785 Genitourinary tract infection in 
pregnancy - deliv +p/n comp 
243786 Fatigue during pregnancy 
243787 Herpes gestationis 
243788 Herpes gestationis with postnatal 
complication 
243789 Glycosuria during pregnancy NOS 
243790 Braxton-Hicks contractions 
243791 Pregnancy induced oedema+proteinuria 
without hypertension 
243792 Other venereal diseases in 
pregnancy/childbirth/puerperium 
243793 Other maternal venereal disease in 
puerperium-baby delivered 
243794 Other mat. Venereal dis. In puerperium-
baby previously deliv 
243795 Pre-existing diabetes mellitus, non-
insulin-dependent 
243796 Anaemia during pregnancy - baby 
delivered 
243797 Other cardiovasc dis in puerp - baby 
previously delivered 
243798 Orthopaedic disorder in puerperium-
baby previously delivered 
243799 Twin pregnancy - delivered 
243800 Triplet pregnancy with antenatal 
problem 
243801 Other multiple pregnancy with antenatal 
problem 
243802 Face presentation unspecified 
243803 Mentum presentation 
243804 High head at term - delivered 
243805 Multiple pregnancy with 
malpresentation 
243806 Generally contracted pelvis unspecified 
243807 Inlet pelvic contraction - delivered 
243808 Large fetus causing disproportion - 
delivered 
243809 Other fetal abnormality causing 
disproportion unspecified 
243810 Other disproportion 
243811 Bicornuate uterus - baby delivered 
243812 Tumour of uterine body in 
pregnancy/childbirth/puerperium 
243813 Retroverted incarcerated gravid uterus - 
delivered 
243814 Retroverted incarcerated gravid uterus - 
delivered +p/n comp 
243815 Cystocele in pregnancy, childbirth and 
the puerperium 
243816 Other uterine/pelvic floor abn - 
delivered+postpartum compl 
243817 Other cervical abnormality - baby 
delivered 
243818 Septate vagina complicating a/n care- 
baby not yet delivered 
243819 Congenital/acquired abnormality vulva 
in preg/childb/puerp 
243820 Vulval abn complicating p/n care - baby 
delivered previously 
243821 Fetus with chromosomal abnormality 
unspecified 
243822 Fetus with chromosomal abnormality - 
delivered 
243823 Maternal care for suspected 
chromosomal abnormality in fetus 
243824 Fetus with viral damage via mother with 
antenatal problem 
243825 Fetus with damage NOS - delivered 
243826 Fetal-maternal haemorrhage - delivered 
243827 Fetal-maternal haemorrhage NOS 
243828 Anti-D antibodies 
243829 Rhesus isoimmunisation - delivered 
243830 Fetal distress - delivered 
243831 Maternal care for poor fetal growth 
243832 Large-for-dates NOS 
243833 Oligohydramnios NOS 
243834 Prolonged artificial rupture of 
membranes 
243835 Other problems of amniotic cavity and 
membranes 
243836 Failed medical or unspecified induction 
NOS 
243837 Other problems affecting labour NOS 
243838 Problems affecting labour NOS with 
antenatal problem 
243839 Obstructed labour due to fetal 
malposition with a/n problem 
243840 Obstruct labour due pelvic outlet and 
mid-cavity contract 
243841 Deep transverse arrest unspecified 
243842 Uterine dystocia NOS 
243843 Hypertonic uterine inertia NOS 
243844 Prolonged first stage 
243845 Short cord unspecified 
243846 Short cord - delivered 
243847 Hymen tear 
243848 Vaginal muscle tear 
243849 Third degree perineal tear during 
delivery, unspecified 
243850 Perineal haematoma 
243851 Vulval/perineal trauma during delivery 
NOS 
243852 Rupture of uterus before labour with 
antenatal problem 
243853 Obstetric inversion of uterus 
243854 Obstetric pelvic joint damage 
243855 Obstetric trauma NOS 
243856 Obstetric trauma NOS - delivered with 
postnatal problem 
243857 Obstetric trauma NOS with antenatal 
problem 
243858 Secondary postpartum haemorrhage - 
deliv with postnatal prob 
243859 Secondary and delayed postpartum 
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haemorrhage NOS 
243860 Retained placenta without haemorrhage 
243861 Retained placenta without haemorrhage 
243862 Obstetric anaesthesia with pulmonary 
complications NOS 
243863 Obstetric anaesthesia with cardiac 
complications unspecified 
243864 Toxic reaction to local anaesthesia 
during labour and deliv 
243865 Other complications of obstetric 
anaesthesia 
243866 Maternal distress 
243867 Maternal distress - delivered 
243868 Obstetric shock 
243869 Obstetric shock - delivered with 
postnatal problem 
243870 Obstetric shock NOS 
243871 Maternal hypotension syndrome - 
delivered 
243872 Maternal hypotension syndrome with 
antenatal problem 
243873 Maternal hypotension syndrome NOS 
243874 Post-delivery acute renal failure with 
postnatal problem 
243875 Breech extraction unspecified 
243876 Caesarean delivery - delivered 
243877 Delivery by elective caesarean section 
243878 Delivery by emergency caesarean 
section 
243879 Other complications of labour and 
delivery 
243880 Complications of the puerperium 
243881 Puerperal endometritis unspecified 
243882 Major puerperal infection NOS - 
delivered with p/n comp 
243883 Varicose veins - obstetric 
243884 Varicose veins of legs in 
pregnancy/puerperium + p/n comp 
243885 VV's of perineum/vulva in 
pregnancy/puerperium - delivered 
243886 Superficial thrombophlebitis in 
pregnancy 
243887 Phlegmasia alba dolens - obstetric 
243888 Postnatal deep vein thrombosis 
unspecified 
243889 Other phlebitis/thrombosis in 
pregnancy/puerperium unsp 
243890 Other phlebitis in pregnancy 
243891 Haemorrhoids in pregnancy and the 
puerperium unspecified 
243892 Haemorrhoids in pregnancy and 
puerperium with a/n comp 
243893 Other venous complication of 
pregnancy and puerperium NOS 
243894 Venous complication 
pregnancy/puerperium NOS 
unspecified 
243895 Puerperal phlebopathy NOS 
243896 Obstetric air pulmonary embolism 
unspecified 
243897 Obstetric air pulmonary embolism with 
a/n complication 
243898 Amniotic fluid pulmonary embolism 
unspecified 
243899 Amniotic fluid pulmonary embolism - 
delivered 
243900 Obstetric blood-clot pulmonary 
embolism + a/n complication 
243901 Obstetric blood-clot pulmonary 
embolism + p/n complication 
243902 Obstetric pyaemic and septic 
pulmonary embolism - delivered 
243903 Obstetric pyaemic and septic 
pulmonary embolism NOS 
243904 Other obstetric pulmonary embolism 
unspecified 
243905 Subinvolution of uterus in the 
puerperium 
243906 Other obstetric breast infection - 
delivered 
243907 Retracted nipple in pregnancy, the 
puerperium or lactation 
243908 Other breast disorder in 
pregnancy/puerperium/lact +p/n comp 
243909 Failure of lactation with antenatal 
complication 
243910 Suppressed lactation NOS 
243911 Galactorrhoea in pregnancy and the 
puerperium unspecified 
243912 [X]Other ectopic pregnancy 
243913 [X]Other abnormal findings on antenatal 
screening of mother 
243914 [X]Maternal care for other abnormalities 
of cervix 
243915 [X]Maternal care for other abnormalities 
of gravid uterus 
243916 [X]Maternal care/known or suspected 
fetal problem,unspecifd 
243917 [X]Other specified obstructed labour 
243918 [X]Oth complicatn/spinl+epidur 
anaesths during lab+delivery 
243919 [X]Labour & delivery complicated by 
fetal stress, unspecif 
243920 [X]Oth infects+parasitc dis complicat 
preg,cldbrth+puerperum 
244603 Fetus or neonate affected by maternal 
medical problems 
244604 Fetus/neonate affected-plac./breast 
transfer addictive drug 
244605 Fetus or neonate affected by oblique lie 
before labour 
244606 Fetus or neonate affected by face 
presentation before labour 
244607 Fetus/neonate affected by 
malpresentation before labour NOS 
244608 Fetus or neonate affected by placental 
insufficiency 
244609 Fetus or neonate affected by amnionitis 
244610 Fetus/neonate affected by 
abnormalities chorion/amnion NOS 
244611 Fetus/neonate affected by shoulder 
presentation - labour/del 
244612 Fetus or neonate affected by caesarean 
section 
244613 Fetus or neonate affected by maternal 
contraction ring 
244614 Fetus or neonate affected by hypertonic 
uterine dysfunction 
244615 Fetus/neonate affected by abnormal 
uterine contractions NOS 
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244616 Fetus or neonate affected by previous 
pelvic surgery 
244617 Maternal problem unrelated preg 
affecting fetus/neonate NOS 
244618 Immature baby 
244619 Large baby born 
244620 Postmature infant - greater than 42 
weeks gestation, unspec 
244621 Subdural and cerebral haemorrhage 
due to birth trauma 
244622 Extradural haemorrhage in fetus or 
newborn 
244623 Cephalhaematoma due to birth trauma 
244624 Birth injury to central nervous system, 
unspecified 
244625 Spleen rupture due to birth trauma 
244626 Toe injury NEC due to birth trauma 
244627 Intrauterine hypoxia 
244628 Liveborn with labour meconium in liquor 
244629 Liveborn with meconium liquor, 
unspecified 
244630 Blue asphyxia 
244631 Aspiration of mucus in newborn 
244632 Aspiration of amniotic fluid in newborn 
244633 Massive aspiration syndrome NOS 
244634 Pneumonitis due to fetal aspiration 
244635 Primary atelectasis 
244636 Perinatal chronic respiratory disease 
244637 Neonatal snuffles 
244638 Congenital cytomegalovirus infection 
244639 Congenital hydrocephalus due to 
toxoplasmosis 
244640 Neonatal conjunctivitis due to E.coli 
244641 Eschericha coli intra-amniotic fetal 
infection 
244642 Intra-amniotic fetal infection NOS 
244643 Intraventric (nontraumatic) haemorhage 
grade 2 fet newborn 
244644 Perinatal nose haemorrhage 
244645 Fetal or newborn haemorrhage NOS 
244646 Haemolytic disease of fetus/newborn 
due to isoimmunisation 
244647 Preterm delivery associated jaundice 
244648 Perinatal jaundice due to other cause 
244649 Perinatal jaundice due to 
mucoviscidosis 
244650 Infant of a diabetic mother syndrome 
244651 Transitory neonatal hyperkalaemia 
244652 Transitory neonatal tyrosinaemia 
244653 Perinatal skin and temperature 
regulation disorders 
244654 Sclerema neonatorum 
244655 Bronze baby 
244656 Neonatal skin infection 
244657 Breast feeding problem in the newborn 
244658 Newborn drug reaction or intoxication 
NOS 
244659 Cardiovascular disorders originating in 
the perinatal period 
244660 Newborn death 
244661 [X]Fetus and newborn affected by other 
maternal medication 
244662 [X]Disorders related to length of 
gestation and fetal growth 
244663 [X]Other preterm infants 
244664 [X]Other specified birth injuries 
244665 [X]Birth injuries to other parts of 
peripheral nerv system 
244666 [X]Respiratory+cardiovasc dis specific 
to perinatal period 
244667 [X]Other respiratory distress of newborn 
244668 [X]Oth pulmonary haemorrhages 
originating/perinatal period 
244669 [X]Other congenital viral diseases 
244670 [X]Congenital viral disease, unspecified 
244671 [X]Sepsis of newborn due to 
other+unspecified streptococci 
244672 [X]Congenital infectious and parasitic 
disease, unspecified 
244673 [X]Other specified disturbanc of temp 
regulation of newborn 
244674 [X]Hypothermia of newborn, unspecified 
246490 [V]Supervision of high-risk pregnancy 
due to social problems 
246491 [V]Examination immediately after 
delivery 
246496 [V]Admission for termination of 
pregnancy (TOP) 
246504 [V]Antenatal screening 
246508 [V]Other multiple birth, mates live born, 
NOS 
246509 [V]Other multiple birth, unspecified, 
born before hospital 
246510 [V]Other multiple birth, unspecified, 
NOS 
246591 [X]Other multiple births, all stillborn 
246626 Suture shirodkar 
246631 Pregnant hysterectomy 
246632 Termination pregnancy surgical 
induction 
246633 Forceps breech aftercoming head 
246634 Ventous assisted delivery 
246635 Elective caesarian section 
246636 Suture cervix postpartum 
246637 Perineorrhaphy postpartum 
246719 Pregnancy test positive 
246832 Pregnancy unwanted 
246857 Baby for adoption 
246953 Termination refused pregnancy 
246983 Newborn clinic 
246986 Screening baby examination abnormal 
246992 Clinic baby attendance 
247032 Prophylactic therapy pregnancy 
247033 Breast screening examination abnormal 
247599 Placenta praevia lateral 
247600 Placenta abruptio 
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247601 Pregnancy anaemia megaloblastic 
247603 Missed abortion 
247604 Primipara old 
247605 Hick's contractions 
247607 Pregnancy phlebitis 
247608 Puerperal albuminuria 
247610 Eclampsia post partum 
247611 Pregnancy hyperemesis 
247614 Abortion induced with complications 
247616 Septic miscarriage 
247617 History of abortion 
247618 Delivery no details 
247619 Placenta praevia noted at delivery 
247620 Presentation face delivery (mother) 
247621 Trauma obstetrical at delivery 
247623 Maternal distress delivery 
247626 Puerperal inflammation nipple 
247636 Cellulitis umbilicus newborn 
247864 Injury birth difficult labour 
247865 Intracranial injury at birth 
247866 Accident birth injury (baby) 
247868 Rhesus incompatibility newborn with 
kern 
247869 Incompatibility a b o newborn 
247871 Syndrome aspiration newborn 
247872 Neonatal disorder 
247874 Neonatal obstruction 
247875 Delivery caesarian section (baby) 
247876 Windy baby 
248077 Problem battered child 
248463 Civil engineering labourer 
248504 FH: Diabetes in pregnancy 
248585 Disabled 
248619 H/O: perinatal fit 
248620 H/O: perinatal problem NOS 
248634 History of past delivery 
248635 H/O: full term delivery 
248640 H/O: perinatal death 
248642 H/O: previous forceps delivery 
248862 O/E - fetal movements felt 
249219 Urine pregnancy test NOS 
249445 Antenatal care: gravida No. 
249446 A/N care: precious preg. NOS 
249447 A/N care: risk NOS 
249448 A/N care:10yrs+since last preg 
249449 A/N care: primip. > 30 years 
249450 Consultant unit booking 
249451 A/N amniocentesis -not offered 
249452 A/N amniocentesis - normal 
249453 A/N U/S scan for slow growth 
249454 AFP - blood sent 
249455 Quickening 
249456 Fetal maturity: dates = size 
249457 Vaginal "show" - A/N 
249458 Bottle feeding stopped 
249459 Postnatal visits 
249460 P/N - third day visit 
249461 P/N - eighth day visit 
249462 Maternal P/N 6 week exam. 
249463 Maternal P/N exam. Offered 
249464 Misc. Postnatal data 
249465 Maternal care NOS 
249466 Place of birth 
249467 Home birth 
249468 Nursing home birth 
249469 Full term baby 
249470 Baby BW = 1.0-1.5kg 
249471 Birth HC = 10th-24th centile 
249472 Birth HC = 90th-96th centile 
249473 Birth length = > 97th centile 
249474 Apgar at 1 minute = 0 
249475 Apgar at 5 minutes = 5 
249476 Risk factor - been on SCBU 
249477 Risk factor - been on special care unit 
249478 Maternal tobacco abuse 
249479 Maternal drug abuse 
249480 Placenta normal O/E 
249481 Paediatric surveillance checks 
249497 Child 6 week exam. Normal 
249515 Child 8 week exam 
249594 Pregnancy smoking advice 
249595 Mothercraft advice 
250263 Curettage of term pregnancy NEC 
250281 Fimbrial extraction of tubal pregnancy 
250295 Therapeutic fetoscopic operations on 
fetus 
250296 Percutaneous sampling of chorionic 
villus 
250297 Mcdonald cerclage of cervix 
250298 Other induction of labour NOS 
250299 Ventouse delivery 
250300 Vacuum delivery NOS 
250301 Cephalic vaginal deliv abnorm 
presentation head - no instrum 
250302 Manually assisted vaginal delivery 
250303 Drainage of hydrocephalus of fetus to 
facilitate delivery 
250304 Other specified other method of delivery 
250305 Manual dilatation of cervix 
250306 Manual removal of placenta from 
delivered uterus 
250307 Brandt-Andrews expression of placenta 
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250308 Other specified other operation on 
delivered uterus 
250309 Immed repair obstetric laceration 
perineum & anal sphincter 
250310 Monitoring during labour 
250973 Prophylactic iron therapy 
251074 Referral to postnatal clinic 
251108 Medical cert. Of still-birth 
251183 Risk life pregnant woman greater than if 
pregnancy terminatd 
251917 Acute posthaemorrhagic anaemia 
252266 Neonatal nasolacrimal duct obstruction 
252882 Other abnormal product of conception 
NOS 
252883 Tubal pregnancy NOS 
252884 Ovarian pregnancy 
252885 Combined or heterotopic pregnancy 
252886 Spontaneous abortion 
252887 Miscarriage 
252888 Incomplete spontaneous abortion + 
pelvic organ/tissue damage 
252889 Incomp spontaneous abortion with no 
mention of complication 
252890 Complete spontaneous abortion NOS 
252891 Inevitable abortion unspecified 
252892 Unspecified inevitable abortion 
complicated by embolism 
252893 Inevitable abortion incomplete 
252894 Incomplete inev mis comp by delayed 
or excessive haemorrhage 
252895 Complete inevitable miscarriage 
complicated by embolism 
252896 Legally induced abortion 
252897 Unspecified legal abortion with 
complication NOS 
252898 Medical abortion - complete 
252899 Complete legal abortion with embolism 
252900 Criminal abortion 
252901 Unspecified illegal abortion with renal 
failure 
252902 Incomplete illegal abortion with 
embolism 
252903 Unspecified abortion 
252904 Unspecified complete abortion + genital 
tract/pelvic infect 
252905 Unspecified complete abortion with 
renal failure 
252906 Unspecified abortion NOS 
252907 Failed attempted abortion 
252908 Failed attempted abortion with no 
mention of complication 
252909 Failed attempted abortion NOS 
252910 Genital or pelvic infection following 
abortive pregnancy 
252911 Salpingo-oophoritis following abortive 
pregnancy 
252912 Uterus damage following abortive 
pregnancy 
252913 Vaginal damage following abortive 
pregnancy 
252914 Amniotic fluid embolism following 
abortive pregnancy 
252915 Other specified complication following 
abortive pregnancy 
252916 Other haemorrhage in early pregnancy 
unspecified 
252917 Placenta praevia without haemorrhage 
252918 Placenta praevia without haemorrhage 
unspecified 
252919 Couvelaire uterus 
252920 Placental abruption - not delivered 
252921 Antepartum haemorrhage with 
coagulation defect unspecified 
252922 Antepartum haemorrhage with 
coagulation defect - delivered 
252923 Antepartum haemorrhage with trauma 
unspecified 
252924 Antepartum haemorrhage with uterine 
leiomyoma - delivered 
252925 Benign ess hypert in preg/childb/puerp - 
deliv with p/n comp 
252926 Benign essential hypertension in 
preg/childb/puerp-not deliv 
252927 Renal hypertension in 
pregnancy/childbirth/puerperium 
252928 Transient hypertension of pregnancy 
252929 Mild or unspecified pre-eclampsia NOS 
252930 Eclampsia unspecified 
252931 Unspecified hypertension in 
preg/childb/puerp -del +p/n comp 
252932 Hyperemesis gravidarum 
252933 Late vomiting of pregnancy 
252934 False labour 
252935 Other threatened labour NOS 
252936 Prolonged pregnancy NOS 
252937 Papyraceous fetus - not delivered 
252938 Excessive weight gain in pregnancy 
252939 Oedema or excessive weight gain in 
pregnancy, unspecified 
252940 Oedema or excessive weight gain in 
pregnancy - not delivered 
252941 Uraemia in pregnancy without 
hypertension 
252942 Unspecified renal disease in pregnancy 
- del with p/n comp 
252943 Habitual aborter - unspecified 
252944 Asymptomatic bacteriuria in pregnancy 
with postnatal comp 
252945 Fatigue during pregnancy unspecified 
252946 Glycosuria during pregnancy - not 
delivered 
252947 Maternal syphilis during pregnancy - 
baby delivered 
252948 Maternal gonorrhoea, unspec whether 
in pregnancy/puerperium 
252949 Other mat. Venereal dis. In 
pregnancy/childbirth/puerp. NOS 
252950 Maternal tuberculosis in puerperium - 
baby delivered 
252951 Maternal rubella, unspecified whether 
pregnancy/puerperium 
252952 Maternal rubella during pregnancy - 
baby delivered 
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252953 Other mat infective/parasit dis in 
pregnancy - not delivered 
252954 Diabetes mellitus in 
pregnancy/childbirth/puerperium NOS 
252955 Thyroid dysfunction - unspec whether in 
pregnancy/puerperium 
252956 Anaemia in the puerperium - baby 
delivered 
252957 Iron deficiency anaemia of pregnancy 
252958 Drug dependence in the puerperium - 
baby delivered 
252959 GTT - glucose tolerance test abnormal 
in preg/childb/puerp 
252960 Abnormal GTT during pregnancy - baby 
not yet delivered 
252961 Medical condition NOS in 
pregnancy/childb/puerp NOS 
252962 Continuing preg after intrauterine death 
one fetus or more 
252963 Multiple delivery, all by caesarean 
section 
252964 Other multiple pregnancy - delivered 
252965 Cephalic version NOS 
252966 Breech delivery 
252967 Oblique lie NOS 
252968 Brow presentation 
252969 High head at term NOS 
252970 Multiple pregnancy with 
malpresentation with antenatal prob 
252971 Other fetal malposition and 
malpresentation NOS 
252972 Fetal malposition and malpresentation 
NOS - delivered 
252973 Large fetus causing disproportion NOS 
252974 Other fetal abnormality causing 
disproportion - delivered 
252975 Disproportion NOS 
252976 Congenital abnormality of uterus - baby 
delivered 
252977 Bicornuate uterus complic p/n care - 
baby previously deliv 
252978 Tumour of uterine body - baby delivered 
+ p/n complication 
252979 Uterine scar from previous surgery in 
pregnancy/childb/puerp 
252980 Cystocele in pregnancy, childbirth or 
the puerperium NOS 
252981 Polyp of cervix in 
pregnancy/childbirth/puerperium NOS 
252982 Stenosis of vagina in 
pregnancy/childbirth/puerperium 
252983 Septate vagina - baby delivered with 
postpartum complication 
252984 Vaginal abnormality in 
pregnancy/childbirth/puerperium NOS 
252985 Vulval abnormality in 
pregnancy/childbirth/puerperium 
252986 Persistent hymen affecting obstetric 
care 
252987 Rigid perineum affecting obstetric care 
252988 Pelvic soft tissue abnorm in 
preg/childb/puerp -del+p/n comp 
252989 Maternal care for suspected CNS 
malformation in fetus 
252990 Fetus with hereditary disease NOS 
252991 Fetus with drug damage 
252992 Fetus with damage due to intra-uterine 
contraceptive device 
252993 Fetus with other damage NEC with 
antenatal problem 
252994 Fetus with damage NOS 
252995 Maternal care for suspect fetal 
abnormal and damage, unspec 
252996 Fetal-maternal haemorrhage 
252997 Other blood-group isoimmunisation 
unspecified 
252998 Fetal distress - affecting management 
252999 Maternal care for fetal decelerations 
during pregnancy 
253000 Large-for-dates with antenatal problem 
253001 Feto-placental problems NOS with 
antenatal problem 
253002 Oligohydramnios - delivered 
253003 Premature rupture of membranes - 
delivered 
253004 Premature rupture of membranes NOS 
253005 Other problem of amniotic cavity and 
membranes unspecified 
253006 Septicaemia during labour - delivered 
253007 Problems affecting labour NOS 
253008 Abnormal finding on antenatal 
screening of mother 
253009 Obstructed labour due to fetal 
malposition unspecified 
253010 Obstructed labour due to fetal 
malposition - delivered 
253011 Obstructed labour due to shoulder 
presentation 
253012 Obstructed labour caused by bony 
pelvis 
253013 Obstructed labour caused by pelvic soft 
tissues + a/n prob 
253014 Persistent occipitopost/occipitoant 
position - delivered 
253015 Failed trial of labour unspecified 
253016 Obstructed labour due to unusually 
large fetus 
253017 Other causes of obstructed labour with 
antenatal problem 
253018 Obstructed labour NOS, unspecified 
253019 Primary uterine inertia 
253020 Other uterine inertia unspecified 
253021 Precipitate labour 
253022 Delayed delivery second twin 
unspecified 
253023 Umbilical cord complications 
253024 Cord tight round neck 
253025 Other cord entanglement unspecified 
253026 Vascular lesions of cord 
253027 Vascular lesions of cord - delivered 
253028 Vascular lesions of cord with antenatal 
problem 
253029 Vascular lesions of cord NOS 
253030 Other umbilical cord complications 
253031 Fourchette tear 
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253032 Vulval tear 
253033 Vaginal tear during delivery 
253034 Second degree perineal tear during 
delivery - delivered 
253035 Mucosal tear of anus or rectum 
253036 Unspecified perineal laceration during 
delivery NOS 
253037 Other vulval/perineal trauma during 
delivery- delivered 
253038 High vaginal tear - obstetric 
253039 Obstetric high vaginal laceration - 
delivered 
253040 Obstetric pelvic ligament damage 
253041 Obstetric trauma NOS 
253042 Retained placenta NOS 
253043 Third-stage postpartum haemorrhage 
NOS 
253044 Retained products with no 
haemorrhage NOS 
253045 Obstetric anaesthesia with CNS 
complications 
253046 Failed or difficult intubation during the 
puerperium 
253047 Obstetric anaesthetic complications 
NOS with a/n problem 
253048 Other complications of labour and 
delivery NEC 
253049 Maternal hypotension syndrome 
253050 Keilland's forceps delivery 
253051 Forceps delivery unspecified 
253052 Caesarean delivery NOS 
253053 Death obst cse occur more 42 day less 
than one yr aft deliv 
253054 Death from sequelae of direct obstetric 
causes 
253055 Obstetric death of unspecified cause 
253056 Puerperal endometritis with postnatal 
complication 
253057 Puerperal peritonitis 
253058 Varicose veins of legs in pregnancy and 
the puerperium 
253059 Varicose veins of legs in pregnancy and 
puerperium NOS 
253060 VV's of perineum/vulva in 
pregnancy/puerperium 
253061 Vaginal varices in the puerperium 
253062 Antenatal deep vein thrombosis 
253063 Antenatal deep vein thrombosis NOS 
253064 Postnatal deep vein thrombosis 
253065 Venous complication pregnancy and 
puerperium NOS - delivered 
253066 Venous complication 
pregnancy/puerperium NOS + p/n comp 
253067 Puerperal thrombosis NOS 
253068 Puerperal pyrexia of unknown origin 
unspecified 
253069 Amniotic fluid pulmonary embolism 
253070 Amniotic fluid pulmonary embolism with 
p/n complication 
253071 Other obstetric pulmonary embolism 
with antenatal comp 
253072 Other obstetric pulmonary embolism 
with postnatal comp 
253073 Obstetric pulmonary embolism NOS - 
delivered with p/n comp 
253074 CVA - cerebrovascular accident in the 
puerperium 
253075 Caesarean wound disruption NOS 
253076 Episiotomy breakdown 
253077 Other complication obstetric surgical 
wound with p/n comp 
253078 Other complications of the puerperium - 
delivered + p/n comp 
253079 Obstetric nipple infection NOS 
253080 Obstetric breast abscess - delivered 
253081 Obstetric nonpurulent mastitis 
unspecified 
253082 Other obstetric breast infection with 
antenatal complication 
253083 Obstetric breast and lactation disorders 
NOS 
253084 Retracted nipple in 
pregnancy/puerp/lact - deliv + p/n comp 
253085 Retracted nipple in 
pregnancy/puerperium/lactation NOS 
253086 Breast engorgement in 
pregnancy/puerperium/lactation - deliv 
253087 Breast engorgement in 
pregnancy/puerperium/lact + a/n comp 
253088 Other breast disorder in 
pregnancy/puerperium/lact - deliv 
253089 Galactorrhoea in pregnancy/puerperium 
with a/n complication 
253090 Galactorrhoea in pregnancy/puerperium 
with p/n complication 
253091 Maternal care for other known or 
suspected fetal problems 
253092 Maternal care for diminished fetal 
movements 
253093 [X]Other abortion 
253094 [X]Other haemorrhage in early 
pregnancy 
253095 [X]Pre-existing diabetes mellitus, 
unspecified 
253096 [X]Maternal 
care/(suspected)damage/fetus/oth 
medicl procedur 
253097 [X]Other immediate postpartum 
haemorrhage 
253098 [X]Other manipulation-assisted delivery 
253099 [X]Other specified assisted single 
delivery 
253100 [X]Other complications of anaesthesia 
during the puerperium 
253101 [X]Cervicitis following delivery 
253102 [X]Obstetric death of unspecified cause 
253758 Birth mark, unspecified 
253821 Fetus/neonate affected-placental/breast 
transfer anti-infect 
253822 Fetus affected by hydramnios 
253823 Fetus or neonate affected by twin 
pregnancy 
253824 Fetus or neonate affected by maternal 
death 
253825 Fetus or neonate affected by external 
version before labour 
253826 Fetus affected by placental abruption 
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253827 Fetus/neonate affected placental 
separation/haemorrhage OS 
253828 Fetus affected by placental insufficiency 
253829 Fetus or neonate affected by prolapsed 
cord 
253830 Fetus or neonate affected by other 
specified cord problems 
253831 Fetus or neonate affected by 
velamentous insertion of cord 
253832 Fetus or neonate affected by long cord 
253833 Fetus/neonate affected by face 
presentation during labour/de 
253834 Fetus/neonate affected by maternal 
pethidine in labour/deliv 
253835 Fetus/neonate affected by other 
maternal opiates in lab/del 
253836 Fetus and newborn affected by 
maternal use of tobacco 
253837 Fet newborn affect mat exposure to 
environml chem subs 
253838 Intrauterine growth retardation 
253839 Light for gestational age 
253840 Birth weight 1000-2499 g 
253841 Premature infant 28-37 weeks 
253842 Born premature NOS 
253843 Disorders slow fetal growth, low and 
high birthweight OS 
253844 Intracerebral haematoma in fetus or 
newborn 
253845 Bruising of scalp due to birth injury 
253846 Fracture of femur due to birth trauma 
253847 Other specified skeleton injury due to 
birth trauma 
253848 Cranial or peripheral nerve palsy due to 
birth trauma OS 
253849 Eye damage due to birth trauma 
253850 Traumatic glaucoma due to birth trauma 
253851 Internal birth injury NEC 
253852 Liveborn with prelabour meconium in 
liquor 
253853 Liveborn with birth asphyxia NOS 
253854 Congenital pneumonia due to 
staphylococcus 
253855 Other specified congenital pneumonia 
253856 Neonatal aspiration of milk and 
regurgitated food 
253857 Perinatal lung alveolar haemorrhage 
253858 Perinatal lung intra-alveolar 
haemorrhage 
253859 Perinatal massive pulmonary 
haemorrhage 
253860 Tracheobronchial haemorrhage origin in 
the perinatal period 
253861 Other specified perinatal pulmonary 
haemorrhage 
253862 Prematurity with interstitial pulmonary 
fibrosis 
253863 Neonatal sniffles 
253864 Umbilical stump infection of the 
newborn 
253865 Neonatal dacryocystitis or conjunctivitis 
due to E.Coli 
253866 Neonatal dacryocystitis due to E.Coli 
253867 Ophthalmia neonatorum - coliform 
253868 Neonatal dacryocystitis due to virus 
253869 Neonatal candida infection 
253870 Neonatal candidiasis of mouth 
253871 Neonatal candida septicaemia 
253872 Neonatal monilial septicaemia 
253873 Other specified neonatal candida 
infection 
253874 Staphylococcal intra-amniotic infection 
NEC 
253875 Group A haemolytic streptococcal intra-
amniotic infect. NEC 
253876 Congenital hepatitis A infection 
253877 Sepsis of newborn due to anaerobes 
253878 Intraventric (nontraumatic) haemorhage 
grade 1 fet newborn 
253879 Intraventric (nontraumatic) haemorhage 
grade 3 fet newborn 
253880 Perinatal subarachnoid haemorrhage 
253881 Perinatal cutaneous haemorrhage 
253882 Perinatal cutaneous bruising 
253883 Erythroblastosis fetalis 
253884 Perinatal jaundice due to galactosaemia 
253885 Neonatal cows' milk hypocalcaemia 
253886 Neonatal hypomagnesaemia 
253887 Newborn late metabolic acidosis 
253888 Trans disorder carbohydrate metab of 
fet and newborn unsp 
253889 Fetal or newborn blood disorder NOS 
253890 Other perinatal digestive system 
disorders 
253891 Perinatal digestive system disorders 
NOS 
253892 Sclerema 
253893 Newborn environmental hyperthermia 
253894 Fits in newborn 
253895 Central nervous system dysfunction in 
newborn NOS 
253896 Newborn regurgitation of food 
253897 Newborn drug withdrawal syndrome 
253898 Acquired periventricular cysts of 
newborn 
253899 Congenital renal failure 
253900 Congenital hypotonia 
253901 Neonatal cardiac dysrhythmia 
253902 [X]Fetus+newborn affectd/oth medical 
procedure on mother,NEC 
253903 [X]Fetus+newbrn affect/oth 
forms/placental separatn+h'morrhg 
253904 [X]Other low birth weight 
253905 [X]Other and unspecified atelectasis of 
newborn 
253906 [X]Other apnoea of newborn 
253907 [X]Other bacterial sepsis of newborn 
253908 [X]Neonat jaun due/drg,toxn transmit 
frm mother/given newbrn 
253909 [X]Other specified transitory neonatal 
endocrine disorders 
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253910 [X]Other transitory metabolic 
disturbances of newborn 
253911 [X]Transitory neonatl disord calcium 
and magnes metab uns 
255064 Accident due to neglect of newborn 
255697 [V]Normal pregnancy 
255698 [V]Unspecified pregnant state 
255703 [V]stillbirth 
255704 [V]Twins, both live born 
255705 [V]Unspecified delivery outcome 
255706 [V]Other specified antenatal screening 
255711 [V]Other multiple birth, unspecified, 
born in hospital 
255848 Top hysterotomy 
255849 Excision ectopic pregnancy 
255850 Repositioning foetus 
255851 Forceps extraction midcavity 
255852 Forceps delivery 
255853 Antepartum operation 
255854 Induction labour missed abortion 
255948 Alpha-feto protein high 
255955 Follicular stimulating hormone level 
255956 Placental function test 
256038 Postnatal visit 
256250 Instruction antenatal 
256251 Examination postnatal normal 
256840 Pregnancy bleeding 
256844 Static weight gain pregnancy 
256845 Induced abortion medical indication 
256846 Self-induced abortion 
256848 Delivery contracted pelvis 
256849 Malpresentation at delivery crossbirth 
256851 Uterine perforation obstetrical 
257126 Erb's palsy due birth injury 
257127 Aspiration contents birth canal 
257129 Insufficiency respiratory newborn 
257130 Neonatal atelectasis 
257131 Caesarian section birth (baby) 
257132 Fontanelle anterior large at birth 
257176 Icterus 
257682 Heavy labourer NOS 
257699 FH: Twin pregnancy 
257775 Pregnancy benefit NOS 
257826 H/O: miscarriage 
257828 H/O: 3 abortions 
257830 H/O: ectopic pregnancy 
257831 H/O: baby feeding method 
258032 O/E - fetal movements 
258309 Serum pregnancy test negative 
258377 Urine pregnancy test 
258378 Urine pregnancy test positive 
258604 Ultrasound in obstetric diagn. 
258605 U-S scan - multiple fetus 
258606 Dating/booking US scan 
258649 Pregnant - V.E. confirms 
258650 A/N care: social risk NOS 
258651 A/N care: medical risk 
258652 Ante-natal care: not wanted 
258653 No A/N care: not known preg. 
258654 Parent craft class not offered 
258655 A/N amniocentesis - not wanted 
258656 A/N U/S scan not offered 
258657 A/N U/S scan offered 
258658 A/N U/S scan normal +? Dates 
258659 Antenatal ultrasound scan at 9-16 
weeks 
258660 A/N Rh antibody screen 
258661 Rubella screen not offered 
258662 A/N sickle cell screen done 
258663 Antenatal examinations 
258664 A/N 16 week examination 
258665 A/N 36 week examination 
258666 A/N 37 week examination 
258667 A/N 41 week examination 
258668 Breast feeding with supplement 
258669 Double test 
258670 Born - place delivered 
258671 Ambulance birth 
258672 2nd stage of labour length 
258673 Length of labour NOS 
258674 Outcome of delivery 
258675 Single stillbirth 
258676 Twins - both live born 
258677 Triplets-1 live+ 2 still born 
258678 Baby female 
258679 2 female babies 
258680 Birthweight of baby NOS 
258681 Birth HC = 50th-74th centile 
258682 Birth length=90th-96th centile 
258683 Apgar at 1 minute = 4 
258684 Apgar at 1 minute = 6 
258685 Apgar at 5 minutes = 1 
258686 Apgar at 10 minutes = 9 
258687 Apgar at 10 minutes NOS 
258688 Cot death liability 
258689 High risk infant 
258690 Birth details NOS 
258693 Child development examinations 
258705 Child exam. - birth 
258706 Child not examined at birth 
258707 Child birth exam. - normal 
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258708 Child exam. - birth NOS 
258794 Pre-pregnancy counselling 
258799 Pregnancy dental advice 
259419 Instillation of therapeutic substance into 
bladder 
259503 Curettage of uterus for termination of 
pregnancy NEC 
259504 Other evacuation of contents of uterus 
259505 Dilation cervix & evacuation products 
conception uterus NEC 
259506 Suction termination of pregnancy 
259509 Intrauterine artificial insemination 
259510 Artficial insemination NEC 
259534 Childbirth operations 
259535 Fetus operations 
259536 Therapeutic foetoscopic operations on 
fetus 
259537 Fetoscopic examination of fetus and 
sampling of fetal blood 
259538 Other specified therapeutic 
percutaneous operation on fetus 
259539 Other specified other operation on 
amniotic cavity 
259540 Repositioning of retroverted gravid 
uterus 
259541 Artificial rupture of membranes 
259542 Induction of labour using prostaglandins 
259543 Syntocinon induction of labour 
259544 Breech extraction delivery NOS 
259545 Other specified forceps cephalic 
delivery 
259546 Normal delivery NOS 
259547 Cleidotomy of fetus to facilitate delivery 
259548 Curettage of delivered uterus 
259549 Manual removal retained products 
conception delivered uterus 
259550 Manual removal products of conception 
delivered uterus NOS 
260216 Child for adoption 
260262 Requests pregnancy termination 
260277 Patient date of birth 
260300 FP24 maternity claim status 
260499 Abortive plague 
261017 Post-birth injury panhypopituitarism 
262094 Complications of pregnancy, childbirth 
and the puerperium 
262095 Blighted ovum 
262097 Tubal pregnancy 
262098 Spontaneous abortion with sepsis 
262099 Incomplete spontaneous abortion with 
metabolic disorder 
262100 Incomp spontaneous abortion + other 
specified complication 
262101 Unsp inevitable mis comp by delayed or 
excessive haemorrhage 
262102 Unspecified inevitable miscarriage 
without complication 
262103 Complete inev misc compl by genital 
tract and pelvic infec 
262104 Complete inevitable miscar comp by 
delayed or excessive haem 
262105 Complete inevitable miscarriage with 
OS complication 
262106 Spontaneous abortion NOS 
262107 Unspecified legal abortion with other 
specified complication 
262108 Legal abortion incomplete 
262109 Complete legal abortion + genital tract 
or pelvic infection 
262110 Complete legal abortion with no 
mention of complication 
262111 Legally induced abortion NOS 
262112 Illegally induced abortion 
262113 Incomplete illegal abortion + genital 
tract/pelvic infection 
262114 Unspecified abortion with complication 
NOS 
262115 Unspecified incomplete abortion + no 
mention of complication 
262116 Failed attempted abortion + damage to 
pelvic organs/tissues 
262117 Failed attempted abortion with renal 
failure 
262118 Failed attempted abortion with shock 
262119 Failed attempted abortion with other 
specified complication 
262120 Delayed/excessive haemorrhage 
following abortive pregnancy 
262121 Readmission for retained produc of 
concept, unspec abortion 
262122 Pregnancy complications 
262123 Inevitable abortion 
262124 Antepartum haemorrhage, abruptio 
placentae, placenta praevia 
262125 Antepartum haemorrhage with 
hypofibrinogenaemia 
262126 Antepartum haemorrhage NOS, 
unspecified 
262127 Benign essential hypertension in 
preg/childb/puerp +p/n comp 
262128 Renal hypertension in 
pregnancy/childbirth/puerperium NOS 
262129 Other pre-existing hypertension in 
preg/childb/puerp - deliv 
262130 Oth pre-exist hypert in 
preg/childb/puerp -del with p/n comp 
262131 Severe pre-eclampsia 
262132 Eclampsia with postnatal complication 
262133 Pre-eclampsia or eclampsia with 
hypertension unspecified 
262134 Unspecified hypertension in 
preg/childb/puerp - not deliv 
262135 Excessive pregnancy vomiting 
262136 Mild hyperemesis unspecified 
262137 Mild hyperemesis-delivered 
262138 Hyperemesis gravidarum with metabolic 
disturbance - not del 
262139 Late pregnancy vomiting - not delivered 
262140 Unspecified pregnancy vomiting NOS 
262141 Other threatened labour 
262142 Papyraceous fetus 
262143 Maternal obesity syndrome 
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262144 Peripheral neuritis in pregnancy - 
delivered 
262145 Peripheral neuritis in pregnancy - 
delivered with p/n comp 
262146 Asymptomatic bacteriuria in pregnancy 
262147 Asymptomatic bacteriuria in pregnancy 
- del with p/n comp 
262148 Cystitis of pregnancy 
262149 Liver disorder in pregnancy 
262150 Liver disorder in pregnancy - not 
delivered 
262151 Herpes gestationis - delivered with 
postnatal complication 
262152 Glycosuria during pregnancy 
262153 Glycosuria during pregnancy with 
postnatal complication 
262154 Maternal syphilis, unspec whether in 
pregnancy or puerperium 
262155 Maternal gonorrhoea in 
pregnancy/childbirth/puerperium NOS 
262156 Maternal tuberculosis,unspec whether 
in pregnancy/puerperium 
262157 Maternal malaria during pregnancy - 
baby delivered 
262158 Maternal malaria in puerperium - baby 
delivered 
262159 Maternal malaria during 
pregnancy/childbirth/puerperium NOS 
262160 Maternal rubella in puerperium - baby 
previously delivered 
262161 Other maternal viral dis. In 
pregnancy/childbirth/puerperium 
262162 Other maternal viral disease in 
puerperium - baby delivered 
262163 Other mat.infective/parasitic disease in 
preg/childb/puerp. 
262164 Mat infect/parasitic dis NOS in 
pregnancy-baby not delivered 
262165 Diabetes mellitus during 
pregnancy/childbirth/puerperium 
262166 Diabetes mellitus in pueperium - baby 
previously delivered 
262167 Thyroid dysfunction during pregnancy - 
baby delivered 
262168 Thyroid dysfunction in puerperium- 
baby previously delivered 
262169 Anaemia during 
pregnancy/childbirth/puerperium NOS 
262170 Drug dependence during pregnancy - 
baby not yet delivered 
262171 Mental disorder in puerperium - baby 
previously delivered 
262172 Congenital cardiovascular disorders in 
preg/childb/puerp 
262173 Risk factors in pregnancy 
262174 Triplet pregnancy - delivered 
262175 Other multiple pregnancy 
262176 Other multiple pregnancy unspecified 
262177 Multiple pregnancy NOS with antenatal 
problem 
262178 Malposition and malpresentation of 
fetus 
262179 Unstable lie - delivered 
262180 Spontaneous breech delivery 
262181 Breech presentation NOS 
262182 Transverse lie unspecified 
262183 Face presentation 
262184 Fetal malposition and malpresentation 
NOS 
262185 Mixed feto-pelvic disproportion 
unspecified 
262186 Mixed feto-pelvic disproportion with 
antenatal problem 
262187 Other fetal abnormality causing 
disproportion 
262188 Other fetal abnormality causing 
disproportion with a/n prob 
262189 Disproportion NOS - delivered 
262190 Uterine operation scar in 
pregnancy/childbirth/puerp unspec 
262191 Other uterine/pelvic floor abnormality in 
preg/childb/puerp 
262192 Other cervical abnormality in 
pregnancy/childbirth/puerp NOS 
262193 Congenital/acquired abnormality vagina 
in preg/childb/puerp 
262194 Vulval abn complicating a/n care - baby 
not yet delivered 
262195 Persistent hymen complicating a/n care 
- baby not delivered 
262196 Persistent hymen complicating p/n care 
- baby delivered prev 
262197 Pelvic soft tissue abnormality in 
preg/childb/puerp - deliv 
262198 Fetus with central nervous system 
malformation 
262199 Fetus with viral damage via mother 
unspecified 
262200 Malformation of placenta 
262201 Feto-placental problems NOS 
262202 Polyhydramnios - delivered 
262203 Polyhydramnios NOS 
262204 Other problems of amniotic cavity and 
membranes 
262205 Anhydramnios 
262206 Premature rupture of membranes, 
labour delayed by therapy 
262207 Prolonged spont/unspec rupture of 
membranes unspecified 
262208 Prolonged artificial rupture of 
membranes with a/n problem 
262209 Amniotic cavity infection unspecified 
262210 Amniotic cavity and membrane problem 
NOS, unspecified 
262211 Amniotic cavity and membrane problem 
NOS - delivered 
262212 Failed mechanical induction with 
antenatal problem 
262213 Failed medical or unspecified induction 
262214 Septicaemia during labour 
262215 Grand multiparity with antenatal 
problem 
262216 Elderly primigravida 
262217 Other problems affecting labour - 
delivered 
262218 Other problems affecting labour with 
antenatal problem 
262219 Obstructed labour caused by pelvic soft 
tissues unspecified 
262220 Other failed trial of labour - delivered 
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262221 Failed forceps NOS 
262222 Other failed ventouse extraction, 
unspecified 
262223 Primary uterine inertia with antenatal 
problem 
262224 Secondary uterine inertia unspecified 
262225 Secondary uterine inertia NOS 
262226 Other uterine inertia with antenatal 
problem 
262227 Prolonged second stage NOS 
262228 Cord tangled with compression with 
antenatal problem 
262229 Vasa praevia unspecified 
262230 Umbilical cord complications NOS, 
unspecified 
262231 Vulval delivery trauma 
262232 Second degree perineal tear during 
delivery 
262233 Fourth degree perineal tear during 
delivery 
262234 Fourth degree perineal tear during 
delivery - delivered 
262235 Unspecified perineal laceration during 
delivery - delivered 
262236 Vulval and perineal haematoma during 
delivery - delivered 
262237 Other obstetric trauma 
262238 Obstetric inversion of uterus - delivered 
with p/n problem 
262239 Obstetric laceration of cervix 
unspecified 
262240 Other obstetric pelvic organ damage 
262241 Urethra injury - obstetric 
262242 Other obstetric pelvic organ damage 
with postnatal problem 
262243 Obstetric damage to pelvic joints and 
ligaments unspecified 
262244 Other obstetric trauma unspecified 
262245 Other obstetric trauma with antenatal 
problem 
262246 Other immediate postpartum 
haemorrhage unspecified 
262247 Secondary postpartum haemorrhage 
unspecified 
262248 Afibrinogenaemia - postpartum 
262249 Postpartum coagulation defects 
unspecified 
262250 Retained membrane without 
haemorrhage 
262251 Retained placenta with no haemorrhage 
unspecified 
262252 Retained placenta with no haemorrhage 
- deliv with p/n prob 
262253 Retained placenta with no haemorrhage 
with postnatal problem 
262254 Retained placenta with no haemorrhage 
NOS 
262255 Retained products with no 
haemorrhage unspecified 
262256 Retained products with no 
haemorrhage - deliv with p/n prob 
262257 Obstetric anaesthesia with pulmonary 
complications - deliv 
262258 Obstetric anaesthesia with CNS comp - 
deliv with p/n problem 
262259 Toxic reaction to local anaesthesia 
during pregnancy 
262260 Spinal/epidural anaesth-induced 
headache during puerp 
262261 Cardiac comps of anaesthesia during 
labour and delivery 
262262 Other complications of obstetric 
anaesthesia - delivered 
262263 Maternal hypotension syndrome - 
delivered with p/n problem 
262264 Other complications of obstetric 
procedures - delivered 
262265 Mid-cavity forceps delivery 
262266 Delivery by combination of forceps and 
vacuum extractor 
262267 Forceps delivery NOS 
262268 Vacuum extractor delivery unspecified 
262269 Other complications of labour and 
delivery - deliv +p/n prob 
262270 Maternal exhaustion 
262271 Complications of labour and delivery 
NOS, unspecified 
262272 Puerperal endometritis 
262273 Major puerperal infection NOS with 
postnatal complication 
262274 Perineal obstetric varicose veins 
262275 VV's of perineum/vulva in 
pregnancy/puerperium -del+p/n comp 
262276 Vaginal varices in pregnancy 
262277 Puerperal phlebitis 
262278 Other venous complication of 
pregnancy and the puerperium 
262279 Other venous comp of 
pregnancy/puerperium - deliv + p/n 
comp 
262280 Venous complications of pregnancy and 
puerperium NOS 
262281 Gestational thrombosis NOS 
262282 Puerperal phlebitis NOS 
262283 Puerperal pyrexia of unknown origin 
262284 Puerperal pyrexia NOS 
262285 Obstetric blood-clot pulmonary 
embolism - delivered 
262286 Puerperal cerebrovascular disorder - 
delivered 
262287 Caesarean wound disruption - delivered 
with p/n complication 
262288 Complications of the puerperium NOS - 
delivered + p/n comp 
262289 Obstetric breast abscess NOS 
262290 Lymphangitis of breast - obstetric 
262291 Obstetric breast infection NOS 
262292 Lactation problems 
262293 Retracted nipple in 
pregnancy/puerperium/lact with p/n 
comp 
262294 Cracked nipple in pregnancy, the 
puerperium or lactation NOS 
262295 Pain on breast feeding 
262296 Other disorder of lactation NOS 
262297 Disorder of lactation NOS, unspecified 
262298 Other specified complications of the 
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puerperium 
262299 Maternal care for fetus 
262300 Maternal care for viable fetus in 
abdominal pregnancy 
262301 [X]Other+unspcf failed induced 
abortion,without complication 
262302 [X]Complic following abortion & ectopic 
& molar preg, unspec 
262303 [X]Infections of other parts of urinary 
tract in pregnancy 
262304 [X]Other+unspcf genitourinary tract 
infection in pregnancy 
262305 [X]Other complications specific to 
multiple gestation 
262306 [X]Intrapartum haemorrhage, 
unspecified 
262307 [X]Other assisted breech delivery 
262308 [X]Other infection of genital tract 
following delivery 
262309 [X]Other venous complications in the 
puerperium 
262310 [X]Oth complicatn/spinal+epidural 
anaesthes during puerperum 
262311 Complications of pregnancy,childbirth 
and the puerperium NOS 
262968 Fetus or neonate affected by maternal 
renal/urinary disease 
262969 Fetus or neonate affected by maternal 
renal disease 
262970 Fetus or neonate affected by maternal 
injury 
262971 Fetus/neonate affected by poison 
transferred placenta/breast 
262972 Fetus/neonate affected-placenta/breast 
transfer hallucinogen 
262973 Fetus/neonate affected-plac./breast 
transfer anticonvulsant 
262974 Fetus/neonate affected-plac./breast 
transfer uterine depress 
262975 Fetus or neonate affected by maternal 
oligohydramnios 
262976 Fetus or neonate affected by tubal 
ectopic pregnancy 
262977 Fetus or neonate affected by triplet 
pregnancy 
262978 Fetus or neonate affected by 
malpresentation before labour 
262979 Fetus affected by malpresentation 
262980 Fetus or neonate affected by transverse 
lie before labour 
262981 Fetus/neonate affected-prem placental 
separation+acc haem'ge 
262982 Fetus or neonate affected by other cord 
compression 
262983 Fetus or neonate affected by 
thrombosis of cord 
262984 Fetus or neonate affected by 
chorioamnionitis 
262985 Fetus/neonate affected by mat 
analgesic agent in labour/del 
262986 Fetus/neonate affected by mat 
tranquillizers in labour/deliv 
262987 Fetus/neonate affected by other labour 
and delivery problems 
262988 Fetus/neonate affected by destructive 
operation aid delivery 
262989 Fetus/neonate affected by 
labour/delivery complication NOS 
262990 Fetal growth retardation NOS 
262991 Vacuum extraction chignon 
262992 Scalp injury due to birth trauma, NOS 
262993 Birth fracture of ulna 
262994 Fracture of skull due to birth trauma 
262995 Spine or spinal cord injury due to birth 
trauma 
262996 Spinal cord rupture due to birth trauma 
262997 Brachial plexus palsy due to birth 
trauma 
262998 Brachial palsy unspecified, due to birth 
trauma 
262999 Other specified brachial plexus palsy 
due to birth trauma 
263000 Cranial or peripheral nerve palsy due to 
birth trauma NOS 
263001 Testicular haematoma due to birth 
trauma 
263002 Renal injury due to birth trauma 
263003 Fetal death due to labour anoxia 
263004 Fetal distress, unspecified when, 
liveborn 
263005 Anoxia in newborn NOS 
263006 Other specified massive aspiration 
syndrome 
263007 Perinatal mediastinal emphysema 
263008 Perinatal haemoptysis 
263009 Perinatal pulmonary fibroplasia 
263010 Respiratory failure of newborn 
263011 Perinatal respiratory problems NOS 
263012 Fetal or newborn respiratory problems 
NOS 
263013 Congenital malaria 
263014 Congenital tuberculosis 
263015 Neonatal infective mastitis 
263016 Neonatal conjunctivitis 
263017 Neonatal dacryocystitis/conjunctivitis 
due to other bacteria 
263018 Neonatal dacryocystitis or conjunctivitis 
due to virus 
263019 Neonatal dacryocystitis due to 
chlamydiae 
263020 Neonatal conjunctivitis due to other 
inclusion body 
263021 Neonatal monilia 
263022 Neonatal thrush 
263023 Congenital hepatitis B infection 
263024 Congenital infectious and parasitic 
disease, unspecified 
263025 Subarachnoid haemorrhage due to birth 
injury 
263026 Umbilical haemorrhage after birth 
263027 Umbilical haemorrhage after birth, 
unspecified 
263028 Newborn slipped umbilical ligature 
263029 Other specified umbilical haemorrhage 
after birth 
263030 Perinatal haematemesis 
263031 Other specified perinatal 
gastrointestinal haemorrhage 
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263032 Intracranial nontraumatic haemorrhage 
of fetus and newborn 
263033 Cerebellar (nontraum) and post fossa 
haemorhage fet newborn 
263034 Other specified fetal or newborn 
haemorrhage 
263035 Isoimmunisation of newborn 
263036 Perinatal jaundice from bleeding 
263037 Perinatal jaundice from other specified 
haemolysis 
263038 Icterus neonatorum, unspecified 
263039 Neonatal hypoparathroidism 
263040 Other neonatal hypocalcaemia 
263041 Transitory neonatl disord calcium and 
magnes metab uns 
263042 Perinatal intestinal perforation 
263043 Meconium obstruction NOS 
263044 Neonatal chloridorrhoea 
263045 Sclerema neonatorum NOS 
263046 Newborn breast engorgement 
263047 Other perinatal skin disorders 
263048 Withdrawal symptoms from therapeutic 
use of drugs in newborn 
263049 Congenital uraemia 
263050 Other perinatal conditions NOS 
263051 Other perinatal conditions NOS 
263052 Perinatal death 
263053 [X]Congenital pneumonia due to other 
organisms 
263054 [X]Infections specific to the perinatal 
period 
263055 [X]Neonatal jaundice from other+unspcf 
hepatocellular damage 
264873 [V]Pregnancy confirmed 
264874 [V]Pregnancy with history of 
trophoblastic disease 
264875 [V]Postnatal care and examination 
264881 [V]Other multiple birth, some live born 
264883 [V]Other multiple birth, mates stillborn 
264884 [V]Unspecified birth 
264960 [V]Pregnancy examination or test, 
pregnancy unconfirmed 
265024 Abortion hysterotomy 
265025 Decapitation foetus 
265026 Forceps extraction low 
265027 Rotation foetal head manually 
265028 Caesarean section classical upper 
segmen 
265029 Retained placenta manual removal 
265030 Suture obstetric laceration 
265122 Alpha-feto protein normal 
265128 Az test 
265129 Pregnancy test sent (awaiting result) 
265178 Seen in neonatal clinic 
265237 Pregnancy planned 
265240 Preconception advice 
265241 Pregnancy symptoms 
265387 Pregnancy out of wedlock 
265408 Screening baby 
265426 Pre-conception counselling clinic attend 
265461 Pregnancy prenatal care 
265462 Medical examination antenatal 
265463 Pregnancy booking consultation 
266073 Placenta praevia marginal 
266075 Braxton hicks contractions 
266076 Multiparity 
266077 Pregnancy phlebothrombosis 
266078 Prolapsed uterus pregnancy 
266079 Svd (spontaneous vertex delivery) 
266080 Delivery domicillary (mother) 
266081 Delivery gp unit (mother) 
266082 Delivery premature in hospital/maternity 
266083 Shoulder presentation at delivery 
266085 Inertia uterus complicating delivery 
266086 Dystocia 
266087 Inversion uterus complicating delivery 
266090 Traumatic birth incident 
266091 Septicaemia puerperal 
266098 Milk excessive 
266327 Injury newborn accident at birth 
266328 Incompatibility rhesus newborn 
266330 Asphyxia newborn 
266331 Gp unit confinement 
266334 Newborn infant dehydration 
266335 Jittering baby 
266336 Neonatal death 
266374 Fat wheezy baby 
266918 FH: Multiple pregnancy 
266965 Midwife attends 11 - 13 days post 
discharge 
266987 Death of infant 
267026 H/O: birth injury 
267038 H/O: stillbirth 
267565 Serum pregnancy test (B-HCG) 
267566 Serum pregnancy test positive 
267650 Urine pregnancy test requested 
267651 High sensitivity urine pregnancy test 
267896 Pregnant - blood test confirms 
267897 Pregnant - planned 
267898 A/N care: obstetric risk NOS 
267899 A/N care: H/O infertility 
267900 A/N care from G.P. 
267901 A/N care midwifery led 
267902 Intends to breast feed 
267903 Feeding intention - NOS 
267904 Pregnancy prolonged - 42 weeks 
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267905 Bottle changed to breast 
267906 P/N care from G.P. 
267907 P/N care started at birth 
267908 Maternal P/N exam. Refused 
267909 Postnatal examination normal 
267910 Triple test not offered 
267911 Double test not wanted 
267912 Delivery place planned 
267913 Length of gestation 
267914 Gestation <24 weeks 
267915 3 male babies 
267916 Sex of baby NOS 
267917 Maturity of baby 
267918 Baby BW = 25 -49% (3150-3449g) 
267919 Baby BW = 2.0 - 2.5kg 
267920 Birth HC = 3rd-9th centile 
267921 Birth length = < 3rd centile 
267922 Apgar at 1 minute = 8 
267923 Apgar at 10 minutes 
267924 Spontaneous onset of labour 
267938 Baby length centiles 
267973 Child 8 week exam.not attended 
268040 TOP counselling 
268042 Care of teeth advice -in preg. 
268687 Dilation cervix uteri & curettage for 
termination pregnancy 
268688 Curettage of uterus for termination of 
pregnancy NEC 
268690 Introduction of abortifacient into uterine 
cavity NOS 
268715 Other specified therapeutic fetoscopic 
operation 
268716 Selective feticide NEC 
268717 Percutaneous biopsy of fetus 
268718 Other operations on amniotic cavity 
268719 Sampling of chorionic villus NEC 
268720 Cerclage of cervix of gravid uterus 
268721 Other specified elective caesarean 
delivery 
268722 Forceps to aftercoming head (breech) 
268723 Other specified breech extraction 
delivery 
268724 Other breech delivery NOS 
268725 Scanzoni forceps cephalic delivery with 
rotation 
268726 Ventouse extraction 
268727 Cephalic vagin deliv abnorm pres head 
without instrument NOS 
268728 Other methods of delivery 
268729 Trial of labour NEC 
268730 Other operations to facilitate delivery 
268731 Manual removal products of conception 
delivered uterus OS 
268732 Expression of placenta 
268733 Immed repair obstetric laceration 
vagina and floor of pelvis 
268734 Other obstetric operation NOS 
268735 Obstetric monitoring 
268741 Excision of birthmark of head or neck 
268832 Open instillation therapeutic substance 
in abdominal cavity 
269234 [SO]Delivered uterus 
269396 Pregnancy vitamin/iron prophyl 
269430 Ante-natal exercises 
269483 Procedure refused 
269573 Less 24 wk involv risk injury 
physic/mentl health preg woman 
269776 Coxsackie myocarditis 
270308 Malnutrition NOS 
271380 Missed abortion 
271381 Delivery of viable fetus in abdominal 
pregnancy 
271382 Unspec spontaneous abortion + genital 
tract/pelvic infection 
271383 Unspec spontaneous abortion + 
delayed/excessive haemorrhage 
271384 Unspec spontaneous abortion + pelvic 
organ/tissue damage 
271385 Unspec spontaneous abortion without 
mention of complication 
271386 Spontaneous abortion incomplete 
271387 Retained products after spontaneous 
abortion 
271388 Complete spontaneous abortion 
+delayed/excessive haemorrhage 
271389 Unspec inev miscarriage comp by 
genital tract pelvic infec 
271390 Unspecified inevitable miscarriage with 
OS complication 
271391 Incomplete inevitable miscarriage with 
unspecified comp 
271392 Incomplete inevitable miscarriage with 
other specified comp 
271393 Unspecified legal abortion + genital 
tract/pelvic infection 
271394 Unspecified legal abortion with shock 
271395 Incomplete legal abortion + delayed or 
excessive haemorrhage 
271396 Incomplete legal abortion + damage to 
pelvic organs/tissues 
271397 Incomplete legal abortion NOS 
271398 Complete legal abortion with renal 
failure 
271399 Complete legal abortion with metabolic 
disorder 
271400 Complete legal abortion with 
complication NOS 
271401 Incomplete illegal abortion NOS 
271402 Complete illegal abortion with other 
specified complication 
271403 Unspecified abortion NOS 
271404 Unspecified incomplete abortion with 
embolism 
271405 Complications following 
abortion/ectopic/molar pregnancies 
271406 Pelvic organ or tissue damage NOS 
follow abortive pregnancy 
271407 Blood-clot embolism following abortive 
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pregnancy 
271408 Readmission for abortive pregnancy 
(NHS codes) 
271409 Cardiac failure following abortive 
pregnancy 
271410 Failed attempted abortion 
271411 Threatened abortion - not delivered 
271412 Early pregnancy haemorrhage NOS 
271413 Antepartum haemorrhage 
271414 Placenta praevia with haemorrhage 
271415 Premature separation of placenta with 
coagulation defect 
271416 Antepartum haemorrhage with 
hyperfibrinolysis 
271417 Other antepartum haemorrhage - 
delivered 
271418 Antepartum haemorrhage NOS - 
delivered 
271419 Renal hypertension in 
preg/childbirth/puerp - not delivered 
271420 Severe pre-eclampsia unspecified 
271421 Pre-exist hyperten heart renal dis comp 
preg chldbirth/puerp 
271422 Hyperemesis of pregnancy 
271423 Other pregnancy vomiting unspecified 
271424 Prolonged or post-term pregnancy 
271425 Post-term pregnancy unspecified 
271426 Papyraceous fetus unspecified 
271427 UTI - urinary tract infection in 
pregnancy 
271428 Glycosuria during pregnancy - delivered 
with p/n comp 
271429 Other pregnancy complication - not 
delivered 
271430 Other pregnancy complication with 
postnatal complication 
271431 Maternal syphilis in puerperium - baby 
previously delivered 
271432 Maternal malaria in pregnancy, 
childbirth and the puerperium 
271433 Rubella contact in pregnancy 
271434 Maternal rubella in puerperium - baby 
delivered 
271435 Other mat.infective/parasit dis in puerp-
baby previously del 
271436 Mat infect/parasitic dis NOS - 
pregnancy/puerperium unspec 
271437 Thyroid dysfunction in 
pregnancy/childbirth/puerperium 
271438 Drug dependence in pregnancy, 
childbirth and the puerperium 
271439 Drug dependence - unspec whether 
during pregnancy/puerperium 
271440 Mental disorder in the puerperium - 
baby delivered 
271441 Mental disorder during 
pregnancy/childbirth/puerperium NOS 
271442 Other cardiovascular disease in 
pregnancy - baby delivered 
271443 Orthopaedic disorder in pregnancy - 
baby not yet delivered 
271444 Abnormal GTT - unspec whether during 
pregnancy/puerperium 
271445 Abnormal GTT in puerperium - baby 
delivered 
271446 Medical condition NOS during 
pregnancy - baby delivered 
271447 Normal delivery in a completely normal 
case 
271448 Multiple pregnancy 
271449 Quadruplet pregnancy unspecified 
271450 Multiple pregnancy NOS - delivered 
271451 Multiple pregnancy NOS 
271452 Unstable lie unspecified 
271453 Unstable lie with antenatal problem 
271454 Prolapsed arm - delivered 
271455 Prolapsed arm NOS 
271456 Generally contracted pelvis - delivered 
271457 Outlet pelvic contraction 
271458 Hydrocephalic disproportion - delivered 
271459 Other fetal abnormality causing 
disproportion NOS 
271460 Other disproportion unspecified 
271461 Other disproportion - delivered 
271462 Double uterus in pregnancy, childbirth 
and the puerperium 
271463 Cong abnormality uterus - baby 
delivered + postpartum compl 
271464 Uterine fibroid - baby delivered + 
postpartum complication 
271465 Cystocele - delivered with postpartum 
complication 
271466 Rectocele in pregnancy, childbirth or 
the puerperium NOS 
271467 Shirodkar suture present 
271468 Vaginal abnormality in 
pregnancy/childbirth/puerperium 
271469 Septate vagina affecting obstetric care 
271470 Septate vagina - baby delivered 
271471 Vaginal abnormality complicating p/n 
care - baby deliv prev 
271472 Stenosis of vagina in 
pregnancy/childbirth/puerperium NOS 
271473 Rigid perineum in pregnancy, childbirth 
and the puerperium 
271474 Suspect fetal hydrocephaly 
271475 Fetus with viral damage via mother 
271476 Maternal care for damage to fetus from 
maternal rubella 
271477 Fetus with damage due to other 
maternal disease unspecified 
271478 Fetus with damage due to coil 
271479 Fetus with other damage NEC, 
unspecified 
271480 Fetal-maternal haemorrhage 
unspecified 
271481 Other blood-group isoimmunisation 
271482 Maternal care for fetal bradycardia 
during pregnancy 
271483 Fetal death in utero 
271484 Intrauterine death with antenatal 
problem 
271485 Small-for-dates fetus in pregnancy 
271486 Large-for-dates fetus in pregnancy 
271487 Other feto-placental problems 
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271488 Feto-placental problems NOS - 
delivered 
271489 Oligohydramnios with antenatal 
problem 
271490 Prolonged spont/unspec rupture of 
membranes - delivered 
271491 Delay deliv after spontaneous or unsp 
rupture of membranes 
271492 Prolonged artificial rupture of 
membranes - delivered 
271493 Prolonged artificial rupture of 
membranes NOS 
271494 Amniotic cavity infection 
271495 Amniotic cavity and membrane 
problems NOS 
271496 Failed mechanical induction NOS 
271497 Failed medical or unspecified induction 
with a/n problem 
271498 Unspecified maternal pyrexia during 
labour, unspecified 
271499 Abnormal haematologic find on 
antenatal screening of mother 
271500 Obstructed labour due to fetal 
malposition NOS 
271501 Obstructed labour caused by bony 
pelvis - delivered 
271502 Locked twins unspecified 
271503 Primary uterine inertia - delivered 
271504 Precipitate labour - delivered 
271505 Hypertonic uterine inertia with antenatal 
problem 
271506 Prolonged labour unspecified 
271507 Prolonged second stage 
271508 Delayed delivery second twin with 
antenatal problem 
271509 Prolapse of cord unspecified 
271510 Cord tangled with compression 
unspecified 
271511 Short cord 
271512 Labial tear 
271513 Anal sphincter tear 
271514 Third degree perineal tear during 
delivery with p/n problem 
271515 Vulval and perineal haematoma during 
delivery 
271516 Vulval/perineal trauma during delivery 
NOS - delivered 
271517 Rupture of uterus before labour 
unspecified 
271518 Rupture of uterus during and after 
labour - delivered 
271519 Obstetric inversion of uterus with 
postnatal problem 
271520 Laceration of cervix - obstetric 
271521 Obstetric laceration of cervix - delivered 
271522 High vaginal laceration - obstetric 
271523 Obstetric trauma NOS, unspecified 
271524 Third-stage postpartum haemorrhage 
271525 Secondary postpartum haemorrhage 
with postnatal problem 
271526 Obstetric anaesthesia with pulmonary 
comp - deliv + p/n prob 
271527 Obstetric anaesthesia with CNS comp 
with postnatal problem 
271528 Failed or difficult intubation during 
pregnancy 
271529 Failed or difficult intubation during 
labour and delivery 
271530 Maternal distress unspecified 
271531 Maternal distress - delivered with 
postnatal problem 
271532 Maternal distress with antenatal 
problem 
271533 Obstetric shock - delivered 
271534 Post-delivery acute renal failure 
unspecified 
271535 Post-delivery acute renal failure NOS 
271536 Other complications of obstetric 
procedures 
271537 Infection of obstetric surgical wound 
271538 Vacuum extractor delivery NOS 
271539 Caesarean delivery 
271540 Complications of labour and delivery 
NOS with antenatal prob 
271541 Complications of labour and delivery 
NOS with p/n problem 
271542 Other specified complications of labour 
or delivery 
271543 Sepsis - puerperal 
271544 Puerperal salpingitis - delivered with 
postnatal comp 
271545 Puerperal salpingitis NOS 
271546 Major puerperal infection NOS 
271547 Genital varices in the puerperium 
271548 Phlebitis - postpartum 
271549 Haemorrhoids in pregnancy and the 
puerperium - delivered 
271550 Venous complication 
pregnancy/puerperium NOS + a/n comp 
271551 Gestational phlebopathy NOS 
271552 Amniotic fluid pulmonary embolism with 
a/n complication 
271553 Other complications of the puerperium 
NEC 
271554 Puerperal cerebrovascular disorder 
NOS 
271555 Caesarean wound disruption 
271556 Obstetric perineal wound disruption - 
deliv + p/n comp 
271557 Obstetric perineal wound disruption 
NOS 
271558 Placental polyp NOS 
271559 Complications of the puerperium NOS 
271560 Obstetric breast infections 
271561 Obstetric breast infection NOS - 
delivered 
271562 Obstetric breast infection NOS with 
postnatal complication 
271563 Failure of lactation 
271564 Suppressed lactation unspecified 
271565 Other disorder of lactation - delivered 
271566 Disorder of lactation NOS - delivered 
271567 Disorder of lactation NOS - delivered 
with p/n complication 
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271568 Disorder of lactation NOS with 
antenatal complication 
271569 Disorder of lactation NOS with postnatal 
complication 
271570 Complications of the puerperium NOS 
271571 Spontaneous vertex delivery 
271572 Spontaneous breech delivery 
271573 [X]Oth+unspcf failed inducd abortn,wth 
oth+unspcf complicatn 
271574 [X]Other complications follow 
abortn+ectopic+molar pregnancy 
271575 [X]Other maternal disorders 
predominant related to pregnancy 
271576 [X]Other complications of anaesthesia 
during pregnancy 
271577 [X]Other specified obstetric trauma 
271578 [X]Other complications of anaesthesia 
during labour+delivery 
271579 [X]Other single delivery by caesarean 
section 
271580 [X]Other specified puerperal 
complications 
271687 Adult still's disease 
272025 Blue baby 
272108 Predislocation status of hip at birth 
272165 Collodion baby 
272216 Fetus or neonate affected by maternal 
infections 
272217 Fetus/neonate affected by other chronic 
maternal RS disease 
272218 Fetus/neonate affected-plac./breast 
transfer chemotherapy 
272219 Fetus/neonate affected-placenta/breast 
transfer medicine NEC 
272220 Fetus/neonate affected maternal 
premature rupture membrane 
272221 Fetus/neonate affected by other 
maternal complic pregnancy 
272222 Fetus/neonate affect by placental 
damage-surgical induction 
272223 Fetus or neonate affected by premature 
placental separation 
272224 Fetus or neonate affected by marginal 
sinus rupture 
272225 Fetus or neonate affected by placental 
abnormality NOS 
272226 Fetus or neonate affected by placental 
transfusion syndrome 
272227 Fetus/neonate affected by twin-to-twin 
transplacental transf 
272228 Fetus or neonate affected by cord 
round neck 
272229 Fetus/neonate affected by 
malposition/disproportion-delivery 
272230 Fetus/neonate affected by disproportion 
during labour/delive 
272231 Fetus or neonate affected by obstructed 
labour NEC 
272232 Fetus/neonate affected by mat 
anaesthetic/analgesia-lab/del 
272233 Fetus/neonate affected by mat 
anaesthetic agent in lab/deliv 
272234 Fetus/neo. Affected maternal 
anaes/analgesia in lab/del OS 
272235 Fetus or neonate affected by long 
labour 
272236 Disorders due to slow fetal growth, low 
and high birthweight 
272237 Slow fetal growth and fetal malnutrition 
272238 Extreme prematurity - less than 28 
weeks 
272239 Very large baby - weight greater than 
4500gm 
272240 Cerebral haemorrhage unspecified, due 
to birth trauma 
272241 Fracture of tibia or fibula due to birth 
trauma 
272242 Birth dislocation of the shoulder 
272243 Birth plexus inj - Erb-Duchenne 
272244 Birth plexus injury - Klumpke-Dejerine 
272245 Klumpke-Dejerine paralysis 
272246 Birth plexus injury - whole plexus 
272247 Brachial plexus palsy due to birth 
trauma NOS 
272248 Cranial nerve injury due to birth trauma 
272249 Other specified birth trauma 
272250 Torticollis due to birth injury 
272251 Birth trauma due to amniocentesis 
272252 Severe birth asphyxia - apgar score 
less than 4 at 1 minute 
272253 Mild to moderate birth asphyxia - apgar 
score 4-7 at 1 min 
272254 Hypoxia in newborn NOS 
272255 Congenital pneumonia due to viral 
agent 
272256 Aspiration of liquor or mucus in 
newborn 
272257 Perinatal pneumopericardium 
272258 Perinatal interstitial emphysema 
272259 Perinatal cyanotic attacks NOS 
272260 Neonatal conjunctivitis due to virus 
272261 Neonatal dacryocystitis due to other 
inclusion body 
272262 Ophthalmia neonatorum due to 
inclusion body NEC 
272263 Neonatal candidiasis of other skin 
272264 Congenital viral hepatitis 
272265 Other specified congenital viral hepatitis 
272266 Sepsis of the newborn 
272267 Perinatal coagulase negative 
staphylococcus 
272268 Sepsis of newborn due to 
other+unspecified streptococci 
272269 Other specified perinatal infection 
272270 Neonatal urinary tract infection 
272271 Fetal haemorrhage into co-twin 
272272 Fetal haemorrhage into mother's 
circulation 
272273 Neonatal haematemesis 
272274 Perinatal jaundice from hereditary 
haemolytic anaemia NOS 
272275 Kernicterus of newborn NOS 
272276 Neonatal myasthenia gravis 
272277 Transitory neonatal electrolyte 
disturbance NOS 
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272278 Neonatal tetany without calcium or 
magnesium deficiency 
272279 Neonatal hypoparathyroidism 
272280 Other transitory neonatal 
endocrine/metabolic disturb. NOS 
272281 Congenital anaemia from fetal blood 
loss 
272282 Inspissated milk causing intestinal 
obstruction 
272283 Delayed passage of meconium NOS 
272284 Neonatal diarrhoea 
272285 Idiopathic hydrops fetalis 
272286 Urticaria neonatorum 
272287 Seizures in newborn 
272288 Central nervous system dysfunction in 
newborn NOS 
272289 Newborn cerebral depression 
272290 Coma in newborn 
272291 Other newborn abnormal cerebral signs 
272292 Neonatal hypotension 
272293 Other specified perinatal condition 
272294 Floppy infant 
272295 Neonatal "craniotabes" 
272296 Persistent fetal circulation 
272297 Cardiovasc disord origin in the perinat 
period, unspecif 
272298 [X]Fetus+newborn affected/other 
compression/umbilical cord 
272299 [X]Fetus+newborn affected/other 
maternal noxious influences 
272300 [X]Other neonatal aspiration syndromes 
272301 [X]Oth conds relat/interstial emphysema 
orig perinatl period 
272302 [X]Other congenital malaria 
272303 [X]Other specified perinatal 
haematological disorders 
272304 [X]Transitory endocr & metab disord 
specif to fetus/newborn 
272305 [X]Oth transitry disordrs/carbohydrat 
metabolsm/fetus+newbrn 
272306 [X]Oth transitry neonatl 
disordrs/calcium+magnesm metabolism 
272307 [X]Other electrolyte disturbances of 
newborn 
272308 [X]Transitory neonatal endocrine 
disorder, unspecified 
272309 [X]Other neonatal peritonitis 
272310 [X]Other feeding problems of newborn 
272346 [D]wheezing 
273430 Accidentally struck by object falling from 
still machine 
273585 War injury due to explosion of breech 
block 
274046 [V]Pregnant state, incidental 
274047 [V]Supervision of other normal 
pregnancy 
274048 [V]High-risk pregnancy supervision 
274057 [V]Other multiple birth, all live born 
274059 [V]Twin, mate liveborn, NOS 
274060 [V]Twin, mate stillborn 
274061 [V]Other multiple birth, mates live born 
274062 [V]Other multiple birth, not hospitalised, 
mates stillborn 
274063 [V]Unspecified birth, not hospitalised 
274157 [X]Other multiple births, all liveborn 
274200 Chorionic villous sampling 
274201 Version internal (assisted delivery) 
274202 Forceps extraction low with episiotomy 
274203 Ventouse extraction delivery (mother) 
274204 Caesarian section lower segment 
274205 Abortion incomplete curettage 
274206 Uterus evacution (abortion) 
274207 Trachelorrhaphy obstetric postpartum 
274208 Repair anal sphincter obstetric 
274291 Breast-fed (baby) 
274296 Alpha-feto protein low 
274465 Wife pregnant 
274493 Pregnancy operation during 
274550 Screening newborn examination normal 
274556 Screening baby examination 
274568 Newborn infant examination 
274597 Pregnancy examination normal 
274599 Care well baby/child- poor 
274600 Twin mate stillborn 
274608 Myocarditis newborn (aseptic/epidemic) 
275198 Vaginitis pregnancy 
275201 Pregnancy abnormal 
275202 Missed labour 
275203 Pregnancy cystitis 
275204 Vomiting pregnancy 
275206 Miscarriage 
275207 Normal delivery (mother) 
275209 Domiciliary confinement (mother) 
275210 Delivery premature outside hospital 
275211 Placenta praevia complicating delivery 
275212 Delivery accreta placenta 
275213 Malpresentation at delivery 
275217 Hydramnios at delivery 
275218 Sudden death childbirth cause unknown 
275224 Postpartum haemorrhage delayed 
275225 Postnatal haemorrhage 
275468 Prolapsed cord (baby) 
275469 Injury birth 
275471 Premature baby 
275472 Delivery domicillary (baby) 
275474 Accident intrauterine foetus/newborn 
275475 Crossbirth (baby) 
275476 Caesarian section (baby) 
275478 Normal apgar rating 
276002 Light labourer NOS 
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276068 Mid-wife attends 
276069 Midwife attends 21 - 24 days post 
discharge 
276071 Unwanted pregnancy 
276142 H/O: perinatal problem 
276143 H/O: birth asphyxia 
276159 H/O: miscarriage NOS 
276160 H/O: normal delivery 
276161 Past pregnancy outcome NOS 
276241 Well baby 
276693 Urine pregnancy test negative 
276942 No ante-natal care 
276943 Private home delivery booking 
276944 A/N amniocentesis - offered 
276945 A/N amniocentesis - awaited 
276946 A/N U/S scan normal += dates 
276947 A/N Rh screen not offered 
276948 Rh screen - 3rd preg. Sample 
276949 AFP blood test offered 
276950 Rubella status not known 
276951 A/N syphilis screen not done 
276952 A/N blood gp screen not done 
276953 A/N 32 week examination 
276954 A/N 42 week examination 
276955 Fetal movements felt 
276956 Vaginal "show" 
276957 Infant breast fed 
276958 Bottle fed 
276959 Infant bottle fed 
276960 Downs screen - blood test 
276961 Gestation = 24 weeks 
276962 Consultant unit birth 
276963 3rd stage of labour length 
276964 Single live birth 
276965 3 female babies 
276966 Baby post-mature 
276967 Baby BW = > 96% (over 4499g) 
276968 Baby BW = 4400 - 4499g 
276969 Birth head circumference NOS 
276970 Birth length=3rd-9th centile 
276971 Apgar at 5 minutes = 3 
276972 Apgar at 5 minutes = 6 
276973 Apgar at 5 minutes = 8 
276974 Bonding problems 
276975 Battered baby suspect - FH 
276984 Birth exam. Abnormal -for obs. 
276999 Child exam.: development 
277005 Child 7 month exam 
277074 Abortion counselling 
277075 Contraception counselling 
277083 Pregnancy advice 
277084 Drugs in pregnancy advice 
277412 Intubation oesophagus & instillation of 
acid or alkali HFQ 
277789 Insertion of prostaglandin abortifacient 
pessary 
277801 Excision of ruptured ectopic tubal 
pregnancy 
277820 Fetus and gravid uterus operations 
277821 Fetus & gravid uterus ops 
277822 Diagnostic percutaneous examination 
of placenta 
277823 Amnioscopy 
277824 Surgical induction of labour NOS 
277825 Oxytocic induction of labour 
277826 Elective caesarean delivery NOS 
277827 Upper uterine segment caesarean 
delivery NEC 
277828 Lower uterine segment caesarean 
delivery NEC 
277829 Breech extraction delivery 
277830 Other breech delivery 
277831 Barton forceps cephalic delivery with 
rotation 
277832 Forceps cephalic delivery NOS 
277833 High vacuum delivery 
277834 Vacuum delivery before full dilation of 
cervix 
277835 Other operation to facilitate delivery 
NOS 
277836 Repair of episiotomy 
277837 Repositioning of umbilical cord 
277838 Other specified other obstetric 
operation 
277839 Obstetric operations NOS 
277918 Open instillation of therapeutic 
substance into pleura 
278174 Intravenous induction of labour 
278231 Epidural anaesthetic using lumbar 
approach 
278426 Pregnancy prophylactic therapy 
278427 Vitamin supplement - pregnancy 
278444 Post partum care 
278530 Referral to fertility clinic 
278628 Reason for termination of pregnancy 
279376 Nutritional deficiencies 
279628 [X]Postnatal depression NOS 
280430 Cervical pregnancy 
280431 Inevitable miscarriage 
280432 Unspec spontaneous abortion + other 
specified complication 
280433 Unspecified inevitable abortion without 
complication 
280434 Complete inev abor comp by genital 
tract and pelvic infec 
280435 Complete inevitable abortion with 
unspecified complication 
280436 Complete inevitable abortion with OS 
complication 
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280437 Unspecified legal abortion + damage to 
pelvic organs/tissues 
280438 Incomplete legal abortion with other 
specified complication 
280439 Unspec illegal abortion + delayed or 
excessive haemorrhage 
280440 Unspecified illegal abortion + pelvic 
organ/tissue damage 
280441 Complete illegal abortion with 
complication NOS 
280442 Unspecified abortion 
280443 Unspecified incomplete abortion + 
delayed/excess haemorrhage 
280444 Unspecified complete abortion 
+delayed/excessive haemorrhage 
280445 Salpingitis following abortive pregnancy 
280446 Septic embolism following abortive 
pregnancy 
280447 Readmission for retained produc of 
concept, legal abortion 
280448 Acute liver necrosis following abortive 
pregnancy 
280449 Cerebral anoxia following abortive 
pregnancy 
280450 Complication NOS following 
abortion/ectopic/molar pregnancy 
280451 Pregnancy with abortive outcome NOS 
280452 Threatened abortion 
280453 Early pregnancy haemorrhage NOS - 
delivered 
280454 Antepartum haemorrhage with 
coagulation defect - not deliv 
280455 Antepartum haemorrhage with trauma 
280456 Antepartum haemorrhage with uterine 
leiomyoma - not deliv 
280457 Other antepartum haemorrhage 
unspecified 
280458 Mild or unspecified pre-eclampsia - 
delivered 
280459 Mild or unspecified pre-eclampsia - 
delivered with p/n comp 
280460 Severe pre-eclampsia with postnatal 
complication 
280461 Eclampsia - delivered 
280462 Pre-eclampsia or eclampsia with 
hypertension - not delivered 
280463 Pre-exist hypertension compl preg 
childbirth and puerperium 
280464 Pre-exist hyperten heart dis compl preg 
childbth+puerperium 
280465 Unspecified hypertension in 
preg/childb/puerp NOS 
280466 Other pregnancy vomiting - delivered 
280467 Threatened premature labour - not 
delivered 
280468 Early onset of delivery - delivered 
280469 Early or threatened labour NOS 
280470 Unspecified renal disease in pregnancy 
- not delivered 
280471 Unspecified renal disease in pregnancy 
NOS 
280472 Pregnancy care of habitual aborter 
280473 Genitourinary tract infections in 
pregnancy 
280474 Genitourinary tract infection in 
pregnancy - not delivered 
280475 Other pregnancy complication - 
delivered with postnatal comp 
280476 Other pregnancy complication NOS 
280477 Maternal gonorrhoea in pregnancy - 
baby not yet delivered 
280478 Maternal tuberculosis during pregnancy 
- baby delivered 
280479 Other maternal viral disease, unspec in 
pregnancy/puerperium 
280480 Other mat.infective/parasitic dis in 
preg/childb/puerp NOS 
280481 Diabetes mellitus arising in pregnancy 
280482 Pre-existing diabetes mellitus, 
unspecified 
280483 Drug dependence during 
pregnancy/childbirth/puerperium NOS 
280484 Mental disorder during pregnancy - 
baby delivered 
280485 Congenital cardiovasc dis in pregnancy 
- baby not delivered 
280486 Orthopaedic disorders in 
pregnancy/childbirth/puerperium 
280487 Abnormal GTT in puerperium - baby 
previously delivered 
280488 Medical condition NOS - unsp whether 
in pregnancy/puerperium 
280489 Sublux of symphysis pubis in preg 
childbirth and puerp 
280490 Normal delivery in completely normal 
case NOS 
280491 Twin pregnancy 
280492 Triplet pregnancy NOS 
280493 Assisted breech delivery 
280494 Breech presentation - delivered 
280495 Oblique presentation 
280496 Oblique lie unspecified 
280497 Shoulder presentation 
280498 Face presentation NOS 
280499 Brow presentation unspecified 
280500 High head at term 
280501 High head at term unspecified 
280502 Multiple pregnancy with 
malpresentation NOS 
280503 Prolapsed arm presentation 
280504 Prolapsed arm with antenatal problem 
280505 Disproportion - major pelvic abnormality 
- delivered 
280506 Disproportion - major pelvic abnormality 
NOS 
280507 Large fetus causing disproportion 
unspecified 
280508 Hydrocephalic disproportion with 
antenatal problem 
280509 Bicornuate uterus in pregnancy, 
childbirth and puerperium 
280510 Congenital abnormality of uterus 
affecting obstetric care 
280511 Bicornuate uterus complicating a/n 
care, baby not delivered 
280512 Uterine fibroid - baby delivered 
280513 Uterine body tumour in 
pregnancy/childbirth/puerperium NOS 
280514 Rectocele in pregnancy, childbirth and 
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the puerperium 
280515 Other uterine/pelvic floor abnormal 
affecting obstetric care 
280516 Cervical incompetence - delivered 
280517 Cervical incompetence - delivered with 
postnatal comp 
280518 Cervical incompetence NOS 
280519 Stenosis of cervix in pregnancy, 
childbirth, puerperium 
280520 Stenosis of cervix complicating a/n 
care- baby not delivered 
280521 Persistent hymen - baby delivered 
280522 Persistent hymen - baby 
delivered+postpartum complication 
280523 Pelvic soft tissue abnormality in 
preg/childb/puerp NOS 
280524 Fetus with central nervous system 
malformation unspecified 
280525 Fetus with chromosomal abnormality 
280526 Fetus with chromosomal abnormality 
with antenatal problem 
280527 Fetus with damage due to other 
maternal disease 
280528 Fetus with radiation damage 
unspecified 
280529 Fetus with damage NOS with antenatal 
problem 
280530 Rhesus isoimmunisation unspecified 
280531 Other blood-group isoimmunisation - 
delivered 
280532 Other placental conditions - delivered 
280533 Other feto-placental problems 
unspecified 
280534 Amnionitis 
280535 Other problems affecting labour 
280536 Problems affecting labour NOS - 
delivered 
280537 Retained intrauterine contraceptive 
device in pregnancy 
280538 Complications occurring during labour 
and delivery 
280539 Obstructed labour 
280540 Shoulder dystocia with antenatal 
problem 
280541 Locked twins - delivered 
280542 Other causes of obstructed labour 
unspecified 
280543 Obstructed labour NOS 
280544 Atony of uterus 
280545 Poor contractions 
280546 Hypertonic uterine inertia unspecified 
280547 Unspecified prolonged labour - 
delivered 
280548 Delayed delivery second twin - 
delivered 
280549 Presentation of cord 
280550 Prolapse of cord with antenatal problem 
280551 Cord tangled with compression - 
delivered 
280552 Other cord entanglement - delivered 
280553 Bruising of cord 
280554 Umbilical cord complications NOS 
280555 Perineal tear 
280556 First degree perineal tear during 
delivery 
280557 Fourchette tear during delivery 
280558 Second degree perineal tear during 
delivery with p/n prob 
280559 Third degree perineal tear during 
delivery 
280560 Fourth degree perineal tear during 
delivery NOS 
280561 Unspecified perineal laceration during 
delivery + p/n prob 
280562 Vulval and perineal haematoma during 
delivery + p/n problem 
280563 Other vulval/perineal trauma during 
delivery, unspecified 
280564 Other vulval/perineal trauma during 
delivery + p/n problem 
280565 Vulval/perineal trauma during delivery 
NOS unspec 
280566 Other obstetric pelvic organ damage - 
delivered 
280567 Obstetric pelvic haematoma with 
postnatal problem 
280568 Postpartum coagulation defects with 
postnatal problem 
280569 Obstetric anaesthesia with cardiac 
comp - deliv + p/n prob 
280570 Obstetric anaesthesia with cardiac 
complications NOS 
280571 Spinal+epidural anaesthesia-inducd 
headache during pregnancy 
280572 Other complications of obstetric 
anaesthesia NOS 
280573 Obstetric anaesthetic complications 
NOS, unspecified 
280574 Mid-cavity forceps with rotation 
280575 Vacuum extractor delivery - delivered 
280576 Breech extraction - delivered 
280577 Caesarean section - pregnancy at term 
280578 Destructive operation for delivery 
280579 Puerperal endometritis NOS 
280580 Puerperal salpingitis 
280581 Varicose veins of legs in the 
puerperium 
280582 VV's of perineum/vulva in 
pregnancy/puerperium + p/n comp 
280583 Superficial thrombophlebitis in 
pregnancy/puerperium unsp 
280584 Antenatal deep vein thrombosis 
unspecified 
280585 Antenatal deep vein thrombosis - 
delivered 
280586 Other phlebitis/thrombosis in pregnancy 
and puerperium NOS 
280587 Haemorrhoids in pregnancy and the 
puerperium 
280588 Cerebral venous thrombosis in 
pregnancy 
280589 Other venous comp of 
pregnancy/puerperium + p/n comp 
280590 Obstetric air pulmonary embolism - 
delivered 
280591 Septic obstetric embolism 
280592 Obstetric pulmonary embolism NOS 
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280593 Puerperal cerebrovascular disorder with 
postnatal comp 
280594 Obstetric perineal wound disruption with 
p/n complication 
280595 Abscess of nipple - obstetric 
280596 Obstetric nipple infection unspecified 
280597 Obstetric nonpurulent mastitis 
280598 Other obstetric breast infection 
unspecified 
280599 Obstetric breast infection NOS with 
antenatal complication 
280600 Other breast disorder in 
pregnancy/puerperium/lact +p/n comp 
280601 Galactorrhoea in pregnancy/puerperium 
- deliv with p/n comp 
280602 Complications of pregnancy,childbirth 
or the puerperium OS 
280603 [X]Pregnancy with abortive outcome 
280604 [X]Other specified pregnancy-related 
conditions 
280605 [X]Other placental disorders 
280606 [X]Other uterine inertia 
280607 [X]Other infection during labour 
280608 [X]Other specified complications of 
labour and delivery 
280609 [X]Multiple delivery, unspecified 
280610 [X]Vaginitis following delivery 
281253 Fetus or neonate affected by maternal 
nutritional disorder 
281254 Fetus/neonate affected - 
placental/breast transfer toxic NEC 
281255 Fetus or neonate affected by multiple 
pregnancy NOS 
281256 Fetus/neonate affected by breech 
presentation before labour 
281257 Fetus/neonate affected by complic of 
placenta/cord/membrane 
281258 Fetus affected by APH - antepartum 
haemorrhage 
281259 Fetus or neonate affected by placental 
damage OS 
281260 Fetus or neonate affected by 
entanglement of cord 
281261 Fetus or neonate affected by cord 
compression NOS 
281262 Fetus/neonate affected-cephalopelvic 
disproportion lab./del. 
281263 Fetus or neonate affected by forceps 
delivery 
281264 Fetus/neonate affected by mat epidural 
anaesth - labour/del 
281265 Fetus or neonate affected by uterine 
inertia 
281266 Fetus small-for-dates (SFD), without 
mention of malnutrition 
281267 Cerebral haematoma in fetus or 
newborn 
281268 Subdural or cerebral haemorrhage due 
to birth trauma OS 
281269 Sampling injury to scalp during birth 
281270 Birth paralysis of phrenic nerve 
281271 Vulval haematoma due to birth trauma 
281272 Subconjunctival haemorrhage due to 
birth trauma 
281273 Liveborn with fetal distress, unspecified 
281274 Liveborn with abnormal heart beat, 
unspecified 
281275 Liveborn with fetal hypoxia, unspecified 
281276 Birth asphyxia 
281277 Congenital pneumonia due to 
Escherichia coli 
281278 Aspiration of vomit in newborn 
281279 Perinatal interstitial emphysema or 
related condition OS 
281280 Perinatal pulmonary haemorrhage 
281281 Perinatal secondary atelectasis 
281282 Wilson-Mikity syndrome 
281283 Extended rubella syndrome 
281284 Other congenital infections 
281285 Congenital herpes simplex 
281286 Omphalitis of the newborn 
281287 Infectious granuloma 
281288 Omphalitis 
281289 Other specified umbilical sepsis 
281290 Neonatal dacryocystitis and 
conjunctivitis 
281291 Neonatal candidiasis of intestine 
281292 Intra-amniotic fetal infection 
281293 Intrauterine fetal sepsis, unspecified 
281294 Fetal blood loss 
281295 Fetal blood loss, unspecified 
281296 Fetal exsanguination 
281297 Other specified fetal blood loss 
281298 Perinatal gastrointestinal haemorrhage 
281299 Perinatal rectal haemorrhage 
281300 Perinatal cutaneous haemorrhage, 
unspecified 
281301 Perinatal superficial haematoma 
281302 Perinatal cutaneous haemorrhage NOS 
281303 Neonatal melaena 
281304 Kernicterus due to isoimmunisation 
281305 Perinatal jaundice from hereditary 
haemolytic anaemias 
281306 Perinatal jaundice from infection 
281307 Perinatal jaundice from swallowed 
maternal blood 
281308 Perinatal jaundice from haemolysis 
NOS 
281309 Delayed conjugation causing neonatal 
jaundice NOS 
281310 Perinatal jaundice due to congenital 
obstruction bile duct 
281311 Transient neonatal hyperbilirubinaemia 
281312 Haemorrhagic disease of the newborn 
281313 Transient neonatal thrombocytopenia 
due to isoimmunisation 
281314 Neonatal thrombocytopenia due to 
platelet alloimmunisation 
281315 Transient neonatal thrombocytopenia 
NOS 
281316 Polycythaemia due to maternal fetal 
transfusion 
281317 Other meconium obstruction 
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281318 Intestinal obstruction of newborn, 
unspecified 
281319 Neonatal peritonitis NOS 
281320 Scleroderma in newborn 
281321 Newborn cold injury syndrome 
281322 Patent processus vaginalis 
281323 Neonatal erythema toxicum 
281324 Other specified perinatal skin disorder 
281325 Newborn cerebral irritability, unspecified 
281326 Newborn feeding problem NOS 
281327 Congenital hypertonia 
281328 Other perinatal condition NOS 
281329 Congenital hepatic fibrosis 
281330 Neonatal hypertension 
281331 Neonatal death 
281332 [X]Other "heavy for gestational age" 
infants 
281333 [X]Other specified respiratory conditions 
of newborn 
281334 [X]Sepsis/newborn due to 
other+unspecified staphylococcus 
281335 [X]Oth 
intracranial(nontraumatic)haemorrhage
s/fetus+newborn 
281336 [X]Other transitory neonatal 
disorders/thyroid function,NEC 
281337 [X]Transitory metabolic disturbance of 
newborn, unspecified 
281338 [X]Digestive system disorders of fetus 
and newborn 
281339 [X]Intestinal obstruction of newborn, 
unspecified 
281340 [X]Conditions involv integument & temp 
reg of fetus/newborn 
282016 Battered baby syndrome NOS 
283103 [V]First normal pregnancy supervision 
283105 [V]Other specified high-risk pregnancy 
283113 [V]Outcome of delivery 
283114 [V]Twins, one live born and one stillborn 
283116 [V]Level of neonatal care 
283117 [V]Newborn receiving intensive care 
283118 [V]Neonatal care on ITU 
283119 [V]Neonatal care on NNU 
283122 [V]Twin, born before admission to 
hospital, mate stillborn 
283125 [V]Other multiple birth, born in hospital, 
mates stillborn 
283126 [V]Other multiple birth, mates live and 
stillborn NOS 
283127 [V]Other multiple birth, unspecified, not 
hospitalised 
283128 [V]Unspecified birth, born in hospital 
283143 [V]Problems related to unwanted 
pregnancy 
283206 [X]Oth multip liveborn infants, unspec 
as to place of birth 
283260 Antenatal operation 
283261 Induction labour 
283262 Episiotomy 
283263 Delivery caesarian section (mother) 
283264 Evacuation retained products 
conception 
283265 Repair lacerated cervix obstetric 
283266 Repair vagina/pelvic floor postpartum 
283361 Pregnancy test 
283362 Human placental lactogen level normal 
283455 Pregnancy unplanned 
283538 Death father child born after 
283633 Screening baby normal 
283679 Pregnant 
283680 Pregnancy antenatal care normal 
283681 Normal pregnancy prenatal care 
throughou 
283682 Foetal movements felt 
283683 Bottle fed baby 
283684 Examination newborn well baby 
283838 Insufficiency dietary baby 
283839 Malnutrition baby 
283874 Heinz-body anaemia of newborn 
284333 Pregnancy pelvis bony abnormal 
284337 Pregnancy induction labour failed 
284338 Leaking amniotic fluid 
284339 False uterine contractions 
284340 Thrombosis pregnancy 
284341 Varix complicating pregnancy 
284342 Pyelocystitis puerperium 
284343 Vomiting pernicious pregnancy 
284344 Induced abortion social reasons 
284346 Pregnancy uncomplicated delivery 
284348 Puerperal anaemia due blood loss 
284349 Obstructed labour 
284350 Laceration perineal at delivery third de 
284352 Labour premature with complications 
284353 Delivery prolapsed cord (mother) 
284355 Puerperal coagulopathy 
284357 Mastitis lactating 
284358 Lactating engorgement breast 
284539 Anuria newborn 
284575 Apnea at birth 
284576 Immaturity at birth 
284578 Neonatal period normal 
284579 Precipitous birth (baby) 
284580 Weak newborn 
285051 Registrar-birth/death/marriage 
285148 Builder's labourer 
285159 Other labourers/general hands 
285160 Other labourer NOS 
285232 Wife pregnant 
285294 H/O: 2 abortions 
285481 O/E - abd.mass still with resp 
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285773 Serum pregnancy test NOS 
286053 U-S obstetric scan abnormal 
286077 Breast feeding problem 
286084 Maternity care 
286085 A/N care: recurrent aborter 
286086 A/N care: multip. > 35 years 
286087 A/N risk NOS 
286088 A/N care provider NOS 
286089 Short stay delivery booking 
286090 Delivery booking - stay NOS 
286091 Intends to bottle feed 
286092 A/N U/S scan wanted 
286093 Antenatal ultrasound scan at 17-22 
weeks 
286094 Antenatal ultrasound scan NOS 
286095 A/N 12 weeks examination 
286096 A/N 24 week examination 
286097 A/N 30 week examination 
286098 Fetal movements seen 
286099 Breast fed 
286100 Breast feeding started 
286101 Breast feeding stopped 
286102 P/N care from consultant 
286103 No post natal care 
286104 Postnatal care 
286105 P/N - first day visit 
286106 P/N - fifth day visit 
286107 Maternal P/N exam. Not offered 
286108 Full term gestation - 40 weeks 
286109 GP unit birth 
286110 Place of birth NOS 
286111 1st stage of labour length 
286112 Livebirth 
286113 Stillbirth [prevention record] 
286114 Twins - both still born 
286115 Triplets - 3 still born 
286116 Delivery - sex of baby 
286117 Baby male 
286118 Baby premature 24-26 weeks 
286119 Apgar at 1 minute = 1 
286120 Apgar at 5 minutes = 4 
286121 Apgar at 5 minutes = 7 
286122 Apgar at 5 minutes = 9 
286123 Apgar at 10 minutes = 2 
286124 Apgar at 10 minutes = 3 
286125 Apgar at 10 minutes = 7 
286126 One of twins 
286127 Placental infarct 
286128 Placental details NOS 
286246 Diet in pregnancy advice 
286963 Dilation cerv & curettage RPC 
286964 Curette of retained products of 
conception from uterus NEC 
286970 Introduction of gamete into uterine 
cavity NOS 
286971 Intraamniotic injection of abortifacient 
NEC 
286976 Manual manipulation of non pregnant 
uterus 
286981 Removal of products of conception from 
fallopian tube 
286994 Pregnancy operations 
286995 Diagnostic endoscopic examination of 
foetus using fetoscope 
286996 Fetoscopy NEC 
286997 Early selective feticide 
286998 Percutaneous insertion of fetal 
pleuroamniotic shunt 
286999 Drainage of amniotic cavity 
287000 Removal of cerclage from cervix of 
gravid uterus 
287001 Induction and delivery operations 
287002 Elective lower uterine segment 
caesarean section (LSCS) 
287003 Other specified other caesarean 
delivery 
287004 Other caesarean delivery NOS 
287005 Assisted breech delivery 
287006 Forceps cephalic delivery 
287007 Mid forceps cephalic delivery NEC 
287008 Dehee forceps cephalic delivery with 
rotation 
287009 Incision of cervix to facilitate delivery 
287010 Other specified other operation to 
facilitate delivery 
287011 Pack to control postnatal vaginal 
bleeding 
287012 Immed repair obstetric laceration of 
uterus or cervix uteri 
287013 Immediate repair of minor obstetric 
laceration 
287649 Abandoned baby care 
287704 Patient requested epidural 
287785 RM10-DHSS DMO report received 
287804 To prevent grave permnt inj 
physic/mental health preg woman 
287823 Seen in baby clinic 
287833 Seen in postnatal clinic 
288647 Phantom pregnancy 
288962 Stilling-Turck-Duane syndrome 
289051 Acute aseptic myocarditis of the 
newborn 
289542 Gravid fallopian tube rupture 
289543 Cornual pregnancy 
289544 Incomplete spontaneous abortion with 
renal failure 
289545 Complete spontaneous abortion with 
metabolic disorder 
289546 Incomp inev mis complicated by genital 
tract pelvic infect 
289547 Incomplete inevitable abortion with 
unspecified complication 
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289548 Complete inevitable abortion 
complicated by embolism 
289549 Complete inevitable abortion without 
complication 
289550 Unspecified legal abortion with 
embolism 
289551 Unspecified legal abortion NOS 
289552 Unspecified illegal abortion + other 
specified complication 
289553 Complete illegal abortion + delayed or 
excessive haemorrhage 
289554 Complete illegal abortion + pelvic 
organ/tissue damage 
289555 Illegally induced abortion NOS 
289556 Unspecified abortion with shock 
289557 Unspecified incomplete abortion with 
metabolic disorder 
289558 Unspecified incomplete abortion with 
shock 
289559 Unspecified incomplete abortion with 
complication NOS 
289560 Unspecified complete abortion with 
shock 
289561 Unspecified complete abortion with 
complication NOS 
289562 Failed attempted abortion + delayed or 
excessive haemorrhage 
289563 Intravascular haemolysis following 
abortive pregnancy 
289564 Embolus following abortive pregnancy 
289565 Pulmonary embolism following abortive 
pregnancy 
289566 Threatened abortion unspecified 
289567 Other haemorrhage in early pregnancy 
NOS 
289568 Antepartum haemorrhage with 
coagulation defect 
289569 Antepartum haemorrhage with 
afibrinogenaemia 
289570 Benign essential hypertension in 
preg/childb/puerp - deliv 
289571 Other pre-existing hypertension in 
preg/childb/puerp NOS 
289572 Transient hypertension of pregnancy + 
postnatal complication 
289573 Mild pre-eclampsia 
289574 Mild or unspecified pre-eclampsia with 
p/n complication 
289575 Mild pre-eclampsia 
289576 Severe pre-eclampsia - not delivered 
289577 HELLP - Syndrome haemolysis, elev 
liver enzyme low platelets 
289578 Proteinuric hypertension of pregnancy 
289579 Unspecified hypertension in 
pregnancy/childbirth/puerperium 
289580 Hyperemesis gravidarum with metabolic 
disturbance - deliv 
289581 Late pregnancy vomiting NOS 
289582 Unspecified pregnancy vomiting 
unspecified 
289583 Unspecified pregnancy vomiting - 
delivered 
289584 False labour at or after 37 completed 
weeks of gestation 
289585 Gestational oedema 
289586 Oedema or excessive weight gain in 
pregnancy NOS 
289587 Habitual aborter 
289588 Peripheral neuritis in pregnancy NOS 
289589 Asymptomatic bacteriuria in pregnancy 
- delivered 
289590 Genitourinary tract infection in 
pregnancy unspecified 
289591 Infections of kidney in pregnancy 
289592 Urinary tract infection following delivery 
289593 Liver disorder in pregnancy NOS 
289594 Fatigue during pregnancy - delivered 
with postnatal comp 
289595 Fatigue during pregnancy - not 
delivered 
289596 Fatigue during pregnancy NOS 
289597 Herpes gestationis - not delivered 
289598 Herpes gestationis NOS 
289599 Other pregnancy complication - 
delivered 
289600 Maternal syphilis in 
pregnancy/childbirth/puerperium 
289601 Other maternal venereal disease during 
pregnancy- baby deliv 
289602 Maternal tuberculosis in puerperium - 
baby previously deliv. 
289603 Maternal malaria, unspec whether 
during pregnancy/puerperium 
289604 Other maternal viral disease in 
pregnancy - baby delivered 
289605 Infections of urethra in pregnancy 
289606 Maternal infect/parasitic dis NOS in 
pregnancy/childb/puerp 
289607 Diabetes mellitus during pregnancy - 
baby not yet delivered 
289608 Pre-existing malnutrition-related 
diabetes mellitus 
289609 Gestational diabetes mellitus 
289610 Anaemia - unspecified whether in 
pregnancy or the puerperium 
289611 Anaemia during pregnancy - baby not 
yet delivered 
289612 Orthopaedic disorder in puerperium - 
baby delivered 
289613 Medical condition NOS in puerperium - 
baby previously deliv 
289614 Complications of 
pregnancy/childbirth/puerperium OS 
289615 Quadruplet pregnancy 
289616 Multiple delivery 
289617 Breech presentation 
289618 Transverse presentation 
289619 Face presentation - delivered 
289620 Brow presentation NOS 
289621 Other fetal malposition and 
malpresentation - delivered 
289622 Inlet pelvic contraction with antenatal 
problem 
289623 Inlet pelvic contraction NOS 
289624 Large fetus causing disproportion with 
antenatal problem 
289625 Disproportion NOS with antenatal 
problem 
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289626 Congenital abnormality of uterus in 
preg/childbirth/puerp 
289627 Bicornuate uterus - baby delivered + 
postpartum complication 
289628 Congenital abnormality uterus in 
pregnancy/childb/puerp NOS 
289629 Retroverted incarcerated gravid uterus 
unspecified 
289630 Retroverted incarcerated gravid uterus 
with antenatal prob 
289631 Pendulous abdomen in 
pregnancy,childbirth and the 
puerperium 
289632 Cystocele - baby delivered 
289633 Cystocele complicating postpartum care 
- baby delivered prev 
289634 Cervical incompetence 
289635 Polyp of cervix complicating p/n care - 
baby deliv prev 
289636 Vaginal abnormality - baby delivered 
289637 Persistent hymen in pregnancy, 
childbirth and the puerperium 
289638 Vulval abnormality - baby 
delivered+postpartum complication 
289639 Rigid perineum - baby delivered with 
postpartum complication 
289640 Maternal care for chromosomal 
abnormality in fetus 
289641 Fetus with hereditary disease - 
delivered 
289642 Suspect fetal damage from maternal 
alcohol 
289643 Fetus with drug damage with antenatal 
problem 
289644 Fetus with drug damage NOS 
289645 Other blood-group isoimmunisation 
NOS 
289646 Lab+del comp fetal ht rate anom wth 
meconium in amnio fluid 
289647 Intrauterine death - delivered 
289648 Placental insufficiency 
289649 Other placental conditions 
289650 Other placental conditions with 
antenatal problem 
289651 Placental transfusion syndromes 
289652 Placenta gritty 
289653 Other feto-placental problems with 
antenatal problem 
289654 Premature rupture of membranes 
289655 Membranitis 
289656 Failed medical or unspecified induction 
unspecified 
289657 Failed medical or unspecified induction 
- delivered 
289658 Maternal pyrexia during labour, 
unspecified 
289659 Septicaemia during labour NOS 
289660 Grand multiparity NOS 
289661 Abnormal biochemical finding on 
antenatal screen of mother 
289662 Obstructed labour due to compound 
presentation 
289663 Obstructed labour caused by pelvic soft 
tissues - delivered 
289664 Deep transverse arrest - delivered 
289665 Persistent occipitoposterior or 
occipitoanterior position 
289666 Other failed forceps with antenatal 
problem 
289667 Other failed ventouse extraction - 
delivered 
289668 Obstructed labour NOS 
289669 Abnormal forces of labour 
289670 Secondary uterine inertia 
289671 Other uterine inertia 
289672 Other uterine inertia NOS 
289673 Long labour 
289674 Delayed delivery of second twin, triplet 
etc 
289675 Other cord entanglement with antenatal 
problem 
289676 Vasa praevia with antenatal problem 
289677 Umbilical cord complications NOS 
289678 Pelvic floor tear 
289679 Second degree perineal tear during 
delivery, unspecified 
289680 Unspecified perineal laceration during 
delivery, unspecified 
289681 Other vulval/perineal trauma during 
delivery NOS 
289682 Rupture of uterus during and after 
labour 
289683 Bladder injury - obstetric 
289684 Fibrinolysis - postpartum 
289685 Postpartum coagulation defects - 
delivered with p/n problem 
289686 Postpartum haemorrhage NOS 
289687 Retained placenta with no haemorrhage 
289688 Obstetric anaesthesia with CNS 
complication NOS 
289689 Toxic reaction to local anaesthesia 
during the puerperium 
289690 Other complications of obstetric 
anaesthesia unspecified 
289691 Other complications of obstetric 
anaesthesia + a/n problem 
289692 Other complications of obstetric 
procedures - del +p/n prob 
289693 Forceps delivery 
289694 Delivery by caesarean hysterectomy 
289695 Complications of labour and delivery 
NOS - delivered 
289696 Puerperal peritonitis with postnatal 
complication 
289697 Genital varices in pregnancy 
289698 Varicose veins of perineum/vulva in 
pregnancy/puerperium NOS 
289699 Superficial thrombophlebitis in 
preg/puerperium + a/n comp 
289700 Superficial thrombophlebitis in 
preg/puerperium + p/n comp 
289701 Thrombophlebitis of legs in pregnancy 
289702 Other phlebitis and thrombosis in 
pregnancy and puerperium 
289703 Other phlebitis/thrombosis in 
preg/puerperium + p/n comp 
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289704 Other venous comp of 
pregnancy/puerperium + a/n comp 
289705 Obstetric air pulmonary embolism with 
p/n complication 
289706 Obstetric blood-clot pulmonary 
embolism NOS 
289707 Pyaemic obstetric embolism 
289708 Obstetric pyaemic and septic 
pulmonary embolism unspecified 
289709 Obstetric pyaemic and septic pulm 
embolism + a/n comp 
289710 Other obstetric pulmonary embolism - 
delivered 
289711 Obstetric pulmonary embolism NOS 
289712 Other complication of obstetric surgical 
wound 
289713 Haematoma - perineal wound 
289714 Infection - perineal wound 
289715 Placental polyp 
289716 Other complications of the puerperium 
289717 Other complications of the puerperium 
unspecified 
289718 Purulent mastitis - obstetric 
289719 Retracted nipple in 
pregnancy/puerperium/lact with a/n 
comp 
289720 Cracked nipple in 
pregnancy/puerperium/lactation 
unspecified 
289721 Cracked nipple in 
pregnancy/puerperium/lactation - 
delivered 
289722 Breast engorgement 
289723 Failure of lactation unspecified 
289724 Suppressed lactation - delivered 
289725 Suppressed lactation - delivered with 
postnatal complication 
289726 [X]Oth+unspcf failed inducd 
abort,complct gen tract+pelv inf 
289727 [X]Maternal care for other abnormalities 
of pelvic organs 
289728 [X]Other premature separation of 
placenta 
289729 [X]Obstructed labour due to other 
abnormalities of fetus 
289730 [X]Other obstetric injury to pelvic organs 
289731 [X]Obstructed labour due to fetopelv 
disproportion, unspec 
289732 [X]Assisted single delivery, unspecified 
290406 Perinatal conditions 
290407 Fetus or neonate affected by maternal 
surgical operation 
290408 Fetus/neonate affected-plac./breast 
transfer endocrine agent 
290409 Fetus or neonate affected by other 
maternal condition 
290410 Fetus or neonate affected by ectopic 
pregnancy 
290411 Fetus or neonate affected by ectopic 
pregnancy NOS 
290412 Fetus or neonate affected by unstable 
lie before labour 
290413 Fetus/neonate affected by maternal 
complic pregnancy NOS 
290414 Fetus or neonate affected by placenta 
previa 
290415 Fetus/neonate affect other placental 
separation/haemorrhage 
290416 Fetus/neonate affected by placental 
damage-caesarian section 
290417 Fetus or neonate affected by placental 
infarction 
290418 Fetus/neonate affected by feto-fetal 
transplacental transfus 
290419 Fetus or neonate affected by 
chorioamnionitis 
290420 Fetus or neonate affected by placentitis 
unspecified 
290421 Fetus or neonate affected by 
complication of labour/delivery 
290422 Fetus or neonate affected by induction 
of labour 
290423 Fetus small-for-dates, without mention 
of malnutrition 
290424 Fetal malnutrition without mention of 
"light for dates" 
290425 Light for gestational age 
290426 Brain injury due to birth trauma NOS 
290427 Cerebral injury due to birth trauma 
290428 Cerebral haemorrhage due to birth 
injury 
290429 Monitoring injury to scalp during birth 
290430 Spine or spinal cord injury due to birth 
trauma NOS 
290431 Facial nerve palsy due to birth trauma 
290432 Peripheral nerve injury due to birth 
trauma 
290433 Other specified birth trauma NOS 
290434 Kidney injury due to birth trauma 
290435 Birth trauma, asphyxia or hypoxia NOS 
290436 Congenital pneumonia due to group A 
haemolytic streptococcus 
290437 Newborn transitory tachypnoea 
290438 Infections specific to perinatal period 
290439 Congenital listeriosis 
290440 Congenital toxoplasmosis 
290441 Lymphadenopathy due to congenital 
toxoplasmosis 
290442 Other congenital infection NOS 
290443 Tetanus omphalitis 
290444 Tetanus neonatorum NOS 
290445 Ophthalmia neonatorum, unspecified 
290446 Neonatal dacryocystitis or conjunctivitis 
due to chlamydiae 
290447 Neonatal conjunctivitis due to 
chlamydiae 
290448 Neonatal dacryocystitis/conjunctivitis-
other inclusion body 
290449 Neonatal haemorrhage 
290450 Fetal blood loss from ruptured cord 
290451 Massive umbilical haemorrhage 
290452 Neonatal vaginal haemorrhage 
290453 Other specified perinatal cutaneous 
haemorrhage 
290454 Haemolytic disease of fetus/newborn 
due isoimmunisation NOS 
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290455 Neonatal jaundice + glucose-6-
phosphate dehydrogenase defic. 
290456 Neonatal jaundice from breast milk 
inhibitor 
290457 Perinatal jaundice due to hepatocellular 
damage 
290458 Perinatal hepatitis causing jaundice, 
unspecified 
290459 Giant cell hepatitis causing neonatal 
jaundice 
290460 Other transitory neonatal electrolyte 
disturbance 
290461 Disturbances of potassium balance of 
newborn 
290462 Neonatal hypoglycaemia 
290463 Neonatal goitre, not elsewhere 
classified 
290464 Vitamin K deficiency of the newborn 
290465 Newborn disseminated intravascular 
coagulation 
290466 Polycythaemia neonatorum 
290467 Congenital anaemia 
290468 Maternal transfer neutropenia 
290469 Transient neonatal neutropenia NOS 
290470 Meconium ileus 
290471 Other hypothermia of newborn 
290472 Floppy baby 
290473 Infant death 
290474 [X]Fetus/newborn affected by maternal 
factors+complications 
290475 [X]Fetus+newborn affected/oth 
maternal circul+resp diseases 
290476 [X]Fet+newbrn affct/oth+unspcf 
morphlogc+functl abnml/plcnta 
290477 [X]Other birth injuries to skull 
290478 [X]Other brachial plexus birth injuries 
290479 [X]Oth cardiovascular disorders 
originating/perinatal period 
290480 [X]Hydrops fetalis due to other+unspcfd 
haemolytic disease 
290481 [X]Other congenital anaemias, not 
elsewhere classified 
290482 [X]Other hypothermia of newborn 
290483 [X]Other and unspecif oedema specific 
to fetus and newborn 
290484 [X]Other disorders originating in the 
perinatal period 
290485 [X]Oth specified disturbances of 
cerebral status of newborn 
291185 Battered baby or child syndrome NOS 
292229 [V]Supervision of normal pregnancy 
292230 [V]Pregnancy with history of vesicular 
mole 
292231 [V]Pregnancy with other poor 
reproductive history 
292232 [V]Unspecified high-risk pregnancy 
292238 [V]Neonatal care in SCBU 
292240 [V]Other multiple birth, not hospitalised, 
mates live born 
292241 [V]Unspecified birth, NOS 
292281 [V]Other unwanted pregnancy 
292376 Termination pregnancy intra-amniotic 
inj 
292377 Forceps extraction high with episiotomy 
292378 Forceps delivery (mother) 
292379 Keillands delivery (mother) 
292380 Episiotomy repair 
292381 Forceps failed 
292383 Suture obstetric laceration uterus 
292488 Luteinization hormone level 
292542 Seen in antenatal clinic 
292577 Contraception cap failure 
292592 Trying to conceive 
292681 Advice given on abortion 
292753 Pre-conception counselling clinic 
292758 Screening baby examination normal 
292808 Prenatal care regularly attended 
292809 Breasts self examination 
292978 Underweight baby due feeding problem 
292996 Newborn infant anaemia 
posthaemorrhagic 
293028 Pregnancy phantom 
293337 Hepatitis neonatal 
293427 Placenta praevia partial 
293429 Concealed pregnancy 
293430 Products of conception passed 
293431 Obstetric history bad 
293432 Multipara 
293434 Toxaemia pre-eclamptic 
293436 Pregnancy bp raised at end of 
293437 Pregnancy nausea & vomiting 
293439 Abortion induced social reasons 
unmarrie 
293440 Spontaneous abortion 
293441 Premature labour dead foetus under 28 
we 
293443 Premature labour 
293444 Malposition foetus complicating delivery 
293446 Twin pregnancy delivery 
293452 Puerperal mastitis 
293453 Postpartum caked breast 
293456 Suppression lactation 
293542 Still's disease 
293627 Blue baby 
293698 Paralysis klumpke(- dejerine) 
293699 Haemolytic disease newborn with 
kernicte 
293700 Abnormal erythrocytes newborn 
293701 Anaemia newborn 
293702 Postmature (baby) 
293704 Pneumonia newborn aspiration 
293706 Neonatal hypotonia 
293768 Jaundice 
293769 Jaundice fading 
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294125 Midwife 
294344 Babysitting service 
294349 Illegitimate pregnancy 
294371 Sudden infant death 
294417 H/O: perinatal convulsion 
294443 H/O: long labour 
295236 U-S obstetric scan requested 
295237 Placenta U-S scan 
295262 IUD failure - pregnant 
295264 Pregnant, sheath failure 
295271 Pregnant - urine test confirms 
295272 Pregnancy unplanned ? Wanted 
295273 Antenatal care: 2nd pregnancy 
295274 A/N care: H/O perinatal death 
295275 A/N care: poor obstetr history 
295276 A/N care: elderly primip. 
295277 A/N care: poor home conditions 
295278 A/N care: late booker 
295279 A/N care: H/O child abuse 
295280 A/N care: under 5ft tall 
295281 A/N care provider 
295282 Parent craft class attended 
295283 Parent craft -individual class 
295284 Feeding intention 
295285 Feeding intention - breast 
295286 A/N amniocentesis - abnormal 
295287 A/N amnio. For ? Chrom.abnorm. 
295288 Antenatal ultrasound scan 
295289 Antenatal ultrasound scan at 22-40 
weeks 
295290 A/N Rh screen offered 
295291 Rh screen - cord blood sample 
295292 Rubella screen - blood sent 
295293 A/N sickle screen not done 
295294 A/N booking examination 
295295 A/N 35 week examination 
295296 Fetal maturity - A/N 
295297 Bottle feeding started 
295298 Post natal care NOS 
295299 P/N - second day visit 
295300 Antenatal blood tests 
295301 Gestation >24 weeks 
295302 Twins - 1 still + 1 live born 
295303 Female baby 
295304 1 male + 2 female babies 
295305 Baby v. Premature 32-36 weeks 
295306 Baby BW = < 3% (under 2500g) 
295307 Apgar at 1 minute 
295308 Maternal alcohol abuse 
295309 Mother has a social worker 
295310 Fraternal twin 
295311 Identical twin 
295312 Normal birth 
295313 Apgar normal 
295398 Genetic counselling 
295401 Maternity grant advice 
295402 Ante-natal relaxation classes 
296049 Open removal of products of conception 
from uterus NEC 
296052 Dilation of cervix uteri and curettage of 
uterus NEC 
296053 Dilation of cervix and extraction 
termination of pregnancy 
296054 Evacuation of contents of uterus NOS 
296055 Introduction of abortifacient into uterine 
cavity OS 
296089 Diagnostic endoscopic examination of 
fetus using fetoscope 
296090 Other specified diagnostic 
percutaneous examination of fetus 
296091 Shirodkar suture in pregnancy 
296092 External version of breech 
296093 Elective caesarian delivery 
296094 Elective lower uterine segment 
caesarean delivery 
296095 High forceps cephalic delivery NEC 
296096 Mid forceps cephalic delivery with 
rotation 
296097 Trial of forceps delivery 
296098 Low vacuum delivery 
296099 Caesarian hysterectomy 
296100 Other operations on delivered uterus 
296101 Manual exploration of delivered uterus 
NEC 
296102 Pack to control postnatal vaginal 
bleeding 
296103 Obstetric uterine tamponade 
296104 Fetal heart monitoring NEC 
296105 Other specified obstetric monitoring 
296106 Obstetric monitoring NOS 
296839 Refer to TOP counselling 
296989 Adoption-birth history report 
297951 Constantly crying baby 
298805 Membranous pregnancy 
298806 Mesometric pregnancy 
298807 Ectopic pregnancy NOS 
298808 Unspecified spontaneous abortion with 
renal failure 
298809 Unspecified spontaneous abortion with 
metabolic disorder 
298810 Incomplete spontaneous abortion with 
embolism 
298811 Spontaneous abortion complete 
298812 Complete spontaneous abortion with 
shock 
298813 Complete spontaneous abortion with 
complication NOS 
298814 Incom inev abor complicated by 
delayed or excessive haemorr 
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298815 Incomplete inevitable abortion 
complicated by embolism 
298816 Inevitable miscarriage complete 
298817 Medal abortion - incomplete 
298818 Legal abortion complete 
298819 Self-induced abortion 
298820 Unspec illegal abortion + genital tract or 
pelvic infection 
298821 Incomplete illegal abortion + 
delayed/excessive haemorrhage 
298822 Incomplete illegal abortion with no 
mention of complication 
298823 Complete illegal abortion with embolism 
298824 Unspecified abortion with damage to 
pelvic organs or tissues 
298825 Unspecified abortion incomplete 
298826 Unspecified incomplete abortion with 
renal failure 
298827 Unspecified incomplete abortion NOS 
298828 Unspecified complete abortion with 
metabolic disorder 
298829 Unspecified complete abortion + other 
specified complication 
298830 Failed attempted abortion + genital 
tract/pelvic infection 
298831 Complications following 
abortion/ectopic/molar pregnancies 
298832 Bladder damage following abortive 
pregnancy 
298833 Oliguria following abortive pregnancy 
298834 Acute renal failure following abortive 
pregnancy 
298835 Metabolic disorder following abortive 
pregnancy 
298836 Pyaemic embolism following abortive 
pregnancy 
298837 Embolism NOS following abortive 
pregnancy 
298838 Other specified complication NOS 
follow abortive pregnancy 
298839 Failed medical abortion, without 
complication 
298840 Bleeding in early pregnancy 
298841 Early pregnancy haemorrhage NOS 
unspecified 
298842 Placenta praevia without haemorrhage - 
not delivered 
298843 Placental abruption 
298844 Antepartum haemorrhage with trauma - 
not delivered 
298845 Antepartum haemorrhage NOS - not 
deliv 
298846 Antepartum haemorrhage NOS 
298847 Transient hypertension of pregnancy - 
delivered 
298848 Transient hypertension of pregnancy - 
deliv with p/n comp 
298849 Transient hypertension of pregnancy 
NOS 
298850 Eclampsia - delivered with postnatal 
complication 
298851 Pre-eclampsia or eclampsia with 
hypertension - del+p/n comp 
298852 Pre-eclampsia or eclampsia + pre-
existing hypertension NOS 
298853 Mild hyperemesis gravidarum NOS 
298854 Hyperemesis gravidarum with metabolic 
disturbance 
298855 Premature labour 
298856 Post-term pregnancy - delivered 
298857 Post-term pregnancy NOS 
298858 Oedema/excessive weight gain in 
preg+postnatal complication 
298859 Habitual aborter - not delivered 
298860 Urinary tract infection complicating 
pregnancy 
298861 Fatigue during pregnancy with postnatal 
complication 
298862 Pregnancy pruritus 
298863 Maternal gonorrhoea in puerperium- 
baby previously delivered 
298864 Other maternal venereal disease, 
unspec pregnancy/puerperium 
298865 Maternal malaria in puerperium - baby 
previously delivered 
298866 Maternal rubella during pregnancy - 
baby not yet delivered 
298867 Other mat.infect/parasit dis in 
puerperium - baby delivered 
298868 Mat infect/parasitic dis NOS in 
preg/childbirth/puerp NOS 
298869 Pre-existing diabetes mellitus, insulin-
dependent 
298870 Thyroid dysfunction in puerperium - 
baby delivered 
298871 Thyroid dysfunction in pregnancy - baby 
not yet delivered 
298872 Anaemia during pregnancy, childbirth 
and the puerperium 
298873 Congenital cardiovascular disorder in 
preg/childb/puerp NOS 
298874 Orthopaedic disorder - unsp whether in 
pregnancy/puerperium 
298875 Abnormal GTT during pregnancy - baby 
delivered 
298876 Dis resp syst comp pregnancy, 
childbirth & puerperium 
298877 Endocrine nutrition+metab dis complic 
pregn,childbirth+puerp 
298878 Complications of 
pregnancy/childbirth/puerperium NOS 
298879 Normal delivery but ante- or post- natal 
conditions present 
298880 Gestation - multiple 
298881 Quadruplet pregnancy with antenatal 
problem 
298882 Multiple pregnancy NOS, unspecified 
298883 Cephalic version NOS, unspecified 
298884 Prolapsed arm unspecified 
298885 Other fetal malposition and 
malpresentation 
298886 Generally contracted pelvis NOS 
298887 Inlet pelvic contraction 
298888 Outlet pelvic contraction with antenatal 
problem 
298889 Large fetus causing disproportion 
298890 Pelvic soft tissue abnormality in 
pregnancy/childbirth/puerp 
298891 Uterine fibroid in 
pregnancy/childbirth/puerperium NOS 
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298892 Uterine operation scar in 
pregnancy/childbirth/puerp - deliv 
298893 Retroverted incarcerated gravid uterus 
298894 Rectocele affecting obstetric care 
298895 Other cervical abnormality in 
pregnancy/childbirth/puerp 
298896 Stenosis of vagina affecting obstetric 
care 
298897 Stenosis of vagina - baby 
delivered+postpartum complication 
298898 Vaginal abnormality complicating a/n 
care-baby not delivered 
298899 Rigid perineum complicating p/n care - 
baby delivered prev 
298900 Fetus with central nervous system 
malformation + a/n problem 
298901 Fetus with chromosomal abnormality 
NOS 
298902 Fetus with hereditary disease 
298903 Fetus with hereditary disease 
unspecified 
298904 Fetus with viral damage via mother - 
delivered 
298905 Fetus with drug damage - delivered 
298906 Fetus with radiation damage - delivered 
298907 Fetus with damage due to IUCD NOS 
298908 Fetus with other damage NEC - 
delivered 
298909 Fetus with damage NOS 
298910 Maternal care for fetal hypoxia 
298911 Fetal distress NOS 
298912 Intrauterine death NOS 
298913 Placental infarct 
298914 Prem rupture of membranes onset of 
labour within 24 hours 
298915 Prem rupture of membranes onset of 
labour after 24 hours 
298916 Prolonged spont/unspec rupture of 
membranes with a/n problem 
298917 Prolonged artificial rupture of 
membranes unspecified 
298918 Failed mechanical induction of labour 
298919 Unspecified maternal pyrexia during 
labour with a/n problem 
298920 Septicaemia during labour with 
antenatal problem 
298921 Grand multiparity - delivered 
298922 Elderly primigravida NOS 
298923 Risk factors in pregnancy NOS 
298924 Obstructed labour due to fetal 
malposition 
298925 Obstructed labour due to face 
presentation 
298926 Obstructed labour due to brow 
presentation 
298927 Obstructed labour caused by bony 
pelvis with a/n problem 
298928 Obstructed labour caused by bony 
pelvis NOS 
298929 Obstructed labour caused by pelvic soft 
tissues 
298930 Deep transverse arrest with antenatal 
problem 
298931 Shoulder dystocia unspecified 
298932 Other failed trial of labour unspecified 
298933 Failed trial of labour NOS 
298934 Other causes of obstructed labour 
298935 Other causes of obstructed labour - 
delivered 
298936 Precipitate labour with antenatal 
problem 
298937 Precipitate labour NOS 
298938 Hypertonic uterine inertia - delivered 
298939 Prolonged first stage NOS 
298940 Unspecified prolonged labour, 
unspecified 
298941 Prolonged second stage unspecified 
298942 Delayed delivery second twin etc NOS 
298943 Prolapse of cord 
298944 Vasa praevia 
298945 Other umbilical cord complications NOS 
298946 Trauma to perineum and vulva during 
delivery 
298947 Perineal muscle tear 
298948 Third degree perineal tear during 
delivery NOS 
298949 Vulval and perineal haematoma during 
delivery, unspecified 
298950 Vulval/perineal trauma during delivery 
NOS 
298951 Obstetric inversion of uterus NOS 
298952 Obstetric laceration of cervix 
298953 Obstetric laceration of cervix with 
postnatal problem 
298954 Other immediate postpartum 
haemorrhage 
298955 Other immediate postpartum 
haemorrhage - deliv with p/n prob 
298956 Secondary and delayed postpartum 
haemorrhage 
298957 Obstetric anaesthesia with cardiac 
complications - delivered 
298958 Obstetric anaesthesia with CNS comp 
with antenatal problem 
298959 Obstetric toxic reaction to local 
anaesthesia 
298960 Obstetric spinal and epidural 
anaesthesia-induced headache 
298961 Maternal distress NOS 
298962 Acute renal failure following labour and 
delivery 
298963 Post-delivery acute renal failure - 
delivered with p/n prob 
298964 Haematoma of obstetric wound 
298965 Other complications of obstetric 
procedures NOS 
298966 Neville - Barnes forceps delivery 
298967 Vacuum extractor delivery 
298968 Breech extraction NOS 
298969 Complications of labour and delivery 
NOS 
298970 Intrapartum haemorrhage with 
coagulation defect 
298971 Puerperal salpingitis unspecified 
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298972 Puerperal salpingitis with postnatal 
complication 
298973 Puerperal peritonitis - delivered with 
postnatal comp 
298974 Puerperal peritonitis NOS 
298975 Puerperal septicaemia unspecified 
298976 Major puerperal infection NOS 
298977 Venous complications of pregnancy and 
the puerperium 
298978 Varicose veins of legs in 
pregnancy/puerperium unspecified 
298979 Varicose veins of legs in 
pregnancy/puerperium - delivered 
298980 Varicose veins of legs in 
pregnancy/puerperium + a/n comp 
298981 Vulval varices in the puerperium 
298982 Superficial thrombophlebitis in 
pregnancy/puerperium -deliv 
298983 DVT - deep venous thrombosis, 
postnatal 
298984 Postnatal deep vein thrombosis - 
delivered with p/n comp 
298985 Other phlebitis/thrombosis in 
preg/puerperium -del +p/n comp 
298986 Haemorrhoids in pregnancy and the 
puerperium NOS 
298987 Venous complication of pregnancy, 
unspecified 
298988 Puerperal pyrexia of unknown origin 
298989 Obstetric air pulmonary embolism NOS 
298990 Obstetric blood-clot pulm embolism - 
delivered with p/n comp 
298991 Obstetric pyaemic and septic 
pulmonary embolism 
298992 Other obstetric pulmonary embolism - 
delivered + p/n comp 
298993 Breakdown of perineum 
298994 Placental polyp unspecified 
298995 Nipple infection - obstetric 
298996 Obstetric breast abscess with postnatal 
complication 
298997 Obstetric nonpurulent mastitis - deliv 
with p/n complication 
298998 Obstetric nonpurulent mastitis with 
postnatal complication 
298999 Other obstetric breast infections 
299000 Fissure of nipple 
299001 Cracked nipple in 
pregnancy/puerperium/lactation + a/n 
comp 
299002 Cracked nipple in 
pregnancy/puerperium/lactation + p/n 
comp 
299003 Breast engorgement in 
pregnancy/puerperium/lactation NOS 
299004 Other breast disorder in 
pregnancy/puerperium/lact unspec 
299005 Other breast disorder in 
pregnancy/puerperium/lact +a/n comp 
299006 Failure of lactation NOS 
299007 Suppressed lactation 
299008 Suppressed lactation with antenatal 
complication 
299009 Suppressed lactation with postnatal 
complication 
299010 Maternal care for hydrops fetalis 
299011 [X]Other+unspcf failed induced 
abortion,complicated/embolism 
299012 [X]Oedema,proteinuria+hypertens in 
pregnancy,childbrth,puerp 
299013 [X]Oth complicatns/spinal+epidural 
anaesthsia during pregncy 
299014 [X]Other failed induction of labour 
299015 [X]Other abnormalities of forces of 
labour 
299016 [X]Labour+delivery complicated by 
other cord entanglement 
299017 [X]Other complications of obstetric 
surgery and procedures 
299018 [X]delivery 
299019 [X]Other multiple delivery 
299088 Alopecia of pregnancy 
299153 Adult-onset Still's disease 
299600 Other specified birthmark 
299649 Fetus affected by maternal toxaemia 
299650 Fetus/neonate affected by 
placental/breast transfer alcohol 
299651 Fetal alcohol syndrome 
299652 Fetus/neonate affected-placental/breast 
transfer antibiotic 
299653 Fetus/neonate affected-placental/breast 
transfer immune sera 
299654 Fetus or neonate affected by maternal 
incompetent cervix 
299655 Fetus or neonate affected by 
unspecified ectopic pregnancy 
299656 Fetus/neonate affected by 
intraperitoneal ectopic pregnancy 
299657 Fetus or neonate affected by 
unspecified malpresentation 
299658 Fetus/neonate affected by antepartum 
haemorrhage unspecified 
299659 Fetus/neonate affected by placental 
abnormality NEC 
299660 Fetus or neonate affected by placental 
dysfunction 
299661 Fetus or neonate affected by placental 
abnormality OS 
299662 Fetus/neonate affected by placental 
transfusion syndrome NOS 
299663 Fetus affected by breech delivery 
299664 Fetus affected by malpresentation 
during delivery 
299665 Fetus/neonate affected by mat bony 
pelvis abn in labour/del 
299666 Fetus/neonate affected by mat contract 
pelvis in labour/del 
299667 Fetus or neonate affected by transverse 
lie in labour/deliv 
299668 Fetus or neonate affected by precipitate 
delivery 
299669 Fetus/neonate affected by abnormal 
uterine contractions OS 
299670 Fetus/neonate affected by abnormality 
maternal soft tissue 
299671 Baby born premature 
299672 Very premature - less than 1000g or 
less than 28 weeks 
299673 Premature - weight 1000g-2499g or 
gestation of 28-37weeks 
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299674 Large or postmature infant NOS 
299675 Intracranial haemorrhage in fetus or 
newborn 
299676 Local subdural haematoma due to birth 
trauma 
299677 Birth brain damage NOS 
299678 Scalp bruising, due to birth trauma 
299679 Other dislocation or subluxation due to 
birth trauma 
299680 Liver subcapsular haematoma due to 
birth trauma 
299681 Liver rupture due to birth trauma 
299682 Spleen injury due to birth trauma 
299683 Sternomastoid injury due to birth injury 
299684 Fetal distress before labour - liveborn 
299685 Liveborn with prelabour fetal distress 
NOS 
299686 Fetal distress in labour - liveborn 
299687 Congenital pneumonia 
299688 Aspiration of liquor in newborn 
299689 Perinatal pneumomediastinum 
299690 Perinatal bronchopulmonary dysplasia 
299691 Perinatal respiratory failure NOS 
299692 Perinatal acrocyanosis 
299693 Other specified respiratory problems in 
fetus or neonate 
299694 Neonatal dacryocystitis 
299695 Neonatal conjunctivitis due to 
staphylococcus 
299696 Ophthalmia neonatorum - bacterial 
NEC 
299697 Ophthalmia neonatorum - chlamydial 
299698 Neonatal candida infection NOS 
299699 Clostridial intra-amniotic fetal infection 
299700 Group B haemolytic streptococcal intra-
amniotic infect. NEC 
299701 Congenital viral hepatitis NOS 
299702 Congenital sepsis NOS 
299703 Septicaemia of newborn 
299704 Perinatal intraventricular haemorrhage 
299705 Intraventricular haemorrhage due to 
birth injury 
299706 Perinatal adrenal haemorrhage 
299707 Haemolytic disease due to 
isoimmunisation NOS 
299708 Late anaemia of newborn due to 
isoimmunisation 
299709 Other perinatal jaundice 
299710 Perinatal jaundice from other excessive 
haemolysis 
299711 Perinatal jaundice from polycythaemia 
299712 Delayed conjugation causing neonatal 
jaundice + disease EC 
299713 Neonatal jaundice with Gilbert's 
syndrome 
299714 Neonatal jaundice with porphyria 
299715 Perinatal jaundice due to hepatocellular 
damage NOS 
299716 Kernicterus not due to isoimmunisation 
299717 Bilirubin encephalopathy 
299718 Perinatal endocrine and metabolic 
problems 
299719 Neonatal thyrotoxicosis 
299720 Neonatal phosphate-loading 
hypocalcaemia 
299721 Cow's milk hypocalcaemia in newborn 
299722 Neonatal hypocalcaemia NOS 
299723 Neonatal dehydration 
299724 Transitory neonatal hyponatraemia 
299725 Transitory metabolic disturbance of 
newborn, unspecified 
299726 Transitory metabolic disturbance-infant 
pre-diabetic mother 
299727 Polycythaemia due to donor twin 
transfusion 
299728 Perinatal necrotising enterocolitis 
299729 Newborn dehydration fever 
299730 Hyperthermia in newborn, unspecified 
299731 Newborn temperature regulation 
disorder NOS 
299732 Congenital hydrocele 
299733 Overfeeding in newborn 
299734 Newborn drug reaction and intoxication 
299735 Neonatal cerebral ischaemia 
299736 Congenital cardiac failure 
299737 Wide cranial sutures 
299738 [X]Fetus+newborn affectd/oth+unspcfd 
conditns/umbilical cord 
299739 [X]Birth injury to central nervous 
system, unspecified 
299740 [X]Cardiovasc disord origin in the 
perinat period, unspecif 
299741 [X]Other specified fetal and neonatal 
haemorrhages 
299742 [X]Other haemolytic diseases of fetus 
and newborn 
299743 [X]Other specified kernicterus 
299744 [X]Neonatal jaundice due/other specifd 
excessive haemolysis 
299745 [X]Other specified perinatal digestive 
system disorders 
299746 [X]Disorder of muscle tone of newborn, 
unspecified 
299747 [X]Complications of intrauterine 
procedures NEC 
299798 [D]wind 
301600 [V]PH comp of pregnancy, childbirth 
and the puerperium 
301612 [V]Pregnancy with other poor obstetric 
history 
301619 [V]Live birth 
301620 [V]Single stillbirth 
301622 [V]Other multiple birth, born in hospital, 
mates live born 
301623 [V]Other multiple birth, mates live and 
stillborn 
301624 [V]Other multiple birth, before hospital, 
mates live+still 
301755 Vacuum aspiration abortion 
301757 Bougie induction labour 
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301758 S f d 
301759 Symphysiotomy 
301760 Trachelorrhaphy obstetric 
301822 Separation conjoined twins 
301859 Az test negative 
301860 Placental function test normal 
301936 Contraception sheath failure 
301949 Contraception i u c d failure 
302018 Problem housing inadequate facilities 
302061 Pregnancy with i u d in place 
302083 Extramarital pregnancy/birth 
302088 Problem pregnancy 
302121 Clinic baby 
302151 Rubella contact in early pregnancy 
302169 Pregnancy prophylactic therapy 
prescribe 
302170 Pregnancy prenatal care normal 
302171 Medical examination pregnancy 
302172 Antenatal care 
302173 Booking antenatal 
302174 Breast examination 
302175 Foetal heart heard 
302176 Foetal heart normal 
302177 Foetal movements stopped 
302178 Postpartum care 
302181 Twin mate liveborn 
302194 Normal delivery 
302219 Spontaneous vaginal delivery 
302224 Early stage of pregnancy 
302225 Delivered by caesarean section - 
pregnancy at term 
302245 Concealed pregnancy 
302260 Mother delivered 
302261 Delivery normal 
302262 SVD - Spontaneous vaginal delivery 
302282 Occasional uterine tightenings 
302283 FTND - Full term normal delivery 
302312 Weeks pregnant 
302331 Type 1 dip 
302367 Blood clots in membranes 
302372 Antenatal care 
302417 Referral to midwife 
302426 Umbilical cord problem 
302446 Delivered by low forceps delivery 
302496 Old meconium staining liquor 
302531 Spontaneous vertex delivery 
302532 Bloodstained liquor 
302535 Advice relating to pregnancy and fertility 
302558 Delivered by mid-cavity forceps delivery 
302571 Niggling uterine contractions 
302675 Deliveries by spontaneous breech 
delivery 
302683 Pregnant abdomen observation 
302695 Baby overdue 
302699 Intermittent uterine contractions 
302724 GENTAMICIN + HYDROCORTISONE 
ear drops 
302753 Number of previous pregnancies 
302789 Confirmation of pregnancy 
302790 Delivery observations 
302805 Painful uterine contractions 
302899 Triple test not wanted 
302964 Umbilical sepsis 
303393 Postnatal depression 
304055 Atelectasis (not neonatal) 
304474 Pregnancy genital infection 
304475 Pregnancy ectopic 
304476 Threatened miscarrage 
304477 Pregnancy bleeding 
304479 Pregnancy iron-deficiency anaemia 
304480 Pregnancy anaemia 
304482 Missed abortion 
304483 Intrauterine death 
304484 Twin pregnancy 
304485 Labour premature 
304486 Pregnancy infection during 
304487 Pregnancy pre-eclampsia 
304488 Pregnancy hypertension 
304489 Pregnancy eclampsia 
304490 Toxaemia pregnancy 
304491 Sickness pregnancy 
304492 Pregnancy morning sickness 
304493 Vomiting pregnancy 
304494 Pregnancy nausea 
304495 Therapeutic abortion 
304496 Termination pregnancy psychiatric 
reason 
304497 Termination of pregnancy requested 
304498 Top (termination of pregnancy) 
304499 Unmarried termination pregnancy 
304500 Induced abortion 
304501 Spontaneous abortion 
304502 Miscarriage 
304503 Inevitable abortion 
304504 Incomplete abortion 
304505 Abortion 
304506 Complete abortion 
304507 Rpc (retained products conception) 
304508 Pregnancy normal delivery 
304509 Normal delivery (mother) 
304510 Labour premature normal delivery 
304511 Premature labour 
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304512 Normal birth (confinement) 
304513 Delivery in hospital (mother) 
304514 Pph (postpartum haemorrhage) 
304515 Delivery breech 
304516 Delivery breech (mother) 
304517 Prolonged labour 
304518 Twin pregnancy delivery 
304519 Twins identical delivered 
304520 Delivery delay in second stage 
304521 Ruptured uterus complicating delivery 
304522 Premature delivery (mother) 
304523 Puerperal anaemia 
304524 Puerperal breast abscess 
304525 Galactorrhoea 
304526 Lactorrhoea 
305031 Twin low birthweight 
305032 Damage brain child congenital 
305033 Syndrome respiratory distress 
(newborn) 
305034 Premature baby 
305035 Premature delivery (child) 
305036 Low birthweight 
305037 Normal baby 
305038 Normal baby delivered normally 
305039 Breech birth (baby) 
305040 Caesarian section birth (baby) 
305041 Caesarian section (baby) 
305042 Forceps birth (baby) 
305043 Failure to thrive perinatal 
305045 Normal birth (baby) 
305046 Floppy baby 
305047 Neonatal jaundice 
305048 Stillbirth 
305237 Jaundice 
305238 Jaundice painless 
306097 Birthmark 
306098 Portwine stain 
306211 Pseudocyesis 
306215 Pregnancy fear 
306823 Pregnancy complication 
306824 Blighted ovum 
306825 Pregnancy abnormal 
306826 Triplet pregnancy 
306827 Labour false 
306828 Pregnancy glycosuria 
306829 Pregnancy hyperemesis 
306830 Termination pregnancy medical 
indication 
306831 Termination pregnancy prostaglandin 
306832 Septic abortion 
306833 Habitual abortion 
306834 Labour 
306835 Svd (spontaneous vertex delivery) 
306836 Delivery no details 
306837 Placenta adherent complicating delivery 
306838 Retained placenta 
306839 Presentation breech (mother) 
306840 Postmature at delivery (mother) 
306843 Overweight baby mother's record 
306844 Retained placenta fragments 
puerperium 
306845 Syndrome chiari- frommel 
307157 Cord compressed (baby) 
307158 Cephalhaematoma 
307159 Haemolytic disease newborn 
307161 Foetal movements decreased 
307162 Prematurity (newborn) 
307163 Born small 
307164 Baby normal at birth 
307165 Newborn cyanotic attack 
307167 Special care baby unit 
307168 Birth no details 
307170 Ventouse birth extraction (baby) 
307493 Jaundice drug induced 
307912 Moderate uterine contractions 
307913 CTG observations 
307930 Type 2 dip 
307958 Performs breast-feeding 
307984 Multiple birth 
308035 Ability to position baby at breast for 
feeding 
308068 Irregular uterine contractions 
308137 Difficulty performing breast-feeding 
308146 Uterine contractions present 
308147 Deliveries by forceps - delivered 
308171 Incomplete placenta at delivery 
308373 Abnormal delivery 
308377 Care relating to reproduction and 
pregnancy 
308378 Face to pubes birth 
308389 Breast feeding problem 
308408 Regular uterine contractions 
308511 Reactive CTG tracing 
308517 Intrauterine pregnancy 
308556 LOCORTEN -VIOFORM ear drops 1% 
+ 0.02% 
308610 Maternal blood loss minimal 
308659 Country of birth (European) 
308661 Fundal height equal to dates 
308662 Vaginal delivery 
308684 Multiple birth delivery 
308686 Observation of amniotic fluid 
308693 Duration of pregnancy 
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308697 Does not perform breast-feeding 
308723 Pelvic assessment - childbirth 
308748 Maternity care 
308749 Delivery place planned 
308759 Observation of position of pregnancy 
308760 Waters broken 
308797 Deliveries by vacuum extractor 
308845 Relation of onset of labour to due date 
308893 SOFRADEX ear drops 
308912 Country of birth (African) 
308942 Postnatal examination observations 
308949 Onset of contractions 
308982 Domino delivery 
308985 Number of caesarean sections 
309012 Deliv caes following prev caes 
309035 Number of spontaneous abortions 
309076 Antenatal class 
309118 Umbilical cord not around baby's neck 
at delivery 
309127 Number of abortions 
309142 Country of birth (Australasian) 
309200 Variable strength uterine contractions 
309252 Fetal heart baseline pattern 
309272 Other obstetric pelvic organ damage 
309277 Country of birth (Asian) 
309281 Normal pregnancy 
309288 Antenatal education 
309380 Pregnancy 
309381 Pregnancy normal 
309382 Pregnant 
309459 Pregnancy with uncertain dates 
309477 Reduced amniotic fluid 
309484 Pregnancy problem 
309501 Able to perform breast-feeding 
309590 Preconception care 
309591 Gravid uterus normal 
309630 Continuous contractions 
309657 Pregnancy review 
309697 Routine antenatal care 
309801 Antenatal HIV screening 
309817 Fetal heart acceleration 
309835 Apnoea of newborn 
309865 Rapid progress in first stage of labour 
309915 Late neonatal death 
310015 Uterine observation in labour 
310057 Premature uterine contraction 
310087 Pendulous pregnant abdomen 
310116 Early neonatal death 
310123 Stale retroplacental clot 
310126 Does perform breast-feeding 
331536 ND - Normal delivery 
331569 Home delivery planned 
331595 Antenatal screening 
331641 Erb's palsy 
331700 Neonatal apnoeic attack 
331716 Fetal heart deceleration 
331717 Performs breast-feeding 
331765 Retroplacental clot 
331777 Midwife unit delivery booking 
331803 Number of live deliveries 
331845 Pregnancy, childbirth and puerperium 
observations 
331860 Identical twins 
331897 Onset of labour pains 
331942 Multiparous 
331975 Born by caesarean section 
331985 Non-viable pregnancy 
331986 Fundus firm 
331987 Time waters ruptured 
331988 Umbilical cord normal 
332005 Rapid first stage of labour 
332011 Suppression of lactation 
332054 O/E - Umbilical stump - neonatal 
332806 Hypertonic lower uterine segment 
during labour 
332951 Cardiotochogram observation 
332954 Continuing pregnancy after abortion of 
sibling fetus 
333039 Postnatal care 
333040 Postnatal depression counselling 
333042 High risk pregnancy 
333043 Length of gestation 
333053 Primigravida 
333077 Onset of labour induced 
333094 Post miscarriage counselling 
333105 Delivery place booked 
333122 EPDS - Edinburgh postnatal depression 
scale 
333188 Meconium stained liquor 
333194 Gravid uterus present 
333216 Observation of pattern of pregnancy 
333445 Appearance of placenta 
333462 Birth history 
333483 Viable pregnancy 
333484 Ruptured membranes 
333509 Not pregnant 
333510 Presentation of pregnancy 
333511 Reported conception - pregnancy 
333512 Number of miscarriages 
333513 Date symptom of pregnancy first noted 
333514 CTG reactivity 
333577 Teenage pregnancy 
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333578 Unplanned pregnancy 
335362 Gravid uterus large-for-dates 
335363 Maternal blood loss moderate 
335364 Delivery problem 
335427 Observation of viability of pregnancy 
335428 Umbilical cord observations 
335961 Uncertain viability of pregnancy 
335997 Application of cold compresses to 
female perineum 
339597 Null 
339605 ROM - Ruptured membranes 
339618 Irritable uterus 
339629 Edinburgh postnatal depression scale 
at 8 months declined 
339675 Discharge from neonatal unit 
339709 Pregnancy care 
339750 Edinburgh postnatal depression scale 
339779 Null 
339780 Null 
339782 Puls umb cord palp intac membr 
339857 Number of lost pregnancies 
340072 Pregnancy advice 
340082 Wanted pregnancy 
340083 Query viability of pregnancy 
340107 Precipitate delivery 
340143 Fetal heart rate variability 
340188 Postnatal counselling 
340260 Low risk pregnancy 
340309 Tender scar of lower uterine segment 
340381 Start of labour 
340435 Undiagnosed twin 
340436 Estimated date of delivery from last 
period 
340476 Lactation management 
340508 AP - Anteroposterior diameter of pelvic 
outlet 
340665 Thick meconium stained liquor 
340681 Single pregnancy 
340706 Anterior posterior diameter of sacral 
outlet 
340715 Surrogate pregnancy 
340753 Biochemical pregnancy 
340806 Diabetes: shared care in pregnancy - 
diabetol and obstet 
340816 Obstetric investigative observation 
340845 Pregnancy observations 
340866 Concave sacral curve 
340890 Fundal height low for dates 
340936 Positions baby at breast for feeding 
340937 Ability to latch on to breast for feeding 
340955 Observation of height of gravid uterus 
340956 Gravid uterus problem 
340988 Number of fetal deaths 
341085 Born by emergency caesarean section 
341092 Normal fetal heart baseline pattern 
341093 Drying female perineal area with hair 
dryer 
341094 Application of egg white to female 
perineal area 
341234 Non-pregnant state 
341265 Postmature labour 
341266 Suppressing milk 
341305 Fair uterine contractions 
341306 Gestational sac present 
341307 Obstetric pelvic observation 
341410 Unwanted pregnancy 
341476 Maternal blood loss heavy 
341616 Spontaneous hindwater rupture of 
membranes 
341668 Multip 
341717 Antenatal deep vein thrombosis 
341729 Number of umbilical arteries 
341735 Accidental pregnancy 
341737 Binovular twins 
341775 Unable to perform breast-feeding 
341808 Neonatal screening test 
341932 Estimated maternal blood loss 
341949 Placenta offensive odour 
341957 Incomplete delivery of placenta 
342018 Labour not established 
342048 Uterine contractions ceased 
342092 EBL - Estimated maternal blood loss 
342141 Number of blood vessels in umbilical 
cord 
342161 Duration of gestation 
342162 Labour established 
342206 Intact membranes 
342218 Monozygotic twins 
342226 Placenta normal 
342250 Latches on to breast-feed 
342341 Placenta calcified 
342386 Undiagnosed pregnancy 
342399 Diabetic pre-pregnancy counselling 
342481 Gravid uterus not observed 
342482 Fundal height high for dates 
342544 Mother not delivered 
342568 Primip 
342569 Observation of gestational sac 
342570 Small pubic arch 
342571 Prominent ischial spines 
342595 Uterus contracted 
342596 Spontaneous forewater rupture of 
membranes 
342618 Able to latch on to breast for feeding 
342628 Frequency of uterine contractions 
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342677 Null 
342728 Placenta problem 
342742 Not pushing well in labour 
342767 Hypertonic contractions 
342779 FHRV - Fetal heart rate variability 
342819 Time vaginal show detected 
342842 Amount of liquor 
342903 Dizygotic twins 
342909 Uterine activity 
342910 Quantity of liquor 
342973 Female perineal area care procedures 
343022 Uterine contractions stopped 
343072 Pregnancy duration 
343089 Onset of second stage of labour 
343102 Labour problem 
343172 Maternal blood loss within normal limits 
343200 Failure to progress in second stage of 
labour 
343265 DZ - Dizygotic twins 
343289 Fresh retroplacental clot 
343314 Deliveries by breech extraction 
343324 Angle of subpubic arch 
343346 Observation of structures of conception 
343373 Observation of blood loss in labour 
343401 Edinburgh postnatal depression scale 
declined 
343439 Gravid uterus small-for-dates 
343493 Placental observation 
343533 Delayed expulsion of placenta 
343560 Observation of uterine contractions 
343561 Non-effective uterine contractions 
343598 Difficulty positioning baby at breast for 
feeding 
343677 Uterine contraction duration 
343690 Emergency caesarean section 
343729 Number of umbilical veins 
343762 Duration of pregnancy at time of 
previous miscarriage 
343763 No progress with delivery 
343791 General shape of pelvis 
343835 Multigravida 
343907 H/O: medical termination of pregnancy 
343909 Uterine contraction frequency 
343923 Observation of shape of pregnant 
abdomen 
343942 Normal CTG tracing 
343977 Labour observations 
344010 Progress of labour - first stage 
344020 Face delivery 
344066 First stage of labour problem 
344125 Uterine contractions problem 
344126 Slow rate of delivery 
344157 Technically poor CTG 
344173 Difficulty latching on to breast for 
feeding 
344229 Duration of labour 
344276 Time contractions became regular 
344311 Beat to beat variability 
344336 Amniotic fluid normal 
344379 Ability to perform breast-feeding 
344417 Uterine contractions absent 
344437 Observation of second stage of labour 
344512 Divergent pelvic side walls 
344524 Late onset of labour 
344603 Referral for termination of pregnancy 
344635 Neonatal abstinence syndrome 
344647 Missed miscarriage 
344675 Observation of quantity of liquor 
344684 Placenta healthy 
344787 Transversely enlarged pregnant 
abdomen 
344847 Nuchal scan 
344917 Membranes complete 
344939 Contin pregnancy after intrauterine 
death of sibling fetus 
344953 Position of ischial tuberosities 
344986 Periventricular leucomalacia 
345008 Observation of sensation of gravid 
uterus 
345009 Does not latch on to breast for feeding 
345034 Girth of pregnant abdomen 
345098 Uterus lax 
345099 Observation of pattern of uterine 
contractions 
345114 Periventricular leukomalacia 
345116 Length of gestation at birth 
345118 Slow progress in first stage of labour 
345175 Unsatisfactory CTG tracing 
345184 EDC - Estimated date of conception 
345275 First stage of labour not established 
345336 Estimated date of conception 
345342 Observation of pattern of delivery 
345356 Rapid second stage of labour 
345362 Anteroposterior diameter of pelvic outlet 
345363 Vulval toilet 
345402 Rate of delivery 
345436 Subpubic arch 
345460 Observation of gravid uterus 
345520 [M]Papilloma NOS(excl.bladder) 
345547 Null 
345548 Null 
345549 Placental infection 
345551 Uterus not contracted 
345554 Observation of measures of pregnancy 
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345598 Number of stillbirths 
345614 Fraternal twins 
345758 Onset of labour first stage 
345789 Refer to early pregnancy unit 
345808 Desire to push 
345835 Observation of completeness of 
placenta 
345881 Normal liquor volume 
345901 Brow delivery 
345906 Gravid uterus absent 
345907 Normal labour 
345908 Fresh meconium staining liquor 
345912 Number of chorions in membranes 
345955 Number of vessels entering umbilical 
cord 
346051 Gestational sac absent 
346234 Uterine membrane observations 
346279 Oblique pelvis 
346311 Mild uterine contractions 
346379 Observation of size of gravid uterus 
346392 Condition of amniotic liquor 
346407 Old retroplacental clot 
346425 Problem of pelvis for delivery 
346480 Able to position baby at breast for 
feeding 
346518 Estimated date of delivery from last 
normal period 
346613 Size of placenta 
346689 Normal position of gravid uterus 
346695 Primiparous 
346718 Condition of amniotic fluid 
346719 Patient advised to have pregnancy test 
346728 Painless uterine contractions 
346734 Sinusoidal pattern of fetal heart 
346764 Ability to push in labour 
346765 Excessive amniotic fluid 
346843 Observation of size of female pelvis 
346856 First stage of labour established 
346897 Flat sacral curve 
347026 Date false contractions first detected 
347053 Cholestasis of pregnancy 
347066 Observation of quantity of pregnancy 
347092 Tender scar of gravid uterus 
347184 Placenta gritty 
347208 Anembryonic pregnancy 
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Appendix D: Pregnancy Care Marker Codes
 
 
GPRD_Medical
_Codes GP_Medical_Term 
246504 [V]Antenatal screening 
283103 [V]First normal pregnancy supervision 
274048 [V]High-risk pregnancy supervision 
228376 [V]Illegitimate pregnancy 
255697 [V]Normal pregnancy 
210188 
[V]Other normal pregnancy 
supervision 
255706 [V]Other specified antenatal screening 
283105 [V]Other specified high-risk pregnancy 
228321 [V]Other specified pregnant state 
292281 [V]Other unwanted pregnancy 
219233 
[V]Personal history of perinatal 
problems 
264873 [V]Pregnancy confirmed 
237381 [V]Pregnancy examination and test 
264960 
[V]Pregnancy examination or test, 
pregnancy unconfirmed 
210284 [V]Pregnancy not (yet) confirmed 
219251 [V]Pregnancy with history of abortion 
228322 
[V]Pregnancy with history of 
hydatidiform mole 
210189 [V]Pregnancy with history of infertility 
264874 
[V]Pregnancy with history of 
trophoblastic disease 
292230 
[V]Pregnancy with history of vesicular 
mole 
301612 
[V]Pregnancy with other poor obstetric 
history 
292231 
[V]Pregnancy with other poor 
reproductive history 
274046 [V]Pregnant state, incidental 
283143 
[V]Problems related to unwanted 
pregnancy 
246490 
[V]Supervision of high-risk pregnancy 
due to social problems 
292229 [V]Supervision of normal pregnancy 
274047 
[V]Supervision of other normal 
pregnancy 
228323 
[V]Supervisn/pregnancy wth history 
insufficnt antenatal care 
255705 [V]Unspecified delivery outcome 
292232 [V]Unspecified high-risk pregnancy 
255698 [V]Unspecified pregnant state 
216734 
[X]Abnormal finding on antenatal 
screening of mother 
207746 
[X]Additional preg,cldbirth+puerperium 
diseas clssfctn terms 
225817 
[X]Complications predominantly 
related to the puerperium 
217455 
[X]Congenital pneumonia due to other 
bacterial agents 
262303 
[X]Infections of other parts of urinary 
tract in pregnancy 
262306 
[X]Intrapartum haemorrhage, 
unspecified 
243914 
[X]Maternal care for other 
abnormalities of cervix 
243915 
[X]Maternal care for other 
abnormalities of gravid uterus 
216735 
[X]Maternal care for other 
isoimmunization 
207748 
[X]Maternal care for other 
malpresentation of fetus 
234925 
[X]Maternal care relat to 
fetus+amniotic cavity+deliv prob 
253096 
[X]Maternal 
care/(suspected)damage/fetus/oth 
medicl procedur 
243916 
[X]Maternal care/known or suspected 
fetal problem,unspecifd 
234927 
[X]Maternal care/oth spcf known or 
suspected fetal problems 
225813 
[X]Maternal care/other(suspected)fetal 
abnormality+damage 
207750 
[X]Obstructd labour due to oth 
maternal pelvic abnormalities 
289729 
[X]Obstructed labour due to other 
abnormalities of fetus 
207749 
[X]Obstructed labour due/other 
malposition+malpresentation 
216739 
[X]Oth d/bld+bld-form org+c d inv im 
mch cm preg,cldbir+puer 
216740 
[X]Oth spcf dis+conditns complicat 
preg,childbirth+puerperum 
243913 
[X]Other abnormal findings on 
antenatal screening of mother 
234932 
[X]Other and unspecified disorders of 
lactation 
234928 [X]Other antepartum haemorrhage 
262305 
[X]Other complications specific to 
multiple gestation 
272302 [X]Other congenital malaria 
225814 
[X]Other disorders of amniotic fluid 
and membranes 
208475 [X]Other fetal blood loss 
253094 
[X]Other haemorrhage in early 
pregnancy 
225815 [X]Other intrapartum haemorrhage 
234926 [X]Other multiple gestation 
216738 
[X]Other obstetric conditions, not 
elsewhere classified 
289728 
[X]Other premature separation of 
placenta 
207747 
[X]Other specified abnormal products 
of conception 
217462 
[X]Other specified conditions originat 
in perinatal period 
243917 [X]Other specified obstructed labour 
225818 [X]Other specified puerperal infection 
234924 
[X]Other venous complications in 
pregnancy 
207756 
[X]Other viral diseases complicating 
preg,cldbirth+puerperum 
234923 
[X]Other vomiting complicating 
pregnancy 
262304 
[X]Other+unspcf genitourinary tract 
infection in pregnancy 
237401 
[X]Supervision of other normal 
pregnancy 
213097 A/N - shared care 
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286095 A/N 12 weeks examination 
258664 A/N 16 week examination 
213115 A/N 20 week examination 
286096 A/N 24 week examination 
213116 A/N 28 week examination 
286097 A/N 30 week examination 
276953 A/N 32 week examination 
231260 A/N 34 week examination 
295295 A/N 35 week examination 
258665 A/N 36 week examination 
258666 A/N 37 week examination 
240246 A/N 38 week examination 
213117 A/N 39 week examination 
213118 A/N 40 week examination 
258667 A/N 41 week examination 
276954 A/N 42 week examination 
295287 A/N amnio. for ? chrom.abnorm. 
213102 A/N amnio. for ? neural tube 
295286 A/N amniocentesis - abnormal 
276945 A/N amniocentesis - awaited 
249452 A/N amniocentesis - normal 
258655 A/N amniocentesis - not wanted 
276944 A/N amniocentesis - offered 
249451 A/N amniocentesis -not offered 
213101 A/N amniocentesis wanted 
276952 A/N blood gp screen not done 
231258 A/N blood group screen done 
231259 A/N blood group screen NOS 
295294 A/N booking examination 
222178 A/N care from consultant 
267900 A/N care from G.P. 
267901 A/N care midwifery led 
295281 A/N care provider 
286088 A/N care provider NOS 
295276 A/N care: elderly primip. 
240226 A/N care: grand multip 
231249 A/N care: gynae. risk 
295279 A/N care: H/O child abuse 
267899 A/N care: H/O infertility 
295274 A/N care: H/O perinatal death 
204090 A/N care: H/O stillbirth 
240227 A/N care: H/O trophoblast.dis. 
295278 A/N care: late booker 
258651 A/N care: medical risk 
286086 A/N care: multip. > 35 years 
240225 A/N care: obstetric risk 
267898 A/N care: obstetric risk NOS 
204091 A/N care: poor A/N attender 
295277 A/N care: poor home conditions 
295275 A/N care: poor obstetr history 
249446 A/N care: precious preg. NOS 
222176 A/N care: precious pregnancy 
213096 A/N care: primip. < 17 years 
249449 A/N care: primip. > 30 years 
286085 A/N care: recurrent aborter 
249447 A/N care: risk NOS 
222177 A/N care: social risk 
258650 A/N care: social risk NOS 
213095 A/N care: uncertain dates 
295280 A/N care: under 5ft tall 
249448 A/N care:10yrs+since last preg 
258660 A/N Rh antibody screen 
213107 A/N Rh antibody screen NOS 
276947 A/N Rh screen not offered 
295290 A/N Rh screen offered 
286087 A/N risk NOS 
258662 A/N sickle cell screen done 
213114 A/N sickle cell screen NOS 
295293 A/N sickle screen not done 
276951 A/N syphilis screen not done 
240244 A/N syphilis screen-blood sent 
213104 A/N U/S scan abnormal 
231254 A/N U/S scan awaited 
222182 A/N U/S scan for ? abnormality 
249453 A/N U/S scan for slow growth 
258658 A/N U/S scan normal +? dates 
276946 A/N U/S scan normal += dates 
258656 A/N U/S scan not offered 
213103 A/N U/S scan not wanted 
258657 A/N U/S scan offered 
286092 A/N U/S scan wanted 
234775 Abdominal pain in pregnancy 
216507 Abdominal pregnancy 
289661 
Abnormal biochemical finding on 
antenatal screen of mother 
234846 
Abnormal chromosomal and genet 
find/antenat screen of mother 
207663 
Abnormal cytological finding on 
antenatal screen of mother 
253008 
Abnormal finding on antenatal 
screening of mother 
207662 
Abnormal findings on antenatal 
screening of mother 
207602 
Abnormal glucose tolerance test in 
pregnancy/childb/puerp 
252960 
Abnormal GTT during pregnancy - 
baby not yet delivered 
225677 
Abnormal GTT in 
pregnancy/childbirth/puerperium NOS 
271499 
Abnormal haematologic find on 
antenatal screening of mother 
207664 
Abnormal radiological finding on 
antenatal screen of mother 
234845 
Abnormal ultrasonic finding on 
antenatal screening of mother 
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216657 
Abnormality of forces of labour NOS 
unspecified 
207672 
Abnormality of forces of labour NOS 
with antenatal problem 
277074 Abortion counselling 
341735 Accidental pregnancy 
302535 
Advice relating to pregnancy and 
fertility 
249454 AFP - blood sent 
213110 AFP blood test NOS 
240239 AFP blood test not offered 
204096 AFP blood test not wanted 
276949 AFP blood test offered 
240240 AFP blood test wanted 
213109 AFP test - antenatal 
216558 
Albuminuria in pregnancy without 
hypertension 
299088 Alopecia of pregnancy 
213108 Alpha-feto protein blood test 
255948 ALPHA-FETO PROTEIN HIGH 
274296 ALPHA-FETO PROTEIN LOW 
203769 Alpha-feto protein normal 
265122 ALPHA-FETO PROTEIN NORMAL 
240238 Alpha-feto protein test - A/N 
228475 AMNIOCENTESIS 
241132 Amniocentesis NEC 
234838 Amnion nodosum 
280534 Amnionitis 
277823 Amnioscopy 
234841 
Amniotic cavity and membrane 
problem NOS 
234840 
Amniotic cavity and membrane 
problem NOS with a/n problem 
262210 
Amniotic cavity and membrane 
problem NOS, unspecified 
271495 
Amniotic cavity and membrane 
problems NOS 
271494 Amniotic cavity infection 
234837 Amniotic cavity infection NOS 
262209 Amniotic cavity infection unspecified 
234836 
Amniotic cavity infection with antenatal 
problem 
225731 Amniotic cyst 
207657 Amniotic fluid leaking 
253069 Amniotic fluid pulmonary embolism 
216712 
Amniotic fluid pulmonary embolism 
NOS 
243898 
Amniotic fluid pulmonary embolism 
unspecified 
271552 
Amniotic fluid pulmonary embolism 
with a/n complication 
289610 
Anaemia - unspecified whether in 
pregnancy or the puerperium 
289611 
Anaemia during pregnancy - baby not 
yet delivered 
347208 Anembryonic pregnancy 
243742 Angular pregnancy 
262205 Anhydramnios 
240234 Antenatal amniocentesis 
240235 Antenatal amniocentesis NOS 
240245 Antenatal blood group screen 
295300 Antenatal blood tests 
219833 ANTENATAL BOOKING 
204088 Antenatal care 
302172 ANTENATAL CARE 
302372 Antenatal care 
295273 Antenatal care: 2nd pregnancy 
240223 Antenatal care: 3rd pregnancy 
249445 Antenatal care: gravida No. 
240224 Antenatal care: gravida NOS 
222175 Antenatal care: multip 
240229 Ante-natal care: not attended 
240228 Ante-natal care: not offered 
258652 Ante-natal care: not wanted 
240222 Antenatal care: primigravida 
309076 Antenatal class 
253062 Antenatal deep vein thrombosis 
341717 Antenatal deep vein thrombosis 
253063 Antenatal deep vein thrombosis NOS 
280584 
Antenatal deep vein thrombosis 
unspecified 
234895 
Antenatal deep vein thrombosis with 
antenatal complication 
309288 Antenatal education 
231261 Antenatal examination NOS 
258663 Antenatal examinations 
269430 Ante-natal exercises 
309801 Antenatal HIV screening 
283260 ANTENATAL OPERATION 
295402 Ante-natal relaxation classes 
231214 
Antenatal scan unable to confirm 
pregnancy 
331595 Antenatal screening 
213113 Antenatal sickle cell screen 
240243 Antenatal syphilis screen 
231257 Antenatal syphilis screen NOS 
204049 
Antenatal ultrasound confirms ectopic 
pregnancy 
213054 
Antenatal ultrasound confirms intra-
uterine pregnancy 
204048 Antenatal ultrasound result received 
295288 Antenatal ultrasound scan 
286093 
Antenatal ultrasound scan at 17-22 
weeks 
295289 
Antenatal ultrasound scan at 22-40 
weeks 
258659 
Antenatal ultrasound scan at 9-16 
weeks 
286094 Antenatal ultrasound scan NOS 
231255 
Antenatal ultrasounds scan at 4-8 
weeks 
216534 Antepartum bleeding 
271413 Antepartum haemorrhage 
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225644 Antepartum haemorrhage NOS 
298846 Antepartum haemorrhage NOS 
298845 
Antepartum haemorrhage NOS - not 
deliv 
262126 
Antepartum haemorrhage NOS, 
unspecified 
289569 
Antepartum haemorrhage with 
afibrinogenaemia 
289568 
Antepartum haemorrhage with 
coagulation defect 
280454 
Antepartum haemorrhage with 
coagulation defect - not deliv 
252921 
Antepartum haemorrhage with 
coagulation defect unspecified 
225642 Antepartum haemorrhage with fibroid 
271416 
Antepartum haemorrhage with 
hyperfibrinolysis 
262125 
Antepartum haemorrhage with 
hypofibrinogenaemia 
280455 Antepartum haemorrhage with trauma 
298844 
Antepartum haemorrhage with trauma 
- not delivered 
225640 
Antepartum haemorrhage with trauma 
NOS 
252923 
Antepartum haemorrhage with trauma 
unspecified 
216539 
Antepartum haemorrhage with uterine 
fibroid 
225641 
Antepartum haemorrhage with uterine 
leiomyoma 
280456 
Antepartum haemorrhage with uterine 
leiomyoma - not deliv 
234754 
Antepartum haemorrhage with uterine 
leiomyoma unspecified 
262124 
Antepartum haemorrhage, abruptio 
placentae, placenta praevia 
255853 ANTEPARTUM OPERATION 
340508 
AP - Anteroposterior diameter of pelvic 
outlet 
259541 Artificial rupture of membranes 
211616 ASPHYXIA ANTENATAL 
262146 
Asymptomatic bacteriuria in 
pregnancy 
234770 
Asymptomatic bacteriuria in 
pregnancy - not delivered 
234771 
Asymptomatic bacteriuria in 
pregnancy NOS 
207583 
Asymptomatic bacteriuria in 
pregnancy unspecified 
265128 AZ TEST 
301859 AZ TEST NEGATIVE 
219491 AZ TEST POSITIVE 
302695 Baby overdue 
234855 Bandl's retraction ring 
240258 Barts test 
225646 
Benign essential hypertension in 
preg/childb/puerp NOS 
216540 
Benign essential hypertension in 
preg/childb/puerp unspec 
225645 
Benign essential hypertension in 
pregnancy/childbirth/puerp 
207619 
Bicornuate uterus affecting obstetric 
care 
280511 
Bicornuate uterus complicating a/n 
care, baby not delivered 
234807 
Bicornuate uterus in pregnancy, 
childbirth or puerperium NOS 
340753 Biochemical pregnancy 
333462 Birth history 
298840 Bleeding in early pregnancy 
302367 Blood clots in membranes 
234910 Blood dyscrasia puerperal 
302173 BOOKING ANTENATAL 
243790 Braxton-Hicks contractions 
207739 
Breast engorgement in pregnancy, the 
puerperium or lactation 
253087 
Breast engorgement in 
pregnancy/puerperium/lact + a/n comp 
225809 
Breast engorgement in 
pregnancy/puerperium/lactation 
unspec 
247033 
BREAST SCREENING 
EXAMINATION ABNORMAL 
207610 Breech presentation unspecified 
225685 
Breech presentation with antenatal 
problem 
207612 
Brow presentation with antenatal 
problem 
210965 
CANNABIS INGESTION IN 
PREGNANCY 
216583 Cardiomyopathy in the puerperium 
332951 Cardiotochogram observation 
268042 Care of teeth advice -in preg. 
308377 
Care relating to reproduction and 
pregnancy 
225684 Cephalic version NOS 
234792 
Cephalic version NOS with antenatal 
problem 
298883 Cephalic version NOS, unspecified 
268720 Cerclage of cervix of gravid uterus 
207720 
Cerebral venous thrombosis in the 
puerperium 
216716 
Cerebrovascular disorders in the 
puerperium 
289634 Cervical incompetence 
207624 Cervical incompetence unspecified 
234817 
Cervical incompetence with antenatal 
problem 
280430 Cervical pregnancy 
347053 Cholestasis of pregnancy 
207656 Chorioamnionitis 
274200 CHORIONIC VILLOUS SAMPLING 
299699 Clostridial intra-amniotic fetal infection 
252885 Combined or heterotopic pregnancy 
262271 
Complications of labour and delivery 
NOS, unspecified 
234911 
Complications of the puerperium NOS, 
unspecified 
234786 
Complications specific to multiple 
gestation 
207614 Compound presentation 
293429 CONCEALED PREGNANCY 
302245 Concealed pregnancy 
302789 Confirmation of pregnancy 
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234806 
Cong abnorm uterus complicating a/n 
care, baby not delivered 
290467 Congenital anaemia 
225673 
Congenital cardiovasc dis - unsp 
whether in preg/puerperium 
280485 
Congenital cardiovasc dis in 
pregnancy - baby not delivered 
234783 
Congenital cardiovasc dis in puerp - 
baby previously deliv 
207596 Congenital heart disease in pregnancy 
243819 
Congenital/acquired abnormality vulva 
in preg/childb/puerp 
216594 Conjoined twins causing disproportion 
249450 Consultant unit booking 
252962 
Continuing preg after intrauterine 
death one fetus or more 
234787 
Continuing pregnancy after abortion of 
one fetus or more 
332954 
Continuing pregnancy after abortion of 
sibling fetus 
309630 Continuous contractions 
292577 CONTRACEPTION CAP FAILURE 
301949 CONTRACEPTION I U C D FAILURE 
301936 
CONTRACEPTION SHEATH 
FAILURE 
207679 
Cord tangled or knotted with 
compression 
234862 
Cord tangled or knotted with 
compression NOS 
262228 
Cord tangled with compression with 
antenatal problem 
207678 Cord tight round neck NOS 
234861 Cord tight round neck unspecified 
207677 
Cord tight round neck with antenatal 
problem 
289543 Cornual pregnancy 
219701 COUNSELLING ABORTION 
252919 Couvelaire uterus 
225808 
Cracked nipple in pregnancy, the 
puerperium or lactation 
299001 
Cracked nipple in 
pregnancy/puerperium/lactation + a/n 
comp 
307913 CTG observations 
333514 CTG reactivity 
262148 Cystitis of pregnancy 
216598 Cystocele affecting obstetric care 
216599 
Cystocele complicating antenatal care 
- baby not delivered 
243815 
Cystocele in pregnancy, childbirth and 
the puerperium 
347026 Date false contractions first detected 
333513 Date symptom of pregnancy first noted 
258606 Dating/booking US scan 
219750 
DECIDED AGAINST TERMINATION 
PREGNANCY 
202611 DECREASED FOETAL MOVEMENTS 
225740 Deep transverse arrest NOS 
298930 
Deep transverse arrest with antenatal 
problem 
271508 Delayed delivery second twin with 
antenatal problem 
213099 Deliv.booking - length of stay 
204093 Delivery booking - place NOS 
286090 Delivery booking - stay NOS 
204092 Delivery booking place 
231251 Delivery booking place changed 
333105 Delivery place booked 
267912 Delivery place planned 
308749 Delivery place planned 
231250 Delivery: no place booked 
216578 
Diabetes mellitus - unspec whether in 
pregnancy/puerperium 
280481 Diabetes mellitus arising in pregnancy 
289607 
Diabetes mellitus during pregnancy - 
baby not yet delivered 
252954 
Diabetes mellitus in 
pregnancy/childbirth/puerperium NOS 
229070 DIABETES PREGNANCY 
340806 
Diabetes: shared care in pregnancy - 
diabetol and obstet 
241128 
Diagnost endoscopic examination 
foetus using foetoscope NOS 
241131 Diagnostic amniocentesis 
213966 
Diagnostic endoscopic examination 
fetus using fetoscope NOS 
222971 
Diagnostic endoscopic examination 
fetus using fetoscope OS 
296089 
Diagnostic endoscopic examination of 
fetus using fetoscope 
286995 
Diagnostic endoscopic examination of 
foetus using fetoscope 
222974 
Diagnostic percutaneous examination 
of fetus 
222975 
Diagnostic percutaneous examination 
of fetus NOS 
277822 
Diagnostic percutaneous examination 
of placenta 
286246 Diet in pregnancy advice 
216584 
Dis nervous syst complic 
pregnancy,childbirth and puerperium 
207603 
Dis of the digestive sys comp preg 
childbirth and puerp 
207604 
Dis of the skin and subcut tis comp 
preg childbrth puerp 
271568 
Disorder of lactation NOS with 
antenatal complication 
216592 
Disproportion - major pelvic 
abnormality 
207616 
Disproportion - major pelvic 
abnormality unspecified 
216593 
Disproportion - major pelvic 
abnormality with antenatal prob 
234805 Disproportion NOS 
289625 
Disproportion NOS with antenatal 
problem 
216596 Disproportion NOS, unspecified 
258669 Double test 
213124 Double test not offered 
267911 Double test not wanted 
204103 Double test offered 
231264 Double test wanted 
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276960 Downs screen - blood test 
204105 Downs screen blood test abnormal 
240259 Downs screen blood test normal 
231265 Downs screening - blood sent 
240260 Downs screening blood test NOS 
286999 Drainage of amniotic cavity 
262170 
Drug dependence during pregnancy - 
baby not yet delivered 
277084 Drugs in pregnancy advice 
207718 
DVT - deep venous thrombosis, 
antenatal 
234852 Dystocia NOS 
216554 Early onset of delivery unspecified 
243781 Early or threatened labour 
280469 Early or threatened labour NOS 
216533 Early pregnancy haemorrhage NOS 
271412 Early pregnancy haemorrhage NOS 
243770 
Early pregnancy haemorrhage NOS - 
not delivered 
298841 
Early pregnancy haemorrhage NOS 
unspecified 
302224 Early stage of pregnancy 
342092 EBL - Estimated maternal blood loss 
234760 Eclampsia 
234761 Eclampsia - not delivered 
243779 Eclampsia in pregnancy 
207570 Eclampsia NOS 
252930 Eclampsia unspecified 
234265 Ectopic beats unspecified 
298807 Ectopic pregnancy NOS 
216641 
Elderly primigravida with antenatal 
problem 
241130 Electrode applied to fetal scalp 
232506 Entonox analgesia in labour 
244641 
Eschericha coli intra-amniotic fetal 
infection 
345336 Estimated date of conception 
239425 Estimated date of delivery 
346518 
Estimated date of delivery from last 
normal period 
340436 
Estimated date of delivery from last 
period 
341932 Estimated maternal blood loss 
237877 EXAMINATION PRENATAL 
262135 Excessive pregnancy vomiting 
216568 Excessive weight gain in pregnancy 
252938 Excessive weight gain in pregnancy 
244622 
Extradural haemorrhage in fetus or 
newborn 
302083 
EXTRAMARITAL 
PREGNANCY/BIRTH 
208428 Extreme immaturity 
243802 Face presentation unspecified 
225686 
Face presentation with antenatal 
problem 
262221 Failed forceps NOS 
271496 Failed mechanical induction NOS 
216637 
Failed mechanical induction 
unspecified 
262212 
Failed mechanical induction with 
antenatal problem 
271497 
Failed medical or unspecified 
induction with a/n problem 
271528 
Failed or difficult intubation during 
pregnancy 
243909 
Failure of lactation with antenatal 
complication 
341305 Fair uterine contractions 
207529 Fallopian tube pregnancy 
252934 False labour 
225798 Fat embolism - obstetric 
243786 Fatigue during pregnancy 
289595 
Fatigue during pregnancy - not 
delivered 
289596 Fatigue during pregnancy NOS 
252945 Fatigue during pregnancy unspecified 
233783 Fear of pregnancy 
295284 Feeding intention 
213100 Feeding intention - bottle 
295285 Feeding intention - breast 
240233 Feeding intention - unsure 
253837 
Fet newborn affect mat exposure to 
environml chem subs 
207640 Fetal acidosis 
299651 Fetal alcohol syndrome 
208411 Fetal and neonatal conditions 
281294 Fetal blood loss 
208450 
Fetal blood loss from cut co-twin's 
cord 
290450 Fetal blood loss from ruptured cord 
208452 Fetal blood loss from vasa praevia 
235621 Fetal blood loss NOS 
281295 Fetal blood loss, unspecified 
216619 Fetal bradycardia 
252998 Fetal distress - affecting management 
298911 Fetal distress NOS 
225723 Fetal distress unspecified 
207642 Fetal distress with antenatal problem 
281296 Fetal exsanguination 
262990 Fetal growth retardation NOS 
309817 Fetal heart acceleration 
309252 Fetal heart baseline pattern 
331716 Fetal heart deceleration 
213979 Fetal heart monitoring in labour 
296104 Fetal heart monitoring NEC 
340143 Fetal heart rate variability 
217390 Fetal malnutrition 
290424 
Fetal malnutrition without mention of 
"light for dates" 
208427 
Fetal malnutrition, no mention light or 
small for gest age 
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207615 
Fetal malposition and malpresentation 
NOS 
216591 
Fetal malposition and malpresentation 
NOS with a/n problem 
234797 
Fetal malposition and malpresentation 
NOS, unspecified 
295296 Fetal maturity - A/N 
249456 Fetal maturity: dates = size 
240247 Fetal maturity: dates not=size 
232136 Fetal monitoring 
276955 Fetal movements felt 
286098 Fetal movements seen 
208451 Fetal placental blood loss 
207641 Fetal tachycardia 
240180 Fetal U-S scan 
252996 Fetal-maternal haemorrhage 
243827 Fetal-maternal haemorrhage NOS 
271480 
Fetal-maternal haemorrhage 
unspecified 
234827 
Fetal-maternal haemorrhage with 
antenatal problem 
225730 Feto-placental problems NOS 
262201 Feto-placental problems NOS 
253001 
Feto-placental problems NOS with 
antenatal problem 
207647 
Feto-placental problems NOS, 
unspecified 
222969 Fetoscopic blood transfusion of fetus 
222970 
Fetoscopic examination of fetus and 
biopsy of fetus 
259537 
Fetoscopic examination of fetus and 
sampling of fetal blood 
286996 Fetoscopy NEC 
234791 Fetus - unstable lie 
277821 Fetus & gravid uterus ops 
281258 
Fetus affected by APH - antepartum 
haemorrhage 
235586 Fetus affected by cord problems 
253822 Fetus affected by hydramnios 
299649 Fetus affected by maternal toxaemia 
253826 Fetus affected by placental abruption 
253828 
Fetus affected by placental 
insufficiency 
277820 Fetus and gravid uterus operations 
232116 
Fetus and gravid uterus operations 
NOS 
253836 
Fetus and newborn affected by 
maternal use of tobacco 
259535 Fetus operations 
235592 
Fetus or neonate affected by abnormal 
uterine contractions 
244609 
Fetus or neonate affected by 
amnionitis 
253825 
Fetus or neonate affected by external 
version before labour 
244606 
Fetus or neonate affected by face 
presentation before labour 
244614 
Fetus or neonate affected by 
hypertonic uterine dysfunction 
208417 Fetus or neonate affected by knot in 
cord 
253832 Fetus or neonate affected by long cord 
262978 
Fetus or neonate affected by 
malpresentation before labour 
244613 
Fetus or neonate affected by maternal 
contraction ring 
208413 
Fetus or neonate affected by maternal 
hypertensive disease 
226508 
Fetus or neonate affected by maternal 
medical problem NOS 
244603 
Fetus or neonate affected by maternal 
medical problems 
235587 
Fetus or neonate affected by 
membranitis 
226509 
Fetus or neonate affected by multiple 
pregnancy 
244605 
Fetus or neonate affected by oblique 
lie before labour 
253830 
Fetus or neonate affected by other 
specified cord problems 
244608 
Fetus or neonate affected by placental 
insufficiency 
244616 
Fetus or neonate affected by previous 
pelvic surgery 
253829 
Fetus or neonate affected by 
prolapsed cord 
208418 
Fetus or neonate affected by short 
cord 
262980 
Fetus or neonate affected by 
transverse lie before labour 
226510 
Fetus or neonate affected by 
unspecified multiple pregnancy 
235593 
Fetus or neonate affected by uterine 
inertia or dysfunction 
253831 
Fetus or neonate affected by 
velamentous insertion of cord 
235598 
Fetus small-for-dates (SFD) with signs 
of malnutrition 
235597 
Fetus small-for-dates with signs of 
malnutrition 
290423 
Fetus small-for-dates, without mention 
of malnutrition 
262198 
Fetus with central nervous system 
malformation 
298900 
Fetus with central nervous system 
malformation + a/n problem 
234822 
Fetus with central nervous system 
malformation NOS 
280524 
Fetus with central nervous system 
malformation unspecified 
280525 Fetus with chromosomal abnormality 
298901 
Fetus with chromosomal abnormality 
NOS 
243821 
Fetus with chromosomal abnormality 
unspecified 
280526 
Fetus with chromosomal abnormality 
with antenatal problem 
271478 Fetus with damage due to coil 
225716 
Fetus with damage due to intra-uterine 
contraceptive device 
252992 
Fetus with damage due to intra-uterine 
contraceptive device 
298907 Fetus with damage due to IUCD NOS 
225717 
Fetus with damage due to IUCD 
unspecified 
225718 
Fetus with damage due to IUCD with 
antenatal problem 
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280527 
Fetus with damage due to other 
maternal disease 
225714 
Fetus with damage due to other 
maternal disease + a/n prob 
225715 
Fetus with damage due to other 
maternal disease NOS 
271477 
Fetus with damage due to other 
maternal disease unspecified 
252994 Fetus with damage NOS 
298909 Fetus with damage NOS 
280529 
Fetus with damage NOS with 
antenatal problem 
225720 Fetus with damage NOS, unspecified 
252991 Fetus with drug damage 
289644 Fetus with drug damage NOS 
234823 Fetus with drug damage unspecified 
289643 
Fetus with drug damage with antenatal 
problem 
298902 Fetus with hereditary disease 
252990 Fetus with hereditary disease NOS 
298903 
Fetus with hereditary disease 
unspecified 
216612 
Fetus with hereditary disease with 
antenatal problem 
207638 Fetus with other damage NEC 
225719 Fetus with other damage NEC NOS 
252993 
Fetus with other damage NEC with 
antenatal problem 
271479 
Fetus with other damage NEC, 
unspecified 
207636 Fetus with radiation damage 
207637 Fetus with radiation damage NOS 
280528 
Fetus with radiation damage 
unspecified 
234825 
Fetus with radiation damage with 
antenatal problem 
216613 
Fetus with suspected rubella damage 
via mother 
271475 Fetus with viral damage via mother 
216614 
Fetus with viral damage via mother 
NOS 
262199 
Fetus with viral damage via mother 
unspecified 
243824 
Fetus with viral damage via mother 
with antenatal problem 
226507 
Fetus/neonate affected - poison 
transfer placenta/breast OS 
244615 
Fetus/neonate affected by abnormal 
uterine contractions NOS 
244610 
Fetus/neonate affected by 
abnormalities chorion/amnion NOS 
281256 
Fetus/neonate affected by breech 
presentation before labour 
208416 
Fetus/neonate affected by feto-
maternal transplacental trans 
244607 
Fetus/neonate affected by 
malpresentation before labour NOS 
226511 
Fetus/neonate affected by 
malpresentation before labour OS 
208412 
Fetus/neonate affected by maternal 
problem unrelated to preg 
226512 
Fetus/neonate affected by materno-
fetal transplacental trans 
208415 
Fetus/neonate affected by placental 
damage-amniocentesis 
235588 
Fetus/neonate affected other 
abnormalities of chorion/amnion 
244604 
Fetus/neonate affected-plac./breast 
transfer addictive drug 
208414 
Fetus/neonate affected-plac./breast 
transfer anticoagulant 
226506 
Fetus/neonate affect-plac./breast 
transf hypoglycaemic agent 
226516 
Fetus+newborn affected/other 
maternal noxious influences 
342779 FHRV - Fetal heart rate variability 
229743 FOETAL DISTRESS 
302175 FOETAL HEART HEARD 
302176 FOETAL HEART NORMAL 
232137 Foetal monitoring 
307161 FOETAL MOVEMENTS DECREASED 
283682 FOETAL MOVEMENTS FELT 
219834 FOETAL MOVEMENTS NORMAL 
220656 FOETAL MOVEMENTS NOT FELT 
302177 FOETAL MOVEMENTS STOPPED 
204990 
Foetoscopic examination foetus and 
sampling of foetal blood 
255955 
FOLLICULAR STIMULATING 
HORMONE LEVEL 
232118 
Fore water rupture of amniotic 
membrane 
240231 Full stay delivery booking 
222179 G.P. unit delivery booking 
214389 Gas and air analgesia in labour 
298886 Generally contracted pelvis NOS 
243806 
Generally contracted pelvis 
unspecified 
234798 
Generally contracted pelvis with 
antenatal problem 
295398 Genetic counselling 
289697 Genital varices in pregnancy 
280474 
Genitourinary tract infection in 
pregnancy - not delivered 
216563 
Genitourinary tract infection in 
pregnancy NOS 
289590 
Genitourinary tract infection in 
pregnancy unspecified 
280473 
Genitourinary tract infections in 
pregnancy 
298880 Gestation - multiple 
276961 Gestation = 24 weeks 
295301 Gestation >24 weeks 
207594 Gestational diabetes mellitus 
289609 Gestational diabetes mellitus 
207567 Gestational hypertension 
289585 Gestational oedema 
216567 Gestational oedema with proteinuria 
234898 Gestational phlebitis NOS 
271551 Gestational phlebopathy NOS 
225662 Gestational proteinuria 
341306 Gestational sac present 
262281 Gestational thrombosis NOS 
345034 Girth of pregnant abdomen 
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262152 Glycosuria during pregnancy 
207585 
Glycosuria during pregnancy - 
delivered 
252946 
Glycosuria during pregnancy - not 
delivered 
243789 Glycosuria during pregnancy NOS 
216566 
Glycosuria during pregnancy 
unspecified 
234843 Grand multiparity 
216640 Grand multiparity unspecified 
262215 
Grand multiparity with antenatal 
problem 
309591 Gravid uterus normal 
253875 
Group A haemolytic streptococcal 
intra-amniotic infect. NEC 
299700 
Group B haemolytic streptococcal 
intra-amniotic infect. NEC 
298859 Habitual aborter - not delivered 
217431 
Haemolytic disease due to ABO 
isoimmunisation 
208456 
Haemolytic disease due to rhesus 
isoimmunisation 
208455 
Haemorrhage of fetus and newborn 
NOS 
225791 Haemorrhoids in pregnancy 
243892 
Haemorrhoids in pregnancy and 
puerperium with a/n comp 
207719 
Haemorrhoids in pregnancy and 
puerperium with p/n comp 
216708 Haemorrhoids in the puerperium 
207599 Heart disease during pregnancy 
243787 Herpes gestationis 
289597 Herpes gestationis - not delivered 
289598 Herpes gestationis NOS 
216565 Herpes gestationis unspecified 
247605 HICK'S CONTRACTIONS 
216589 
High head at term with antenatal 
problem 
333042 High risk pregnancy 
267651 High sensitivity urine pregnancy test 
204996 
Hind water rupture of amniotic 
membrane 
213098 Home delivery booked 
231266 Home delivery planned 
331569 Home delivery planned 
225752 Hourglass uterine contraction 
228592 
HUMAN PLACENTAL LACTOGEN 
LEVEL ABNORMAL 
283362 
HUMAN PLACENTAL LACTOGEN 
LEVEL NORMAL 
207649 Hydramnios 
234804 Hydrocephalic disproportion NOS 
280508 
Hydrocephalic disproportion with 
antenatal problem 
226558 Hydrops fetalis due to isoimmunisation 
208458 
Hydrops fetalis due to other+unspcfd 
haemolytic disease 
229504 
HYPERCHROMIC ANAEMIA 
PREGNANCY 
252932 Hyperemesis gravidarum 
298854 
Hyperemesis gravidarum with 
metabolic disturbance 
262138 
Hyperemesis gravidarum with 
metabolic disturbance - not del 
234764 
Hyperemesis gravidarum with 
metabolic disturbance NOS 
207574 
Hyperemesis gravidarum with 
metabolic disturbance unsp 
271422 Hyperemesis of pregnancy 
243774 
Hypertension complicating 
pregnancy/childbirth/puerperium 
216654 Hypertonic uterine inertia 
271505 
Hypertonic uterine inertia with 
antenatal problem 
294349 Illegitimate pregnancy 
234856 Incoordinate uterine action 
259542 
Induction of labour using 
prostaglandins 
207589 Infections of bladder in pregnancy 
289591 Infections of kidney in pregnancy 
207584 
Infections of the genital tract in 
pregnancy 
289605 Infections of urethra in pregnancy 
216570 
Infective/parasitic disease in 
preg/childbirth/puerperium 
240248 Initial booking of patient 
298887 Inlet pelvic contraction 
289623 Inlet pelvic contraction NOS 
234799 Inlet pelvic contraction unspecified 
289622 
Inlet pelvic contraction with antenatal 
problem 
256250 INSTRUCTION ANTENATAL 
237876 INSTRUCTION ANTENATAL GIVEN 
342206 Intact membranes 
286091 Intends to bottle feed 
302699 Intermittent uterine contractions 
281292 Intra-amniotic fetal infection 
244642 Intra-amniotic fetal infection NOS 
208446 
Intra-amniotic fetal infection, 
unspecified 
208430 
Intracerebral haemorrhage in fetus or 
newborn 
234725 Intraligamentous pregnancy 
298912 Intrauterine death NOS 
281293 Intrauterine fetal sepsis, unspecified 
238425 
INTRAUTERINE GROWTH 
RETARDATION 
253838 Intrauterine growth retardation 
244627 Intrauterine hypoxia 
308517 Intrauterine pregnancy 
207696 Inversion of uterus - obstetric 
232730 Iron supplement in pregnancy 
308068 Irregular uterine contractions 
228838 IUCD FAILED 
295262 IUD failure - pregnant 
207680 Knot in cord 
207633 Known or suspected fetal abnormality 
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238432 LABOUR 
342162 Labour established 
306827 LABOUR FALSE 
232117 Labour operations 
221207 Labourer NOS 
289624 
Large fetus causing disproportion with 
antenatal problem 
271486 Large-for-dates fetus in pregnancy 
243832 Large-for-dates NOS 
234834 Large-for-dates unspecified 
253000 Large-for-dates with antenatal problem 
262139 
Late pregnancy vomiting - not 
delivered 
289581 Late pregnancy vomiting NOS 
216549 Late pregnancy vomiting unspecified 
252933 Late vomiting of pregnancy 
284338 LEAKING AMNIOTIC FLUID 
213125 Length of labour 
290425 Light for gestational age 
216628 Lithopaedian 
262149 Liver disorder in pregnancy 
262150 
Liver disorder in pregnancy - not 
delivered 
289593 Liver disorder in pregnancy NOS 
216564 
Liver disorder in pregnancy 
unspecified 
225744 Locked twins NOS 
225743 Locked twins with antenatal problem 
340260 Low risk pregnancy 
234847 Low weight gain in pregnancy 
292488 LUTEINIZATION HORMONE LEVEL 
216701 Major puerperal infection 
216702 
Major puerperal infection NOS, 
unspecified 
234848 Malnutrition in pregnancy 
262178 
Malposition and malpresentation of 
fetus 
225683 Malpresentation of fetus 
290451 Massive umbilical haemorrhage 
295308 Maternal alcohol abuse 
341476 Maternal blood loss heavy 
308610 Maternal blood loss minimal 
335363 Maternal blood loss moderate 
343172 
Maternal blood loss within normal 
limits 
234824 
Maternal care for (suspected) damage 
to fetus from alcohol 
289640 
Maternal care for chromosomal 
abnormality in fetus 
225711 
Maternal care for CNS malformation in 
fetus 
271476 
Maternal care for damage to fetus 
from maternal rubella 
253092 
Maternal care for diminished fetal 
movements 
234826 
Maternal care for fetal abnormality and 
damage, unspecified 
216621 
Maternal care for fetal acidosis during 
pregnancy 
271482 
Maternal care for fetal bradycardia 
during pregnancy 
252999 
Maternal care for fetal decelerations 
during pregnancy 
234830 Maternal care for fetal hypoxia 
298910 Maternal care for fetal hypoxia 
225724 
Maternal care for fetal tachycardia 
during pregnancy 
262299 Maternal care for fetus 
234833 
Maternal care for intrauterine growth 
retardation 
253091 
Maternal care for other known or 
suspected fetal problems 
207745 Maternal care for poor fetal growth 
243831 Maternal care for poor fetal growth 
207643 
Maternal care for reduced fetal heart 
rate during pregnancy 
252995 
Maternal care for suspect fetal 
abnormal and damage, unspec 
243823 
Maternal care for suspected 
chromosomal abnormality in fetus 
252989 
Maternal care for suspected CNS 
malformation in fetus 
262300 
Maternal care for viable fetus in 
abdominal pregnancy 
249465 Maternal care NOS 
234920 
Maternal care/known or suspected 
fetal problem,unspecifd 
243866 Maternal distress 
271530 Maternal distress unspecified 
271532 
Maternal distress with antenatal 
problem 
249479 Maternal drug abuse 
262270 Maternal exhaustion 
207588 
Maternal gonorrhoea during 
pregnancy/childbirth/puerperium 
280477 
Maternal gonorrhoea in pregnancy - 
baby not yet delivered 
253049 Maternal hypotension syndrome 
243873 Maternal hypotension syndrome NOS 
216690 
Maternal hypotension syndrome 
unspecified 
243872 
Maternal hypotension syndrome with 
antenatal problem 
216574 
Maternal malaria during pregnancy - 
baby not yet delivered 
262143 Maternal obesity syndrome 
244617 
Maternal problem unrelated preg 
affecting fetus/neonate NOS 
226517 
Maternal problems unrelated preg 
affecting fetus/neonate OS 
298866 
Maternal rubella during pregnancy - 
baby not yet delivered 
225666 
Maternal rubella in pregnancy, 
childbirth and the puerperium 
225667 
Maternal rubella in 
pregnancy/childbirth/puerperium NOS 
207587 
Maternal syphilis during pregnancy - 
baby not yet delivered 
216571 
Maternal syphilis in 
pregnancy/childbirth/puerperium NOS 
249478 Maternal tobacco abuse 
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216573 
Maternal tuberculosis in pregnancy - 
baby not yet delivered 
216572 
Maternal tuberculosis in 
pregnancy/childbirth/puerperium 
234778 
Maternal tuberculosis in 
pregnancy/childbirth/puerperium NOS 
231398 Maternity benefit advice 
286084 Maternity care 
295401 Maternity grant advice 
214712 Maternity services admin. 
250297 McDonald cerclage of cervix 
225722 Meconium stained liquor 
216585 
Medical condition NOS in pregnancy - 
baby not yet delivered 
225678 
Medical condition NOS in 
pregnancy/childbirth/puerperium 
265462 
MEDICAL EXAMINATION 
ANTENATAL 
302171 
MEDICAL EXAMINATION 
PREGNANCY 
344917 Membranes complete 
289655 Membranitis 
298805 Membranous pregnancy 
207705 Mendelson's syndrome 
216582 
Mental disorder - unspec whether in 
pregnancy/puerperium 
225672 
Mental disorder during pregnancy - 
baby not yet delivered 
234782 
Mental disorders in pregnancy, 
childbirth and the puerperium 
243803 Mentum presentation 
207531 Mesenteric pregnancy 
298806 Mesometric pregnancy 
331777 Midwife unit delivery booking 
216548 Mild hyperemesis gravidarum 
298853 Mild hyperemesis gravidarum NOS 
262136 Mild hyperemesis unspecified 
225652 Mild hyperemesis-not delivered 
234758 Mild or unspecified pre-eclampsia 
207568 
Mild or unspecified pre-eclampsia - not 
delivered 
252929 
Mild or unspecified pre-eclampsia 
NOS 
243777 
Mild or unspecified pre-eclampsia 
unspecified 
289573 Mild pre-eclampsia 
289575 Mild pre-eclampsia 
231262 Misc. antenatal data 
231263 Misc. antenatal data NOS 
234802 Mixed feto-pelvic disproportion 
234803 Mixed feto-pelvic disproportion NOS 
262186 
Mixed feto-pelvic disproportion with 
antenatal problem 
234763 Moderate pre-eclampsia 
307912 Moderate uterine contractions 
243780 Morning sickness 
249595 Mothercraft advice 
293432 MULTIPARA 
266076 MULTIPARITY 
331942 Multiparous 
271448 Multiple pregnancy 
225682 Multiple pregnancy NOS 
271451 Multiple pregnancy NOS 
262177 
Multiple pregnancy NOS with 
antenatal problem 
298882 Multiple pregnancy NOS, unspecified 
243805 
Multiple pregnancy with 
malpresentation 
225688 
Multiple pregnancy with 
malpresentation unspecified 
252970 
Multiple pregnancy with 
malpresentation with antenatal prob 
225611 Mural pregnancy 
208445 Neonatal candidiasis of lung 
208444 Neonatal candidiasis of perineum 
216559 
Nephropathy NOS in pregnancy 
without hypertension 
258653 No A/N care: not known preg. 
276942 No ante-natal care 
240230 No ante-natal care NOS 
226577 Non-immune hydrops fetalis 
331985 Non-viable pregnancy 
343942 Normal CTG tracing 
341092 Normal fetal heart baseline pattern 
309281 Normal pregnancy 
283681 
NORMAL PREGNANCY PRENATAL 
CARE THROUGHOU 
344847 Nuchal scan 
279376 Nutritional deficiencies 
221558 O/E - breech presentation 
258032 O/E - fetal movements 
248862 O/E - fetal movements felt 
203493 O/E - fetal movements NOS 
230631 O/E - fetal movements seen 
234793 Oblique lie with antenatal problem 
308686 Observation of amniotic fluid 
342569 Observation of gestational sac 
345554 
Observation of measures of 
pregnancy 
333216 Observation of pattern of pregnancy 
308759 Observation of position of pregnancy 
347066 Observation of quantity of pregnancy 
335427 Observation of viability of pregnancy 
234900 Obstetric air pulmonary embolism 
243897 
Obstetric air pulmonary embolism with 
a/n complication 
216684 
Obstetric anaesthesia with cardiac 
comp with antenatal prob 
216683 
Obstetric anaesthesia with cardiac 
complications 
298958 
Obstetric anaesthesia with CNS comp 
with antenatal problem 
225776 
Obstetric anaesthesia with CNS 
complications unspecified 
  - 262- 
225774 
Obstetric anaesthesia with pulmonary 
comp with a/n problem 
216682 
Obstetric anaesthesia with pulmonary 
complications unsp 
207709 
Obstetric anaesthetic complications 
NOS 
216687 
Obstetric anaesthetic complications 
NOS 
253047 
Obstetric anaesthetic complications 
NOS with a/n problem 
216713 
Obstetric blood-clot pulmonary 
embolism 
243900 
Obstetric blood-clot pulmonary 
embolism + a/n complication 
234901 
Obstetric blood-clot pulmonary 
embolism unspecified 
207735 
Obstetric breast abscess with 
antenatal complication 
225805 Obstetric breast infection NOS 
225806 
Obstetric breast infection NOS, 
unspecified 
216709 Obstetric cerebral venous thrombosis 
216673 
Obstetric damage to pelvic joints and 
ligaments NOS 
234868 Obstetric high vaginal laceration 
234869 Obstetric high vaginal laceration NOS 
216670 
Obstetric high vaginal laceration 
unspecified 
293431 OBSTETRIC HISTORY BAD 
216669 
Obstetric inversion of uterus 
unspecified 
225764 Obstetric laceration of cervix NOS 
296106 Obstetric monitoring NOS 
207731 
Obstetric nipple infection with 
antenatal complication 
207737 Obstetric nonpurulent mastitis NOS 
225802 
Obstetric nonpurulent mastitis with 
antenatal complication 
207698 
Obstetric pelvic haematoma 
unspecified 
225795 Obstetric pulmonary embolism 
234904 
Obstetric pulmonary embolism NOS 
with antenatal complication 
207722 Obstetric pulmonary embolus 
289709 
Obstetric pyaemic and septic pulm 
embolism + a/n comp 
243903 
Obstetric pyaemic and septic 
pulmonary embolism NOS 
207711 Obstetric shock unspecified 
234881 
Obstetric shock with antenatal 
problem 
234871 
Obstetric trauma causing pelvic 
haematoma 
225769 
Obstetric trauma causing pelvic 
haematoma NOS 
216671 
Obstetric trauma damaging pelvic 
joints and ligaments 
243857 
Obstetric trauma NOS with antenatal 
problem 
243840 
Obstruct labour due pelvic outlet and 
mid-cavity contract 
216646 
Obstructed labour caused by bony 
pelvis unspecified 
298927 
Obstructed labour caused by bony 
pelvis with a/n problem 
253013 
Obstructed labour caused by pelvic 
soft tissues + a/n prob 
262219 
Obstructed labour caused by pelvic 
soft tissues unspecified 
207665 
Obstructed labour due abnormality of 
maternal pelv organs 
271500 
Obstructed labour due to fetal 
malposition NOS 
253009 
Obstructed labour due to fetal 
malposition unspecified 
243839 
Obstructed labour due to fetal 
malposition with a/n problem 
216647 
Obstructed labour due to pelvic inlet 
contraction 
207670 
Obstructed labour NOS with antenatal 
problem 
252940 
Oedema or excessive weight gain in 
pregnancy - not delivered 
225657 
Oedema or excessive weight gain in 
pregnancy no hypertension 
289586 
Oedema or excessive weight gain in 
pregnancy NOS 
252939 
Oedema or excessive weight gain in 
pregnancy, unspecified 
207652 Oligohydramnios 
243833 Oligohydramnios NOS 
207653 Oligohydramnios unspecified 
271489 
Oligohydramnios with antenatal 
problem 
308949 Onset of contractions 
331897 Onset of labour pains 
232114 Operation on gravid uterus NOS 
232113 Operations on gravid uterus 
208443 
Ophthalmia neonatorum - 
staphylococcal 
271443 
Orthopaedic disorder in pregnancy - 
baby not yet delivered 
234785 
Orthopaedic disorder in 
pregnancy/childbirth/puerperium NOS 
216636 
Other amniotic/membrane problem 
with antenatal problem 
208439 
Other and unspecified perinatal 
atelectasis 
243773 Other antepartum haemorrhage 
234755 
Other antepartum haemorrhage - not 
delivered 
234756 Other antepartum haemorrhage NOS 
280457 
Other antepartum haemorrhage 
unspecified 
234828 Other blood-group isoimmunisation 
271481 Other blood-group isoimmunisation 
289645 
Other blood-group isoimmunisation 
NOS 
252997 
Other blood-group isoimmunisation 
unspecified 
225721 
Other blood-group isoimmunisation 
with antenatal problem 
299005 
Other breast disorder in 
pregnancy/puerperium/lact +a/n comp 
207741 
Other breast disorder in 
pregnancy/puerperium/lactation 
234915 
Other breast disorder in 
pregnancy/puerperium/lactation NOS 
234784 
Other cardiovascular dis - unsp 
whether in preg/puerperium 
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207600 
Other cardiovascular dis in pregnancy 
- baby not delivered 
207601 
Other cardiovascular disease in 
pregnancy/childb/puerp NOS 
207598 
Other cardiovascular diseases in 
pregnancy/childbirth/puerp 
225749 
Other causes of obstructed labour 
NOS 
253017 
Other causes of obstructed labour with 
antenatal problem 
216603 
Other cervical abn complicating a/n 
care- baby not delivered 
234908 
Other complication of obstetric 
surgical wound unspecified 
289691 
Other complications of obstetric 
anaesthesia + a/n problem 
216691 
Other complications of obstetric 
procedures unspecified 
216722 
Other complications of the puerperium 
NOS 
207681 Other cord entanglement 
216658 Other cord entanglement NOS 
289675 
Other cord entanglement with 
antenatal problem 
243810 Other disproportion 
207618 Other disproportion NOS 
216595 
Other disproportion with antenatal 
problem 
207530 Other ectopic pregnancy 
289666 
Other failed forceps with antenatal 
problem 
207668 Other failed forceps, unspecified 
225745 
Other failed trial of labour with 
antenatal problem 
225747 
Other failed ventouse extraction with 
antenatal problem 
262222 
Other failed ventouse extraction, 
unspecified 
262187 
Other fetal abnormality causing 
disproportion 
243809 
Other fetal abnormality causing 
disproportion unspecified 
262188 
Other fetal abnormality causing 
disproportion with a/n prob 
207639 Other fetal and placental problems 
298885 
Other fetal malposition and 
malpresentation 
216590 
Other fetal malposition and 
malpresentation unspecified 
225689 
Other fetal malposition and 
malpresentation with a/n prob 
225727 Other fetal problems 
225729 Other fetal problems 
271487 Other feto-placental problems 
234835 Other feto-placental problems NOS 
280533 
Other feto-placental problems 
unspecified 
289653 
Other feto-placental problems with 
antenatal problem 
243769 Other haemorrhage in early pregnancy 
216532 
Other haemorrhage in early pregnancy 
- not delivered 
252916 
Other haemorrhage in early pregnancy 
unspecified 
252953 Other mat infective/parasit dis in 
pregnancy - not delivered 
225669 
Other mat. infective/parasitic disease 
in preg/puerp unspec 
216576 
Other maternal viral dis. in 
pregnancy/childbirth/puerp. NOS 
234779 
Other maternal viral dis.in pregnancy-
baby not yet delivered 
225670 
Other medical condition in 
pregnancy/childbirth/puerperium 
262175 Other multiple pregnancy 
234790 Other multiple pregnancy NOS 
262176 Other multiple pregnancy unspecified 
243801 
Other multiple pregnancy with 
antenatal problem 
253082 
Other obstetric breast infection with 
antenatal complication 
234870 
Other obstetric pelvic organ damage 
NOS 
225765 
Other obstetric pelvic organ damage 
unspecified 
225797 Other obstetric pulmonary embolism 
216715 
Other obstetric pulmonary embolism 
NOS 
253071 
Other obstetric pulmonary embolism 
with antenatal comp 
207700 Other obstetric trauma NOS 
234873 Other obstetric trauma OS 
262245 
Other obstetric trauma with antenatal 
problem 
204992 
Other operation on amniotic cavity 
NOS 
268718 Other operations on amniotic cavity 
243890 Other phlebitis in pregnancy 
225790 Other phlebitis in the puerperium 
225789 
Other phlebitis/thrombosis in 
preg/puerperium + a/n comp 
225728 Other placental conditions NOS 
216624 Other placental conditions unspecified 
289650 
Other placental conditions with 
antenatal problem 
207566 
Other pre-exist hypertension in 
preg/childb/puerp-not deliv 
216544 
Other pre-existing hypertension in 
preg/childb/puerp unspec 
216543 
Other pre-existing hypertension in 
preg/childbirth/puerp 
271429 
Other pregnancy complication - not 
delivered 
207579 Other pregnancy complication NEC 
280476 Other pregnancy complication NOS 
225664 
Other pregnancy complication 
unspecified 
225663 Other pregnancy complications 
216551 Other pregnancy vomiting 
207575 
Other pregnancy vomiting - not 
delivered 
207576 Other pregnancy vomiting NOS 
271423 Other pregnancy vomiting unspecified 
207658 
Other problem of amniotic cavity and 
membranes NOS 
253005 
Other problem of amniotic cavity and 
membranes unspecified 
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216643 Other problems affecting labour 
280535 Other problems affecting labour 
243837 Other problems affecting labour NOS 
207661 
Other problems affecting labour 
unspecified 
262218 
Other problems affecting labour with 
antenatal problem 
243835 
Other problems of amniotic cavity and 
membranes 
262204 
Other problems of amniotic cavity and 
membranes 
296090 
Other specified diagnostic 
percutaneous examination of fetus 
281297 Other specified fetal blood loss 
296105 Other specified obstetric monitoring 
204994 
Other specified operation on gravid 
uterus 
232115 
Other specified operations on fetus or 
gravid uterus 
259539 
Other specified other operation on 
amniotic cavity 
290453 
Other specified perinatal cutaneous 
haemorrhage 
216645 
Other specified risk factors in 
pregnancy 
232119 
Other specified surgical induction of 
labour 
268715 
Other specified therapeutic fetoscopic 
operation 
259538 
Other specified therapeutic 
percutaneous operation on fetus 
262141 Other threatened labour 
207577 
Other threatened labour - not 
delivered 
252935 Other threatened labour NOS 
225654 Other threatened labour unspecified 
216662 
Other umbilical cord complications 
unspecified 
225758 
Other umbilical cord complications 
with antenatal problem 
262226 
Other uterine inertia with antenatal 
problem 
216600 
Other uterine/pelvic floor abn in 
preg/childb/puerp NOS 
243792 
Other venereal diseases in 
pregnancy/childbirth/puerperium 
289704 
Other venous comp of 
pregnancy/puerperium + a/n comp 
234897 
Other venous complication of 
pregnancy/puerperium unsp 
271457 Outlet pelvic contraction 
207617 Outlet pelvic contraction NOS 
234800 Outlet pelvic contraction unspecified 
298888 
Outlet pelvic contraction with antenatal 
problem 
252884 Ovarian pregnancy 
262142 Papyraceous fetus 
252937 Papyraceous fetus - not delivered 
225656 Papyraceous fetus NOS 
271426 Papyraceous fetus unspecified 
231253 Parent craft - group class 
295282 Parent craft class attended 
222181 Parent craft class NOS 
258654 Parent craft class not offered 
222180 Parent craft classes 
231252 Parent craft classes offered 
295283 Parent craft -individual class 
240232 Parent craft not wanted 
240220 Patient ? pregnant 
346719 
Patient advised to have pregnancy 
test 
213093 Patient currently pregnant 
203268 Patient Pregnant 
231247 Patient pregnant 
240221 Patient pregnant NOS 
216608 
Pelvic soft tissue abnorm in 
preg/childb/puerp with a/n prob 
207632 
Pelvic soft tissue abnormality in 
preg/childb/puerp unspec 
216607 
Pelvic soft tissue abnormality in 
pregnancy/childbirth/puerp 
310087 Pendulous pregnant abdomen 
268717 Percutaneous biopsy of fetus 
222973 
Percutaneous blood transfusion of 
fetus 
286998 
Percutaneous insertion of fetal 
pleuroamniotic shunt 
232111 
Percutaneous insertion of fetal 
vesicoamniotic shunt 
250296 
Percutaneous sampling of chorionic 
villus 
232112 Percutaneous sampling of fetal blood 
213968 Percutaneous sampling of foetal blood 
208441 Perinatal apnoeic spells NOS 
208440 
Perinatal chronic respiratory disease 
NOS 
208454 Perinatal cutaneous ecchymoses 
208453 
Perinatal gastrointestinal haemorrhage 
NOS 
217447 Perinatal skin disorder NOS 
216703 Perineal varices in pregnancy 
225786 Perineal varices in the puerperium 
216561 Peripheral neuritis in pregnancy 
207582 
Peripheral neuritis in pregnancy - not 
delivered 
289588 Peripheral neuritis in pregnancy NOS 
216562 
Peripheral neuritis in pregnancy 
unspecified 
272296 Persistent fetal circulation 
252986 
Persistent hymen affecting obstetric 
care 
262195 
Persistent hymen complicating a/n 
care - baby not delivered 
207630 
Persistent hymen in 
pregnancy/childbirth/puerperium NOS 
216649 
Persistent occipitopost/occipitoant 
position + a/n problem 
234849 
Persistent occipitopost/occipitoant 
position, unspecified 
225741 
Persistent 
occipitoposterior/occipitoanterior 
position NOS 
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216706 Piles - obstetric 
247600 PLACENTA ABRUPTIO 
289652 Placenta gritty 
225643 Placenta praevia 
238418 PLACENTA PRAEVIA CENTRAL 
247599 PLACENTA PRAEVIA LATERAL 
266073 PLACENTA PRAEVIA MARGINAL 
271414 Placenta praevia with haemorrhage 
243771 
Placenta praevia with haemorrhage - 
not delivered 
216537 
Placenta praevia with haemorrhage 
NOS 
252917 Placenta praevia without haemorrhage 
298842 
Placenta praevia without haemorrhage 
- not delivered 
225637 
Placenta praevia without haemorrhage 
NOS 
252918 
Placenta praevia without haemorrhage 
unspecified 
295237 Placenta U-S scan 
298843 Placental abruption 
252920 Placental abruption - not delivered 
225639 Placental abruption NOS 
216538 Placental abruption unspecified 
255956 PLACENTAL FUNCTION TEST 
210444 
PLACENTAL FUNCTION TEST 
ABNORMAL 
301860 
PLACENTAL FUNCTION TEST 
NORMAL 
298913 Placental infarct 
216625 Placental infarction 
345549 Placental infection 
289651 Placental transfusion syndromes 
216634 Placentitis 
281316 
Polycythaemia due to maternal fetal 
transfusion 
216630 Polyhydramnios 
207648 Polyhydramnios and hydramnios 
207651 Polyhydramnios NOS 
262203 Polyhydramnios NOS 
207650 Polyhydramnios unspecified 
216631 
Polyhydramnios with antenatal 
problem 
207626 
Polyp of cervix complicating a/n care- 
baby not delivered 
225701 
Polyp of cervix in pregnancy, childbirth 
and the puerperium 
220416 POSSIBLE LABOUR 
278444 Post partum care 
225655 Post-term pregnancy - not delivered 
271425 Post-term pregnancy unspecified 
340107 Precipitate delivery 
216653 Precipitate labour unspecified 
298936 
Precipitate labour with antenatal 
problem 
265240 PRECONCEPTION ADVICE 
292753 
PRE-CONCEPTION COUNSELLING 
CLINIC 
265426 
PRE-CONCEPTION COUNSELLING 
CLINIC ATTEND 
298852 
Pre-eclampsia or eclampsia + pre-
existing hypertension NOS 
280462 
Pre-eclampsia or eclampsia with 
hypertension - not delivered 
207572 
Pre-eclampsia or eclampsia with 
hypertension + p/n comp 
262133 
Pre-eclampsia or eclampsia with 
hypertension unspecified 
207571 
Pre-eclampsia or eclampsia with pre-
existing hypertension 
225649 Pre-eclampsia, unspecified 
289608 
Pre-existing malnutrition-related 
diabetes mellitus 
204244 Preg. prescription exempt adv. 
204234 Preg. termination counselling 
237874 PREGNANCY 
309380 PREGNANCY 
275201 PREGNANCY ABNORMAL 
306825 PREGNANCY ABNORMAL 
238657 
PREGNANCY ACCIDENT 
AFFECTING BABY 
277083 Pregnancy advice 
340072 Pregnancy advice 
213258 Pregnancy advice NOS 
202344 PREGNANCY ALBUMINURIA 
204243 Pregnancy alcohol advice 
304480 PREGNANCY ANAEMIA 
238420 
PREGNANCY ANAEMIA 
HYPOCHROMIC 
247601 
PREGNANCY ANAEMIA 
MEGALOBLASTIC 
234781 Pregnancy and drug dependence 
283680 
PREGNANCY ANTENATAL CARE 
NORMAL 
257775 Pregnancy benefit NOS 
203250 Pregnancy benefits 
211355 PREGNANCY BICORNATE UTERUS 
256840 PREGNANCY BLEEDING 
304477 PREGNANCY BLEEDING 
265463 
PREGNANCY BOOKING 
CONSULTATION 
293436 
PREGNANCY BP RAISED AT END 
OF 
240216 Pregnancy care 
339709 Pregnancy care 
280472 Pregnancy care of habitual aborter 
306823 PREGNANCY COMPLICATION 
216569 Pregnancy complication NOS 
262122 Pregnancy complications 
231248 Pregnancy confirmed 
275203 PREGNANCY CYSTITIS 
202645 PREGNANCY DELUSIONS 
258799 Pregnancy dental advice 
201997 PREGNANCY DEPRESSION 
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202339 PREGNANCY DISPROPORTION 
304489 PREGNANCY ECLAMPSIA 
304475 PREGNANCY ECTOPIC 
274597 
PREGNANCY EXAMINATION 
NORMAL 
240393 Pregnancy exercise advice 
306215 PREGNANCY FEAR 
304474 PREGNANCY GENITAL INFECTION 
306828 PREGNANCY GLYCOSURIA 
220414 PREGNANCY HAEMORRHAGE 
210605 PREGNANCY HIGH RISK 
247611 PREGNANCY HYPEREMESIS 
306829 PREGNANCY HYPEREMESIS 
304488 PREGNANCY HYPERTENSION 
243791 
Pregnancy induced 
oedema+proteinuria without 
hypertension 
304486 PREGNANCY INFECTION DURING 
304479 
PREGNANCY IRON-DEFICIENCY 
ANAEMIA 
229503 
PREGNANCY MACROCYTIC 
ANAEMIA 
238421 
PREGNANCY MALPOSITION 
FOETUS 
229506 PREGNANCY MILK LEG 
304492 PREGNANCY MORNING SICKNESS 
202338 PREGNANCY MULTIPLE 
304494 PREGNANCY NAUSEA 
293437 PREGNANCY NAUSEA & VOMITING 
211357 PREGNANCY NEPHRITIS 
237875 PREGNANCY NORMAL 
309381 PREGNANCY NORMAL 
340845 Pregnancy observations 
274493 PREGNANCY OPERATION DURING 
286994 Pregnancy operations 
265387 PREGNANCY OUT OF WEDLOCK 
284333 
PREGNANCY PELVIS BONY 
ABNORMAL 
293028 PREGNANCY PHANTOM 
247607 PREGNANCY PHLEBITIS 
266077 
PREGNANCY 
PHLEBOTHROMBOSIS 
220413 PREGNANCY PLACENTA PRAEVIA 
265237 PREGNANCY PLANNED 
304487 PREGNANCY PRE-ECLAMPSIA 
265461 PREGNANCY PRENATAL CARE 
302170 
PREGNANCY PRENATAL CARE 
NORMAL 
309484 Pregnancy problem 
204098 Pregnancy prolonged - 41 weeks 
278426 Pregnancy prophylactic therapy 
302169 
PREGNANCY PROPHYLACTIC 
THERAPY PRESCRIBE 
298862 Pregnancy pruritus 
309657 Pregnancy review 
249594 Pregnancy smoking advice 
265241 PREGNANCY SYMPTOMS 
283361 PREGNANCY TEST 
210514 PREGNANCY TEST DONE 
237550 PREGNANCY TEST NEGATIVE 
246719 PREGNANCY TEST POSITIVE 
265129 
PREGNANCY TEST SENT 
(AWAITING RESULT) 
219746 PREGNANCY UNMARRIED 
283455 PREGNANCY UNPLANNED 
295272 Pregnancy unplanned ? wanted 
246832 PREGNANCY UNWANTED 
269396 Pregnancy vitamin/iron prophyl 
202341 
PREGNANCY WEIGHT GAIN 
EXCESSIVE 
302061 PREGNANCY WITH I U D IN PLACE 
309459 Pregnancy with uncertain dates 
237790 
PREGNANCY/BIRTH 
EXTRAMARITAL 
283679 PREGNANT 
309382 PREGNANT 
204089 Pregnant - ? planned 
267896 Pregnant - blood test confirms 
222174 Pregnant - on abdom. palpation 
240217 Pregnant - on history 
267897 Pregnant - planned 
240218 Pregnant - unplanned - wanted 
295271 Pregnant - urine test confirms 
258649 Pregnant - V.E. confirms 
302683 Pregnant abdomen observation 
240219 Pregnant -unplanned-not wanted 
240212 Pregnant, diaphragm failure 
213085 Pregnant, IUD failure 
295264 Pregnant, sheath failure 
202340 
PREMATURE LABOUR 
UNDELIVERED 
289654 Premature rupture of membranes 
253004 
Premature rupture of membranes 
NOS 
216632 
Premature rupture of membranes 
unspecified 
207654 
Premature rupture of membranes with 
antenatal problem 
262206 
Premature rupture of membranes, 
labour delayed by therapy 
310057 Premature uterine contraction 
210745 
PRENATAL CARE NORMAL 
PREGNANCY 
292808 
PRENATAL CARE REGULARLY 
ATTENDED 
228930 PRENATAL EXAMINATION 
258794 Pre-pregnancy counselling 
333510 Presentation of pregnancy 
234853 Primary uterine inertia NOS 
225750 Primary uterine inertia unspecified 
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262223 
Primary uterine inertia with antenatal 
problem 
247604 PRIMIPARA OLD 
346695 Primiparous 
276943 Private home delivery booking 
302088 PROBLEM PREGNANCY 
237791 
PROBLEM PREGNANCY 
UNMARRIED 
219747 
PROBLEM UNMARRIED 
PREGNANCY 
234844 Problems affecting labour NOS 
216644 
Problems affecting labour NOS 
unspecified 
243838 
Problems affecting labour NOS with 
antenatal problem 
207676 Prolapse of cord NOS 
280550 
Prolapse of cord with antenatal 
problem 
271455 Prolapsed arm NOS 
298884 Prolapsed arm unspecified 
280504 Prolapsed arm with antenatal problem 
266078 PROLAPSED UTERUS PREGNANCY 
243834 
Prolonged artificial rupture of 
membranes 
271493 
Prolonged artificial rupture of 
membranes NOS 
298917 
Prolonged artificial rupture of 
membranes unspecified 
262208 
Prolonged artificial rupture of 
membranes with a/n problem 
207673 Prolonged first stage unspecified 
225754 
Prolonged first stage with antenatal 
problem 
225756 Prolonged labour NOS 
234860 Prolonged labour NOS 
271424 Prolonged or post-term pregnancy 
252936 Prolonged pregnancy NOS 
262227 Prolonged second stage NOS 
234859 
Prolonged second stage with 
antenatal problem 
262207 
Prolonged spont/unspec rupture of 
membranes unspecified 
298916 
Prolonged spont/unspec rupture of 
membranes with a/n problem 
207655 
Prolonged spontaneous or unspecified 
rupture of membranes 
216633 
Prolonged spontaneous/unspecified 
rupture of membranes NOS 
247032 
PROPHYLACTIC THERAPY 
PREGNANCY 
289578 Proteinuric hypertension of pregnancy 
238480 PRURITUS OF PREGNANCY 
225766 Pubic symphysis separation 
234906 
Puerperal cerebrovascular disorder 
unspecified 
216718 
Puerperal cerebrovascular disorder 
with antenatal comp 
238427 PUERPERAL CYSTITIS 
262272 Puerperal endometritis 
225783 Puerperal peritonitis unspecified 
225794 Puerperal pyrexia NOS 
207714 Puerperal septicaemia 
234889 Puerperal septicaemia NOS 
211356 PYELITIS PREGNANCY 
238426 PYELOCYSTITIS PREGNANCY 
289615 Quadruplet pregnancy 
225681 Quadruplet pregnancy NOS 
271449 Quadruplet pregnancy unspecified 
298881 
Quadruplet pregnancy with antenatal 
problem 
340083 Query viability of pregnancy 
249455 Quickening 
225732 Ragged membranes 
216626 Ragged placenta 
308511 Reactive CTG tracing 
278628 Reason for termination of pregnancy 
298894 Rectocele affecting obstetric care 
225699 
Rectocele complicating antenatal care 
- baby not delivered 
309477 Reduced amniotic fluid 
216627 Reduced fetal movements 
345789 Refer to early pregnancy unit 
296839 Refer to TOP counselling 
344603 Referral for termination of pregnancy 
205674 Referral to antenatal clinic 
278530 Referral to fertility clinic 
302417 Referral to midwife 
219551 REFERRED TO ANTENATAL CLINIC 
308408 Regular uterine contractions 
204993 Removal of Shirodkar suture 
271419 
Renal hypertension in 
preg/childbirth/puerp - not delivered 
207565 
Renal hypertension in 
pregnancy/childbirth/puerp unspecified 
333511 Reported conception - pregnancy 
255850 REPOSITIONING FOETUS 
259540 
Repositioning of retroverted gravid 
uterus 
219702 REQUESTS ABORTION 
260262 Requests pregnancy termination 
280537 
Retained intrauterine contraceptive 
device in pregnancy 
289719 
Retracted nipple in 
pregnancy/puerperium/lact with a/n 
comp 
298893 Retroverted incarcerated gravid uterus 
225698 
Retroverted incarcerated gravid uterus 
NOS 
289629 
Retroverted incarcerated gravid uterus 
unspecified 
289630 
Retroverted incarcerated gravid uterus 
with antenatal prob 
213106 Rh - 6/12 after anti-D sample 
240237 Rh - random, non-preg. sample 
240236 Rh screen - 1st preg. sample 
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213105 Rh screen - 2nd preg. sample 
276948 Rh screen - 3rd preg. sample 
219680 RHESUS ANTI-D GIVEN 
238424 
RHESUS INCOMPATIBILITY 
PREGNANCY/PUERPER 
216616 Rhesus isoimmunisation 
216618 Rhesus isoimmunisation NOS 
280530 Rhesus isoimmunisation unspecified 
216617 
Rhesus isoimmunisation with 
antenatal problem 
252987 Rigid perineum affecting obstetric care 
207631 
Rigid perineum in 
pregnancy/childbirth/puerperium NOS 
262173 Risk factors in pregnancy 
298923 Risk factors in pregnancy NOS 
339605 ROM - Ruptured membranes 
309697 Routine antenatal care 
302151 
RUBELLA CONTACT IN EARLY 
PREGNANCY 
237854 
RUBELLA CONTACT IN 
PREGNANCY 
271433 Rubella contact in pregnancy 
240241 Rubella screen 
295292 Rubella screen - blood sent 
213112 Rubella screen NOS 
258661 Rubella screen not offered 
240242 Rubella screen not wanted 
213111 Rubella screen offered 
231256 Rubella screen wanted 
276950 Rubella status not known 
216668 Rupture of uterus before labour NOS 
243852 
Rupture of uterus before labour with 
antenatal problem 
234867 
Rupture of uterus during and after 
labour unspecified 
333484 Ruptured membranes 
207691 Ruptured uterus before labour 
268719 Sampling of chorionic villus NEC 
219785 SCREENING BABY ABNORMAL 
292758 
SCREENING BABY EXAMINATION 
NORMAL 
262225 Secondary uterine inertia NOS 
262224 Secondary uterine inertia unspecified 
234854 
Secondary uterine inertia with 
antenatal problem 
232952 Seen in antenatal clinic 
292542 SEEN IN ANTENATAL CLINIC 
271469 Septate vagina affecting obstetric care 
243818 
Septate vagina complicating a/n care- 
baby not yet delivered 
225704 
Septate vagina in pregnancy, 
childbirth and the puerperium 
225708 
Septate vagina in 
pregnancy/childbirth/puerperium NOS 
262214 Septicaemia during labour 
216639 Septicaemia during labour unspecified 
298920 
Septicaemia during labour with 
antenatal problem 
267565 Serum pregnancy test (B-HCG) 
212739 Serum pregnancy test equivocal 
258309 Serum pregnancy test negative 
285773 Serum pregnancy test NOS 
267566 Serum pregnancy test positive 
262131 Severe pre-eclampsia 
243778 Severe pre-eclampsia NOS 
271420 Severe pre-eclampsia unspecified 
296091 Shirodkar suture in pregnancy 
216659 Short cord NOS 
243845 Short cord unspecified 
207682 Short cord with antenatal problem 
286089 Short stay delivery booking 
234850 Shoulder dystocia 
207666 Shoulder dystocia NOS 
304491 SICKNESS PREGNANCY 
340681 Single pregnancy 
346734 Sinusoidal pattern of fetal heart 
272237 Slow fetal growth and fetal malnutrition 
229507 SMALL FOR DATES (FOETUS) 
271485 Small-for-dates fetus in pregnancy 
207645 Small-for-dates NOS 
234832 Small-for-dates unspecified 
207644 Small-for-dates with antenatal problem 
280571 
Spinal+epidural anaesthesia-inducd 
headache during pregnancy 
342596 
Spontaneous forewater rupture of 
membranes 
341616 
Spontaneous hindwater rupture of 
membranes 
222183 Spontaneous membrane rupture 
253874 
Staphylococcal intra-amniotic infection 
NEC 
204097 Static weight gain pregnancy 
256844 STATIC WEIGHT GAIN PREGNANCY 
280520 
Stenosis of cervix complicating a/n 
care- baby not delivered 
216605 
Stenosis of cervix in 
pregnancy/childbirth/puerperium NOS 
298896 
Stenosis of vagina affecting obstetric 
care 
207627 
Stenosis of vagina complicating a/n 
care- baby not delivered 
225799 Stroke in the puerperium 
289699 
Superficial thrombophlebitis in 
preg/puerperium + a/n comp 
243886 
Superficial thrombophlebitis in 
pregnancy 
234894 
Superficial thrombophlebitis in 
pregnancy and puerperium NOS 
207717 
Superficial thrombophlebitis in 
pregnancy and the puerperium 
234893 
Superficial thrombophlebitis in the 
puerperium 
204995 Surgical induction of labour 
340715 Surrogate pregnancy 
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216611 Suspect cystic fibrosis fetus 
216610 Suspect fetal anencephaly 
289642 
Suspect fetal damage from maternal 
alcohol 
207635 
Suspect fetal damage from maternal 
toxoplasmosis 
271474 Suspect fetal hydrocephaly 
225710 Suspect fetal spina bifida 
225712 Suspect mongol fetus 
207646 Suspected macroscopic fetus 
225767 Symphysis pubis separation 
202345 
SYNDROME NEPHROTIC 
PREGNANCY 
235629 
Syndrome of infant of mother with 
gestational diabetes 
259543 Syntocinon induction of labour 
225763 Tear of cervix - obstetric 
344157 Technically poor CTG 
221281 Teenage pregnancy 
333577 Teenage pregnancy 
222291 Termination counselling 
229509 
TERMINATION OF PREGNANCY 
REQUESTED 
304497 
TERMINATION OF PREGNANCY 
REQUESTED 
241127 
Therapeutic endoscopic operations on 
fetus 
204989 Therapeutic fetoscopic operation NOS 
250295 
Therapeutic fetoscopic operations on 
fetus 
259536 
Therapeutic foetoscopic operations on 
fetus 
241129 
Therapeutic percutaneous operation 
on fetus NOS 
204991 
Therapeutic percutaneous operations 
on fetus 
216704 
Thombophlebitis of legs in the 
puerperium 
280452 Threatened Abortion 
271411 Threatened abortion - not delivered 
243768 Threatened abortion NOS 
289566 Threatened abortion unspecified 
304476 THREATENED MISCARRAGE 
216552 Threatened premature labour 
280467 
Threatened premature labour - not 
delivered 
216553 Threatened premature labour NOS 
243782 
Threatened premature labour 
unspecified 
289701 Thrombophlebitis of legs in pregnancy 
284340 THROMBOSIS PREGNANCY 
252955 
Thyroid dysfunction - unspec whether 
in pregnancy/puerperium 
298871 
Thyroid dysfunction in pregnancy - 
baby not yet delivered 
225671 
Thyroid dysfunction in 
pregnancy/childbirth/puerperium NOS 
268040 TOP counselling 
293434 TOXAEMIA PRE-ECLAMPTIC 
220417 TOXAEMIA PREGNANCY 
304490 TOXAEMIA PREGNANCY 
229738 
TOXAEMIA PREGNANCY 
AFFECTING FOETUS/NEWB 
262259 
Toxic reaction to local anaesthesia 
during pregnancy 
243776 Transient hypertension of pregnancy 
252928 Transient hypertension of pregnancy 
225648 
Transient hypertension of pregnancy - 
not delivered 
298849 
Transient hypertension of pregnancy 
NOS 
243775 
Transient hypertension of pregnancy 
unspecified 
234796 Transverse lie NOS 
234795 Transverse lie with antenatal problem 
344787 
Transversely enlarged pregnant 
abdomen 
204102 Triple test 
267910 Triple test not offered 
204104 Triple test not wanted 
302899 Triple test not wanted 
213123 Triple test offered 
222191 Triple test wanted 
216587 Triplet pregnancy 
306826 TRIPLET PREGNANCY 
280492 Triplet pregnancy NOS 
207607 Triplet pregnancy unspecified 
243800 
Triplet pregnancy with antenatal 
problem 
292592 TRYING TO CONCEIVE 
225696 
Tumour of uterine body affecting 
obstetric care 
234809 
Tumour of uterine body complicating 
a/n care, baby not deliv 
243812 
Tumour of uterine body in 
pregnancy/childbirth/puerperium 
280491 Twin pregnancy 
304484 TWIN PREGNANCY 
216586 Twin pregnancy NOS 
207606 Twin pregnancy unspecified 
225680 
Twin pregnancy with antenatal 
problem 
258604 Ultrasound in obstetric diagn. 
240181 Ultra-sound scan - obstetric 
216664 
Umbilical cord complications NOS with 
antenatal problem 
262230 
Umbilical cord complications NOS, 
unspecified 
302426 Umbilical cord problem 
208442 Umbilical sepsis NOS 
214774 
Unborn child at risk physi/ment 
abnormal serious handicap 
335961 Uncertain viability of pregnancy 
342386 Undiagnosed pregnancy 
213094 Unplanned pregnancy 
333578 Unplanned pregnancy 
345175 Unsatisfactory CTG tracing 
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262134 
Unspecified hypertension in 
preg/childb/puerp - not deliv 
207573 
Unspecified hypertension in 
preg/childb/puerp unspecified 
207659 
Unspecified maternal pyrexia during 
labour NOS 
298919 
Unspecified maternal pyrexia during 
labour with a/n problem 
225653 Unspecified pregnancy vomiting 
234765 
Unspecified pregnancy vomiting - not 
delivered 
262140 Unspecified pregnancy vomiting NOS 
289582 
Unspecified pregnancy vomiting 
unspecified 
225755 
Unspecified prolonged labour with 
antenatal problem 
234768 
Unspecified renal disease in 
pregnancy 
280470 
Unspecified renal disease in 
pregnancy - not delivered 
207581 
Unspecified renal disease in 
pregnancy unspecified 
207609 Unstable lie NOS 
271453 Unstable lie with antenatal problem 
276071 Unwanted pregnancy 
341410 Unwanted pregnancy 
252941 
Uraemia in pregnancy without 
hypertension 
229508 URINARY INFECION PUERPERIUM 
202343 URINARY INFECTION PREGNANCY 
298860 
Urinary tract infection complicating 
pregnancy 
258377 Urine pregnancy test 
230992 Urine pregnancy test equivocal 
276693 Urine pregnancy test negative 
249219 Urine pregnancy test NOS 
258378 Urine pregnancy test positive 
267650 Urine pregnancy test requested 
222139 U-S obstetric diagn. scan NOS 
286053 U-S obstetric scan abnormal 
231213 U-S obstetric scan normal 
295236 U-S obstetric scan requested 
222138 U-S scan - fetal abnormality 
204044 U-S scan - fetal cephalometry 
204045 U-S scan - fetal maturity 
204046 U-S scan - fetal presentation 
258605 U-S scan - multiple fetus 
213053 U-S scan - obstetric, diagn. 
222137 U-S scan -placental localisatn 
342048 Uterine contractions ceased 
308146 Uterine contractions present 
225697 Uterine fibroid affecting obstetric care 
234810 
Uterine fibroid complicating a/n care, 
baby not delivered 
216597 
Uterine fibroids in pregnancy, 
childbirth and the puerperium 
207620 
Uterine operation scar in 
pregnancy/childb/puerp + a/n prob 
234813 
Uterine operation scar in 
pregnancy/childbirth/puerp NOS 
216656 Uterine or cervical spasm 
271427 
UTI - urinary tract infection in 
pregnancy 
276956 Vaginal "show" 
249457 Vaginal "show" - A/N 
225705 
Vaginal abnormality affecting obstetric 
care 
298898 
Vaginal abnormality complicating a/n 
care-baby not delivered 
262276 Vaginal varices in pregnancy 
275198 VAGINITIS PREGNANCY 
309200 Variable strength uterine contractions 
207715 Varicose veins of legs in pregnancy 
298980 
Varicose veins of legs in 
pregnancy/puerperium + a/n comp 
229505 VARICOSE VEINS PREGNANCY 
284341 
VARIX COMPLICATING 
PREGNANCY 
216660 Vasa praevia NOS 
262229 Vasa praevia unspecified 
289676 Vasa praevia with antenatal problem 
216661 Vascular lesions of cord unspecified 
253028 
Vascular lesions of cord with antenatal 
problem 
234863 Velamentous insertion of cord 
225793 
Venous complication in the 
puerperium, unspecified 
216711 
Venous complication of pregnancy 
and puerperium NOS 
271550 
Venous complication 
pregnancy/puerperium NOS + a/n 
comp 
204047 Viability US scan 
333483 Viable pregnancy 
216575 
Viral hepatitis comp pregnancy, 
childbirth & the puerperium 
278427 Vitamin supplement - pregnancy 
284343 
VOMITING PERNICIOUS 
PREGNANCY 
275204 VOMITING PREGNANCY 
304493 VOMITING PREGNANCY 
262194 
Vulval abn complicating a/n care - 
baby not yet delivered 
234819 
Vulval abnormality affecting obstetric 
care 
207629 
Vulval abnormality in 
pregnancy/childbirth/puerperium NOS 
225785 Vulval obstetric varicose veins 
234892 Vulval varices in pregnancy 
207716 
VV's of perineum/vulva in 
pregnancy/puerperium + a/n comp 
234891 
VV's of perineum/vulva in 
pregnancy/puerperium unspecified 
340082 Wanted pregnancy 
308760 Waters broken 
302312 Weeks pregnant 
274465 WIFE PREGNANT 
204051 U-S abdominal scan 
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219469 ULTRASOUND SCAN ABNORMAL 
228576 ULTRASOUND SCAN 
240181 Ultra-sound scan - obstetric 
246703 ULTRASOUND SCAN ABDOMEN 
249419 Ultrasound scan normal 
258604 Ultrasound in obstetric diagn. 
258616 Ultrasound scan 
276910 Ultrasound scan abnormal 
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Appendix E: End-Of-Pregnancy Event 
Codes 
 
GPRD 
Medical 
Codes GP Medical Term 
208471 Stillbirth NEC 
226530 Fetal death due to prelabour anoxia 
226583 [X]Macerated stillbirth 
235647 [X] stillbirth 
235648 [X]Fresh stillbirth 
238662 Asphyxia birth 
238671 Stillbirth 
251108 Medical cert. Of still-birth 
253055 Obstetric death of unspecified cause 
255703 [V]stillbirth 
258675 Single stillbirth 
263003 Fetal death due to labour anoxia 
271483 Fetal death in utero 
289647 Intrauterine death - delivered 
301620 [V]Single stillbirth 
305048 Stillbirth 
274060 [V]Twin, mate stillborn 
210202 [V]Twin, born in hospital, mate stillborn 
219255 [V]Twins, both stillborn 
219256 [V]Other multiple birth, all stillborn 
219262 [V]Twin, not hospitalised, mate stillborn 
219264 
[V]Other multiple birth,born before 
hospital,mates stillborn 
237317 [V]Twin, mate stillborn, NOS 
237319 [V]Other multiple birth, mates stillborn, NOS 
237320 
[V]Other multiple birth, born in hospital, mates 
live+still 
237321 
[V]Other multiple birth, not hospitalised, 
mates live+still 
246591 [X]Other multiple births, all stillborn 
264883 [V]Other multiple birth, mates stillborn 
274062 
[V]Other multiple birth, not hospitalised, 
mates stillborn 
274600 Twin mate stillborn 
283114 [V]Twins, one live born and one stillborn 
283122 
[V]Twin, born before admission to hospital, 
mate stillborn 
283125 
[V]Other multiple birth, born in hospital, mates 
stillborn 
283126 
[V]Other multiple birth, mates live and 
stillborn NOS 
286114 Twins - both still born 
295302 Twins - 1 still + 1 live born 
301623 
[V]Other multiple birth, mates live and 
stillborn 
301624 
[V]Other multiple birth, before hospital, mates 
live+still 
207608 Multiple delivery, all spontaneous 
207667 Locked twins 
211613 Twin conjoined 
213126 1 male + 1 female baby 
213127 2 male + 1 female babies 
213142 Heterozygous twin 
216594 Conjoined twins causing disproportion 
220428 Twins non identical delivered 
222192 Triplet birth 
225743 Locked twins with antenatal problem 
225744 Locked twins NOS 
228933 Twin 
228934 Twin (non identical) 
231268 Twin birth 
231269 Triplets - all live born 
234789 
Multiple delivery, all by forceps and vacuum 
extractor 
237881 Twin (identical) 
240262 2 male babies 
240275 Monozygous twin 
243799 Twin pregnancy - delivered 
252963 Multiple delivery, all by caesarean section 
253022 Delayed delivery second twin unspecified 
255704 [V]Twins, both live born 
258676 Twins - both live born 
258679 2 female babies 
267915 3 male babies 
271450 Multiple pregnancy NOS - delivered 
271502 Locked twins unspecified 
274057 [V]Other multiple birth, all live born 
276965 3 female babies 
286126 One of twins 
295304 1 male + 2 female babies 
301822 Separation conjoined twins 
304518 Twin pregnancy delivery 
304519 Twins identical delivered 
305031 Twin low birthweight 
307984 Multiple birth 
340435 Undiagnosed twin 
342218 Monozygotic twins 
342903 Dizygotic twins 
343265 DZ - Dizygotic twins 
202348 Delivery antepartum haemorrhage 
202350 Labour difficult atony uterus 
202351 Perineal laceration at delivery 
202352 Pregnancy complicated delivery 
204106 Birth details 
204110 Baby BW = 3% - 9% (2500-2849g) 
204113 Apgar at 10 minutes = 8 
204116 Labour details 
204117 Normal labour 
204997 Low forceps cephalic delivery 
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204998 
Kielland forceps cephalic delivery with 
rotation 
205000 Episiotomy to facilitate delivery 
205001 Induction and delivery operations NOS 
205002 Normal delivery of placenta 
205003 Other operation on delivered uterus NOS 
207569 Eclampsia in labour 
207592 
Diabetes mellitus during pregnancy - baby 
delivered 
207622 
Rectocele - delivered with postpartum 
complication 
207623 
Rectocele complicating postpartum care - 
baby delivered prev 
207634 
Fetus with central nervous system 
malformation - delivered 
207669 Other failed forceps - delivered 
207674 Prolonged second stage - delivered 
207684 Umbilical cord complications NOS - delivered 
207685 
First degree perineal tear during delivery with 
p/n problem 
207686 Labial tear during delivery 
207687 
First degree perineal tear during delivery 
NOS 
207688 
Second degree perineal tear during delivery 
NOS 
207689 
Fourth degree perineal tear during delivery 
with p/n problem 
207707 
Spinal/epidural anesth-induced headache dur 
labour/delivery 
207736 Obstetric nonpurulent mastitis - delivered 
207754 
[X]Infection of caesarian section wound 
following delivery 
208431 Scalp injuries due to birth trauma 
208432 Caput succedaneum due to birth trauma 
208433 
Other specified scalp injury due to birth 
trauma 
208434 Fracture of radius or ulna due to birth trauma 
208437 Subcutaneous fat necrosis due to birth injury 
208438 Birth injury NOS 
210352 Ventouse extraction delivery (baby) 
210713 Newborn infant examination- normal 
211363 Placenta praevia delivered 
211368 Delivery bicornate uterus 
211369 Laceration perineal at delivery slight 
211371 Delivery sudden death  (mother) 
213130 Birthweight of baby 
213131 Baby BW = 10%-24% (2850-3149g) 
213132 Baby BW = 90%-96% (4050-4399g) 
213136 Birth length 
213139 Apgar at 1 minute = 3 
213140 Apgar at 1 minute = 7 
213141 Apgar at 1 minute = 10 
213145 Birth details not known 
213162 Baby normal at birth 
213162 Baby normal at birth 
213969 
Lower uterine segment caesarean section 
(LSCS) NEC 
213970 Extraperitoneal caesarean section 
213971 Other specified other breech delivery 
213972 Normal delivery 
213973 Other method of delivery NOS 
213974 Other obstetric operations 
216536 
Placenta praevia with haemorrhage - 
delivered 
216541 
Renal hypertension in 
pregnancy/childbirth/puerp - delivered 
216546 
Unspecified hypertension in preg/childb/puerp 
- delivered 
216550 Late pregnancy vomiting - delivered 
216580 
Drug dependence during pregnancy - baby 
delivered 
216588 Cephalic version NOS - delivered 
216620 
Labour+delivery complicatd by biochem 
evidence/fetal stress 
216622 Small-for-dates - delivered 
216623 Large-for-dates - delivered 
216642 
Vaginal delivery following previous caesarean 
section 
216647 
Obstructed labour due to pelvic inlet 
contraction 
216652 Other uterine inertia - delivered 
216666 
First degree perineal tear during delivery - 
delivered 
216693 Ventouse delivery 
216694 Breech extraction 
216697 
Other complications of labour and delivery 
with p/n problem 
216700 Complications of labour and delivery NOS 
216707 
Haemorrhoids in pregnancy and puerperium - 
deliv + p/n comp 
217392 Birth trauma 
217393 Tentorial tear due to birth trauma 
217395 Fracture of clavicle due to birth trauma 
217397 Other fractures due to birth trauma 
217398 Other birth fracture 
217399 Birth fracture of radius 
217400 Fracture due to birth trauma NEC 
217401 Fracture of nose due to birth trauma 
217406 Liveborn with prelabour fetal distress 
217408 Liveborn with labour fetal distress 
217409 Liveborn with labour abnormal heart beat 
219388 Delivery assisted breech 
219689 Child born 
219722 Labour induction nonsurgical 
219798 Newborn clinic attendance 
220420 Normal labour 
220423 Placenta abruptio complicating delivery 
220425 Disproportion at delivery 
220659 Domiciliary confinement (baby) 
220666 Low apgar rating 
222193 Outcome of delivery NOS 
222194 Birth of child 
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222195 Male baby 
222197 Baby maturity NOS 
222198 Baby BW = 50%-74% (3450-3749g) 
222199 Baby BW = 75%-89% (3750-4049g) 
222200 Apgar at 1 minute = 9 
222201 Apgar at 5 minutes 
222202 Apgar at 5 minutes NOS 
222206 Apgar at 10 minutes = 6 
222976 Spontaneous breech delivery 
222977 High forceps cephalic delivery with rotation 
222978 Vacuum delivery 
222979 Trial of vacuum delivery 
222981 Water birth delivery 
223676 
Discharged from hospital within 6 hours of 
delivery 
223710 FP58 - newborn registration 
225638 Placental abruption - delivered 
225650 Severe pre-eclampsia - delivered 
225661 Liver disorder in pregnancy - delivered 
225679 Spontaneous vaginal delivery 
225687 Brow presentation - delivered 
225692 Mixed feto-pelvic disproportion - delivered 
225733 Failed mechanical induction 
225734 Failed medical induction of labour 
225736 Obstructed labour due to breech presentation 
225738 
Obstructed labour due to generally contracted 
pelvis 
225742 Shoulder dystocia - delivered 
225746 Failed forceps unspecified 
225748 Failed ventouse extraction NOS 
225759 Vulval tear during delivery 
225760 
Third degree perineal tear during delivery - 
delivered 
225762 
Unspecified perineal laceration during 
delivery 
225780 
Caesarean delivery following previous 
Caesarean delivery 
225782 
Puerperal endometritis - delivered with 
postnatal comp 
225811 
Galactorrhoea in pregnancy and the 
puerperium - delivered 
225816 [X]Other and unspecified forceps delivery 
226513 
Fetus or neonate affected by vacuum 
extraction delivery 
226519 Low birthweight 
226521 Birth trauma, asphyxia and hypoxia 
226523 Scalp abrasions due to birth trauma 
226525 Fracture of humerus due to birth trauma 
226527 Birth injury to phrenic nerve 
226528 Phrenic nerve palsy in newborn 
226529 Cerebral oedema due to birth injury 
228333 [V]Birth - type 
228334 [V]Single live birth 
228476 High foetal forceps delivery 
228477 Rotation foetal head forceps 
229515 Labour difficult 
229517 Delivery obstetric trauma 
229746 Infant condition normal 
231267 Born before arrival 
231273 Birthweight 
231274 Weight - baby 
231279 Apgar at 10 minutes = 10 
231294 Birth exam. Abnormal -referred 
232120 Other induction of labour 
232121 Other caesarean delivery 
232123 
Manip cephalic vaginal deliv abnorm pres 
head without instrm 
232125 
Cephalic vagin deliv abnorm pres head 
without instrument OS 
232126 Other specified normal delivery 
232128 Symphysiotomy to facilitate delivery 
232130 
Other specified induction or delivery 
operations 
232131 
Instrumental removal products of concep 
delivered uterus OS 
234762 
Pre-eclampsia or eclampsia with 
hypertension - delivered 
234766 Early onset of delivery 
234773 Fatigue during pregnancy - delivered 
234794 Transverse lie - delivered 
234815 Rectocele - baby delivered 
234829 
Labour and delivery complicated by fetal 
heart rate anomaly 
234831 
Labour and delivery complic by meconium in 
amniotic fluid 
234842 
Unspecified maternal pyrexia during labour - 
delivered 
234851 Failed ventouse extraction unspecified 
234857 Abnormality of forces of labour NOS 
234864 
First degree perineal tear during delivery, 
unspecified 
234865 
Vulval and perineal haematoma during 
delivery 
234866 
Other vulval and perineal trauma during 
delivery 
234876 
Other immediate postpartum haemorrhage 
NOS 
234877 
Retained placenta or membranes with no 
haemorrhage NOS 
234879 
CNS comps of anaesthesia during labour and 
delivery 
234882 Simpson's forceps delivery 
234883 Forceps delivery - delivered 
234884 Low forceps delivery 
234885 Caesarean delivery unspecified 
234886 
Other complications of labour and delivery 
NOS 
234905 
Obstetric pulmonary embolism NOS with 
postnatal complication 
234914 
Breast engorgement in 
pregnancy/puerperium/lact + p/n comp 
234930 
[X]Labour+delivery complicat/oth evidence of 
fetal distress 
235589 Fetus or neonate affected by breech delivery 
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and extraction 
235590 
Fetus/neonate affect persistent occip-
posterior - labour/del 
235596 
Fetus/neonate affected by complic 
labour/delivery NOS 
235601 
Subdural haemorrhage unspecified, due to 
birth trauma 
235602 Scalpel wound due to birth trauma 
235603 Birth injury to face 
235606 Labour fetal anoxia 
235608 Liveborn with unspecified fetal distress NOS 
237450 Forceps extraction high 
237451 Forceps extraction midcavity with episio 
238434 Delivery after antepartum haemorrhage 
238437 Delivery abnormal bony pelvis 
238438 Foetopelvic disproportion complicating d 
238439 Brow presentation 
238441 Delay 2nd stage (labour) 
238442 Laceration perineal at delivery extensiv 
238659 Trauma birth 
238664 Infant condition- required resusitation 
238665 Infant condition- apgar score 
238666 Face presentation birth (baby) 
240261 Sex of baby 
240263 Baby full term maturity 
240266 Birth head circumference 
240267 Birth HC = < 3rd centile 
240269 Apgar at 1 minute = 2 
240270 Apgar at 1 minute = 5 
240271 Apgar at 5 minutes = 2 
240272 Apgar at 5 minutes = 10 
240273 Apgar at 10 minutes = 5 
241135 Other specified other induction of labour 
241136 
Elective upper uterine segment caesarean 
delivery 
241137 Failed forceps delivery 
241138 Repositioning of inverted delivered uterus 
241139 
Instrumental exploration of delivered uterus 
NEC 
243783 Early onset of delivery NOS 
243784 
Genitourinary tract infection in pregnancy - 
delivered 
243796 Anaemia during pregnancy - baby delivered 
243811 Bicornuate uterus - baby delivered 
243817 Other cervical abnormality - baby delivered 
243822 
Fetus with chromosomal abnormality - 
delivered 
243830 Fetal distress - delivered 
243836 Failed medical or unspecified induction NOS 
243849 
Third degree perineal tear during delivery, 
unspecified 
243851 Vulval/perineal trauma during delivery NOS 
243859 
Secondary and delayed postpartum 
haemorrhage NOS 
243861 Retained placenta without haemorrhage 
243875 Breech extraction unspecified 
243876 Caesarean delivery - delivered 
243877 Delivery by elective caesarean section 
243878 Delivery by emergency caesarean section 
243879 Other complications of labour and delivery 
243908 
Other breast disorder in 
pregnancy/puerperium/lact +p/n comp 
244611 
Fetus/neonate affected by shoulder 
presentation - labour/del 
244612 
Fetus or neonate affected by caesarean 
section 
244618 Immature baby 
244621 
Subdural and cerebral haemorrhage due to 
birth trauma 
244623 Cephalhaematoma due to birth trauma 
244626 Toe injury NEC due to birth trauma 
244629 Liveborn with meconium liquor, unspecified 
246491 [V]Examination immediately after delivery 
246634 Ventous assisted delivery 
246635 Elective caesarian section 
247619 Placenta praevia noted at delivery 
247620 Presentation face delivery (mother) 
247865 Intracranial injury at birth 
247875 Delivery caesarian section (baby) 
249469 Full term baby 
249472 Birth HC = 90th-96th centile 
249474 Apgar at 1 minute = 0 
249475 Apgar at 5 minutes = 5 
250298 Other induction of labour NOS 
250299 Ventouse delivery 
250300 Vacuum delivery NOS 
250301 
Cephalic vaginal deliv abnorm presentation 
head - no instrum 
250302 Manually assisted vaginal delivery 
250303 
Drainage of hydrocephalus of fetus to 
facilitate delivery 
250304 Other specified other method of delivery 
250306 
Manual removal of placenta from delivered 
uterus 
250310 Monitoring during labour 
252931 
Unspecified hypertension in preg/childb/puerp 
-del +p/n comp 
252947 
Maternal syphilis during pregnancy - baby 
delivered 
252952 
Maternal rubella during pregnancy - baby 
delivered 
252956 Anaemia in the puerperium - baby delivered 
252966 Breech delivery 
252968 Brow presentation 
253003 Premature rupture of membranes - delivered 
253007 Problems affecting labour NOS 
253012 Obstructed labour caused by bony pelvis 
253014 
Persistent occipitopost/occipitoant position - 
delivered 
253015 Failed trial of labour unspecified 
253018 Obstructed labour NOS, unspecified 
- 276- 
 
253019 Primary uterine inertia 
253021 Precipitate labour 
253033 Vaginal tear during delivery 
253034 
Second degree perineal tear during delivery - 
delivered 
253036 
Unspecified perineal laceration during 
delivery NOS 
253042 Retained placenta NOS 
253048 
Other complications of labour and delivery 
NEC 
253050 Keilland's forceps delivery 
253051 Forceps delivery unspecified 
253052 Caesarean delivery NOS 
253078 
Other complications of the puerperium - 
delivered + p/n comp 
253080 Obstetric breast abscess - delivered 
253086 
Breast engorgement in 
pregnancy/puerperium/lactation - deliv 
253099 [X]Other specified assisted single delivery 
253101 [X]Cervicitis following delivery 
253833 
Fetus/neonate affected by face presentation 
during labour/de 
253834 
Fetus/neonate affected by maternal pethidine 
in labour/deliv 
253835 
Fetus/neonate affected by other maternal 
opiates in lab/del 
253840 Birth weight 1000-2499 g 
253845 Bruising of scalp due to birth injury 
253849 Eye damage due to birth trauma 
253853 Liveborn with birth asphyxia NOS 
255705 [V]Unspecified delivery outcome 
255851 Forceps extraction midcavity 
255852 Forceps delivery 
256848 Delivery contracted pelvis 
257126 Erb's palsy due birth injury 
258670 Born - place delivered 
258671 Ambulance birth 
258674 Outcome of delivery 
258678 Baby female 
258681 Birth HC = 50th-74th centile 
258683 Apgar at 1 minute = 4 
258684 Apgar at 1 minute = 6 
258685 Apgar at 5 minutes = 1 
258686 Apgar at 10 minutes = 9 
258687 Apgar at 10 minutes NOS 
258690 Birth details NOS 
258705 Child exam. - birth 
258706 Child not examined at birth 
258707 Child birth exam. - normal 
258708 Child exam. - birth NOS 
259534 Childbirth operations 
259544 Breech extraction delivery NOS 
259545 Other specified forceps cephalic delivery 
259546 Normal delivery NOS 
259547 Cleidotomy of fetus to facilitate delivery 
259548 Curettage of delivered uterus 
259549 
Manual removal retained products conception 
delivered uterus 
259550 
Manual removal products of conception 
delivered uterus NOS 
262180 Spontaneous breech delivery 
262183 Face presentation 
262189 Disproportion NOS - delivered 
262202 Polyhydramnios - delivered 
262213 Failed medical or unspecified induction 
262227 Prolonged second stage NOS 
262231 Vulval delivery trauma 
262232 Second degree perineal tear during delivery 
262233 Fourth degree perineal tear during delivery 
262234 
Fourth degree perineal tear during delivery - 
delivered 
262236 
Vulval and perineal haematoma during 
delivery - delivered 
262247 
Secondary postpartum haemorrhage 
unspecified 
262250 Retained membrane without haemorrhage 
262251 
Retained placenta with no haemorrhage 
unspecified 
262254 Retained placenta with no haemorrhage NOS 
262255 
Retained products with no haemorrhage 
unspecified 
262256 
Retained products with no haemorrhage - 
deliv with p/n prob 
262261 
Cardiac comps of anaesthesia during labour 
and delivery 
262265 Mid-cavity forceps delivery 
262266 
Delivery by combination of forceps and 
vacuum extractor 
262267 Forceps delivery NOS 
262308 
[X]Other infection of genital tract following 
delivery 
262991 Vacuum extraction chignon 
262994 Fracture of skull due to birth trauma 
262995 Spine or spinal cord injury due to birth trauma 
262997 Brachial plexus palsy due to birth trauma 
262998 
Brachial palsy unspecified, due to birth 
trauma 
263004 Fetal distress, unspecified when, liveborn 
263005 Anoxia in newborn NOS 
265026 Forceps extraction low 
265027 Rotation foetal head manually 
265028 Caesarean section classical upper segmen 
265029 Retained placenta manual removal 
266080 Delivery domicillary (mother) 
266081 Delivery gp unit (mother) 
266083 Shoulder presentation at delivery 
266085 Inertia uterus complicating delivery 
266086 Dystocia 
266090 Traumatic birth incident 
266091 Septicaemia puerperal 
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266330 Asphyxia newborn 
267916 Sex of baby NOS 
267917 Maturity of baby 
267918 Baby BW = 25%-49% (3150-3449g) 
267921 Birth length = < 3rd centile 
267922 Apgar at 1 minute = 8 
267923 Apgar at 10 minutes 
267924 Spontaneous onset of labour 
268721 Other specified elective caesarean delivery 
268724 Other breech delivery NOS 
268727 
Cephalic vagin deliv abnorm pres head 
without instrument NOS 
268728 Other methods of delivery 
268730 Other operations to facilitate delivery 
271417 Other antepartum haemorrhage - delivered 
271418 Antepartum haemorrhage NOS - delivered 
271447 Normal delivery in a completely normal case 
271456 Generally contracted pelvis - delivered 
271465 
Cystocele - delivered with postpartum 
complication 
271491 
Delay deliv after spontaneous or unsp rupture 
of membranes 
271504 Precipitate labour - delivered 
271506 Prolonged labour unspecified 
271507 Prolonged second stage 
271514 
Third degree perineal tear during delivery with 
p/n problem 
271515 
Vulval and perineal haematoma during 
delivery 
271518 
Rupture of uterus during and after labour - 
delivered 
271524 Third-stage postpartum haemorrhage 
271525 
Secondary postpartum haemorrhage with 
postnatal problem 
271538 Vacuum extractor delivery NOS 
271539 Caesarean delivery 
271542 
Other specified complications of labour or 
delivery 
271556 
Obstetric perineal wound disruption - deliv + 
p/n comp 
271571 Spontaneous vertex delivery 
271572 Spontaneous breech delivery 
271579 [X]Other single delivery by caesarean section 
272229 
Fetus/neonate affected by 
malposition/disproportion-delivery 
272230 
Fetus/neonate affected by disproportion 
during labour/delive 
272240 
Cerebral haemorrhage unspecified, due to 
birth trauma 
272241 Fracture of tibia or fibula due to birth trauma 
272242 Birth dislocation of the shoulder 
272243 Birth plexus inj - Erb-Duchenne 
272244 Birth plexus injury - Klumpke-Dejerine 
272246 Birth plexus injury - whole plexus 
272250 Torticollis due to birth injury 
272252 
Severe birth asphyxia - apgar score less than 
4 at 1 minute 
272253 
Mild to moderate birth asphyxia - apgar score 
4-7 at 1 min 
272254 Hypoxia in newborn NOS 
274059 [V]Twin, mate liveborn, NOS 
274201 Version internal (assisted delivery) 
274202 Forceps extraction low with episiotomy 
274203 Ventouse extraction delivery (mother) 
274204 Caesarian section lower segment 
274568 Newborn infant examination 
275209 Domiciliary confinement (mother) 
275211 Placenta praevia complicating delivery 
275212 Delivery accreta placenta 
275213 Malpresentation at delivery 
275217 Hydramnios at delivery 
275224 Postpartum haemorrhage delayed 
275225 Postnatal haemorrhage 
275469 Injury birth 
275472 Delivery domicillary (baby) 
275478 Normal apgar rating 
276962 Consultant unit birth 
276964 Single live birth 
276967 Baby BW = > 96% (over 4499g) 
276969 Birth head circumference NOS 
276971 Apgar at 5 minutes = 3 
276972 Apgar at 5 minutes = 6 
276973 Apgar at 5 minutes = 8 
276984 Birth exam. Abnormal -for obs. 
276984 Birth exam. Abnormal -for obs. 
277826 Elective caesarean delivery NOS 
277827 
Upper uterine segment caesarean delivery 
NEC 
277828 
Lower uterine segment caesarean delivery 
NEC 
277829 Breech extraction delivery 
277830 Other breech delivery 
277832 Forceps cephalic delivery NOS 
280459 
Mild or unspecified pre-eclampsia - delivered 
with p/n comp 
280461 Eclampsia - delivered 
280468 Early onset of delivery - delivered 
280475 
Other pregnancy complication - delivered with 
postnatal comp 
280490 
Normal delivery in completely normal case 
NOS 
280493 Assisted breech delivery 
280494 Breech presentation - delivered 
280497 Shoulder presentation 
280512 Uterine fibroid - baby delivered 
280538 
Complications occurring during labour and 
delivery 
280539 Obstructed labour 
280540 Shoulder dystocia with antenatal problem 
280544 Atony of uterus 
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280545 Poor contractions 
280547 Unspecified prolonged labour - delivered 
280556 First degree perineal tear during delivery 
280557 Fourchette tear during delivery 
280558 
Second degree perineal tear during delivery 
with p/n prob 
280559 Third degree perineal tear during delivery 
280561 
Unspecified perineal laceration during 
delivery + p/n prob 
280564 
Other vulval/perineal trauma during delivery + 
p/n problem 
280565 
Vulval/perineal trauma during delivery NOS 
unspec 
280574 Mid-cavity forceps with rotation 
280575 Vacuum extractor delivery - delivered 
280576 Breech extraction - delivered 
280577 Caesarean section - pregnancy at term 
280610 [X]Vaginitis following delivery 
281262 
Fetus/neonate affected-cephalopelvic 
disproportion lab./del. 
281263 Fetus or neonate affected by forceps delivery 
281267 Cerebral haematoma in fetus or newborn 
281271 Vulval haematoma due to birth trauma 
281273 Liveborn with fetal distress, unspecified 
281275 Liveborn with fetal hypoxia, unspecified 
281276 Birth asphyxia 
283113 [V]Outcome of delivery 
283261 Induction labour 
283262 Episiotomy 
283263 Delivery caesarian section (mother) 
284337 Pregnancy induction labour failed 
284342 Pyelocystitis puerperium 
284346 Pregnancy uncomplicated delivery 
284349 Obstructed labour 
284350 Laceration perineal at delivery third de 
284355 Puerperal coagulopathy 
284576 Immaturity at birth 
286108 Full term gestation - 40 weeks 
286109 GP unit birth 
286112 Livebirth 
286116 Delivery - sex of baby 
286117 Baby male 
286119 Apgar at 1 minute = 1 
286120 Apgar at 5 minutes = 4 
286121 Apgar at 5 minutes = 7 
286122 Apgar at 5 minutes = 9 
286123 Apgar at 10 minutes = 2 
286124 Apgar at 10 minutes = 3 
286125 Apgar at 10 minutes = 7 
287001 Induction and delivery operations 
287002 
Elective lower uterine segment caesarean 
section (LSCS) 
287003 Other specified other caesarean delivery 
287004 Other caesarean delivery NOS 
287005 Assisted breech delivery 
287006 Forceps cephalic delivery 
287007 Mid forceps cephalic delivery NEC 
289570 
Benign essential hypertension in 
preg/childb/puerp - deliv 
289592 Urinary tract infection following delivery 
289599 Other pregnancy complication - delivered 
289616 Multiple delivery 
289616 Multiple delivery 
289617 Breech presentation 
289619 Face presentation - delivered 
289632 Cystocele - baby delivered 
289633 
Cystocele complicating postpartum care - 
baby delivered prev 
289658 Maternal pyrexia during labour, unspecified 
289665 
Persistent occipitoposterior or occipitoanterior 
position 
289667 Other failed ventouse extraction - delivered 
289669 Abnormal forces of labour 
289670 Secondary uterine inertia 
289673 Long labour 
289674 Delayed delivery of second twin, triplet etc 
289679 
Second degree perineal tear during delivery, 
unspecified 
289680 
Unspecified perineal laceration during 
delivery, unspecified 
289681 
Other vulval/perineal trauma during delivery 
NOS 
289686 Postpartum haemorrhage NOS 
289687 Retained placenta with no haemorrhage 
289693 Forceps delivery 
289694 Delivery by caesarean hysterectomy 
290421 
Fetus or neonate affected by complication of 
labour/delivery 
290422 
Fetus or neonate affected by induction of 
labour 
290426 Brain injury due to birth trauma NOS 
290427 Cerebral injury due to birth trauma 
290431 Facial nerve palsy due to birth trauma 
290432 Peripheral nerve injury due to birth trauma 
290435 Birth trauma, asphyxia or hypoxia NOS 
292377 Forceps extraction high with episiotomy 
292378 Forceps delivery (mother) 
292379 Keillands delivery (mother) 
292381 Forceps failed 
293444 Malposition foetus complicating delivery 
293452 Puerperal mastitis 
295291 Rh screen - cord blood sample 
295303 Female baby 
295306 Baby BW = < 3% (under 2500g) 
295307 Apgar at 1 minute 
295312 Normal birth 
295313 Apgar normal 
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296093 Elective caesarian delivery 
296094 
Elective lower uterine segment caesarean 
delivery 
296095 High forceps cephalic delivery NEC 
296096 Mid forceps cephalic delivery with rotation 
296097 Trial of forceps delivery 
296098 Low vacuum delivery 
296100 Other operations on delivered uterus 
298847 
Transient hypertension of pregnancy - 
delivered 
298850 
Eclampsia - delivered with postnatal 
complication 
298855 Premature labour 
298867 
Other mat.infect/parasit dis in puerperium - 
baby delivered 
298879 
Normal delivery but ante- or post- natal 
conditions present 
298914 
Prem rupture of membranes onset of labour 
within 24 hours 
298915 
Prem rupture of membranes onset of labour 
after 24 hours 
298924 Obstructed labour due to fetal malposition 
298939 Prolonged first stage NOS 
298946 Trauma to perineum and vulva during delivery 
298948 
Third degree perineal tear during delivery 
NOS 
298949 
Vulval and perineal haematoma during 
delivery, unspecified 
298950 Vulval/perineal trauma during delivery NOS 
298954 Other immediate postpartum haemorrhage 
298956 
Secondary and delayed postpartum 
haemorrhage 
298962 
Acute renal failure following labour and 
delivery 
298966 Neville - Barnes forceps delivery 
298967 Vacuum extractor delivery 
298968 Breech extraction NOS 
298969 Complications of labour and delivery NOS 
298970 
Intrapartum haemorrhage with coagulation 
defect 
298996 
Obstetric breast abscess with postnatal 
complication 
298997 
Obstetric nonpurulent mastitis - deliv with p/n 
complication 
298998 
Obstetric nonpurulent mastitis with postnatal 
complication 
299018 [X]delivery 
299663 Fetus affected by breech delivery 
299667 
Fetus or neonate affected by transverse lie in 
labour/deliv 
299675 Intracranial haemorrhage in fetus or newborn 
299676 
Local subdural haematoma due to birth 
trauma 
299679 
Other dislocation or subluxation due to birth 
trauma 
299683 Sternomastoid injury due to birth injury 
299684 Fetal distress before labour - liveborn 
299686 Fetal distress in labour - liveborn 
301619 [V]Live birth 
301619 [V]Live birth 
302181 Twin mate liveborn 
302194 Normal delivery 
302219 Spontaneous vaginal delivery 
302225 
Delivered by caesarean section - pregnancy 
at term 
302261 Delivery normal 
302262 SVD - Spontaneous vaginal delivery 
302283 FTND - Full term normal delivery 
302446 Delivered by low forceps delivery 
302531 Spontaneous vertex delivery 
302558 Delivered by mid-cavity forceps delivery 
302675 Deliveries by spontaneous breech delivery 
302790 Delivery observations 
304485 Labour premature 
304508 Pregnancy normal delivery 
304509 Normal delivery (mother) 
304510 Labour premature normal delivery 
304511 Premature labour 
304512 Normal birth (confinement) 
304513 Delivery in hospital (mother) 
304515 Delivery breech 
304516 Delivery breech (mother) 
304517 Prolonged labour 
304520 Delivery delay in second stage 
304521 Ruptured uterus complicating delivery 
305032 Damage brain child congenital 
305036 Low birthweight 
305037 Normal baby 
305037 Normal baby 
305038 Normal baby delivered normally 
305038 Normal baby delivered normally 
305039 Breech birth (baby) 
305039 Breech birth (baby) 
305040 Caesarian section birth (baby) 
305040 Caesarian section birth (baby) 
305041 Caesarian section (baby) 
305041 Caesarian section (baby) 
305042 Forceps birth (baby) 
305042 Forceps birth (baby) 
305045 Normal birth (baby) 
305045 Normal birth (baby) 
306834 Labour 
306835 Svd (spontaneous vertex delivery) 
306836 Delivery no details 
306837 Placenta adherent complicating delivery 
306838 Retained placenta 
306839 Presentation breech (mother) 
306843 Overweight baby mother's record 
306844 Retained placenta fragments  puerperium 
307164 Baby normal at birth 
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307164 Baby normal at birth 
307168 Birth no details 
307170 Ventouse birth extraction (baby) 
307170 Ventouse birth extraction (baby) 
331975 Born by caesarean section 
341085 Born by emergency caesarean section 
237321 
[V]Other multiple birth, not hospitalised, 
mates live+still 
237320 
[V]Other multiple birth, born in hospital, mates 
live+still 
225737 Obstructed labour due to deformed pelvis 
225739 
Obstructed labour caused by pelvic soft 
tissues NOS 
243785 
Genitourinary tract infection in pregnancy - 
deliv +p/n comp 
204950 Hysterotomy and termination of pregnancy 
204953 Termination of pregnancy NEC 
204957 Introduction of abortifacient into uterine cavity 
205718 HSA1-therap. Abort. Green form 
207538 Termination of pregnancy 
207539 
Unspecified legal abortion + 
delayed/excessive haemorrhage 
207540 
Unspecified legal abortion with no mention of 
complication 
207541 Surgical abortion - incomplete 
207542 
Complete legal abortion + damage to pelvic 
organs or tissues 
207543 Complete legal abortion NOS 
207544 Unspecified illegal abortion with shock 
207545 Incomplete illegal abortion with metabolic 
disorder 
207546 
Unspecified abortion with other specified 
complication 
207547 Unspecified abortion complete 
207556 Readmission for retained produc of concept, 
illegal abortion 
207557 Failed medical abortion complic by genital 
tract/pelvic infn 
207558 Failed medical abortion comp by 
delayed/excessive haem'ge 
211359 Induced abortion legal 
211362 Incomplete abortion 
211373 Postabortion bleeding 
213967 Selective destruction of fetus NOS 
216517 Elective abortion 
216518 
Unspecified legal abortion with metabolic 
disorder 
216519 Incomplete legal abortion with shock 
216520 Incomplete legal abortion with embolism 
216521 
Complete legal abortion with other specified 
complication 
216522 Incomplete illegal abortion with complication 
NOS 
216523 Complete illegal abortion NOS 
216524 
Unspecified abortion with genital tract or 
pelvic infection 
216525 
Unspecified abortion with no mention of 
complication 
216526 
Unspecified complete abortion + pelvic 
organ/tissue damage 
216527 
Unspecified complete abortion + no mention 
of complication 
216733 [X]Failed medical abortion,wth 
other+unspcfied complications 
219389 Termination pregnancy caesarean section 
222972 Selective destruction of fetus 
225610 Tubal abortion 
225619 Legal abortion unspecified 
225620 
Incomplete legal abortion + genital tract/pelvic 
infection 
225621 
Incomplete legal abortion with no mention of 
complication 
225622 
Complete legal abortion with 
delayed/excessive haemorrhage 
225623 Illegal abortion unspecified 
225624 Unspecified illegal abortion with embolism 
225625 Incomplete illegal abortion + other specified 
complication 
225626 Complete illegal abortion + genital tract/pelvic 
infection 
225627 Complete illegal abortion with no mention of 
complication 
225628 Unspecified abortion with renal failure 
225629 Unspecified abortion with metabolic disorder 
225630 
Unspecified incomplete abortion +genital 
tract/pelvic infect 
225631 
Unspecified incomplete abortion + pelvic 
organ/tissue damage 
225632 Unspecified complete abortion with embolism 
229500 Tubal abortion 
229510 Top (termination of pregnancy) 
229511 Complete abortion 
229512 Complicated abortion 
232074 Vacuum termination of pregnancy 
232108 Feticide 
232109 Late selective feticide 
232110 Other specified selective destruction of fetus 
234733 Incomplete legal abortion with renal failure 
234734 
Incomplete legal abortion with metabolic 
disorder 
234735 
Incomplete legal abortion with complication 
NOS 
234736 Surgical abortion - complete 
234737 Complete legal abortion with shock 
234738 Unspecified illegal abortion with no mention of 
complication 
234739 Unspecified illegal abortion NOS 
234740 Illegal abortion incomplete 
234741 Incomplete illegal abortion with renal failure 
234742 Complete illegal abortion with renal failure 
234743 Complete illegal abortion with metabolic 
disorder 
234744 Complete illegal abortion with shock 
277789 Insertion of prostaglandin abortifacient 
pessary 
286971 Intraamniotic injection of abortifacient NEC 
296055 Introduction of abortifacient into uterine cavity 
OS 
255848 Top hysterotomy 
- 281- 
 
207532 Spontaneous abortion unspecified 
207533 
Complete spontaneous abortion + other 
specified complication 
207534 
Complete spontaneous abortion + no mention 
of complication 
207535 Inevitable miscarriage unspecified 
207536 
Unspecified inevitable miscarriage with 
unspec complication 
207537 Inevitable miscarriage incomp 
211361 Inevitable abortion 
216508 Unspecified spontaneous abortion with shock 
216509 
Unspecified spontaneous abortion with 
embolism 
216510 
Incomp spontaneous abortion + genital 
tract/pelvic infection 
216512 
Unspecified inevitable abortion with OS 
complication 
216514 
Incomplete inevitable abortion complicated by 
embolism 
216515 
Incomplete inevitable abortion with OS 
complication 
216516 Inevitable abortion complete 
225613 Incomplete spontaneous abortion NOS 
225614 
Complete spontaneous abortion + pelvic 
organ/tissue damage 
225615 
Unspec inevit abortion comp by delayed or 
excessive haemorr 
225616 
Unspecified inevitable abortion with unspec 
complication 
225617 
Incomplete inevitable miscarriage without 
complication 
225618 
Complete inevitable miscarriage without 
complication 
232075 
Dilation and curettage removal of missed 
abortion 
234726 
Unspecified spontaneous abortion with 
complication NOS 
234727 
Incomp spontaneous abortion + 
delayed/excessive haemorrhage 
234728 
Incomplete spontaneous abortion with 
complication NOS 
234729 
Complete spontaneous abortion with 
embolism 
234730 
Unspecified inevitable miscarriage 
complicated by embolism 
234732 
Complete inevitable miscarriage with 
unspecified comp 
234745 
Unspec incomplete abortion with other 
specified complication 
234746 
Failed attempted abortion with metabolic 
disorder 
234751 Readmis for retain products of concept, 
spontaneous abortion 
234752 Failed medical abortion, complicated by 
embolism 
234753 
Other specified pregnancy with abortive 
outcome 
234921 [X]Oth+unspc fail induc 
abortn,complict/delay/exces h'morrhg 
235646 Fetal death due to termination of pregnancy 
238429 Pregnancy terminated medical reasons 
243738 Pregnancy with abortive outcome 
243743 Spontaneous abortion with heavy bleeding 
243744 Unspecified spontaneous abortion NOS 
243745 Incomplete spontaneous abortion with shock 
243746 
Complete spontaneous abortion + genital 
tract/pelvic infect 
243747 
Complete spontaneous abortion with renal 
failure 
243748 
Incomplete inevitable abortion without 
complication 
243749 Therapeutic abortion 
243750 Unspecified legal abortion with renal failure 
243751 Unspecified illegal abortion with metabolic 
disorder 
243752 Unspecified illegal abortion with complication 
NOS 
243753 Incomplete illegal abortion + pelvic 
organ/tissue damage 
243754 Incomplete illegal abortion with shock 
243755 Illegal abortion complete 
243756 
Unspecified abortion with delayed or 
excessive haemorrhage 
243757 Unspecified abortion with embolism 
243758 Unspecified complete abortion NOS 
243759 Failed attempted abortion with embolism 
243760 
Failed attempted abortion with complication 
NOS 
246632 Termination pregnancy surgical induction 
246953 Termination refused pregnancy 
247603 Missed abortion 
247614 Abortion induced with complications 
252886 Spontaneous abortion 
252887 Miscarriage 
252888 
Incomplete spontaneous abortion + pelvic 
organ/tissue damage 
252889 
Incomp spontaneous abortion with no 
mention of complication 
252890 Complete spontaneous abortion NOS 
252891 Inevitable abortion unspecified 
252892 
Unspecified inevitable abortion complicated 
by embolism 
252893 Inevitable abortion incomplete 
252894 Incomplete inev mis comp by delayed or 
excessive haemorrhage 
252895 
Complete inevitable miscarriage complicated 
by embolism 
252896 Legally induced abortion 
252897 
Unspecified legal abortion with complication 
NOS 
252898 Medical abortion - complete 
252899 Complete legal abortion with embolism 
252900 Criminal abortion 
252901 Unspecified illegal abortion with renal failure 
252902 Incomplete illegal abortion with embolism 
252903 Unspecified abortion 
252904 
Unspecified complete abortion + genital 
tract/pelvic infect 
252905 
Unspecified complete abortion with renal 
failure 
252906 Unspecified abortion NOS 
252907 Failed attempted abortion 
252908 
Failed attempted abortion with no mention of 
complication 
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252909 Failed attempted abortion NOS 
253093 [X]Other abortion 
255854 Induction labour missed abortion 
256845 Induced abortion medical indication 
256846 Self-induced abortion 
259503 
Curettage of uterus for termination of 
pregnancy NEC 
259506 Suction termination of pregnancy 
260499 Abortive plague 
262095 Blighted ovum 
262098 Spontaneous abortion with sepsis 
262099 
Incomplete spontaneous abortion with 
metabolic disorder 
262100 
Incomp spontaneous abortion + other 
specified complication 
262102 
Unspecified inevitable miscarriage without 
complication 
262105 
Complete inevitable miscarriage with OS 
complication 
262106 Spontaneous abortion NOS 
262107 
Unspecified legal abortion with other specified 
complication 
262108 Legal abortion incomplete 
262109 
Complete legal abortion + genital tract or 
pelvic infection 
262110 
Complete legal abortion with no mention of 
complication 
262111 Legally induced abortion NOS 
262112 Illegally induced abortion 
262113 Incomplete illegal abortion + genital 
tract/pelvic infection 
262114 Unspecified abortion with complication NOS 
262115 
Unspecified incomplete abortion + no mention 
of complication 
262116 
Failed attempted abortion + damage to pelvic 
organs/tissues 
262117 Failed attempted abortion with renal failure 
262118 Failed attempted abortion with shock 
262119 
Failed attempted abortion with other specified 
complication 
262121 
Readmission for retained produc of concept, 
unspec abortion 
262123 Inevitable abortion 
265024 Abortion hysterotomy 
268687 
Dilation cervix uteri & curettage for 
termination pregnancy 
268688 
Curettage of uterus for termination of 
pregnancy NEC 
271380 Missed abortion 
271382 
Unspec spontaneous abortion + genital 
tract/pelvic infection 
271383 
Unspec spontaneous abortion + 
delayed/excessive haemorrhage 
271384 
Unspec spontaneous abortion + pelvic 
organ/tissue damage 
271385 
Unspec spontaneous abortion without 
mention of complication 
271386 Spontaneous abortion incomplete 
271387 Retained products after spontaneous abortion 
271388 
Complete spontaneous abortion 
+delayed/excessive haemorrhage 
271389 
Unspec inev miscarriage comp by genital 
tract pelvic infec 
271390 
Unspecified inevitable miscarriage with OS 
complication 
271391 
Incomplete inevitable miscarriage with 
unspecified comp 
271392 
Incomplete inevitable miscarriage with other 
specified comp 
271393 
Unspecified legal abortion + genital 
tract/pelvic infection 
271394 Unspecified legal abortion with shock 
271395 
Incomplete legal abortion + delayed or 
excessive haemorrhage 
271396 
Incomplete legal abortion + damage to pelvic 
organs/tissues 
271397 Incomplete legal abortion NOS 
271398 Complete legal abortion with renal failure 
271399 
Complete legal abortion with metabolic 
disorder 
271400 
Complete legal abortion with complication 
NOS 
271401 Incomplete illegal abortion NOS 
271402 Complete illegal abortion with other specified 
complication 
271403 Unspecified abortion NOS 
271404 
Unspecified incomplete abortion with 
embolism 
271405 Complications following 
abortion/ectopic/molar pregnancies 
271410 Failed attempted abortion 
274205 Abortion incomplete curettage 
274206 Uterus evacution (abortion) 
275206 Miscarriage 
280431 Inevitable miscarriage 
280432 
Unspec spontaneous abortion + other 
specified complication 
280433 
Unspecified inevitable abortion without 
complication 
280434 Complete inev abor comp by genital tract and 
pelvic infec 
280435 
Complete inevitable abortion with unspecified 
complication 
280436 
Complete inevitable abortion with OS 
complication 
280437 
Unspecified legal abortion + damage to pelvic 
organs/tissues 
280438 
Incomplete legal abortion with other specified 
complication 
280439 Unspec illegal abortion + delayed or 
excessive haemorrhage 
280440 Unspecified illegal abortion + pelvic 
organ/tissue damage 
280441 Complete illegal abortion with complication 
NOS 
280442 Unspecified abortion 
280443 
Unspecified incomplete abortion + 
delayed/excess haemorrhage 
280444 
Unspecified complete abortion 
+delayed/excessive haemorrhage 
280447 
Readmission for retained produc of concept, 
legal abortion 
280451 Pregnancy with abortive outcome NOS 
284344 Induced abortion social reasons 
286971 Intraamniotic injection of abortifacient NEC 
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289544 
Incomplete spontaneous abortion with renal 
failure 
289545 
Complete spontaneous abortion with 
metabolic disorder 
289547 
Incomplete inevitable abortion with 
unspecified complication 
289548 
Complete inevitable abortion complicated by 
embolism 
289549 
Complete inevitable abortion without 
complication 
289550 Unspecified legal abortion with embolism 
289551 Unspecified legal abortion NOS 
289552 Unspecified illegal abortion + other specified 
complication 
289553 Complete illegal abortion + delayed or 
excessive haemorrhage 
289554 Complete illegal abortion + pelvic 
organ/tissue damage 
289555 Illegally induced abortion NOS 
289556 Unspecified abortion with shock 
289557 
Unspecified incomplete abortion with 
metabolic disorder 
289558 Unspecified incomplete abortion with shock 
289559 
Unspecified incomplete abortion with 
complication NOS 
289560 Unspecified complete abortion with shock 
289561 
Unspecified complete abortion with 
complication NOS 
289562 Failed attempted abortion + delayed or 
excessive haemorrhage 
289726 [X]Oth+unspcf failed inducd abort,complct 
gen tract+pelv inf 
292376 Termination pregnancy intra-amniotic inj 
293430 Products of conception passed 
293439 Abortion induced social reasons unmarrie 
293440 Spontaneous abortion 
293441 Premature labour dead foetus under 28 we 
296054 Evacuation of contents of uterus NOS 
298808 
Unspecified spontaneous abortion with renal 
failure 
298809 
Unspecified spontaneous abortion with 
metabolic disorder 
298810 
Incomplete spontaneous abortion with 
embolism 
298811 Spontaneous abortion complete 
298812 Complete spontaneous abortion with shock 
298813 
Complete spontaneous abortion with 
complication NOS 
298814 Incom inev abor complicated by delayed or 
excessive haemorr 
298815 
Incomplete inevitable abortion complicated by 
embolism 
298816 Inevitable miscarriage complete 
298817 Medal abortion - incomplete 
298818 Legal abortion complete 
298819 Self-induced abortion 
298820 Unspec illegal abortion + genital tract or 
pelvic infection 
298821 Incomplete illegal abortion + 
delayed/excessive haemorrhage 
298822 Incomplete illegal abortion with no mention of 
complication 
298823 Complete illegal abortion with embolism 
298824 
Unspecified abortion with damage to pelvic 
organs or tissues 
298825 Unspecified abortion incomplete 
298826 
Unspecified incomplete abortion with renal 
failure 
298827 Unspecified incomplete abortion NOS 
298828 
Unspecified complete abortion with metabolic 
disorder 
298829 
Unspecified complete abortion + other 
specified complication 
298830 Failed attempted abortion + genital 
tract/pelvic infection 
298831 Complications following 
abortion/ectopic/molar pregnancies 
298839 Failed medical abortion, without complication 
299011 [X]Other+unspcf failed induced 
abortion,complicated/embolism 
301755 Vacuum aspiration abortion 
304482 Missed abortion 
304495 Therapeutic abortion 
304496 Termination pregnancy psychiatric reason 
304498 Top (termination of pregnancy) 
304499 Unmarried termination pregnancy 
304500 Induced abortion 
304501 Spontaneous abortion 
304502 Miscarriage 
304503 Inevitable abortion 
304504 Incomplete abortion 
304505 Abortion 
304506 Complete abortion 
304507 Rpc (retained products conception) 
306824 Blighted ovum 
333094 Post miscarriage counselling 
344647 Missed miscarriage 
204107 Baby premature 36-38 weeks 
207578 Premature delivery 
213128 Premature baby 
213129 Baby extremely prem.28-32 week 
222196 Postmature baby 
226518 
Short gestation and unspecified low 
birthweight problems 
231271 Baby premature 26-28 weeks 
244647 Preterm delivery associated jaundice 
253841 Premature infant 28-37 weeks 
253842 Born premature NOS 
266082 Delivery premature in hospital/maternity 
272238 Extreme prematurity - less than 28 weeks 
275210 Delivery premature outside hospital 
276966 Baby post-mature 
284352 Labour premature with complications 
284576 Immaturity at birth 
295305 Baby v. Premature 32-36 weeks 
298856 Post-term pregnancy - delivered 
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299671 Baby born premature 
299672 
Very premature - less than 1000g or less than 
28 weeks 
299673 
Premature - weight 1000g-2499g or gestation 
of 28-37weeks 
304522 Premature delivery  (mother) 
305034 Premature baby 
305035 Premature delivery  (child) 
307162 Prematurity (newborn) 
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